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Abstract
Chapter 1
A procedure for forming a highly active Pd(0) catalyst from Pd(OAc) 2, water, and
biarylphosphine ligands has been developed. This protocol generates a catalyst system, which
exhibits excellent reactivity and efficiency in the coupling of a variety of amides and anilines with
aryl chlorides.
Chapter 2
A new class of one-component Pd precatalysts bearing biarylphosphine ligands is
described. These precatalysts are air- and thermally-stable, are easily-activated under normal
reaction conditions at or below room temperature, and ensure the formation of the highly-active
mono-ligated Pd(0) complex necessary for oxidative addition. The use of these precatalysts as
a convenient source of LPd(0) in C-N cross-coupling reactions is explored. The reactivity that is
demonstrated in this study is unprecedented in palladium chemistry.
Chapter 3
A catalyst system based on a new biarylphosphine ligand that shows excellent reactivity
for C-N cross-coupling reactions is reported. This catalyst system enables the use of aryl
mesylates as a coupling partner in C-N bond-forming reactions. Additionally, the use of of this
ligand permits the highly selective monoarylation of an array of primary aliphatic amines and
anilines at low catalyst loadings and with fast reaction times, including the first monoarylation of
methylamine. Lastly, oxidative addition complexes based on the new ligand are included, which
provide insight into the origin of reactivity for this system.
Chapter 4
An investigation into the Pd-catalyzed C-N cross-coupling reactions of aryl iodides is
described. Nal is shown to have a significant inhibitory effect on these processes. By switching
to a solvent system in which the iodide byproduct was insoluble, reactions of aryl iodides were
accomplished with the same efficiencies as aryl chlorides and bromides. Using catalyst systems
based on certain biarylphosphine ligands, aryl iodides were successfully reacted with an array
of primary and secondary amines in high yields. Lastly, reactions of heteroarylamines and
heteroaryliodides were also conducted in high yields.
Chapter 5
A catalyst based on a new biarylphosphine ligand for the Pd-catalyzed cross-coupling
reactions of amides and aryl chlorides is described. This system shows the highest turnover
frequencies reported to date for these reactions, especially for aryl chloride substrates bearing
an ortho substituent. An array of amides and aryl chlorides were successfully reacted in good to
excellent yields.
Chapter 6.
An efficient Pd-catalyst for the transformation of aryl chlorides, triflates and nonaflates to
nitroaromatics has been developed. This reaction proceeds under weekly basic conditions and
displays a broad scope and excellent functional group compatibility. Moreover, this method
allows for the synthesis of aromatic nitro compounds that cannot be accessed efficiently via
other nitration protocols. Mechanistic insight into the trasmetallation step of the catalytic process
is also reported.
Chapter 7.
An alternative approach to catalyst development, which led to a Pd catalyst based on
two biarylphosphine ligands for C-N cross-coupling reactions, is reported. By effectively being
able to take the form of multiple catalysts this system manifests the best properties that
catalysts based on either of the two ligands exhibit separately and displays the highest reactivity
and substrate scope of any system that has been reported to date for these reactions.
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Introduction
Pd-catalyzed C-N cross-coupling reactions have become increasingly important and
have seen widespread use in natural product synthesis, medicinal chemistry, process
chemistry, materials chemistry, and agricultural chemistry (Figure 1).1 Due to the applicability of
this process to a variety of disciplines, this area of research has received considerable attention
and advances in this field have had an immediate impact on the chemistry community.
H
NN N,
Me(H)N- NMe
0 NN
MeO ~NH 2OMe
MeO N
Desbromoceratamineld Cancer Therapyie
Boc Boc
Boco N N N N Boc
H Boo H
End-Functionalized Polyanilineslf
Figure 1. Applications of C-N cross-coupling reactions in natural product synthesis, medicinal
chemistry, and materials chemistry.
In 1983 Migita and Kosugi reported the first Pd-catalyzed C-N coupling of a tin-amide
and an aryl bromide.2 It wasn't until a decade later that Buchwald and Hartwig developed
variants of this reaction that eliminated the need for the highly toxic and unstable tin-amide and
allowed the utilization of a free amine as the substrate (Figure 2).3 This breakthrough increased
the practicality of these processes and initiated a significant research effort in the field of C-N
cross-coupling.
"Pd"
X Ligand NR'R"
R+ HNR'R" RBase, Solvent
Figure 2. Generic Pd-catalyzed C-N cross-coupling reaction.
After the initial discovery, the development of new catalyst systems, along with
mechanistic studies, increased the scope of these reactions to include a wide variety of both
amines and aryl halides/psuedohalides as substrates.4 In particular, the design of new
supporting ligands for these catalyst systems led to the most significant advances.c'5 In most
cases these ligands were designed to maximize catalyst activity by facilitating one or more of
the steps in the catalytic cycle (i.e., oxidative addition, amine binding, deprotonation, or
reductive elimination), as well as increase catalyst stability (Figure 3). However, it has been
difficult to produce a catalyst system that displays both catalyst stability and high activity
throughout the entire catalytic process.
Catalyst Activation
Pd(O) or Pd(II)
Precursor
Ar-NR2  Ar-XLPd(O)
Reductive Oxidative
Elimination Addition
Ar Ar
L-Pd-NR2  L-Pd-X
Deprotonation
Base-HX HNR 2
Ar
Base I AmineL-Pd-N(H)R2  BindingIX
Figure 3. Proposed catalytic cycle for Pd-catalyzed C-N cross-coupling reactions.
Along with ligand design, research on the formation of the active ligated Pd(O) complex
has also played a major role in improving these reactions.6 Although this process of catalyst
activation is often overlooked, it is one of the most important factors in reaction efficiency. The
formation of the active catalyst is most commonly done by either starting with a Pd(O) source
(e.g., Pd2(dba)3)7 or by reducing a Pd(II) salt in situ (e.g., Pd(OAc) 2).8 However, most Pd(O)
sources are unstable and contain strongly coordinating ligands, which can significantly hinder
the formation of the active catalyst. Furthermore, the reduction of Pd(II) salts is often inefficient
and can require the addition of exogenous reducing agents.
The results reported herein focus on the development of Pd catalysts with the objective
of increasing the overall practicality and understanding of C-N cross-coupling processes. Three
different approaches toward catalyst system design have been utilized to achieve this goal.
First, methods to increase the efficiency of catalyst activation have been investigated. Second,
with the help of mechanistic studies, new rationally designed phosphine ligands have been
synthesized and examined. Third, in order to develop a truly general catalyst, systems based on
multiple ligands have been analyzed.
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1.1 Introduction
Over the past decade great progress has been made in improving the efficiency and
applicablilty of palladium-catalyzed C-N cross-coupling reactions.' Despite these recent
advances, many limitations of these methods remain. We have previously shown that
biaryldialkylphosphines, of which 1 (Figure 1) is prototypical,2 are excellent supporting ligands in
C-N cross-coupling processes. We now disclose a procedure that helps to maximize the
efficiency of these ligands when used with a Pd(II) precatalyst.
Me
Me Me
PCy 2
i-Pr i-Pr Me P(t-Bu) 2
i-Pr i-Pr
i-Pr
i-Pr
1(XPhos) 2
Figure 1. Biarylphosphine ligands.
The formation of an active LnPd(O) complex is most commonly accomplished in one of
the following ways: 1) use of a Pd(O) source such as Pd2(dba)3,3 2) use of [(allyl)PdC] 2,4 3)
reduction of a Pd(Il) salt [e.g., Pd(OAc)2] using PhB(OH) 2,2 a tertiary amine,5 a tertiary
phosphine,6 or an amine substrate,' or 4) employment of a single component precatalyst.7
These methods all have deficiencies when used with biaryldialkylphosphine ligands. Although
Pd2(dba)3 has been shown to work well in combination with 1 in many instances,2 diminished
reactivity is observed due to the coordination of the dba to the palladium; this is a well known
consequence of using dba containing precatalysts.8 Attempts to use [(allyl)PdCI] 2 have not
proven to be productive with dialkylbiarylphosphine ligands. Reduction of Pd(OAc) 2 with 1 is
slow due to the steric hindrance of the ligand and initial results show that the use of tertiary
amines or PhB(OH) 2 as reducing agents give slow formation of the active LnPd(O) catalyst.
Lastly, reduction of Pd(OAc)2 works well with primary or secondary amine substrates that have
P-hydrogens. However, when non-reducing nucleophiles, such as anilines or amides, are used,
formation of LnPd(O) is inefficient.
Because of these deficiencies, we set out to develop a protocol that utilized water and 1
to reduce Pd(OAc)2 and generate the active LnPd(O) complex. This type of activation was first
reported in 1992 by Ozawa and Hayashi, in which they were able to reduce Pd(OAc) 2 in the
presence of 3 equivalents of BINAP.9 They disclosed that in the absence of water the reduction
did not proceed; however, by adding extra equivalents of water the rate of activation could be
accelerated. This showed that water played a direct role in the formation of the Pd(0) catalyst.
Amatore and Jutand further delineated a method in which water and several different tertiary
phosphines were employed as reducing agents to form a Pd(0) complex that underwent
oxidative addition to aryl halides (Scheme 1).14 In their investigations they found that water
converted an intermediate phosphonium salt to the corresponding phosphine oxide in the
reduction of Pd(OAc)2.
Scheme 1. Water-Promoted Activation of Pd(OAc) 2
2 PR3 + Pd(II)(OAc) 2  (R3P)2Pd(II)(OAc) 2
H20 G(R3P)Pd(0) + O=PR3 - H--- (R3P)Pd(0)(OAc) + AcOPR 3
-2 HOAc
1.2 Results and Discussion
We began our studies by seeking out a fast, efficient, and practical protocol for
preactivation of Pd(OAc)2. It was found that a highly active catalyst could be generated by
heating the Pd(OAc)2 (1 mol %), water (4 mol %), and 1 (3 mol %) for 1 minute at 80 0C in 1,4-
dioxane. The activation could be monitored visually by color change as shown in Figure 2. The
resulting green catalyst solution" could then be transferred into a reaction vessel containing the
substrates and base. Figure 3 shows the reaction of aniline and 4-chloroanisole utilizing several
modes of activation. The water-mediated preactivation protocol gave a 99% GC yield, whereas
[(allyl)PdCl] 2, Pd(OAc) 2 / PhB(OH) 2, and Pd2(dba)3 all resulted in yields lower than 50%. This
demonstrates the efficiency in which water-mediated preactivation forms the active catalyst,
without the detrimental effects of impeding ligands (e.g., dba).
Figure 2. Visualization of Water-Mediated Preactivationa
11111 i ~ -11W 43
0 sec
[a] Reaction conditions:
dioxane, 80 *C.
Figure 3. Comparison of
MeO
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Pd(OAc)2 (0.01 mmol), 1 (0.03 mmol), H20 (0.04 mmol), 1 mL 1,4-
Water-Mediated Preactivation with Several Pd Sourcesa
HH2N 1 mol % Pd(OAc)2, 2.2 mol % 1 N
K2cO, t-BuOH, 4 mol % H20 M80 *C, 2 min ef
[a] Reaction conditions: aniline (1.2 mmol), 4-chloroanisole (1.0 mmol), Pd
mol %), 1,4-dioxane (1 mL), 80 *C, 2 min.
(1 mol %), 1 (2.2
We next investigated the application of this protocol to amidation reactions of aryl
chlorides. Our research group recently reported an efficient catalyst system for this
transformation utilizing the combination of Pd2(dba)3 and ligand 2 (Figure 1). It has been
proposed that with biaryldialkylphosphine ligands the rate-limiting step in amidation reactions is
the "transmetallation" (amide binding and/or deprotonation).' We postulated that by replacing
the Pd2(dba)3 with a preactivation of Pd(OAc)2 a more active catalyst system could be achieved,
because there would be no dba present in the reaction to compete for binding at the Pd center.
By heating Pd(OAc) 2 (1 mol %), water (4 mol %), and 2 (3 mol %) for 1.5 minutes at 110 0C in t-
BuOH a highly active catalyst was generated for these reactions. For example, whereas the
coupling of either cyclohexanecarboxamide or acetamide with 4-chloroanisole using Pd2(dba)3
and 2 previously proceeded in 24 hours, water-mediated preactivation decreased the reaction
times to 3 hours, and provided the products in excellent yields (Table 1, entries 1 and 2).12
Table 1. Coupling of Amides With Aryl
c + 0S CI OR_ +H 2N R'
Chloridesa
1 mol % Pd(OAc) 2, 3 mol % 2
K3P04, t-BuOH, 4 mol % H20
110 *C, 3 h
entry ArCl amide product yieldb
H
1 CI N O 98%
MeO H2N Cy MeO
H
2 Cl ~N O 98%
MeO H2N Me MeOtN Me
H
cl0 NO
H2N H N HN N
4 C0 HN N 83%
N (N
H
0 N 0
H2N 95%
N N
N N NN
[a] Reaction conditions: 1.5 min preactivation at 110 0C with 4 mol % H20, 1 mol % Pd(OAc)2,
and 3 mol % 2 in 2 mL/mmol of t-BuOH; 1.0 equiv aryl chloride, 1.2 equiv amide, and 1.4 equiv
K2CO 3. [B] Yields represent isolated yields (average of 2 runs). [c] 1.5 equiv of amide.
We next looked at cross-couplings reactions of amides with 3-chloropyridine, which have
been difficult in the past.1" 3 When the preactivation protocol was employed, formamide,
nicotinamide, and 2-pyrrolidinone were all successfully coupled with 3-chloropyridine, in 3 h,
using 1 mol % Pd (Table 1, entries 3, 4, and 5). Previously, the reactions with formamide and 2-
pyrrolidinone had required the use of 2 mol % Pd and reaction times of 812 and 24 hours,13
respectively. Additionally, the latter case required the addition of Et3B to achieve good yields.
H
NO
Table 2. Coupling of Electron-Deficient Anilinesa
1 mol % Pd(OAc)2, 3 mol % 1
K3PO4, t-BuOH, 4 mol % H20110 *C, 1 h
N
R -R'
entry ArCI aniline product yieldb
Cl H2N N
1 n-Bu C H2 NO2  n-Bu N NO2  94%
2 ci HN 1 ~ 1 1  ~If1 86%c
n-Bu C Nn-Bu 02N
M eO C 1 H 2N C E M eO NONt 86%
3" CO2Et MeCN- CO 2Et 86
cl H2N N N H
4 MeO Cl H2N CN MeO N N 93%
Me AcMe HAc
5 C H2N N95%
Me Me
Ac H
6 Me CI H2N N(H)Ac Me N(H)Ac 92%d
Me Me
[a] Reaction conditions: 1 min preactivation at 110 *C with 4 mol % H2 0, 1 mol % Pd(OAc)2, and3 mol % I in 2 mL/mmol of t-BuOH; 1.0 equiv aryl chloride, 1.2 equiv amine, and 1.4 equiv
K2CO 3. [b] Yields represent isolated yields (average of 2 runs). [c] Reaction time of 2 h. [d] 2.5
equiv of K2 CO 3 was used.
Having established that the combination of water and 2 efficiently converted Pd(OAc) 2 to
an active catalyst, we sought to expand the protocol to include reactions of electron-deficient
anilines. Electron-deficient anilines have been difficult coupling partners due to their modest
nucleophilicity and intolerance of strong base.a 14 By performing a preactivation of Pd(OAc)2, 1,
and water at 110 *C for 1 minute, electron deficient 4-nitroaniline and 2-nitroaniline were
successfully coupled with 4-n-butylchlorobenzene in excellent yields (Table 2, entries 1 and 2).
c
R-
H2N
+ 
-- R'
Other electron-deficient anilines containing an ester or a cyano group were coupled as well in
excellent yields using the newly developed protocol (Table 2, entries 3 and 4).
The chemoselectivity of the system was also briefly explored. Using 2'-
aminoacetophenone ketone a-arylation was completely suppressed and exclusive C-N coupling
was observed (Table 2, entry 5). This selectivity can be attributed to the high activity of the
catalyst achieved utilizing water-mediated preactivation, which allows for the use of K2C0 3.15
The reaction of 4-aminoacetanilide also showed complete selectivity for arylation at the free
aniline (Table 2, entry 6).2 This catalyst system showed both high activity and excellent
functional group compatibility.
Table 3. Couplings of Anilines at 0.05 mol % Catalyst Loadinga
cR
R-r
H2N
| -R'
0.05 mol % Pd(OAc)2, 0.15 mol % 1
NaOt-Bu,dioxane, 4 mol % H20110*C, 20 min
H
R - | -" R'
entry ArCI aniline product yieldb
Me Me
C1 H2N 95%
Me Me
Me Me Me H Me
Ci H2N NN N
2 CH98%
Me Me Me Me
Cl H2N H
3 MeO C MeO N95%
CF3  CF3
OMe OMe
CI H2N N 99%
4rF N ) F
OMe OMe
[a] Reaction conditions: 1 min preactivation at 80 *C with 2 mol % H20, 0.05 mol % Pd(OAc)2,
and 0.15 mol % I in 1 mL/mmol of 1,4-dioxane; 1.0 equiv aryl chloride, 1.2 equiv amine, and 1.2
equiv NaOt-Bu. [B] Yields represent isolated yields (average of 2 runs).
Last, we wanted to examine the applicability of this protocol for the coupling of anilines at
low catalyst loadings. There are currently very few examples of couplings with anilines and aryl
chlorides below 0.5 mol % catalyst loading. 7a,7b,16 Using the preactivation protocol several
examples were performed at 0.05 mol % catalyst loading in 20 minutes (Table 3). For example,
electron- deficient 3-aminobenzotrifluoride and 4-fluoroaniline were successfully coupled with
electron-rich aryl chlorides within 20 minutes, affording the products in excellent yields (Table 3,
entries 3 and 4).
1.3 Conclusion
In conclusion, an efficient protocol for C-N cross-coupling reactions has been described.
An active catalyst was formed by water-mediated preactivation of readily available Pd(OAc)2
using biaryldialkylphosphine ligands. This new protocol allowed lower catalyst loadings, shorter
reactions times, and exclusion of additives, such as Et3B, in couplings of amides with aryl
chlorides. It also gives access to a system that exhibits both high activity and
excellent catalyst stability in couplings of electron- deficient anilines, and couplings of anilines
at low catalyst loadings. Further studies of other applications of this protocol are currently
ongoing in our laboratories.
1.4 Experimental
General Reagent Information: All reactions were carried out under an argon
atmosphere. The 1,4-dioxane and tert-butanol were purchased from Aldrich Chemical Co. in
Sure-Seal bottles and were used as recieved. Pd(OAc) 2 was a gift from BASF and aryl halides
and amines were purchased from Aldrich Chemical Co., Alfa Aesar, or TCI America. All amines
that were a liquid were distilled from calcium hydride and stored under argon. Amines that were
a solid and all aryl halides were used as purchased without furthur purification. Distilled water
was degassed by brief (30 sec) sonication under vacuum. Anhydrous tribasic potassium
phosphate was purchased from Fluka Chemical Co. and both potassium carbonate and sodium
tert-butoxide were purchased from Aldrich Chemical Co. and used as received. Ligands 12 and
217 were synthesized using literature procedures.
General Analytical Information: All compounds were characterized by 1H NMR, 13C
NMR, IR spectroscopy, and elemental analysis. Copies of the 'H and 13C spectra can be found
at the end of the Supporting Information. Nuclear Magnetic Resonance spectra were recorded
on a Varian 300 MHz instrument. All 1H NMR experiments are reported in 6 units, parts per
million (ppm), and were measured relative to the signals for residual chloroform (7.26 ppm) in
the deuterated solvent, unless otherwise stated. All 13C NMR spectra are reported in ppm
relative to deuterochloroform (77.23 ppm), unless otherwise stated, and all were obtained with
'H decoupling. All IR spectra was taken on a Perkin - Elmer 2000 FTIR. All GC analyses were
performed on a Agilent 6890 gas chromatograph with an FID detector using a J & W DB-1
column (10 m, 0.1 mm l.D.). Elemental analyses were performed by Atlantic Microlabs Inc.,
Norcross, GA.
General Procedure A
An oven-dried test tube, which was equipped with a magnetic stir bar and fitted with a
teflon septum, was charged with Pd(OAc)2 (1 mol%) and ligand (3 mol%). The vessel was
evacuated and backfilled with argon (this process was repeated a total of 3 times) and the
solvent (2 mL) and degassed H20 (4 mol%) were added via syringe. After addition of the water,
the solution was heated to 110 0C for 1.5 min.
A second oven-dried test tube, which was equipped with a magnetic stir bar and fitted
with a Teflon septum, was charged with base (1.4 mmol) (aryl chlorides or amines that were
solids at room temperature were added with the base). The vessel was evacuated and
backfilled with argon (this process was repeated a total of 3 times) and then the aryl chloride
(1.0 mmol) and amine (1.2 mmol) were added via syringe and the activated catalyst solution
was transferred from the first reaction vessel into the second via cannula. The solution was
heated to 110 0C until the aryl chloride had been completely consumed as judged by GC
analysis. The reaction mixture was then cooled to room temperature, diluted with ethyl acetate,
washed with water, concentrated in vacuo, and purified via flash chromatography on silica gel.
General Procedure B
General procedure A was used with the following modification: 1.4 mmol of
amine was used.
General Procedure C
General procedure A was used with the following modification: after addition of
the water the solution was heated to 80 0C for 1 min.
General Procedure D
General procedure A was used with the following modification: after addition of
the water the solution was heated to 80 *C for 1 min and 2.5 mmol of the base was used.
General Procedure E
An oven-dried test tube, which was equipped with a magnetic stir bar and fitted with a
teflon septum, was charged with a pre-milled 1:3 mixture of Pd(OAc)2 and XPhos (0.05 mol%
Pd).* The vessel was evacuated and backfilled with argon (this process was repeated a total of
3 times) and the solvent (1 mL) and degassed H2 0 (2 mol%) were added via syringe. After
addition of the water, the solution was heated to 80 0C for 1 min.
A second oven-dried test tube, which was equipped with a magnetic stir bar and fitted
with a Teflon septum, was charged with base (2.4 mmol) (aryl chlorides or amines that were
solids at room temperature were added with the base). The vessel was evacuated and
backfilled with argon (this process was repeated a total of 3 times) and then the aryl chloride
(2.0 mmol), amine (2.4 mmol) and solvent (1 mL) were added via syringe and the activated
catalyst solution was transferred from the first reaction vessel into the second via cannula. The
solution was heated to 110 0C until the aryl chloride had been completely consumed as judged
by GC analysis. The reaction mixture was then cooled to room temperature, diluted with ethyl
acetate, washed with water, concentrated in vacuo, and purified via flash chromatography on
silica gel.
*The Pd(OAc) 2 (1 equiv) and XPhos (3 equiv) were ground together in a mortar and
pestle and stored in a desicator.
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N-(4-Methoxyphenyl)cyclohexanecarboxamide (Table 1, entry 1) Following general
procedure A, a mixture of 4-chloroanisole (123 mL, 1.0 mmol), cyclohexanecarboxamide (153
mg, 1.2 mmol), K3P0 4 (297 mg, 1.4 mmol), Pd(OAc) 2 (2.2 mg, 0.01 mmol), 2 (14.6 mg, 0.03
mmol), H20 (1 mL, 0.04 mmol) and t-BuOH (2 mL) was heated to 110 0C for 3 h. The crude
product was purified via the Biotage SP4 (silica-packed 25+M; 10-50% EtOAc/hexanes) to
provide the title compound as a white solid (227 mg, 97%), mp 147-149 *C. 'H NMR (300 MHz,
CDC13) 6: 7.55, (s, 1 H), 7.42 (d, J = 9.0 Hz, 2H), 6.81 (d, J = 9.0 Hz, 2H), 3.76 (s, 3H), 2.20 (tt,
J = 3.5 Hz, J = 11.5 Hz, 1H), 1.91 (m, 2H), 1.80 (m, 2H), 1.68 (m, 1H), 1.51 (m, 2H), 1.25 (m,
3H) ppm. 13C NMR (75 MHz, CDCI3) 6: 174.8, 156.4, 131.6, 122.0, 114.2, 55.7, 46.5, 29.9,
25.9 ppm. IR (neat, cm-1): 3295, 2922, 2852, 1528, 1514, 1384, 1247, 1031, 824. Anal. Calcd.
for C14 H19NO2: C, 72.07; H, 8.21. Found: C, 71.96; H, 8.24.
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N-(4-Methoxyphenyl)ethanamide (Table 1, entry 2) Following general procedure A, a
mixture of 4-chloroanisole (123 mL, 1.0 mmol), acetamide (71 mg, 1.2 mmol), K3 P04 (297 mg,
1.4 mmol), Pd(OAc) 2 (2.2 mg, 0.01 mmol), 2 (14.6 mg, 0.03 mmol), H20 (1 mL, 0.04 mmol) and
t-BuOH (2 mL) was heated to 110 OC for 3 h. The crude product was purified via the Biotage
SP4 (silica-packed 25+M; 10-50% EtOAc/hexanes) to provide the title compound as a white
solid (138 mg, 84%), mp 126-128 *C. 1H NMR (300 MHz, CDC13) 6: 7.62 (s, 1H), 7.38 (d, J=
9.0 Hz, 2H), 6.82 (d, J = 9.0 Hz, 2H), 3.77 (s, 3H), 2.12 (s, 3H) ppm. 13C NMR (75 MHz, CDC 3)
6: 168.8, 156.6, 131.3, 122.2, 114.3, 55.7, 24.5 ppm. IR (neat, cm'): 3240, 3066, 1604, 1514,
1410, 1029, 838, 775. Anal. Calcd. for CqH 11N02: C, 65.44; H, 6.71. Found: C, 65.37; H, 6.78.
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N-(pyridin-3-yl)methanamide (Table 1, entry 3) Following general procedure B, a
mixture of 3-chloropyridine (95 mL, 1.0 mmol), formamide (56 mL, 1.4 mmol), K3PO4 (297 mg,
1.4 mmol), Pd(OAc)2 (2.2 mg, 0.01 mmol), 2 (14.6 mg, 0.03 mmol), H20 (1 mL, 0.04 mmol) and
t-BuOH (2 mL) was heated to 110 0C for 3 h. The crude product was purified via the Biotage
SP4 (silica-packed 25+M; 7-9% MeOH/CH 2C2) to provide the title compound as a white solid
(102 mg, 84%), mp 93-94 *C. 'H NMR (300 MHz, CDC13) 6: 9.60 (bm, 0.25H), 9.44 (s, 0.75H),
8.72 (d, J = 11.0 Hz, 0.25H), 8.67 (d, J = 2.5 Hz, 0.75H), 8.49 (d, J = 2.5 Hz, 0.25H), 8.43 (m,
1 H), 8.33, (d, J = 4.5 Hz, 0.75H), 8.20 (d, J = 8.0 Hz, 0.75H), 7.50 (d, J = 8.0 Hz, 0.25H), 7.29
(m, 1H) ppm. 13C NMR (75 MHz, CDC13) 6: 162.7, 160.2, 146.5, 145.3, 141.0, 140.8, 134.8,
134.3, 128.0, 126.3, 124.6, 124.3 ppm. IR (neat, cm-1): 3244, 3131, 1648, 1606, 1370, 1247,
1031, 839. Anal. Calcd. for C6H6N20: C, 59.01; H, 4.95. Found: C, 59.06; H, 5.03.
N1-(Pyridin-3-yl)pyrrolidin-2-one (Table 1, entry 4) Following general procedure A, a
mixture of 3-chloropyridine (95 mL, 1.0 mmol), 3-pyrrolidinone (102 mg, 1.2 mmol), K3 PO4 (297
mg, 1.4 mmol), Pd(OAc) 2 (2.2 mg, 0.01 mmol), 2 (14.6 mg, 0.03 mmol), H20 (1 mL, 0.04 mmol)
and t-BuOH (2 mL) was heated to 110 0C for 3 h. The crude product was purified via the
Biotage SP4 (silica-packed 25+M; 7-9% MeOH/CH 2Cl2) to provide the title compound as a white
solid (135 mg, 83%), mp 39-41 0C. 1H NMR (300 MHz, CDC13) 6: 8.61 (d, J= 2.5 Hz), 8.22 (dd,
J = 1.5 Hz, J = 5.0 Hz, 1H), 8.02 (qd, J = 1.5 Hz, J = 8.5 Hz, 1H), 7.14 (m, 1H), 3.73 (t, J = 7.0
Hz, 2H), 2.46 (t, J = 8.0 Hz, 2H), 2.06 (p, J = 7.0 Hz) ppm. 13C NMR (75 MHz, CDCI3) 6: 174.9,
145.3, 140.7, 136.2, 126.9, 123.5, 48.1, 32.5, 18.1 ppm. IR (neat, cm 1): 3384, 2976, 1698,
1486, 1390, 1308, 1231, 806, 707. Anal. Calcd. for CH 10N20: C, 66.65; H, 6.21. Found: C,
66.56; H, 6.23.
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N-(Pyridin-3-yl)pyridine-3-carboxamide (Table 1, entry 5) Following general
procedure A, a mixture of 3-chloropyridine (95 mL, 1.0 mmol), nicotinamide (146 mg, 1.2 mmol),
K3 P0 4 (297 mg, 1.4 mmol), Pd(OAc) 2 (2.2 mg, 0.01 mmol), 2 (14.6 mg, 0.03 mmol), H20 (1 mL,
0.04 mmol) and t-BuOH (2 mL) was heated to 110 *C for 3 h. The crude product was purified
via the Biotage SP4 (silica-packed 25+M; 7-9% MeOH/CH 2Cl2) to provide the title compound as
a white solid (199 mg, 99%), mp 189-190 *C. 1H NMR (300 MHz, DMSO) 6: 10.65 (s, 1H),
9.12 (s, 1H), 8.92 (s, 1H), 8.77 (d, J = 5.0 Hz, 1H), 8.31 (m, 2H), 8.18 (d, J = 8.0 Hz, 1H), 7.57
(q, J = 5.0 Hz, 1H), 7.40 (q, J = 5.0 Hz, 1H) ppm. 13C NMR (75 MHz, DMSO) 6: 165.2, 153.1,
149.4, 145.5, 142.6, 136.3, 136.2, 130.7, 128.1, 124.3, 124.2 ppm. IR (neat, cm~1): 3309, 2922,
2852, 1680, 1590, 1429, 1384, 1117. Anal. Calcd. for CjjHqN30: C, 66.32; H, 4.55. Found: C,
66.22; H, 4.57.
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N-(4-Butylphenyl)-4-nitroaniline (Table 2, entry 1) Following general procedure C, a
mixture of 1-butyl-4-chlorobenzene (169 mg, 1.0 mmol), 4-nitroaniline (166 mg, 1.2 mmol),
K2CO3 (193 mg, 1.4 mmol), Pd(OAc) 2 (2.2 mg, 0.01 mmol), XPhos (14.3 mg, 0.03 mmol), H20
(1 mL, 0.04 mmol) and t-BuOH (2 mL) was heated to 110 0C for 1 h. The crude product was
purified via the Biotage SP4 (silica-packed 25+M; 0-20% EtOAc/Hexane) to provide the title
compound as an orange solid (258 mg, 96%), mp 76-77 *C. 'H NMR (300 MHz, CDC13) 6: 8.09
(d, J = 9.0 Hz, 2H), 7.20 (d, J = 8.5 Hz, 2H), 7.12 (d, J = 8.5 Hz, 2H), 6.89 (d, J = 9.0 Hz, 2H),
6.43 (s, 1 H), 2.62 (t, J = 7.5 Hz, 2H), 1.62 (p, J = 7.5 Hz, 2H), 1.38 (sextet, J = 7.0 Hz, 2H), 0.95
(t, J= 7.0 Hz, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 151.2, 140.0, 139.4, 137.1, 129.9, 126.6,
122.7, 113.5, 35.3, 33.9, 22.6, 14.2 ppm. IR (neat, cm~1): 3344, 2928, 1593, 1502, 1182, 1112,
834, 751. Anal. Calcd. for C16Hl9N20 2: C, 71.09; H, 6.71. Found: C, 71.35; H, 6.87.
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N-(4-Butylphenyl)-2-nitroaniline (Table 2, entry 2) Following general procedure C, a
mixture of 1-butyl-4-chlorobenzene (169 mg, 1.0 mmol), 2-nitroaniline (166 mg, 1.2 mmol),
K2CO3 (193 mg, 1.4 mmol), Pd(OAc)2 (2.2 mg, 0.01 mmol), XPhos (14.3 mg, 0.03 mmol), H20
(1 mL, 0.04 mmol) and t-BuOH (2 mL) was heated to 110 0C for 2 h. The crude product was
purified via the Biotage SP4 (silica-packed 25+M; 0-20% EtOAc/Hexane) to provide the title
compound as an red oil (252 mg, 93%). 1H NMR (300 MHz, CDC13) 6: 9.48 (s, 1 H), 8.19 (d, J =
8.5 Hz, 1 H), 7.34 (t, J = 7.0 Hz, 1 H), 7.21 (m, 5H), 6.73 (t, J = 7.0 Hz, 1 H), 2.63 (t, J = 7.5 Hz,
2H), 1.62 (p, J = 7.0 Hz, 2H), 1.38 (sextet, J = 7.0 Hz, 2H), 0.94 (t, J = 7.0 Hz, 3H) ppm. 13C
NMR (75 MHz, CDC13 ) 6: 143.9, 141.0, 136.3, 135.9, 133.0, 129.9, 126.8, 124.9, 117.3, 116.2,
35.4, 33.9, 22.6, 14.3 ppm. IR (neat, cm 1): 3353, 2929, 2858, 1607, 1573, 1348, 1262, 1147,
740. Anal. Calcd. for C16H19N202: C, 71.09; H, 6.71. Found: C, 71.34; H, 6.97.
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Ethyl 4-(3-methoxyphenylamino)benzoate (Table 2, entry 3) Following general
procedure C, a mixture of 3-chloroanisole (123 mL, 1.0 mmol), ethyl-4-aminobenzoate (198 mg,
1.2 mmol), K2CO 3 (193 mg, 1.4 mmol), Pd(OAc)2 (2.2 mg, 0.01 mmol), XPhos (14.3 mg, 0.03
mmol), H2 0 (1 mL, 0.04 mmol) and t-BuOH (2 mL) was heated to 110 *C for 1 h. The crude
product was purified via the Biotage SP4 (silica-packed 25+M; 0-30% EtOAc/Hexane) to provide
the title compound as a white solid (232 mg, 86%), mp 87-88 0C. 1H NMR (300 MHz, CDC13) 6:
7.93 (d, J = 8.5 Hz, 2H), 7.23 (t, J = 8.0 Hz, 1 H), 7.02 (d, J = 8.5 Hz, 2H), 6.75 (m, 2H), 6.61 (d,
J = 8.0 Hz, 1 H), 6.30 (s, 1 H), 4.34 (q, J = 7.0 Hz, 2H), 3.78 (s, 3H), 1.38 (t, J = 7.0 Hz, 3H) ppm.
13C NMR (75 MHz, CDC13 ) 6: 166.9, 160.9, 148.0, 142.6, 131.7, 130.5, 121.7, 115.2, 112.7,
108.4, 106.0, 60.8, 55.5, 14.7 ppm. IR (neat, cm-1): 3351, 2980, 1688, 1523, 1493, 1278, 1175,
1108, 769. Anal. Calcd. for C16H17NO3: C, 70.83; H, 6.32. Found: C, 70.89; H, 6.23.
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3-(4-methoxyphenylamino)benzonitrile (Table 2, entry 4) Following general
procedure C, a mixture of 4-chloroanisole (123 mL, 1.0 mmol), 3-aminobenzonitrile (142 mg, 1.2
mmol), K2CO3 (193 mg, 1.4 mmol), Pd(OAc)2 (2.2 mg, 0.01 mmol), XPhos (14.3 mg, 0.03
mmol), H20 (1 mL, 0.04 mmol) and t-BuOH (2 mL) was heated to 110 0C for 1 h. The crude
product was purified via the Biotage SP4 (silica-packed 25+M; 0-30% EtOAc/Hexane) to provide
the title compound as a yellow oil (209 mg, 93%), mp 87-89 C. 1H NMR (300 MHz, CDCI3) 6:
7.24 (t, J = 6.5 Hz, 1 H), 7.06 (m, 5H), 6.90 (d, J = 9.0 Hz, 2H), 5.82 (s, 1 H), 3.81 (s, 3H) ppm.
13C NMR (75 MHz, CDC13) 6: 201.4, 149.2, 138.7, 136.6, 134.9, 132.8, 131.2, 130.3, 126.1,
125.6, 118.7, 116.1, 114.3, 28.3, 21.3, 18.0 ppm. IR (neat, cm-1): 3377, 2226, 1601, 1524,
1330, 1237, 1034, 778. Anal. Calcd. for C14H12N2 0: C, 74.98; H, 5.39. Found: C, 75.10; H,
5.40.
Ac
HN
Me
Me
1-(2-(2,5-Dimethylphenylamino)phenyl)ethanone (Table 2, entry 5) Following general
procedure C, a mixture of 2-chloro-1,4-dimethylbenzene (134 mL, 1.0 mmol), 2'-
aminoacetophenone (146 mL, 1.2 mmol), K2CO3 (193 mg, 1.4 mmol), Pd(OAc)2 (2.2 mg, 0.01
mmol), XPhos (14.3 mg, 0.03 mmol), H20 (1 mL, 0.04 mmol) and t-BuOH (2 mL) was heated to
110 0C for 1 h. The crude product was purified via the Biotage SP4 (silica-packed 25+M; 0-30%
EtOAc/Hexane) to provide the title compound as a yellow oil (227 mg, 95%). 'H NMR (300
MHz, CDCl3) 6: 10.46 (s, 1H), 7.85 (d, J = 8.0 Hz, 1H), 7.32 (t, J = 7.0 Hz, 1H), 7.21 (m, 2H),
6.97 (m, 2H), 6.73 (t, J = 7.0 Hz, 1 H), 2.70 (s, 3H), 2.37 (s, 3H), 2.30 (s, 3H) ppm. 13C NMR (75
MHz, CDC13) 5: 201.4, 149.2, 138.7, 136.6, 134.9, 132.8, 131.2, 130.3, 126.1, 125.6, 118.7,
116.1, 114.3, 28.3, 21.3,18.0 ppm. IR (neat, cm 1): 3256, 2922, 1639, 1578, 1453, 1246, 1233,
1164, 745. Anal. Calcd. for C16H17NO: C, 80.30; H, 7.16. Found: C, 80.44; H, 7.30.
S N(H)Ac
HN
Me
Me
N-(4-(3,4-Dimethylphenylamino)phenyl)ethanamide (Table 2, entry 6) Following
general procedure D, a mixture of 4-chloro-1,2-dimethylbenzene (141 mg, 1.0 mmol), 4'-
aminoacetanilide (180 mg, 1.2 mmol), K2C03 (345 mg, 2.5 mmol), Pd(OAc)2 (2.2 mg, 0.01
mmol), XPhos (14.3 mg, 0.03 mmol), H20 (1 mL, 0.04 mmol) and t-BuOH (2 mL) was heated to
110 *C for 1 h. The crude product was purified via the Biotage SP4 (silica-packed 25+M; 50-
100% EtOAc/Hexane) to provide the title compound as a white solid (223 mg, 88%), mp 116-
117 *C. 'H NMR (300 MHz, CDC13) 6: 7.86 (s, 1 H), 7.35 (d, J = 9.0 Hz, 2H), 7.01 (d, J = 8.0
Hz, 1H), 6.95 (d, J= 9.0 Hz, 2H), 6.81 (m, 2H), 5.61 (s, 1H), 2.21 (s, 6H), 2.13 (s, 3H) ppm. 1C
NMR (75 MHz, CDCl3) 6: 169.0, 141.3, 140.8, 137.8, 130.6, 129.5, 122.2, 119.8, 118.1, 115.7,
24.5, 20.3, 19.3 ppm. IR (neat, cm'): 3308, 2920, 1659, 1606, 1556, 1370, 1317, 814. Anal.
Calcd. for C16H19N20: C, 75.56; H, 7.13. Found: C, 75.26; H, 7.17.
HNC
Me 
Me
2,5-Dimethyl-N-phenylaniline (Table 3, entry 1) Following general procedure E, a
mixture of 2-chloro-1,4-dimethylbenzene (268 mL, 2.0 mmol), aniline (220 mL, 2.4 mmol), NaOt-
Bu (230 mg, 2.4 mmol), 1:3 Pd(OAc) 2:XPhos (1.7 mg, 0.05 mol% Pd), H20 (1 mL, 0.04 mmol)
and t-BuOH (2 mL) was heated to 110 0C for 1 h. The crude product was purified via the
Biotage SP4 (silica-packed 25+M; 0-30% EtOAc/Hexane) to provide the title compound as a
yellow oil (375 mg, 95%). 'H NMR (300 MHz, CDC13) 6: 7.48 (t, J = 8.5 Hz, 2H), 7.31 (m, 2H),
7.15 (m, 3H), 7.01 (d, J = 7.5 Hz, 1H), 5.51 (s, 1H), 2.51 (s, 3H), 2.42 (s, 3H) ppm. 13C NMR
(75 MHz, CDC13 ) 6: 144.5, 141.3, 136.8, 131.2, 129.7, 125.7, 123.2, 120.7, 120.0, 117.8, 21.6,
17.9 ppm. IR (neat, cm'): 3388, 3048, 2920, 1601, 1578, 1519, 1311, 748, 694. Anal. Calcd.
for C14 H15N: C, 85.24; H, 7.66. Found: C, 85.17; H, 7.64.
Me
HN Me
Me I
Me
Bis(2,5-dimethylphenyl)amine (Table 3, entry 2) Following general procedure E, a
mixture of 2-chloro-1,4-dimethylbenzene (268 mL, 2.0 mmol), 2,5-dimethylaniline (298 mL, 2.4
mmol), NaOt-Bu (230 mg, 2.4 mmol), 1:3 Pd(OAc) 2:XPhos (1.7 mg, 0.05 mol% Pd), H2 0 (1 mL,
0.04 mmol) and t-BuOH (2 mL) was heated to 110 0C for 1 h. The crude product was purified
via the Biotage SP4 (silica-packed 25+M; 0-30% EtOAc/Hexane) to provide the title compound
as a yellow oil (436 mg, 97%). 1H NMR (300 MHz, CDC13) 6: 7.35 (d, J = 7.5 Hz, 2H), 7.11 (s,
2H), 7.01 (d, J = 7.5 Hz, 2H), 5.33 (s, 1 H), 2.55 (s, 6H), 2.49 (s, 6H) ppm. 13C NMR (75 MHz,
CDC13 ) 6: 142.4, 136.9, 131.2, 125.0, 122.6, 119.6, 21.7, 17.9 ppm. IR (neat, cm 1): 3399,
2921, 2859, 1579, 1459, 1415, 1293, 1003, 798. Anal. Calcd. for C16H19N: C, 85.28; H, 8.50.
Found: C, 84.99; H, 8.46.
HN CF3
OMe
N'(4-methoxyphenyl)-3-(trifluoromethyl)anili ne (Table 3, entry 3) Following general
procedure E, a mixture of 2-chloro-1,4-dimethoxybenzene (286 mL, 2.0 mmol), 4-fluoroaniline
(286 mL, 2.4 mmol), NaOt-Bu (230 mg, 2.4 mmol), 1:3 Pd(OAc) 2:XPhos (1.7 mg, 0.05 mol%
Pd), H2 0 (1 mL, 0.04 mmol) and t-BuOH (2 mL) was heated to 110 0C for 1 h. The crude
product was purified via the Biotage SP4 (silica-packed 25+M; 0-30% EtOAc/Hexane) to provide
the title compound as a white solid (523 mg, 98%), mp 58-60 C. 1H NMR (300 MHz, CDC 3) 6:
7.30 (t, J = 8.0 Hz, 1 H), 7.06 (m, 5H), 6.93 (d, J = 9.0 Hz, 2H), 5.66 (s, 1 H), 3.84 (s, 3H) ppm.
13C NMR (75 MHz, CDC13) 6: 156.4, 146.3, 134.5, 132.1, 131.7, 130.1, 130.0, 129.9, 126.3,
123.7, 122.7, 118.1, 118.1, 115.9, 115.8, 115.8, 115.7, 115.1, 111.5, 111.5, 111.4, 111.4, 55.8
ppm. IR (neat, cm-1): 3367, 2968, 2843, 1506, 1217, 1164, 1112, 1071, 1027, 788. Anal.
Calcd. for C14H12F3NO: C, 62.92; H, 4.53. Found: C, 63.01; H, 4.56.
HN F
MeO N
OMe
N-(4-Fluorophenyl)-2,5-dimethoxyaniline (Table 3, entry 4) Following general
procedure E, a mixture of 2-chloro-1,4-dimethoxybenzene (286 mL, 2.0 mmol), 4-fluoroaniline
(286 mL, 2.4 mmol), NaOt-Bu (230 mg, 2.4 mmol), 1:3 Pd(OAc)2:XPhos (1.7 mg, 0.05 mol%
Pd), H2 0 (1 mL, 0.04 mmol) and t-BuOH (2 mL) was heated to 110 0C for 1 h. The crude
product was purified via the Biotage SP4 (silica-packed 25+M; 0-30% EtOAc/Hexane) to provide
the title compound as a yellow oil (492 mg, 99%). 1H NMR (300 MHz, CDC13) 6: 7.16 (m, 2H),
7.03 (m, 2H), 6.79 (m, 2H), 6.37 (dd, J = 3.0 Hz, J = 8.5 Hz, 1 H), 6.15 (s, 1 H), 3.87 (s, 3H), 3.76
(s, 3H) ppm. 13C NMR (75 MHz, CDCl3) 6: 160.2, 157.0, 154.5, 122.1, 122.0, 116.3, 116.0,
111.3, 102.5, 101.1, 56.3, 55.8 ppm. IR (neat, cm-1): 3413, 2939, 1605, 1523, 1215,1050, 829,
785. Anal. Calcd. for C14H14FN0 2: C, 68.00; H, 5.71. Found: C, 68.07; H, 5.74.
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Chapter 2.
A New Class of Easily Activated Palladium Precatalysts for Facile C-N Cross-Coupling
Reactions and Low Temperature Oxidative Addition of Aryl Chlorides
72
2.1 Introduction
Although phosphine-ligated Pd(O) complexes constitute the active catalysts in many C-N
bond-forming cross-coupling methodologies,1 ,2 such complexes are usually difficult to prepare
and extremely air-sensitive. Pd2(dba)3, developed as a stable source of Pd(0), includes
coordinating dba ligands that can significantly retard the formation of active catalyst and/or
diminish its reactivity.3 The use of a Pd(II) salt such as Pd(OAc)2, which circumvents problems
of precatalyst instability, requires in situ reduction in order to generate the active Pd(O)
complex. In light of the complications in forming phosphine-ligated Pd(0) complexes, we sought
to develop a precatalyst scaffold constituting the source of Pd and phosphine ligand, which
could form the active, mono-ligated Pd complex under mild conditions and without the need for
exogenous additives.4 Herein, we report the development of a new class of air- and moisture-
stable, one-component, Pd precatalysts that is activated under standard reaction conditions and
ensures the formation of the active, L1Pd(0) (L = biarylphosphine) complex. We additionally
demonstrate these precatalysts to be convenient Pd sources for facile C-N bond-forming
reactions. Finally, we show the efficient oxidative addition of PhCI to a LPd(0) complex at -40
*C.
PCy2
i-Pr i-Pr PCy 2  PCy 2
MeO OMe i-PrO Oi-Pr
i-Pr
1 (XPhos) 2 (SPhos) 3 (RuPhos)
Figure 1. Biarylphosphine ligands.
2.2 Results and Discussion
Our group has recently reported the isolation of a phosphine-ligated Pd(ll) complex
bearing a free amine.5 Building on this result, we proposed that an intramolecularly coordinated
amine complex would provide an stable, monoligated Pd precatalyst. Precatalysts bearing
ligands 1,6a 2 6b and 3 ,6c (4, 5 and 6, respectively) were prepared in excellent yields via the route
illustrated in Figure 2. Yields of >85% were obtained for each step of this sequence without the
need for a glovebox and using only recrystallization for purification. The X-ray crystal structure
of 5 is shown in Figure 3.
Me2
MeCN N
rt N I
Me297%
Me2MeLi, N
MTBE C de
-: KPdMe20 *c N
Me2
90 - 95%
S NH2  L = 1; 90% (4)
ci 
- NH 2 L = 2; 94% (5)ligand, Pd' L = 3; 86% (6)MTBE, L CI
55 *C
In situ use of (tmeda)PdMe2: 70% (4, 8 g); 85% (5,12 g)
Figure 2. Synthesis of precatalysts 4 - 6.
Calorimetric analysis of 4-6 shows that activation is complete after ca. 3 minutes when the
complexes are treated with NaOt-Am in dioxane at room temperature. In general, this activation
process occurs readily with weak bases (e.g., Cs2CO3 and K3P0 4) at 80 *C, with alkoxide bases
at room temperature, and with HMDS bases at -20 *C, as judged by 31P NMR.
NaOt-Am
Pd- dioxane, rt
4-6
0.01
o-0.008
E 0.006
0.004
i 0.002
0
Pd.NH rt JW
LPd(0)
Active Catalys
+ 1Pd-NH2 (5)
SPhos' 'ci
11
-4 XPhos Precat.
5 SPhos Precat.
6 RuPhos Precat.
* C
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5 5.5
Time (min)
Figure 3. Calorimetric scans of the addition of precatalysts
temperature; X-ray crystal structure of 5.
6
4-6 to NaOt-Am in dioxane at room
Figure 4 shows the progress of cross-coupling reactions of 4-chloroanisole and aniline
using 0.1% Pd at 80 0C employing ligand 1 with different Pd sources and different methods of
activation. The use of Pd(OAc)2/PhB(OH) 2,6a [Pd(allyl)C] 2, and Pd2dba3 as the Pd source
affects a maximum conversion of ca. 25% before loss of catalytic activity. However, the use of 4-
allows complete conversion to be achieved in 35 minutes. These results demonstrate the
limitations of Pd(II) activation methods and the deleterious nature of the dba ligand in cross-
(MeCN) 2PdCI2
TMEDA
coupling reactions. Using precatalyst 4, a highly active, L1Pd(O) complex is readily accessed in
the absence of potentially inhibitory complexing ligands and without the need for exogenous
additives.
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Figure 4. Effect of Pd source on the cross-coupling of aniline and 4-chloroanisole using 0.1%
Pd and ligand I at 80 *C.
Because of their low nucleophilicity, electron-deficient anilines are typically difficult
substrates to employ in C-N cross-coupling reactions. Using 4, numerous highly electron-
deficient anilines were successfully coupled with unactivated aryl chlorides in excellent yields
(Table 1). 2-NO 2, 2-CO 2Et, 4-CF3, and 4-CN anilines had not been previously employed in C-N
cross-coupling reactions involving aryl chlorides. Further, we have achieved the first C-N cross-
coupling reactions of anilines with aryl chlorides bearing unprotected aldehydes. The success
of these reactions reveals the advantages of using a highly reactive Pd source in C-N cross-
coupling reactions.
H
N
MeOj
Table 1. Cross-Coupling Reactions of Electron-Deficient Anilines with Aryl Chlorides Using a
Weak Basea
NH2
EWG-a,
CI
± R-
1 mol % 4, K2 0 3
t-BuOH, 1 h, 110 'C
H
EWG- -R
EtO2C H
N N OCH 3
86%
N0 2 H
N n-Bu
83%b
H
MeO N OCH3
0
92%
H OCH3
NCN
99% OCH3
H
0 2N n-Bu
97%
H
NIJ IaH
84%
90%
H
Me OCH3
0
92%
i-PrH
(N NC
i-Pr CHO
90%C
[a] ArCI (1 mmol), amine (1.2 mmol), K2 CO3 (1.4 mmol); average isolated yields of 2 runs. [b] 2
h reaction time. [c] using precatalyst 6.
The ability to achieve high yields from cross-coupling reactions using low catalyst
loadings with short reaction times is of great synthetic importance. Table 2 shows the use of 4 in
several C-N cross-coupling reactions of unactivated aryl chlorides with anilines using 0.1 mol %
Pd. Few examples of C-N cross-coupling reactions using anilines have been previously
demonstrated using catalyst loadings of less than 1 mol % Pd. The products displayed in Table
3 are each obtained in excellent yield in fewer than 10 minutes despite the use of such low
catalyst loadings.
Table 2. Rapid C-N Bond-Forming Reactions with 0.1% Catalyst.a
Ci 0.1% 4, 0.1% 1, NaOt-Bu NR 2R1
R + R1R 2NH dioxane, 100 *C
10 min'
H H H
3O N R H3C N N CH3
H3 00 OH3  F 3C
R = H, 98%
R = CF 3, 96% 93% 96%
[a] ArC! (1 mmol), amine (1.2 mmol), base (1.2 mmol); average isolated yields of 2 runs.
To show the ease with which 4 - 6 can be activated, we performed numerous C-N cross-
coupling reactions at or below room temperature (Table 3). These precatalysts are particularly
useful for substrate combinations that are incompatible with elevated reaction temperatures.
Previously, 4 days were required to achieve a 61 % yield in the formation of the coupling product
of dibutylamine and 3-chlorophenethyl alcohol.7 Using 4, we can now obtain an isolated yield of
94% in only 4 hours. Similarly, the less reactive 4-chlorophenethyl alcohol can now be
successfully employed in an analogous reaction. In addition, we have successfully
demonstrated the compatibility of esters of secondary alcohols in room temperature cross-
coupling reactions using an alkoxide base. Our ability to perform amination reactions of an aryl
chloride at -10 0C further illustrates the ease with which these precatalysts undergo activation.
Table 3. C-N Bond-Forming Reactions Using ArCI at or below Room Temperaturea
R'R 2NH + R 3 - I 4, 5, or 6, base R R2N -- R3
W'C dioxane, -10 - 25 C
BU2 N- 0 N \ o'0HB 2 --O H O N O i-P r B u 2N )O C H 3
3-NBu2, 4, LHMDS, rt, 4 h, 9 4%b4-NBu2, 4, LHMDS, rt, 7 h, 84%b 5, NaOt-Am, rt, 2 h, 8 2 %C 6, LHMDS, rt, 3 h, 93%
HC HH H 00H 3
H30 'NN 'NN N
OH 3  OH 3  OCH36, LHMDS, -10 0C, 24 h, 9 2 %d 6, NaOt-Am, rt, 20 min, 99% 4, NaOt-Bu, rt, 2 h, 97%
[a] ArCI (1 mmol), amine (1.2 mmol), base (1.2 mmol); average yield of 2 runs. [b] LHMDS (2.4
mmol). [c] NaOt-Am (1.02 mmol). [d] in DME.
To demonstrate the reactivity of a LPd(0) complex in the absence of competitive
coordinating ligands, we prepared the .N-Me derivatives of precatalysts 5 and 4 (7 and 9,
respectively).8 As shown in Figure 5, chlorobenzene undergoes facile oxidative addition to
SPhosPd(0) generated by deprotonation of 7 at -40 0C.9 This suggests that aryl chlorides
should be usable in low temperature C-C cross-coupling reactions using precatalysts 4-6.
Previously, only aryl iodides have been employed in cross-coupling reactions conducted at such
low temperatures.10
NMe PhC, LHMDS SPhosPd(Ph)CI +Pd'H toluene, -40 0C 8M
SPhos Ci
(7)
65 60 55 50 45 40 35 ppm
Figure 5. 31P{1H} NMR spectra of: (a) 7 in toluene/PhCI at -40 0C and (b) 7 in toluene/PhCI wi
LHMDS (1 equiv.) after 110 min at -40 C.
The ability to generate L1Pd(0) complexes in the absence of competing ligands is also
very useful for mechanistic investigations. Precatalyst 9 was employed at room temperature to
conduct a direct Hammett study of the oxidative addition of aryl chlorides to the XPhosPd(0)
complex (see experimental Section). The slope of p = +2.3 for Hammett's correlation is
consistent with results previously obtained from (PPh 3)2Pd(0) with aryl iodides, suggesting a
concerted 3-centered transition state for oxidative addition." This is the first information of this
type available for the reaction of aryl chlorides with monodentate ligands.12
2.3 Conclusion
In summary, we have developed a new class of Pd precatalysts bearing biarylphosphine
ligands that are particularly useful in cases where a highly active Pd complex is required to
promote a difficult cross-coupling reaction or where functional group instability requires the use
of low temperatures. We have additionally demonstrated that an unactivated aryl chloride can
undergo oxidative addition to SPhosPd(0) at temperatures as low as -40 0C. The use of these
precatalysts should greatly expand the general scope of Pd-catalyzed cross-coupling reactions.
2.4 Experimental
General Reagent Information: THF, Et2 0, CH2Cl2 and toluene were purchased from
J.T. Baker in CYCLE-TAINER* solvent-delivery kegs and vigorously purged with argon for 2 h.
The solvents were further purified by passing them under argon pressure through two packed
columns of neutral alumina (for THF and Et20) or through neutral alumina and copper (1l) oxide
(for toluene and CH2CI2). All reagents and solvents were used as received unless otherwise
noted. Acetonitrile (HPLC grade) was purchased from Fischer. N, N, N', N'-
tetramethylethylenediamine (redistilled >99.5% grade) was purchased from Aldrich. MeLi (1.6
M in ether) was purchased from Aldrich. Methyl t-butyl ether (MTBE) (ACS reagent grade,
sparged with argon) was purchased from Fischer. Anhydrous chlorobenzene, DME, and
dioxane (Aldrich) were purged with argon for 1 h and stored in a nitrogen-filled glovebox.
(CH3CN) 2PdCI2 was received as a gift from Strem. 2-Chlorophenethylamine was purchased
from Acros. p-Toluidine was purified by sublimation prior to use. XPhos was received as a gift
from Lanxess. RuPhos was purchased from Strem. SPhos was prepared as described in
reference 6b. Flash chromatography was performed using a) Silicycle silica gel (ultra pure
grade) or b) a Biotage SP4 instrument with prepacked silica cartridges.
General Analytical Information: All compounds were characterized by 1H NMR, 13C
NMR, and 31P NMR (where applicable) spectroscopy. Copies of the 1H, 13C, and 31P NMR
spectra can be found at the end of the Supporting Information. Nuclear Magnetic Resonance
spectra were recorded on a Varian 300 MHz or a Bruker 400 Mhz instrument. All 'H NMR
experiments are reported in 6 units, parts per million (ppm), and were measured relative to the
signals for residual chloroform (7.26 ppm) in the deuterated solvent, unless otherwise stated. All
13C NMR spectra are reported in ppm relative to deuterochloroform (77.23 ppm), unless
otherwise stated, and all were obtained with 1H decoupling. All 31P NMR spectra are reported in
ppm relative to H3 PO4 (0 ppm - external standard). All GC analyses were performed on a
Hewlett-Packard 6890 gas chromatograph with an FID detector using a 25 m x 0.20 mm
capillary column with cross-linked methyl siloxane as the stationary phase.
General Procedural Information
Procedure A: An oven-dried test tube, which was equipped with a magnetic stir bar and
fitted with a teflon septum, was charged with the precatalyst (0.01 equiv.) and K2C0 3 (193 mg,
1.4 mmol). The vessel was evacuated and backfilled with argon (this process was repeated a
total of 3 times) and then the aryl chloride (1.0 mmol), amine (1.2 mmol), and tert-butanol (2 mL)
were added via syringe (aryl chlorides or amines that were solids at room temperature were
added with the precatalyst and base). The solution was heated to 110 0C until the starting
material was completely consumed as monitored by GC. The reaction mixture was then cooled
to room temperature, diluted with ethyl acetate, washed with water, concentrated in vacuo, and
purified via the Biotage SP4 (silica-packed 25+M cartridge).
Procedure B: General procedure A was used with the following modification: 1.05
mmol of the amine was used.
Procedure C: An oven-dried test tube, which was equipped with a magnetic stir bar and
fitted with a teflon septum, was charged with the precatalyst (0.01 equiv.), ligand (0.01 equiv.),
and NaOt-Bu (115 mg, 1.2 mmol). The vessel was evacuated and backfilled with argon (this
process was repeated a total of 3 times) and then the aryl chloride (1.0 mmol), amine (1.2
mmol), and 1,4-dioxane (1 mL) were added via syringe (aryl chlorides or amines that were
solids at room temperature were added with the pre-catalyst and base). The solution was
heated until the starting material was completely consumed as monitored by GC. The reaction
mixture was then cooled to room temperature, diluted with ethyl acetate, washed with water,
concentrated in vacuo, and purified via the Biotage SP4 (silica-packed 25+M cartridge).
Procedure D: General procedure A was used with the following modification:
0.001 equiv of precatalyst and ligand were used, which had been previously ground together
using a mortar and pestle.
Procedure E: An oven-dried test tube, which was equipped with a magnetic stir bar and
fitted with a teflon septum, was charged with the precatalyst (0.01 mmol) and NaOt-Bu (115 mg,
1.2 mmol). The vessel was evacuated and backfilled with argon (this process was repeated a
total of 3 times) and then the aryl chloride (1.0 mmol), amine (1.2 mmol), and 1,4-dioxane (1
mL) were added via syringe (aryl chlorides or anilines that were solids at room temperature
were added with the precatalyst and base). The solution was stirred at room temperature until
the starting material was completely consumed as monitored by GC. The reaction mixture was
then either a) diluted with ethyl acetate, washed with water, concentrated in vacuo, and purified
via the Biotage SP4 (silica-packed 25+M cartridge); or b) diluted with ethyl acetate, washed with
aqueous ammonium chloride, dried over Na2SO4 , concentrated in vacuo, and purified via silica
column chromatography.
Procedure F: An oven-dried test tube, which was equipped with a magnetic stir bar and
fitted with a teflon septum, was charged with the precatalyst (0.01 equiv.). The vessel was
evacuated and backfilled with argon (this process was repeated a total of 3 times) and then the
aryl chloride (1.0 mmol) and amine (1.2 mmol) were added via syringe (aryl chlorides or amines
that were solids at room temperature were added with the precatalyst). Finally, LHMDS solution
(1.5 mL, 0.8 M in dioxane, 1.2 mmol) was added via syringe. The solution was stirred at room
temperature until the starting material was completely consumed as monitored by GC. The
reaction mixture was diluted with ethyl acetate, washed with aqueous ammonium chloride, dried
over Na2SO4 , concentrated in vacuo, and purified via silica column chromatography.
General Procedure for Calorimetric Studies - Activation: An oven-dried 16 mL vial
was equipped with a magnetic stir bar, fitted with a screw-cap Teflon septum, and taken into the
glovebox. Once in the glovebox, the vial was charged with NaOt-Am (264 mg, 2.4 mmol) and
1,4-dioxane (1.5 mL). The reaction mixture was then taken out of the glovebox and placed in an
Omnical CRC reaction calorimeter along with a syringe containing a solution of the precatalyst
in 1,4-dioxane (500 pL, 0.04 M). The calorimeter was set to 22.5 0C and allowed to thermally
equilibrate. After equilibration, the solution of pre-catalyst was injected and the reaction was
stirred until the heat flow on the calorimeter returned to the baseline. A correction was then
applied to the raw data due to the delay between the moment that the heat is given off of the
reaction and the moment that it is detected. The corrected heat flow curve was then converted
to rate by using the equation q = AHrxn - V - r, where q is the heat flow, Arxn is the heat of
reaction, V is the reaction volume, and r is the reaction rate. The heat of reaction was found by
integrating the heat flow vs. time curves, which gave an average of 61.7 KJ/mol for all three
reactions.
General Procedure for Calorimetric Studies - Catalysis: An oven-dried 16 mL vial
was equipped with a magnetic stir bar, fitted with a screw-cap Teflon septum, and taken into the
glovebox. Once in the glovebox, the vial was charged with 4-chloroanisole (123 pL, 1.0 mmol),
aniline (110 pL, 1.2 mmol), NaOt-Am (132 mg, 1.2 mmol), and toluene (1.8 mL). The reaction
was then taken out of the glovebox and placed in an Omnical CRC reaction calorimeter along
with a syringe containing a solution of the Pd source and 1 in toluene (200 pL, 0.1 mol% Pd, 0.2
mol% 1). The calorimeter was set to 80 0C and allowed to thermally equilibrate. After
equilibration, the solution of Pd and 1 was injected and the reaction was stirred until the heat
flow on the calorimeter returned to the baseline. A correction was then applied to the raw data
due to the delay between the moment that the heat is given off of the reaction and the moment
that it is detected. The corrected heat flow curve was then converted to fractional conversion by
dividing the area under the curve to any point by the total area under the curve (equation 1).
Equation 1
t
fractional conversion =
nal
q dt
Hammett plot of oxidative addition to XPhosPd(O).
y = 2.309x + 0.0238
R2 = 0.9993
WA 0.5 1
a*: a- value used for CN. a values used for all other substituents. See ref. 12
for a similar usage of a- in oxidative addition studies.
Representative procedure for oxidative addition to XPhosPd(O). Complex 9 (20
mg, 0.027 mmol) was added to an NMR tube inside of a glovebox. Toluene (250 mL) was
added to the NMR tube followed by chlorobenzene (50 mL, 0.49 mmol) and 4-chloroanisole
(100 mL, 0.82 mmol). LHMDS (4.5 mg, 0.027 mmol) was weighed in a vial, dissolved in toluene
(500 mL) and transferred to the NMR tube. The solution becomes deep red and turns pale
yellow over 5 minutes. Dibutylamine (200 mL) was then added via syringe to the NMR tube.
The amine complexes that form upon addition of dibutylamine to the solution are separately
observable in the 31P NMR spectrum of the sample. See the end of spectra section below for
4 r-
W. j
the P NMR spectrum from this experiment. The measured integral of the amine complex
formed from the oxidative addition complex of XPhosPd(0) and 4-chloroanisole was divided by
1.67 to account for the excess of 4-chloroanisole that was initially used, giving a selectivity ratio
of 1:4.05 for 4-choroanisole v. chlorobenzene.
Procedure for the preparation of precatalysts 4, 5, and 6.
Me2  Me2(MeCN) 2PdCI N MeLi, N NH2  /1 L = 1; 90% (4)+ 2 MeCN PdCI 2 MTBE K PdMe2  NH2 L = 2; 94% (5)+ ~ o  MTB NH2 -oTMEDA ft N 0 00 N ligand, Pd'Me2  Me2  MTBE, L CI L = 3; 86% (6)
97% 90 - 95% 55 0C
In situ use of (tmeda)PdMe2: 70% (4, 8 g); 85% (5,12 g)
CI2Pd(II)(TMEDA). The following procedure was conducted without the exclusion of air.
To a 250 mL round bottom flask equipped with a stirbar and a condenser, (CH3CN) 2PdCl2 (4.8
g, 18.5 mmol) was added. Next, acetonitrile (125 mL) was added through a side neck. At room
temperature N, N, N', N'-tetramethylethylenediamine (TMEDA) (20.4 mL, 135 mmol) was added
via syringe. The resulting solution was stirred for 1 h at room temperature. The precipitated
yellow solid (5.2 g, 97%) was collected by suction filtration on a fritted funnel.
Me2Pd(II)(TMEDA). To an oven-dried 200 mL Schlenk flask equipped with stirbar,
Cl2Pd(Il)(TMEDA) (1.2 g, 4 mmol) was added. The flask was evacuated and back-filled with
argon; this sequence was carried out a total of three times. Methyl t-butyl ether (MTBE) (32 mL)
was added via syringe. Under a positive pressure of argon, the reaction solution was cooled to
0 0C in an ice bath. Over 10 min, MeLi in ether (1.6 M, 7.5 mL, 12 mmol) was added dropwise
via syringe. The solution was stirred at 0 0C for 20 min, after which time, the ice bath was
removed. After having stirred for 1 h at room temperature, the solution was milky brown in
color. The reaction flask was returned to the ice bath, and the excess MeLi was quenched by
the careful dropwise addition of H20 (10 mL). The resulting black solution was poured into a
separatory funnel and extracted with MTBE (4 x 50 mL). The combined MTBE washes were
dried over Na2SO4 . The MTBE solution was then decanted from the drying agent, which was
washed with an additional 50 mL MTBE, and the combined MTBE washes were evaporated
under reduced pressure. Me2Pd(ll)(TMEDA) (0.98 g, 95%) was isolated as an off-white powder
Over multiple syntheses, between 90-95% yield was consistently obtained. Me2Pd(ll)(TMEDA)
should be stored inside a nitrogen-filled glovebox or in a freezer under argon. Differential
scanning calorimetry (DSC) data shows exothermic decomposition of solid Me2Pd(ll)(TMEDA)
between 115-130 *C (see end of document for DSC data). These data imply that
Me2Pd(I)(TMEDA) should never be heated to a temperature greater than ca. 105 *C. No
steps in the formation of the pre-catalysts require reaction temperatures higher than 55 0C. The
procedure for the formation of Me2Pd(ll)(TMEDA) was adapted from reference 13.
DSC scan of solid Me2Pd(II)(TMEDA)
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SPhos palladium(II) phenethylamine chloride (5). To a Schlenk tube equipped with a
stirbar and a Teflon stopper, Me2Pd(ll)(TMEDA) (0.13 g, 0.49 mmol) was added. The Schlenk
tube was evacuated and back-filled with argon; this sequence was repeated a total of four times.
Exo Down
----- --
Under a positive pressure of argon, the Teflon stopper was replaced with a rubber septum,
through which MTBE (4 mL) and 2-chloro phenethylamine (0.08 g, 0.49 mmol) (Aldrich) were
added via syringe. Still under a positive pressure of argon, the rubber septum was removed and
SPhos (0.2 g, 0.49 mmol) was added. The reaction mixture was then resealed with the Teflon
stopper. The mixture was heated to 55 0C for 2 h. After the solution cooled to room
temperature, it became milky-white in appearance. Methylene chloride (5 mL) was employed to
homogenize mixture in order to facilitate transfer to a round bottom flask. The solvent was
removed under reduced pressure. The resulting solid was dissolved in MTBE (2 mL). Hexanes
(40 mL) was added, and the solution was placed in a -20 0C freezer for 10 h. An off-white
powder (0.34 g, 92%) was collected by suction filtration and identified as a 1:1 complex of
MTBE and 5. MTBE could be removed by dissolving powder in CH2Cl 2 and reprecipitating with
hexanes. 'H NMR (400 MHz, CDC13): d 7.36 (t, 1H, J=8.4 Hz), 7.15 (m, 2H), 6.91 (m, 1H), 6.83
(m, 2H), 6.79 (t, 1H, J=7.6 Hz), 6.73 (t, 1H, J=7.0 Hz), 6.63 (d, 2H, J=8.4 Hz), 6.40 (t, 1H, J=7.0
Hz), 3.70 (s, 6H), 3.21 (s, 3H), 3.15 (br m, 4H), 2.73 (br s, 2H), 2.22 (br m, 2H), 2.08 (br s, 1H),
1.87 (br s, 2H), 1.72 (br m, 4H), 1.55 (br m, 6H), 1.22 (s, 9H), 1.10 (br m, 4H), 0.94 (br m, 2H).
13C NMR (100 MHz, CDCI3): d 158.10, 152.33, 139.36, 138.52, 138.32, 137.72, 137.55, 132.86,
132.79, 129.49, 128.70, 128.25, 127.90, 126.10, 124.67, 124.55, 124.32, 123.47, 119.54,
103.83, 55.42, 53.64, 43.91, 38.12, 35.47, 31.11, 29.68, 27.78, 27.67, 27.33, 27.21, 26.21
(observed complexity results from C-P coupling). 3 P NMR (162 MHz, CDC13): d 56.7. MS
(ESI+): observed: 636.2241 (M*-Cl), calculated: 636.2217.
r yl* ')PCy 2
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XPhos palladium(II) phenethylamine chloride (4). Compound 4 was prepared in an
analogous fashion to complex 5. A white powder (90% yield) was isolated as a 1:1 complex of
4 and MTBE. MTBE could be removed by dissolving powder in CH2Cl2 and reprecipitating with
hexanes. 1H NMR (400 MHz, CDCI3): d 7.78 (br s, 1H), 7.19 (t, 1H, J=7.2 Hz), 7.03 (s, 2H),
6.97 (m, 2H), 6.88 (d, 1 H, J=6.6 Hz), 6.78 (t, 2H, J=7.0 Hz), 6.43 (br t, 1 H, J=6.7 Hz), 3.28 (br s,
2H), 3.21 (s, 3H), 3.11 (br s, 2H), 2.94 (septet, 1H, J=6.9 Hz), 2.37-2.85 (br m, 4H), 1.1-2.0 (br
m, 41 H) [1.27 (d, ca. 6H, J=6.9 Hz), 1.22 (s, ca. 9H)], 0.95 (br s, 3H), 0.87 (br s, 3H), 0.63 (br s,
1H), 0.25 (br s, 1H). 13C NMR (100 MHz, CDCI3): d 151.4, 148.9, 146.8, 143.7, 139.8, 138.5,
136.9, 136.5, 134.3, 128.1, 126.7, 125.1, 124.2, 124.0, 121.6, 121.0, 43.6, 38.2, 34.6, 34.1,
31.9, 30.7, 29.4, 27.4, 27.0, 26.3, 26.1, 24.3, 23.5, 22.3 (observed complexity results from C-P
coupling). 31P NMR (162 MHz, CDCl3): d 61.6. MS (ESI+): observed: 702.3395 (M*-CI),
calculated: 702.3414.
NH2  RuPhos Pcy 2
u Pd \ e MTBE i-PrO Oi-PrRuPhos' CI
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RuPhos palladium(li) phenethylamine chloride (6). Compound 6 was prepared in an
analogous fashion to complex 5. A white powder (86% yield) was isolated as a 1:1 complex of
6 and MTBE. MTBE could be removed by dissolving powder in CH2Cl2 and reprecipitating with
hexanes. 1H NMR (300 MHz, CDC13) 6: 7.32 (t, J= 7.0 Hz, 1H), 7.06 (t, J= 7.0 Hz, 1H), 6.91
(m, 1 H), 6.78 (m, 4H), 6.62 (d, J = 8.5 Hz, 3H), 6.42 (t, J = 7.0 Hz, 1 H), 4.48 (septet, J = 6.0 Hz,
2H), 3.17 (s, 4H), 2.74 (s, 2H), 2.40-1.85 (m, 6H), 1.85-1.35 (m, 10H), 1.26 (d, J = 6.0 Hz, 6H),
1.06 (d, J = 6.0 Hz, 6H), 1.10-0.80 (m, 8H). 31P NMR (121 MHz, CDCI3) 6: 61.7 ppm. IR (neat,
cm-1): 3275, 2978, 2929, 2221, 1591, 1457, 1246, 1114, 1059, 912.
Large-scale formation of pre-catalysts 4 and 5 with in situ formation of
Me2Pd(lI)(TMEDA)
SPhos palladium(Ii) phenethylamine chloride (5). Cl2Pd(ll)(TMEDA) (5.87 g, 20
mmol) was added to an oven-dried 250 mL Schlenk tube. MTBE (100 mL) was added via
cannula. The solution was cooled to 0 0C in an ice bath and 1.6 M MeLi in ether (31 mL, 50
mmol) was added dropwise via syringe over 40 min with' rapid stirring. The solution was
allowed to stir at 0 *C for an additional 30 min. The ice bath was removed and the reaction
solution was allowed to stir for an additional 30 min at room temperature. The reaction tube was
placed back into the ice bath and the excess MeLi was quenched by dropwise addition of
degassed (freeze-pump-thaw) H20 (20 mL). When stirring was stopped, two distinct layers
formed. The transparent, upper layer was transferred into a degassed 500 mL round bottom
flask containing Na2SO4 under argon via cannula. The H20 layer was washed with MTBE (3 x
25 mL), which was transferred to the drying flask via cannula. After drying for 45 min, the MTBE
solution was transferred via filter cannula to an oven-dried 500 mL 3-neck flask that was
equipped with a condenser, stirbar, SPhos (8.21 g, 20 mmol), and degassed 2-chloro
phenethylamine (3.12 g, 20 mmol) under argon. The drying agent was washed with MTBE (3 x
40 mL), which was transferred to the 500 mL 3-neck flask via filter cannula. This mixture was
stirred at 55 0C under argon for 9 h and then placed in a -20 *C freezer overnight (ca. 10 h).
The reaction mixture was brown with an off-white precipitate. The precipitate was collected via
suction filtration on a fritted funnel and washed with cold MTBE (150 mL). An off-white powder
(12.9 g, 85%) was isolated, which was identified as a 1:1 complex of MTBE and 5. >99% purity
was exhibited by 'H and 31P NMR spectroscopy.
XPhos palladium(II) phenethylamine chloride (4). An analogous procedure to that
described above was employed for the large-scale preparation of XPhos palladium(II)
phenethylamine chloride (4). Cl2Pd(Il)(TMEDA) (4.31 g, 14.7 mmol), 1.6 M MeLi in ether (25 mL,
40 mmol), XPhos (7.0 g, 14.7 mmol), and 2-chloro phenethylamine (2.3 g, 14.7 mmol) were
employed in this procedure. After having stirred at 55 0C for 5 h, the final reaction solution was
allowed to cool to rt. The solvent was removed under reduced pressure. The remaining solid
was triturated with hot acetone (200 mL), and the resulting white powder was isolated using
suction filtration. The acetone was removed under reduced pressure. The remaining residue
was again triturated with hot acetone (125 mL), and remaining white powder isolated using
suction filtration. Combined crops of white powder (8.5 g, 70%) were identified as a 1:1
complex of MTBE and 4. 98% purity was exhibited by 'H and 31P NMR spectroscopy.
N(H)Me
ci
2-(2-chlorophenyl)-N-methylethanamine. 2-Chlorophenethylamine (1.5 g, 9.6 mmol)
was added to formic acid (50 mL) under a condenser. Over 30 min, acetic anhydride (12 mL)
was added dropwise with stirring. After 2 h, GC/MS analysis showed no remaining 2-
chlorophenethylamine. H20 (50 mL) was added to the reaction mixture, which was then
extracted with ether (100 mL) and dried over Na2SO4 . The dried solution was rotovapped,
leaving a pale yellow liquid. This product was dissolved in dry ether (50 mL) under argon and
cooled in an ice bath. Lithium aluminum hydride (1g, 26 mmol) was added in 4 portions. After 1
h, the ice bath was removed and the reaction mixture was allowed to stir for 2 h at room
temperature. The reaction flask was placed back into an ice bath, and the excess lithium
aluminum hydride was carefully quenched by slow addition of i-PrOH. H20 was then added until
the aluminum salts freely separated. Ether (100 mL) was added and mixture was passed
through a fritted filter. The separated salts were then washed with ether (2 x 50 mL). The
combined organics were dried over Na2SO4 and rotovapped, leaving a pale yellow oil. The oil
was purified by column chromatography using 95:5:1 CH2Cl2:MeOH:NEt3 to afford the title
compound (1.17 g, 72%) as a colorless oil. "H NMR (300 MHz, CDC13 ) 6: 7.28 (m, 1H), 7.04-
7.20 (m, 3H), 2.88 (m, 2H), 2.78 (m, 2H), 2.40 (s, 3H), 0.91 (bs, 1 H). "C NMR (75 MHz, CDC13)
6: 137.9, 134.3, 131.0, 129.7, 127.8, 127.0, 51.7, 36.6, 34.2.
NMe
Pd H
SPhos cl
SPhos palladium(II) phenethyl(methyl)amine chloride (7). SPhos (400 mg, 0.97
mmol) was added to an oven-dried Schlenk tube, which was transferred to a glovebox. In the
glovebox, 2-(2-chlorophenyl)-N-methylethanamine (165 mg, 0.97 mmol) and Me2Pd(tmeda)
(246 mg, 0.97 mmol) were added to the Schlenk tube with ether (3 mL). The Schlenk tube was
sealed with a Teflon stopper and heated to 50 *C in an oil bath for 3 h outside of the glovebox.
The contents of the Schlenk tube were allowed to cool to rt and were poured into a 25 mL flask.
Hexanes (3 mL) were added and the mixture was placed in a -20 0C freezer. After 36 h, yellow-
orange, rock-like crystals of the title compound were collected (450 mg, 68%) "H NMR (400
MHz, CDC13) 6: 7.35 (t, J = 8.4 Hz, 1H), 7.13 (t, J = 7.5 Hz, 1H), 7.05 (m, 1H), 6.80-6.88 (m,
3H), 6.61-6.74 (m, 4H), 6.37 (t, J = 7.3 Hz, 1H), 4.15 (bs, 1H), 3.77 (s, 3H), 3.66 (s, 3H), 3.41
(m, 2H), 2.85 (bd, J = 14 Hz, 1H), 2.57 (bs, 1H), 3.34 (m, 4H), 1.84-2.17 (m, 5H), 1.45-1.80 (m,
9H), 0.71-1.44 (m, 7H). 31P NMR (162 MHz, THF) 6: 59.3 ppm.
NMe
PdN H
XPhos CI
XPhos palladium(lI) phenethyl(methyl)amine chloride (9). XPhos (400 mg, 0.84
mmol) was added to an oven-dried Schlenk tube, which was transferred to a glovebox. In the
glovebox, 2-(2-chlorophenyl)-N-methylethanamine (142 mg, 0.84 mmol) and Me2Pd(tmeda)
(212 mg, 0.84 mmol) were added to the Schlenk tube with MTBE (3 mL). The Schlenk tube was
sealed with a Teflon stopper and heated to 55 0C in an oil bath for 2.5 h outside of the glovebox.
The cooled reaction mixture was poured into a 25 mL flask to which hexanes (10 mL) were
added. The solution was placed in a -20 0C freezer for 18 h. The mother liquor was decanted
from the grey precipitate that formed. The mother liquor was then concentrated under reduced
pressure, affording the title compound (404 mg, 64%) as a fluffy yellow solid. 1H NMR (300
MHz, CDC13) 6: 6.69-7.43 (m, 9H), 6.38 (bs, 1H), 4.20 (bs, 1H), 3.39 (bs, 2H), 2.81-3.15 (m,
3H), 0.50-2.78 (m, ca. 44H), 0.26 (bs, 1H). 31P NMR (121 MHz, CDC13) 6: 63.2 ppm.
HN NO2
n-Bu
4-Butyl-N-(4-nitrophenyl)aniline. Following general procedure A, a mixture of 4-n-
butylchlorobenzene (169 mg, 1.0 mmol), 4-nitroaniline (166 mg, 1.2 mmol), K2 CO 3 (193 mg, 1.4
mmol), the XPhos pre-catalyst (7.4 mg, 0.01 mmol), and t-BuOH (2 mL) was heated to 110 0C
for 1 h. The crude product was purified via the Biotage SP4 (silica-packed 25+M; 0-20%
EtOAc/hexanes) to provide the title compound as an orange solid (264 mg, 98%), mp 77-78 0C.
1H NMR (300 MHz, CDC13) 6: 8.10 (d, J = 9.0 Hz, 2H), 7.20 (d, J = 8.5 Hz, 2H), 7.12 (d, J = 8.5
Hz, 2H), 6.88 (d, J = 9.0 Hz, 2H), 6.32 (s, 1 H), 2.62 (t, J = 7.5 Hz, 2H), 1.61 (quintet, J = 7.5 Hz,
2H), 1.38 (sextet, J = 7.5 Hz, 2H), 0.95 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3) 6:
151.1, 140.1, 139.5, 137.1, 129.9, 126.5, 122.7, 113.5, 35.4, 33.9, 22.6, 14.2 ppm. IR (neat,
cm-1): 3350, 2929, 2858, 1595, 1512, 1182, 1112, 835, 751, 694, 489. Anal. Calcd for
C16H18N20 2: C, 71.09; H, 6.71. Found: C, 71.20; H, 6.72.
02N
HN
n-Bu
N-(4-Butylphenyl)-2-nitroaniline. Following general procedure A, a mixture of 4-n-
butylchlorobenzene (169 mg, 1.0 mmol), 2-nitroaniline (166 mg, 1.2 mmol), K2C0 3 (193 mg, 1.4
mmol), the XPhos pre-catalyst (7.4 mg, 0.01 mmol), and t-BuOH (2 mL) was heated to 110 0C
for 2 h. The crude product was purified via the Biotage SP4 (silica-packed 25+M; 0-20%
EtOAc/hexanes) to provide the title compound as a red oil (225 mg, 83%). 'H NMR (300 MHz,
CDC13) 6: 9.48 (s, 1H), 8.19 (d, J = 8.5 Hz, 1H), 7.33 (t, J= 8.5 Hz, 1H), 7.18 (m, 5H), 6.73 (t, J
= 8.0 Hz, 1 H), 2.63 (t, J = 7.5 Hz, 2H), 1.62 (quintet, J = 7.5 Hz, 2H), 1.38 (sextet, J = 7.5 Hz,
2H), 0.94 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 143.9, 141.0, 136.3, 135.9,
133.0, 129.9, 126.9, 124.9, 117.3, 116.2, 35.4, 33.9, 22.6, 14.2 ppm. IR (neat, cm 1): 3353,
2929, 1618, 1607, 1575, 1348, 1327, 1263, 1148, 1077, 1039, 740. Anal. Calcd for
C16H18N20 2: C, 71.09; H, 6.71. Found: C, 71.30; H, 6.74.
0
HN Me
OMe
1-(4-(4-Methoxyphenylamino)phenyl)ethanone. Following general procedure A, a
mixture of 4-chloroanisole (123 pL, 1.0 mmol), 4-aminoacetophenone (162 mg, 1.2 mmol),
K2 CO3 (193 mg, 1.4 mmol), the XPhos pre-catalyst (7.4 mg, 0.01 mmol), and t-BuOH (2 mL)
was heated to 110 0C for 1 h. The crude product was purified via the Biotage SP4 (silica-
packed 25+M; 10-50% EtOAc/hexanes) to provide the title compound as a white solid (223 mg,
93%), mp 115-117 *C. 'H NMR (300 MHz, CDCI3) 6: 7.82 (d, J = 9.0 Hz, 2H), 7.14 (d, J = 9.0
Hz, 2H), 6.90 (d, J = 9.0 Hz, 2H), 6.81 (d, J = 9.0 Hz, 2H), 5.98 (s, 1 H), 3.82 (s, 3H), 2.51 (s,
3H) ppm. 13C NMR (75 MHz, CDC13) 6: 196.7, 156.8, 150.4, 133.5, 131.0, 128.2, 124.7, 115.0,
113.3, 55.8, 26.4 ppm. IR (neat, cm-1): 3313, 1648, 1587, 1384, 1358, 1279, 1239, 1173, 959,
833, 598. Anal. Calcd for C15H15NO2: C, 74.67; H, 6.27. Found: C, 74.39; H, 6.45.
SCO2Et
HN 
N C 
2
HN
OMe
Ethyl-4-(3-methoxyphenylamino)benzoate. Following general procedure A, a mixture
of 3-chloroanisole (123 pL, 1.0 mmol), ethyl-4-aminobenzoate(198 mg, 1.2 mmol), K2C03 (193
mg, 1.4 mmol), the XPhos pre-catalyst (7.4 mg, 0.01 mmol), and t-BuOH (2 mL) was heated to
110 0C for 0.5 h. The crude product was purified via the Biotage SP4 (silica-packed 25+M; 0-
30% EtOAc/hexanes) to provide the title compound as a white solid (255 mg, 94%), mp 77 *C.
'H NMR (300 MHz, CDC13) 6: 7.94 (d, J = 7.0 Hz, 2H), 7.23 (t, J = 8.5 Hz, 1 H), 7.02 (d, J = 8.5
Hz, 2H), 6.75 (m, 2H), 6.60 (d, J = 8.0 Hz, 1 H), 6.34 (s, 1 H), 4.34 (q, J = 7.0 Hz, 2H), 3.78, (s,
3H), 1.38 (t, J = 7.0 Hz, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 166.9, 160.9, 148.1, 142.6,
131.7, 130.5, 121.6, 115.2, 112.7, 108.3, 106.0, 60.8, 55.5, 14.7 ppm. IR (neat, cm-1): 3350,
2980, 1684, 1599, 1525, 1175, 1111, 1048, 840, 770, 692. Anal. Calcd for C16H17NO 3: C,
70.83; H, 6.32. Found: C, 70.67; H, 6.27.
Et 2C
HN:
OMe
Ethyl-2-(3-methoxyphenylamino)benzoate. Following general procedure A, a mixture
of 3-chloroanisole (123 pL, 1.0 mmol), ethyl-2-aminobenzoate(198 mg, 1.2 mmol), K2 CO3 (193
mg, 1.4 mmol), the XPhos pre-catalyst (7.4 mg, 0.01 mmol), and t-BuOH (2 mL) was heated to
110 0C for 0.5 h. The crude product was purified via the Biotage SP4 (silica-packed 25+M; 0-
30% EtOAc/hexanes) to provide the title compound as a yellow oil (264 mg, 97%). 'H NMR
(300 MHz, CDC13) 6: 9.58 (s, 1 H), 8.02 (d, J = 7.5 Hz, 1 H), 7.37 (m, 2H), 7.26 (t, J = 8.0 Hz, 1 H),
6.88 (d, J = 8.0, 1 H), 6.85 (s, 1 H), 6.77 (m, 1 H), 6.66 (dd, J = 2.5 Hz, J = 7.5 Hz, 1 H), 4.39 (q, J
= 7.0 Hz, 2H), 3.82 (s, 3H), 1.44 (t, J = 7.0 Hz, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 168.8,
160.9,147.9, 142.4, 134.3, 131.9, 130.3, 117.5, 114.7, 114.7, 112.7, 109.1, 107.9, 60.9, 55.5,
14.6 ppm. IR (neat, cm-1): 3319, 2980, 1684, 1595, 1493, 1453, 1198, 1159, 1082, 749. Anal.
Calcd for C 6H17NO3: C, 70.83; H, 6.32. Found: C, 71.02; H, 6.41.
HN 
CF 3
Me
Me
2,5-Dimethyl-N-(4-(trifluoromethyl)phenyl)aniline. Following general procedure A, a
mixture of 2-chloro-p-xylene (134 pL, 1.0 mmol), 4-(trifluoromethyl)aniline (151 pL, 1.2 mmol),
K2CO3 (193 mg, 1.4 mmol), the XPhos pre-catalyst (7.4 mg, 0.01 mmol), and t-BuOH (2 mL)
was heated to 110 0C for 1 h. The crude product was purified via the Biotage SP4 (silica-
packed 25+M; 0-30% EtOAc/hexanes) to provide the title compound as a yellow oil (238 mg,
90%). 1H NMR (300 MHz, CDC13) 6: 7.50 (d, J = 8.5 Hz, 2H), 7.19 (d, J = 7.5 Hz, 1H), 7.14 (s,
1 H), 6.96 (d, J = 7.5 Hz, 1 H), 6.88 (d, J = 8.5 Hz, 2H), 5.59 (s, 1 H), 2.37 (s, 3H), 2.25 (s, 3H)
ppm. 13C NMR (75 MHz, CDC13 ) 6: 148.3, 139.2, 137.0, 131.3, 28.6, 126.9 (q, J = 4.0 Hz),
125.5, 125.1 (q, J = 269.0 Hz), 123.4, 120.9 (q, J = 32.5 Hz), 114.9, 21.3, 17.7 ppm. IR (neat,
cm 1): 3391, 3021, 2923, 2862, 1611, 1526, 1400, 1331, 1186, 1067, 831. C13 H14 F3N: C, 67.91;
H, 5.32. Found: C, 68.48; H, 5.37.
HN CN
MeO
OMe
4-(2,5-Dimethoxyphenylamino)benzonitrile. Following general procedure A, a mixture
of chloro-2,5-dimethoxybenzene (143 pL, 1.0 mmol), 4-aminobenzonitrile (142 mg, 1.2 mmol),
K2CO3 (193 mg, 1.4 mmol), the XPhos pre-catalyst (7.4 mg, 0.01 mmol), and t-BuOH (2 mL)
was heated to 110 0C for 1 h. The crude product was purified via the Biotage SP4 (silica-
packed 25+M; 25-80% EtOAc/hexanes) to provide the title compound as a white solid (253 mg,
99%), mp 98-99 *C. 1H NMR (300 MHz, CDC13) 6: 7.46 (d, J = 8.5 Hz, 2H), 7.07 (d, J = 8.5 Hz,
2H), 6.94 (d, J = 2.5 Hz, 1 H), 6.83 (d, J = 9.0 Hz, 1 H), 6.51 (dd, J = 2.5 Hz, J = 9.0 Hz, 1 H), 6.47
(s, 1H), 3.81 (s, 3H), 3.75 (s, 3H) ppm. 13C NMR (75 MHz, CDCl3) 6: 154.0, 147.3, 144.3,
133.9, 130.7, 120.2, 116.1, 111.8, 106.3, 105.6, 102.1, 56.4, 55.9 ppm. IR (neat, cm'): 3351,
2938, 2834, 2217, 1529, 1508, 1247, 1217,1175, 1047, 829, 544. Anal. Calcd for C15H14N202:
C, 70.85; H, 5.55. Found: C, 70.59; H, 5.52.
CHO
HN
i-Pr i-Pr
4-(2,6-Diisopropylphenylamino)benzaldehyde. Following general procedure A, a
mixture of 4-chlorobenzaldehyde (141 mg, 1.0 mmol), 2,6-diisopropylaniline (198 pL, 1.05
mmol), K2CO3 (193 mg, 1.4 mmol), the RuPhos pre-catalyst (7.3 mg, 0.01 mmol), and t-BuOH
(2 mL) was heated to 110 0C for 1 h. The crude product was purified via the Biotage SP4
(silica-packed 25+M; 0-20% EtOAc/hexanes) to provide the title compound as a white solid (255
mg, 91%), mp 125-127 *C. 1H NMR (300 MHz, CDC13) 6: 9.72 (s, 1H), 7.68 (d, J= 8.0 Hz, 2H),
7.38 (t, J = 7.0 Hz, 1 H), 7.27 (d, J = 7.0 Hz, 2H), 6.85-6.30 (bs, 2H), 6.23 (s, 1 H), 3.17 (septet, J
= 7.0 Hz, 2H), 1.16 (d, J =7.0 Hz, 12H) ppm. 13C NMR (75 MHz, CDC13) 6:190.7,154.2, 148.0,
133.5, 132.7, 128.6, 127.1, 124.4, 112.4, 28.6, 24.1 ppm. IR (neat, cm'): 3327, 2963, 2869,
2819, 2743, 1671, 1521, 1470, 1339, 1307, 1227, 1160, 829, 751, 734. Anal. Calcd for
C19H23NO: C, 81.10; H, 8.24. Found: C, 80.97; H, 8.31.
CHO
HN
4-(Phenylamino)benzaldehyde. Following general procedure B, a mixture of 4-
chlorobenzaldehyde (141 mg, 1.0 mmol), aniline (95 pL, 1.05 mmol), K2CO 3 (193 mg, 1.4
mmol), the XPhos pre-catalyst (7.3 mg, 0.01 mmol), and t-BuOH (2 mL) was heated to 110 0C
for 1 h. The crude product was purified via the Biotage SP4 (silica-packed 25+M; 0-30%
EtOAc/hexanes) to provide the title compound as a yellow solid (175 mg, 89 %), mp 0C. 1H
NMR (300 MHz, CDC13) 6: 9.78 (s, 1 H), 7.74 (d, J = 9.0 Hz, 2H), 7.36 (t, J = 7.5 Hz, 2H), 7.21
(d, J = 7.5 Hz, 2H), 7.11 (t, J = 7.5 Hz, 1 H), 7.04 (d, J = 9.0 Hz, 2H), 6.91 (s, 1 H) ppm. 13C NMR
(75 MHz, CDC13) 6: 190.8, 150.3, 140.4, 132.5, 129.8, 128.5, 124.1, 121.6, 114.7 ppm. IR
(neat, cm'): 3328, 2825, 2744, 1667, 1526, 1497, 1452, 1327, 1227, 1163, 827, 748, 696,
508. Anal. Calcd for C13H1NO: C, 79.16; H, 5.62. Found: C, 78.89; H, 5.56.
HN
OCH 3
4-Methoxy-N-phenylaniline. Following general procedure D, a mixture of 4-
chloroanisole (123 pL, 1.0 mmol), aniline (110 pL, 1.2 mmol), NaOt-Bu (115 mg, 1.2 mmol), the
XPhos precatalyst:XPhos mixture (1.2 mg, 0.001 mmol), and 1,4-dioxane (1 mL) was heated to
100 *C for 10 min. The crude product was purified via the Biotage SP4 (silica-packed 25+M; 0-
30% EtOAc/hexanes) to provide the title compound as a white solid (195 mg, 98%), mp 104-106
C. 'H NMR (300 MHz, CDC13) 6: 7.27 (t, J = 7.0 Hz, 2H), 7.12 (d, J = 7.0 Hz, 2H), 6.96 (d, J =
7.5 Hz, 2H), 6.90 (m, 3H), 5.54 (bs, 1H), 3.84 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 155.5,
145.5, 136.1, 129.7, 122.5, 119.9, 115.9, 115.0, 55.9 ppm. IR (neat, cm'): 3400, 3057, 2999,
2930, 2834, 1598, 1506, 1247, 1031. Anal. Calcd for C13H13NO: C, 78.36; H, 6.58. Found: C,
78.44; H, 6.69.
HN
OCH 3
4-Methoxy-N-phenylaniline. Following general procedure C, a mixture of 4-
chloroanisole (123 pL, 1.0 mmol), aniline (110 pL, 1.2 mmol), NaOt-Bu (115 mg, 1.2 mmol), the
XPhos precatalyst (7.4 mg, 0.01 mmol), XPhos (4.4 mg, 0.01mmol), and 1,4-dioxane (1 mL)
was heated to 100 0C for 1 min. The crude product was purified via the Biotage SP4 (silica-
packed 25+M; 0-30% EtOAc/hexanes) to provide the title compound as a white solid (194 mg,
97%), mp 104-106 *C. 1H NMR (300 MHz, CDC13) 6: 7.27 (t, J = 7.0 Hz, 2H), 7.12 (d, J = 7.0
Hz, 2H), 6.96 (d, J = 7.5 Hz, 2H), 6.90 (m, 3H), 5.54 (bs, 1 H), 3.84 (s, 3H) ppm. 13C NMR (75
MHz, CDC13) 6:155.5, 145.5, 136.1, 129.7, 122.5, 119.9, 115.9, 115.0, 55.9 ppm. IR (neat, cm-
1): 3400, 3057, 2999, 2930, 2834, 1598, 1506, 1247,1031.
HN CF3
OCH3
N-(4-Methoxyphenyl)-3-(trifl uoromethyl)ani line. 4 Following general procedure D, a
mixture of 4-chloroanisole (123 pL, 1.0 mmol), 3-(trifluoromethyl)aniline (150 pL, 1.2 mmol),
NaOt-Bu (115 mg, 1.2 mmol), the XPhos precatalyst:XPhos mixture (1.2 mg, 0.001mmol), and
1,4-dioxane (1 mL) was heated to 100 0C for 10 min. The crude product was purified via the
Biotage SP4 (silica-packed 25+M; 0-30% EtOAc/hexanes) to provide the title compound as a
white solid (254 mg, 95%), mp 56-58 *C. 1H NMR (300 MHz, CDC13 ) 6: 7.30 (t, J = 8.0 Hz, 1 H),
7.10 (d, J = 9.0 Hz, 2H), 7.01 (m, 3H), 6.93 (d, J = 9.0 Hz, 2H), 5.66 (bs, 1 H), 3.84 (s, 3H) ppm.
13C NMR (75 MHz, CDC13 ) 6: 156.4, 146.3, 134.5, 131.8 (q, J = 31.5 Hz), 130.1, 124.5 (q, J =
271 Hz), 123.7, 118.1, 115.8 (q, J = 4.0 Hz), 115.1, 111.5 (q, 4.0 Hz), 55.8 ppm. IR (neat, cm~
1): 3400, 3040, 2937, 2837, 1617,1492,1320,1123,1069.
HN F
H3C I
CH3
N-(4-Fluorophenyl)-2,5-dimethylaniline. Following general procedure D, a mixture of
2-chloro-p-xylene (134 pL, 1.0 mmol), 4-fluoroaniline (114 pL, 1.2 mmol), NaOt-Bu (115 mg, 1.2
mmol), the XPhos precatalyst:XPhos mixture (1.2 mg, 0.001 mmol), and 1,4-dioxane (1 mL) was
heated to 100 0C for 10 min. The crude product was purified via the Biotage SP4 (silica-packed
25+M; 0-30% EtOAc/hexanes) to provide the title compound as a yellow oil (199 mg, 93%). 1H
NMR (300 MHz, CDCl3) 6: 7.16 (d, J= 7.5 Hz, 1H), 7.04 (m, 5H), 6.82 (d, J= 7.5 Hz, 1H), 5.32
(bs, 1H), 2.36 (s, 3H), 2.29 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 158.1 (d, J = 238 Hz),
142.2, 140.2 (d, J = 2.5 Hz), 131.1, 124.5, 122.6, 120.4 (d, J = 8.0 Hz), 118.3, 116.2 (d, J= 22.0
Hz), 21.5, 17.7 ppm. IR (neat, cm-1): 3419, 3017, 2972, 2921, 2859, 1580, 1459, 1309, 1214,
827, 804, 504. Anal. Calcd for C14H14NF: C, 78.11; H, 6.56. Found: C, 78.13; H, 6.71.
H3 C
HN CH3
6
2,5-Dimethyl-N-phenylaniline.15 Following general procedure D, a mixture of
chlorobenzene (102 pL, 1.0 mmol), 2,5-dimethylaniline (149 pL, 1.2 mmol), NaOt-Bu (115 mg,
1.2 mmol), the XPhos precatalyst:XPhos mixture (1.2 mg, 0.001 mmol), and 1,4-dioxane (1 mL)
was heated to 100 0C for 10 min. The crude product was purified via the Biotage SP4 (silica-
packed 25+M; 0-30% EtOAc/hexanes) to provide the title compound as a yellow oil (187 mg,
95%). 1H NMR (300 MHz, CDC13) 6: 7.45 (t, J = 8.5 Hz, 2H), 7.28 (m, 2H), 7.12 (m, 3H), 6.97
(d, J = 7.5 Hz, 1 H), 5.49 (bs, 1 H), 2.48 (s, 3H), 2.40 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6:
144.6, 141.4, 136.9, 131.2, 129.8, 125.9, 123.3, 120.7, 120.1, 117.8, 21.6, 17.9 ppm. IR (neat,
cm-1): 3388, 3048, 3019, 2920, 1600, 1519, 1311, 748.
HN
MeO
OMe
2,5-Dimethoxy-N-phenylaniline. Following general procedure E, a mixture of chloro-
2,5-dimethoxybenzene (143 mg, 1.0 mmol), aniline (110 pL, 1.2 mmol), NaOt-Bu (115 mg, 1.2
mmol), the XPhos pre-catalyst (7.4 mg, 0.01 mmol), and 1,4-dioxane (1 mL) was stirred at room
temperature for 2 h. The crude product was purified via the Biotage SP4 (silica-packed 25+M;
0-20% EtOAc/hexanes) to provide the title compound as a yellow oil (225 mg, 98%). 1H NMR
(300 MHz, CDC13 ) 6: 7.33 (t, J = 7.0 Hz, 2H), 7.21 (d, J = 7.0 Hz, 2H), 7.00 (t, J = 7.0 Hz, 1 H),
6.96 (d, J = 3.0 Hz, 1 H), 6.82 (d, J = 9.0 Hz, 1 H), 6.38 (dd, J = 3.0 Hz, J = 9.0 Hz, 1 H), 6.25 (s,
1H), 3.88 (s, 3H), 3.77 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 154.3, 142.8, 142.4, 134.3,
129.6, 121.8, 119.3, 111.3, 103.0, 101.7, 56.5, 55.9 ppm. IR (neat, cm'): 3407, 2938, 2833,
1526, 1497, 1464, 1415, 1247, 1215, 1047, 749. Anal. Calcd for C14H15NO2: C, 73.34; H, 6.59.
Found: C, 73.22; H, 6.65.
OMe
Me N
Me
4-Dibutylaminoanisole.16 Following general procedure F, a mixture of 4-chloroanisole
(123 mL, 1.0 mmol), dibutylamine (202 mL, 1.2 mmol), RuPhos precatalyst (7.3 mg, 0.01 mmol),
and LHMDS solution (1.5 mL, 0.8 M in dioxane, 1.2 mmol) was stirred at room temperature for 3
h. The crude product was purified by column chromatography, using 95:5 Hex:EtOAc as the
eluent, to provide the title compound as a colorless oil (219 mg, 93%). 1H NMR (400 MHz,
CDC13) 6: 6.85 (d, J = 9.1 Hz, 2H), 6.68 (d, J = 9.1 Hz, 2H), 3.78 (s, 3H), 3.22 (t, J = 7.6 Hz, 4H),
1.55 (m, 4H), 1.37 (m, 4H), 0.97 (t, J = 7.3 Hz, 6H). 13C NMR (100 MHz, CDC13): d 151.1, 143.5,
114.9, 114.4, 56.0, 51.8, 29.6, 20.6, 14.2.
Me '"N OH
Me
3-Dibutylaminophenethyl alcohol.7 Following general procedure F, a mixture of 3-
chlorophenethyl alcohol (133 mL, 1.0 mmol), dibutylamine (202 mL, 1.2 mmol), XPhos
precatalyst (7.4 mg, 0.01 mmol), and LHMDS solution (3.0 mL, 0.8 M in dioxane, 2.4 mmol) was
stirred at room temperature for 4 h. The crude product was purified by column chromatography,
using 97:3 CH 2Cl2:MeOH as the eluent, to provide the title compound as a pale yellow oil (234
mg, 94%). 1H NMR (400 MHz, CDC13) 6: 7.17 (t, J= 8.0 Hz, 1H), 6.54 (m, 3H), 3.86 (t, J = 6.6
Hz, 2H), 3.29 (m, 4H), 2.83 (t, J = 6.6 Hz, 2H), 1.61 (m, 4H), 1.51 (bs, 1 H), 1.39 (m, 4H), 0.99 (t,
J = 7.4 Hz, 6H). 13C NMR (100 MHz, CDC13): d 148.6, 139.4, 129.6, 115.8, 112.4, 110.0, 64.0,
50.9, 40.0, 29.6, 20.5, 14.2.
OH
Me ,N
Me
4-Dibutylaminophenethyl alcohol.17 Following general procedure F, a mixture of 4-
chlorophenethyl alcohol (135 mL, 1.0 mmol), dibutylamine (202 mL, 1.2 mmol), XPhos
precatalyst (7.4 mg, 0.01 mmol), and LHMDS solution (3.0 mL, 0.8 M in dioxane, 2.4 mmol) was
stirred at room temperature for 8 h. The crude product was purified by column chromatography,
using 98:2 CH2Cl2:MeOH as the eluent, to provide the title compound as a pale yellow oil (209
mg, 84%). 1H NMR (400 MHz, CDCI3) 6: 7.07 (d, J = 8.7 Hz, 2H), 6.62 (d, J = 8.7 Hz, 2H), 3.80
(t, J = 6.6 Hz, 2H), 3.26 (t, J = 7.5 Hz, 4H), 2.76 (t, J = 6.6 Hz, 2H), 1.63 (bs, 1 H), 1.57 (m, 4H),
1.37 (m, 4H), 0.97 (t, J = 7.3 Hz, 6H). 13C NMR (100 MHz, CDCI3): d 147.1, 130.0, 124.5,
112.1, 64.2, 51.0, 38.2, 29.6, 20.5, 14.2.
CH 3
N
0 CH 3
4-(2,5-Dimethylphenyl)morpholine.'8 RuPhos precatalyst (7.3 mg, 0.01 mmol) was
added to an oven-dried Schlenk tube. The vessel was evacuated and backfilled with argon.
This sequence was performed three times. With the Schlenk tube under a positive pressure of
argon, 2,5-dimethyl chlorobenzene (134 mL, 1 mmol) and morpholine (106 mL, 1.2 mmol) were
added through an attached septum using a syringe. This mixture was cooled to -10 0C in a
Neslab CC100 immersion cooler. LHMDS solution (1.2 M in DME, 1 mL, 1.2 mmol) was added
through the septum dropwise via syringe. The rubber septum was replaced with a Teflon
stopper and reaction mixture was allowed to stir at -10 0C for 24 h. Saturated ammonium
chloride (5 mL) was added to the reaction vessel. The resulting mixture was poured into a
separatory funnel and extracted with EtOAc (3 x 25 mL). The combined organics were dried
over Na2SO4, and concentrated under reduced pressure. The remaining yellow liquid was
purified via silica column chromatography using 80:20 Hex:EtOAc as the eluent to provide the
title compound as a colorless oil (180 mg, 94%). 1H NMR (400 MHz, CDC13) 6: 7.18 (d, J = 7.2
Hz, 1 H), 6.85 (s, 1 H), 6.84 (d, J = 7.6 Hz, 1 H), 3.87 (t, J = 4.8 Hz, 2H), 2.92 (t, J = 4.8 Hz, 2H),
2.34 (s, 1H), 2.30 (s, 1H). 13C NMR (100 MHz, CDC13): d 151.3, 136.4, 131.2, 129.4, 124.2,
119.8, 67.7, 52.4, 21.4, 17.7.
0 CH3
N0 
C H3
0
iso-Propyl-4-morpholine benzoate. Following general procedure C, a mixture of 4-
chloro-isopropylbenzoate (198 mg, 1.0 mmol), morpholine (106 pL, 1.2 mmol), NaOt-Am (112
mg, 1.02 mmol), the SPhos precatalyst (6.8 mg, 0.01 mmol), and 1,4-dioxane (1.5 mL) was
stirred at room temperature for 2 h. The crude product was purified by column chromatography,
using 75:25 Hex:EtOAc as the eluent, to provide the title compound as a white solid (204 mg,
84%). 'H NMR (400 MHz, CDC13) 6: 7.94 (m, 2H), 6.86 (m, 2H), 5.21 (septet, J = 6.2 Hz, 1 H),
3.86 (m, 4H), 3.27 (m, 4H), 1.34 (d, J = 6.4 Hz, 6H). 13C NMR (100 MHz, CDC13): d 166.3,
154.3, 131.3, 121.4, 113.7, 67.8, 66.8, 48.0, 22.3.
CH3 H
CH3
N-Benzyl-2,6-dimethylaniline. 4a Following general precedure E, a mixture of 2-chloro-
m-xylene (133 pL, 1.0 mmol), benzylamine (131 pL, 1.2 mmol), NaOt-Bu (115 mg, 1.2 mmol),
the RuPhos pre-catalyst (7.4 mg, 0.01 mmol), and 1,4-dioxane (1 mL) was stirred at room
temperature for 20 min. The crude product was purified by column chromatography, using 95:5
Hex:EtOAc as the eluent, to provide the title compound as a colorless oil (209 mg, 99%).'H
NMR (400 MHz, CDCI3) 6: 7.34-7.41 (m, 4H), 7.31 (m, 1 H), 7.03 (d, J = 7.4 Hz, 2H), 6.87 (t, J =
7.4 Hz, 1H), 4.13 (s, 2H), 3.23 (s, 1H), 2.30 (s, 6H). 13C NMR (100 MHz, CDC13): d 146.1,
140.6, 130.0, 129.0, 128.8, 128.2, 127.5, 122.4, 53.1, 18.7.
X-ray Crystal Structure Data for 5 - CH 2Cl2 :
Table 1. Crystal data and structure
Identification code
Empirical formula
Formula weight
Temperature
Wavelength
Crystal system
Space group
Unit cell dimensions
Volume
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
refinement for 5 * CH2Cl2-
5 - CH 2Cl 2
C35H47CI3NO2PPd
757.46
100(2) K
0.71073 A
Triclinic
P-1
a = 10.2166(5) A
b = 10.2662(5) A
c = 18.1889(9) A
1821.70(15) A3
a = 82.5960(10)0.
@ = 81.6320(10).
y = 75.8760(10)0.
1.381 Mg/m 3
0.804 mm-1
784
0.34 x 0.21 x 0.19 mm3
1.14 to 23.280.
-11 <=h<=1 1, -11 <=k<=1 1, -20<=I<=20
25715
Independent reflections
Completeness to theta = 23.280
Absorption correction
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [l>2sigma(l)]
R indices (all data)
Largest diff. peak and hole
Table 2. Atomic coordinates (x 104)
103). U(eq) is defined as one third of
CI(3)
Cl(2)
C(36)
Pd(1)
P(1)
Cl(1)
N(1)
C(25)
0(2)
0(1)
C(7)
C(4)
C(24)
C(30)
C(3)
C(1)
C(5)
C(11)
C(12)
6388(3)
5936(3)
6941(10)
623(1)
1257(1)
757(1)
-62(4)
387(4)
2135(3)
3765(3)
3019(4)
-267(4)
705(4)
-868(4)
-1016(4)
841(3)
1013(4)
4582(4)
3274(4)
5242 [R(int) = 0.0212]
99.8 %
SADABS
Full-matrix least-squares on F2
5242 /0 / 398
1.107
R1 = 0.0355, wR2 = 0.1237
R1 = 0.0363, wR2 = 0.1247
1.534 and -0.432 e.A-3
and equivalent isotropic displacement parameters (A2 x
the trace of the orthogonalized Uij tensor.
7741(3)
5882(3)
6168(12)
3039(1)
3594(1)
5192(1)
2551(4)
1211(4)
4114(3)
41(3)
2123(4)
1067(4)
5917(4)
937(4)
1589(3)
2572(3)
1295(4)
3188(4)
3165(4)
5068(1)
4109(1)
4743(6)
3634(1)
2403(1)
3978(1)
4773(2)
3489(2)
67(1)
1442(2)
777(2)
900(2)
1343(2)
3798(2)
1536(2)
1736(2)
687(2)
-85(2)
239(2)
50(1)
52(1)
54(3)
17(1)
16(1)
29(1)
23(1)
21(1)
25(1)
27(1)
19(1)
22(1)
21(1)
26(1)
20(1)
17(1)
21(1)
29(1)
22(1)
C(19) 324(3) 5343(3) 2142(2) 18(1)
C(26) 1363(4) 212(4) 3144(2) 29(1)
C(22) -1507(4) 7670(4) 1407(2) 27(1)
C(21) -1937(4) 7032(4) 2187(2) 25(1)
C(2) -461(3) 2314(3) 1944(2) 18(1)
C(13) 3078(4) 3646(4) 2223(2) 20(1)
C(18) 3354(4) 4899(4) 2490(2) 24(1)
C(9) 5431(4) 1054(4) 617(2) 31(1)
C(6) 1596(4) 2034(3) 1089(2) 18(1)
C(10) 5646(4) 2128(4) 110(2) 32(1)
C(29) -1114(5) -323(4) 3725(2) 35(1)
C(15) 5435(4) 2349(5) 2481(3) 35(1)
C(16) 5702(4) 3600(5) 2741(2) 34(1)
C(8) 4114(4) 1053(4) 947(2) 24(1)
C(14) 3924(4) 2363(4) 2608(2) 26(1)
C(27) 1110(5) -1047(4) 3100(2) 37(1)
C(33) 4842(4) -1008(4) 1703(3) 35(1)
C(32) -1402(4) 2171(4) 4940(2) 31(1)
C(34) 2303(5) 5269(4) -435(2) 32(1)
C(17) 4882(4) 4873(4) 2356(2) 33(1)
C(31) -1909(4) 1965(4) 4227(2) 29(1)
C(23) 37(4) 7424(4) 1239(2) 25(1)
C(28) -113(5) -1308(4) 3383(2) 39(1)
C(20) -1225(4) 5535(4) 2313(2) 21(1)
Table 3. Bond lengths [ A] and angles [*].
Cl(3)-C(36) 1.726(11)
CI(2)-C(36) 1.747(9)
Pd(1)-C(25) 2.004(4)
Pd(1)-N(1) 2.124(3)
Pd(1)-P(1) 2.2786(9)
Pd(1)-CI(1) 2.4126(9)
P(1)-(1 9) 1.853(3)
P(1)-C(13)
P(1)-C(1)
N(1)-C(32)
C(25)-C(26)
C(25)-C(30)
0(2)-C(1 2)
O(2)-C(34)
0(1)-C(8)
0(1)-C(33)
C(7)-C(1 2)
C(7)-C(8)
C(7)-C(6)
C(4)-C(5)
C(4)-C(3)
C(24)-C(1 9)
C(24)-C(23)
C(30)-C(29)
C(30)-C(31)
C(3)-C(2)
C(1)-C(6)
C(1)-C(2)
C(5)-C(6)
C(11)-C(12)
C(1 1)-C(10)
C(1 9)-C(20)
C(26)-C(27)
C(22)-C(23)
C(22)-C(21)
C(21)-C(20)
C(1 3)-C(1 8)
C(1 3)-C(1 4)
C(1 8)-C(1 7)
C(9)-C( 10)
C(9)-C(8)
C(29)-C(28)
C(1 5)-C(1 6)
1.855(4)
1.855(3)
1.492(5)
1.387(6)
1.402(6)
1.369(5)
1.429(5)
1.364(5)
1.428(5)
1.401(5)
1.402(5)
1.502(5)
1.376(5)
1.383(5)
1.529(5)
1.531(5)
1.402(6)
1.509(6)
1.377(5)
1.407(5)
1.408(5)
1.400(5)
1.385(5)
1.388(6)
1.537(5)
1.393(6)
1.527(6)
1.534(6)
1.535(5)
1.532(5)
1.534(5)
1.538(5)
1.383(6)
1.392(6)
1.388(7)
1.520(6)
C(1 5)-C(1 4) 1.525(5)
C(1 6)-C(1 7) 1.518(6)
C(27)-C(28) 1.356(7)
C(32)-C(31) 1.521(6)
CI(3)-C(36)-CI(2) 113.3(6)
C(25)-Pd(1)-N(1) 84.83(15)
C(25)-Pd(1)-P(1) 94.85(10)
N(1)-Pd(1)-P(1) 177.35(10)
C(25)-Pd(1)-CI(1) 172.27(11)
N(1)-Pd(1)-CI(1) 87.53(12)
P(1)-Pd(1)-CI(1) 92.73(3)
C(19)-P(1)-C(13) 104.84(16)
C(19)-P(1)-C(1) 104.60(15)
C(1 3)-P(1)-C(1) 110.52(16)
C(19)-P(1)-Pd(1) 108.36(11)
C(1 3)-P(1)-Pd(1) 111.60(12)
C(1)-P(1)-Pd(1) 116.05(11)
C(32)-N(1)-Pd(1) 117.3(3)
C(26)-C(25)-C(30)119.0(4)
C(26)-C(25)-Pd(1) 125.7(3)
C(30)-C(25)-Pd(1) 115.2(3)
C(1 2)-O(2)-C(34) 118.4(3)
C(8)-O(1)-C(33) 117.5(3)
C(1 2)-C(7)-C(8) 118.3(3)
C(12)-C(7)-C(6) 121.5(3)
C(8)-C(7)-C(6) 119.7(3)
C(5)-C(4)-C(3) 119.1(3)
C(1 9)-C(24)-C(23)110.0(3)
C(25)-C(30)-C(29)118.9(4)
C(25)-C(30)-C(31)120.2(3)
C(29)-C(30)-C(31)120.9(4)
C(2)-C(3)-C(4) 119.3(3)
C(6)-C(1)-C(2) 117.3(3)
C(6)-C(1)-P(1) 131.2(3)
C(2)-C(1)-P(1) 111.5(3)
C(4)-C(5)-C(6) 122.6(3)
C(1 2)-C(11 )-C(1 0)118.9(4)
O(2)-C(1 2)-C(1 1) 124.5(3)
O(2)-C(1 2)-C(7) 114.4(3)
C(11 )-C(1 2)-C(7) 121.1(4)
C(24)-C(1 9)-C(20)110.4(3)
C(24)-C(19)-P(1) 115.3(2)
C(20)-C(19)-P(1) 112.8(2)
C(25)-C(26)-C(27)121.0(4)
C(23)-C(22)-C(21)111.6(3)
C(22)-C(21)-C(20)112.4(3)
C(3)-C(2)-C(1) 122.9(3)
C(1 8)-C(1 3)-C(1 4)110.1(3)
C(18)-C(13)-P(1) 112.6(3)
C(14)-C(13)-P(1) 109.1(2)
C(1 3)-C(1 8)-C(1 7)110.7(3)
C(10)-C(9)-C(8) 118.8(4)
C(5)-C(6)-C(1) 118.7(3)
C(5)-C(6)-C(7) 114.1(3)
C(1)-C(6)-C(7) 127.1(3)
C(9)-C(1 0)-C(1 1) 121.7(4)
C(28)-C(29)-C(30)120.8(4)
C(1 6)-C(1 5)-C(1 4)111.2(3)
C(1 7)-C(1 6)-C(1 5)110.8(3)
O(1)-C(8)-C(9) 124.5(4)
0(1)-C(8)-C(7) 114.5(3)
C(9)-C(8)-C(7) 121.0(4)
C(1 5)-C(1 4)-C(1 3)111.5(3)
C(28)-C(27)-C(26)120.3(4)
N(1)-C(32)-C(31) 110.9(3)
C(1 6)-C(1 7)-C(1 8)111.0(3)
C(30)-C(31)-C(32)110.9(3)
C(22)-C(23)-C(24)111.0(3)
C(27)-C(28)-C(29)120.0(4)
C(21)-C(20)-C(1 9)110.6(3)
Symmetry transformations used to generate equivalent atoms:
Table 4. Anisotropic displacement parameters (A2x
exponent takes the form: -2p2[ h2 a*2 U1 1 + ... + 2 h
103). The anisotropic displacement factor
k a* b* U12 ]
Uli U22 U33 U23 U13 U12
CI(3)52(1)
CI(2)53(1)
C(36)
Pd(1)
P(1)17(1)
Cl(1)51 (1)
N(1)34(2)
C(25)
0(2)30(1)
0(1)25(1)
C(7)21(2)
C(4)28(2)
C(24)
C(30)
C(3)20(2)
C(1)21(2)
C(5)25(2)
C(11)
C(12)
C(19)
C(26)
C(22)
C(21)
C(2)20(2)
C(13)
C(18)
C(9)20(2)
C(6)20(2)
C(10)
66(2)
71(2)
36(5)
23(1)
16(1)
22(1)
19(2)
34(2)
22(1)
24(1)
24(2)
21(2)
24(2)
41(2)
19(2)
14(2)
20(2)
33(2)
25(2)
22(2)
45(2)
31(2)
21(2)
18(2)
19(2)
23(2)
40(2)
16(2)
22(2)
40(1)
39(1)
81(8)
16(1)
14(1)
18(1)
18(2)
19(2)
22(1)
29(2)
14(2)
21(2)
23(2)
24(2)
22(2)
14(2)
18(2)
38(2)
25(2)
16(2)
22(2)
18(2)
22(2)
15(2)
27(2)
28(2)
32(2)
16(2)
48(3)
-11(1)
-21(1)
53(6)
13(1)
-2(1)
-5(1)
-6(2)
13(2)
2(1)
-2(1)
-7(1)
-4(2)
19(2)
15(2)
1(2)
1(1)
-4(1)
21(2)
18(2)
17(2)
21(2)
33(2)
31(2)
-1(1)
16(2)
25(2)
-14(2)
1(1)
28(2)
2(1)
-6(1)
-35(6)
-2(1)
-3(1)
1(1)
-3(1)
2(1)
-1(1)
-4(1)
-3(1)
-6(2)
-1(2)
4(2)
-3(2)
-6(1)
-3(2)
-9(2)
-9(2)
-3(1)
-1(2)
0(2)
-2(2)
0(1)
-3(2)
-3(2)
-3(2)
-3(1)
-14(2)
-30(1)
-22(1)
-20(5)
-2(1)
-4(1)
-16(1)
-8(2)
-8(2)
-10(1)
1(1)
-7(2)
-9(2)
-5(2)
-11(2)
-7(2)
-3(1)
-4(2)
3(2)
-2(2)
-3(1)
-6(2)
-13(2)
-6(2)
-3(1)
-2(1)
-5(2)
-2(2)
-2(1)
4(2)
-4(5)
-5(1)
-7(2)
-7(2)
-13(2)
-19(2)
-9(2)
-5(1)
-6(2)
-4(2)
-1(2)
-7(2)
-9(2)
-13(2)
C(29)
C(15)
C(16)
C(8)27(2)
C(14)
C(27)
C(33)
C(32)
C(34)
C(17)
C(31)
C(23)
C(28)
C(20)
55(3)
22(2)
20(2)
28(2)
23(2)
64(3)
33(2)
37(2)
45(2)
28(2)
28(2)
31(2)
72(3)
22(2)
34(2)
43(2)
51(3)
19(2)
27(2)
21(2)
29(2)
35(2)
30(2)
43(2)
33(2)
22(2)
20(2)
22(2)
25(2)
37(2)
34(2)
-9(2)
29(2)
25(2)
38(2)
22(2)
25(2)
33(2)
28(2)
23(2)
30(2)
21(2)
9(2)
-9(2)
-6(2)
-4(2)
-6(2)
-5(2)
-2(2)
-3(2)
6(2)
-1(2)
1(2)
1(2)
1(2)
-3(2)
-19(2)
-6(2)
-5(2)
-6(2)
-6(2)
-11(2)
-11(2)
5(2)
-5(2)
-4(2)
-2(2)
-6(2)
-23(2)
-5(2)
-25(2)
-1(2)
-12(2)
-3(2)
-6(2)
4(2)
-16(2)
-19(2)
-19(2)
-14(2)
-8(2)
-17(2)
-4(2)
Table 5. Hydrogen coordinates (x 104) and isotropic displacement parameters (A2x 10 3).
x y z U(eq)
H(100)
H(99)
H(36A)
H(36B)
H(3)
H(4A)
H(4B)
H(6)
H(8)
H(9)
H(11)
H(12)
H(13A)
H(13B)
H(14A)
580(50)
-80(40)
6946
7887
-632
398
1704
-1904
1521
4749
584
2218
-1864
-1906
-2933
1880(50)
3080(40)
5470
6071
559
5435
5782
1448
935
3918
5920
389
7283
8653
7121
4930(30)
4950(20)
5174
4500
614
987
1239
1690
248
-435
2474
2936
1028
1373
2252
33(12)
1(11)
65
65
27
26
26
24
25
34
22
35
32
32
30
H(14B)
H(15)
H(1 6)
H(17A)
H(17B)
H(18)
H(20)
H(21)
H(22A)
H(22B)
H(23A)
H(23B)
H(25A)
H(25B)
H(26)
H(27A)
H(27B)
H(27C)
H(28A)
H(28B)
H(29A)
H(29B)
H(29C)
H(30A)
H(30B)
H(31 A)
H(31B)
H(32A)
H(32B)
H(33)
H(34A)
H(34B)
-1721
-980
3361
3032
2844
6169
6545
-1976
5944
5765
5456
6683
3616
3776
1796
5375
4460
5431
-2073
-1309
2871
1411
2740
5186
5042
-2767
-2100
385
281
-285
-1548
-1459
7529
2655
3659
4932
5721
329
2141
-505
1534
2310
3594
3588
2307
1562
-1725
-1470
-1655
-617
2891
1328
5748
5873
4979
4918
5673
1656
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Chapter 3.
A Highly Active Catalyst for Pd-Catalyzed Amination Reactions: Cross-Coupling
Reactions Using Aryl Mesylates and the Highly Selective Monoarylation of Primary Amines
Using Aryl Chlorides
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3.1 Introduction
Palladium-catalyzed C-N cross-coupling reactions are an important technology both in
industry and academia.' Despite considerable advances in the field,2 notable limitations remain
for which improved methods will have an immediate impact on the chemistry community.
Herein, we report a catalyst comprised of a new biaryldialkylphosphine ligand that shows
excellent reactivity and stability in C-N cross-coupling reactions and overcomes many
restrictions that previous catalyst systems have possessed. This improved ligand enables the
aminations of aryl mesylates as well as, for the first time, the highly selective monoarylation of
primary amines using low catalyst loadings of a monophosphine-based catalyst.
Me
OMe Me Me
MeO I IOMe
i-P i-2 PCy 2  P(t-Bu) 2  Me P(t-Bu) 2  Oi-Pr i-Pr i-Pr i-Pr i-Pr i-Pr P Cy P 2
OMe L CI
i-Pr i-Pr i-Pr i-Pr 6; L 1
1 XPhos 2 t-BuXPhos 3 4 5 8; L =3
Figure 1. Biarylphosphine ligands and Pd precatalysts.
3.2 Results and Discussion
Due to their high stability, good atom economy, and low cost, aryl mesylates represent
an important substrate class for C-N cross-coupling reactions.3 4 Recently, we demonstrated
that substitution of the phosphine-containing arene in biarylmonophosphine ligands can have
profound effects of the observed reactivity in catalytic reactions.6 In continued efforts to explore
this effect, we have prepared a new ligand with methoxy substitution on the phosphine-
containing arene (1)7 and have found it to be effective in the amination of aryl mesylates (Figure
1).
Initial studies focused on the coupling of 4-t-butylphenyl methanesulfonate and aniline.
Whereas catalyst systems based on the combination of Pd2(dba)3 and 1 failed to produce
product (Table 1, entry 1), precatalyst8 6 provided a 98% yield in 3 h (Table 1, entry 2).
Similarly, utilization of water-mediated catalyst activation with 1 and Pd(OAc) 2 gave the desired
product in 99% yield (Entry 3).9 In contrast, the use of ligand 2 (XPhos), which has been shown
to be efficient in couplings of other aryl sulfonates, 3c but lacks the methoxy groups, provided
only trace amounts of product when used either as precatalyst 7 or with the water-mediated
activation protocol (Table 1, entries 4 and 5).
Table 1. Screen of Ligands and Pd Sources for the Coupling of Aniline and 4-t-Butylphenyl
Methanesulfonatea
OMs H2N 1% Pd, Ligand N
t-Bu t-BuOH, 110 *Ct-Bu t-Bu."
Entry Ligand Pd Source Yieldc
1 1 Pd2(dba)3  0%
2 1 6 98%
3 1 Pd(OAc)2  99%
4 2 7 4%
5 2 Pd(OAc) 2  2%6 3 8 0%
7 4 Pd(OAc) 2  0%
8 5 Pd(OAc) 2 0%
[a] ArOMs (1mmol), amine (1.2 mmol), Pd (1 mol%), ligand (2 mol%), K2CO 3 (1.4 mmol), t-
BuOH (12 mL/mmol), 110 C, 3 h. [b] Using water activation protocol (ref. 9c). [c] GC Yields.
Because these results clearly implicate the importance of substitution in the upper arene
in 1, we also examined the use of the tetra-methyl substituted ligand 4, a congener of a ligand
which has been shown to be effective in amidation reactions.6 Unlike reactions employing 1,
reactions employing 4 failed to provide even detectable amounts of the desired product (Table
1, entry 7). These results demonstrate that the nature of the arene substituent is critical to the
performance of 1. Further, in order to show that the activity of 1 does not only arise from the
ortho methoxy substituent dimethoxy ligand 5, was synthesized. As with 4, the use of 5 as the
ligand failed to provide detectable product (Table 1, entry 8). These results, taken together,
reveal a cooperative effect between the methoxy substituents and the biaryl motiff and
demonstrate that both are required for the observed reactivity in catalytic reactions employing
ligand 1.
Having defined an efficient catalytic system, the scope of aryl mesylate coupling
reactions was next explored. Highlighted below (Table 2), a number of electron-deficient
anilines, which are less reactive in coupling reactions than electron-rich or -neutral anilines,10
were successfully reacted with both electron-rich and electron-deficient aryl mesylates in
excellent yields. Ortho substituents on both the aniline and aryl mesylate and several functional
groups were well tolerated (Table 2).11
Table 2. Formation of Diarylamines Using Aryl Mesylatesa
1 mol %6, 1mol %1
ArOMs + H2NAr' - ArN(H)Ar'
K2CO3, t-BuOH, 110 0C
HMe H
N C 2Et MeO NNi NH
F MeO Oe)
eOMe
99% 82% 90%
HMeO N
CO2Et Ph Ac E CF3
82% 97% 84%
[a] ArOMs (1 mmol), amine (1.2 mmol), 1 (1 mol%), 6 (1 mol%), K2CO 3 , (1.4 mmol), t-BuOH (12
ML/ mmol), 110 *C, 16 h.
Encouraged by the level of reactivity that catalysts based on 1 displayed in cross-
coupling reactions involving aryl mesylates, we decided to examine the monoarylation of
primary amines. Although this transformation has long been proficient with aryl bromides,' 2
recent progress has extended the method to aryl chlorides.2 ,13 However, despite this success,
challenges still remain, including the monoarylation of methylamine, which has yet to be
described. Because it is the smallest aliphatic primary amine and, therefore, most likely to
undergo diarylation, methylamine is a particularly challenging coupling partner to monoarylate.
Using 6, methylamine was successfully coupled with 4-chloroanisole with a selectivity of >97:3
for monoarylation over diarylation (Table 3, entry 1). The analogous reaction using 7 did not give
any product at room temperature. By increasing the temperature to 80 C, the reaction
proceeded but favored diarylation, reversing the selectivity to 20:80 (Table 3, entry 3). Using
the more bulky ligand 3,14 the selectivity increased to 82:18 (Table 3, entry 4) but was still not
nearly as selective as 1. The use of ligand 1 successfully inhibits reactions involving
disubstituted amines and allows for the highly selective monarylation of methylamine at room
temperature (Table 4).
Table 3. Screen of Ligands for the Arylation of Methylaminea
CI H2NMe 1% Pd precat N(H)Me
MeO 2M in THF NaOt-Bu, t-BuOH, 2 h MeO K-
Entry Precatatalyst Yield' Temp MeN(H)Ar: MeNAr2c
1 6 92% rt >97:3
2 7 0% rt --
3 7 11% 80 *C 20:80
4 8 70% rt 82:18
[a] ArCI (1 mmol), 2M MeNH 2 in THF (2.0 mmol), Pd [6, 7, or 8] (1 mol %),15 NaOt-Bu (1.2
mmol). [b] GC yields. [c] Selectivities determined by GC.
Table 4. Mono-arylation of Methylaminea
ArCI + H2NMe 0.1 - 1% 6, NaOt-Bu D ArN(H)Me2M in THF t-BuOH, rt, 2 h
N(H)Me N(H)Me MeO N(H)Me N(H)Me
OMe
R = OMe: 92% (9 1 %)b 9 0 %d ( 8 9 %)b'd 90% (9 7 %)b 9 5 %e (9 1 %)bR = n7-Bu: 99% (9 8 %)c
[a] ArCI (1 mmol), 2M MeNH 2 in THF (2.0 mmol), 6 (1 mol %), NaOt-Bu (1.2 mmol). [b] 0.3 mol
% 6. [c] 0.1 mol % 6. [d] 35:1 mixture of monoarylation to diarylation. [e] 17 h reaction time.
We then turned our attention to the selective monoarylation of other primary aliphatic
amines, which have been difficult to achieve using biarylphosphine ligands. With a catalyst
system using 1 as ligand, we were able to successfully couple several primary aliphatic amines
and aryl chlorides in excellent yields at 0.05 mol % catalyst loading in 1 h (Table 5). It is also
noteworthy that less than 1% of the diarylation product was observed in all cases. Common
perception has been that chelating bisphosphine ligands are required for these couplings in
order to suppress diarylation. However, these results not only show that biarylmonophosphines
can efficiently support cross-coupling reactions involving primary aliphatic amines, but in some
cases they are more efficient than bisphosphine systems. For example, the coupling of
octylamine and 4-chloroanisole with a bisphosphine based catalyst system formerly required 0.1
mol % Pd and a reaction time of 48 hours.13 With a catalyst system based on 1, the reaction of
hexylamine and 4-chloroanisole was complete after 1 h using only 0.05 mol % Pd.
We recently reported a catalyst system using ligand 2, in which anilines were
successfully coupled with aryl chlorides at catalyst loadings as low as 0.05 mol %.9c By
switching to ligand 1 we were able to lower the catalyst loadings to 0.01 mol % while keeping
the reaction times at 1 h (Table 5). This is the lowest palladium loading that has been reported
in C-N bond-forming reactions of primary anil-ines with aryl chlorides.2a These results
demonstrate clearly the exceptional activity of 1 in these reactions in comparison to previously
reported catalyst systems.
Table 5. Coupling Reactions at Low Catalyst Loadings and Short Reaction Times
0.01-0.05 mol % 6, 0.01-0.05 mol % 1
ArCI + H2NAr' NaOt-Bu, Bu2O, 80-110 *C, 1 h - ArN(H)Ar'
N(H)Hex N(H)Bn N(H)Hex N(H)Bn N(H)Hex
1 6 6Me
OMe OMe
88%a 9 7%a 9 1%a 9 0%a 91%a
Me
F3  HN 
OEt HN 
F HN 
OEt HN
Me N MMe e I Me
Me Me OMe OMe OMe
97%b 93%b 9 9 %b 97%e 97%b
[a] ArCI (1 mmol), amine (1.4 mmol), 1 (0.05 mol %), 6 (0.05 mol %), NaOt-Bu (1.2 mmol). [b]
ArCI (1 mmol), amine (1.2 mmol), 1 (0.01 mol %), 6 (0.01 mol %), NaOt-Bu (1.2 mmol).
The results described above suggested that we should see high levels of
chemoselectivity for the arylation of a primary amine over a secondary amine. Using 1, we were
able to couple the primary amino group of 9 in the presence of a secondary anilino group with
>40:1 selectivity (Table 6). This result is complimentary to a previous report by our group in
which anilines reacted in preference to aliphatic amines.16 Further in the intramolecular
competition between a primary and cyclic secondary amine in 10, and between a primary and
secondary aniline in 11, the primary amino group was preferentially N-arylated and proceeded in
excellent yields with selectivities of >20:1 (Table 6).
Table 6. Selectivity of Primary Amines Over Secondary Aminesa
R(H)Nr'4H 2  + PhC 1mol % 6,1 mol % 1 R(H)C"1\J(H)Ph
NaOt-Bu, dioxane, 80 0C
Ph NH2 HN NH2 Ph(H)N NH2
1011
H HN-Ph
Ph'N 'Ph HNN- Ph(H)N / N(H)Ph
H
89% 84% 92%
[a] ArCI (1 mmol), amine (1.2 mmol), NaOt-Bu (2.0 mmol), 2 - 15 h.
In an attempt to understand the unique reactivity of 1 compared to other ligands, we
have prepared a series of 1-Pd(II)ArX (X = Cl or Br, Scheme 1) complexes by combining
(COD)Pd(CH 2SiPhMe 2 )2,18 1 and ArX. These complexes exist in solution as a mixture of two
well-defined conformational isomers. Examination of the reaction mixture by in situ 31P NMR
revealed two products in an approximate 2:1 ratio. Addition of pentane to the solution induces
precipitation of the Pd(ll) complex, which crystallizes as a single conformer. Freshly prepared
solutions of the isolated complexes display only signals from the major conformer ('H and 31P
NMR). However, rapid isomerization is observed, with the minor isomer becoming detectable
within 5 minutes at room temperature.19
Subjecting either 2 or 4 to the conditions shown in Scheme 1 provided dramatically
different results from those obtained using 1. The in situ31 P NMR spectrum from the reaction of
2 is complex and shows broad resonances that we have yet to deconvolute. The reaction with 4
results in the formation of Pd black. These differences, to the extent that they reflect the
behavior of the resulting Pd(II) complexes, may be related to the observed differences in
reactivity observed with these ligands.
OMe R R H R
Me =H X \ , ! HX
MeO PCy2  (COD)Pd(CH 2 SiPhMe 2)2  MeO cy H MeO Pd\ CYi-Pr i-Pr P________  Pd-X MeO P~~c ) 8
- ArX, THF, rt, 48 h H - Me \, Pd
~ iP ~/ i-Pr \ P "i iPr -
i-Pr MeO MeO
12a; X = Br, R = H, 75% 12b-14b1 13a; X = CI, R = H, 69%
14a; X = Br, R = Me, 77%
12a
Scheme 1. Synthesis and NOESY NMR cross-peaks of 12, 13, and 14; crystal structure of 12a.
X-ray crystal analysis of 12 revealed that the complex exists as a monomer in solid
state, and, although some disorder about the Br atom was observed, the resulting structure
clearly demonstrates that the Pd center is bound over the tri-isopropylphenyl ring (Scheme 1). In
solution, the conformations of the major and minor rotamers are analogous in 12, 13, and 14 ('H
NMR). 20 For all three complexes, both conformers display 'H NMR resonances consistent with
D2 symmetry. NOESY NMR analysis of an equilibrated sample of 14 (2:1 mixture) allowed the
assignment of the solution state conformation of both rotamers. The conformation of the major
rotamer 14a is the same as that observed in the solid state. In the minor isomer 14b, the P-CAr
bond is rotated by 1800, and the palladium atom is chelated by the phosphine atom and the
proximal methoxy group. Important cross-peaks used in these assignments are summarized in
Scheme 1. 12, 13 and 14 are active precatalysts in C-N bond-forming reactions.
Two notable points arise from the structural data. First, the NMR data demonstrate that
the Pd(II) aryl halide complexes of 1 likely remain monomeric in solution and are not in
equilibrium with the non-D2 symmetric dimeric form.15 Second, the observed monomeric
equilibrium demonstrates that the proximal methoxy does not prevent rotation about the P-CAr
bond. Theoretical studies have shown that this rotation may play an important role in catalytic
systems with other biarylphosphines.9 The implications of these findings are not yet fully
understood, and further studies to clarify the role of the methoxy groups in 1 are ongoing.
3.3 Conclusion
In summary, a new ligand with unprecedented reactivity for C-N cross-coupling
reactions has been developed. Use of this ligand has allowed Pd-catalyzed amination reactions
of aryl mesylates to take place in high yield. Arylations of methylamine were also performed for
the first time with exceptional selectivities for monoarylation. Primary aliphatic amines and
anilines were coupled with aryl chlorides at low catalyst loadings and with fast reaction times,
demonstrating the exceptional reactivity and stability of the catalyst derived from 1. Finally,
isolation of oxidative addition complexes of 1 has led to insight into the importance of the
methoxy substitutent proximal to the phosphine for the reactivity of this catalyst system. Further
studies into the origin of the reactivity of 1 are currently underway in our laboratories.
3.4 Experimental
General Reagent Information: All reactions were carried out under an argon
atmosphere. The methylamine solution, 1,4-dioxane, THF, and tert-butanol were purchased
from Aldrich Chemical Co. in Sure-Seal bottles and were used as recieved. Dibutyl ether was
purchased from Aldrich Chemical Co., anhydrous and was distilled from sodium metal.
Pd(OAc) 2 was a gift from BASF and aryl halides and amines were purchased from Aldrich
Chemical Co., Alfa Aesar, Parkway Scientific, or TCI America. The 1,4-dimethoxyfluorobenzene
was purchased from Synquest Labs, Inc. and used as received. All amines that were a liquid
and the aryl chlorides used in Table 5 were distilled from calcium hydride and stored under
argon. Amines that were a solid and all other aryl halides were used as purchased without
furthur purification. Distilled water was degassed by brief (30 sec) sonication under vacuum.
Both potassium carbonate and sodium tert-butoxide were purchased from Aldrich Chemical Co.
and used as received. The bulk of the bases were stored in an N2 glovebox. Small portions
were taken outside the box in glass vials and weighed in the air. Ligands 23' and 314 and
precatalyst 68 were synthesized using literature procedures.
General Analytical Information: All compounds were characterized by 'H NMR, 13C
NMR, and IR spectroscopy. Copies of the 'H and '3C spectra can be found at the end of the
Supporting Information. Nuclear Magnetic Resonance spectra were recorded on a Varian 300
MHz instrument and Bruker 400 MHz instrument. All 'H NMR experiments are reported in 6
units, parts per million (ppm), and were measured relative to the signals for residual chloroform
(7.26 ppm) in the deuterated solvent, unless otherwise stated. All 13C NMR spectra are reported
in ppm relative to deuterochloroform (77.23 ppm), unless otherwise stated, and all were
obtained with 'H decoupling. All IR spectra was taken on a Perkin - Elmer 2000 FTIR. All GC
analyses were performed on a Agilent 6890 gas chromatograph with an FID detector using a J
& W DB-1 column (10 m, 0.1 mm I.D.). Elemental analyses were performed by Atlantic
Microlabs Inc., Norcross, GA.
Synthesis of 1
OMe
OMe OMe MgBr
F n-BuLi / i-Pr i-Pr 1) -78 C to rt MeO I
-78 C + 2)12 i-Pr i-Pr
OMe OMe i-Pr
i-Pr
2-lodo-2',4',6'-triisopropyl-3,6-dimethoxybiphenyl. An oven-dried three-neck 500 mL
round bottom flask, which was equipped with a magnetic stir bar and charged with magnesium
shavings (1.48 g, 61 mmol), was fitted with a reflux condenser, glass stopper, and rubber
septum. The flask was purged with argon and then THF (120 mL) and 2,4,6-
triisopropylbromobenzene (14.48 g, 51.2 mmol) were added via syringe. The reaction was
heated to reflux and 1,2-dibromethane (40 uL) was added via syringe. The reaction mixture was
allowed to stir at ref lux for 1 h and was then cooled to room temperature. A separate oven-dried
1 L round bottom flask, which was equipped with a magnetic stir bar and fitted with a septum,
was purged with argon and then THF (300 mL) and 1,4-dimethoxy-2-fluorobenzene (8 g, 51.2
mmol) were added to the flask via syringe. The reaction vessel was cooled via a -78 0C bath
and n-BuLi (2.5 M in Hexane, 20.5 mL, 51.2 mmol) was added in a dropwise fashion over a 15
min period. The solution was stirred for an additional 30 min and the Grignard reagent, which
was prepared in the first reaction vessel, was added via cannula over a 20 min period and the
reaction mixture was allowed to stir at -78 0C for 1 h. The reaction mixture was slowly warmed to
room temperature where it was stirred for an additional 1.5 h. The mixture was then cooled to 0
0C and a solution of Iodine in THF (1 M, 61 mL, 61 mmol) was added via syringe over a 15 min
period and then the dark red solution was warmed -to room temperature and stirred for 1 h. The
solvent was removed with the aid of a rotary evaporator, and the remaining dark brown oil was
taken up in CH2Cl2, washed with a saturated solution of sodium sulfite, and with brine. The
organic layer was then dried over MgSO 4, filtered, and the solvent was removed with the aid of a
rotary evaporator to give a yellow solid. The crude material was recrystallized from EtOAc to
yield the product as white crystals (3.430 g). The mother liquor was then concentrated and the
remaining yellow solid was recrystallized from EtOAc to yield additional white crystals (3.728 g,
31% overall yield), mp 189 - 191 C. 1H NMR (300 MHz, CDC13) 6: 7.07 (s, 2H), 6.90 (d, J= 9.0
Hz, 1H), 6.81 (d, J= 9.0 Hz, 1H), 3.90 (s, 3H), 3.67 (s, 3H), 2.98 (septet, J= 7.0 Hz, 1H), 2.39
(septet, J = 7.0 Hz, 2H), 1.33 (d, J = 7.0 Hz, 6H), 1.20 (d, 7.0 Hz, 6H), 1.02 (d, J = 7.0 Hz, 6H)
ppm. 13C NMR (75 MHz, CDC13) 6: 152.7, 152.5, 148.4, 145.9, 136.4, 136.1, 121.0, 110.3,
109.4, 96.6, 57.0, 55.8, 34.3, 31.1, 24.8, 24.3, 23.9 ppm. IR (neat, cm 1): 2957, 2865, 1567,
1460, 1428, 1257, 1032, 755. Anal. Calcd. for C23H31102 : C, 59.23; H, 6.70. Found: C, 59.23; H,
6.72.
01
OMe OMe
MeO I 1) n-BuLi MeO PCy 2
i-Pr i-Pr 2) CIPCy2 i-Pr i-Pr ~
i-Pr i-Pr
1
Ligand 1. An oven-dried 25 mL round bottom flask, which was equipped with a magnetic
stir bar and charged with 2-iodo-2',4',6'-triisopropyl-3,6-dimethoxybiphenyl (1 g, 2.15 mmol), was
evacuated and backfilled with argon (this process was repeated a total of 3 times). THF (10 mL)
was added via syringe and the reaction was cooled to -78 0C and n-BuLi (2.5 M in Hexane, 940
pL, 2.36 mmol) was added in a dropwise fashion over a 10 min period. The solution was stirred
for 30 min and then the CIPCy2 (527 mg, 2.26 mmol) was added via syringe over 10 min. The
reaction mixture was stirred for 1 h at -78 0C and then warmed slowly to room temperature
where it was stirred for an additional 1.5 h. The solution was filtered through a plug of celite
layered on a plug of silica (eluting with EtOAc) and then the solvent was removed with the aid of
a rotary evaporator to give a white solid. The crude material was recrystallized from acetone to
yield the desired product as white crystals. The mother liquor was then concentrated and the
remaining white solid was recrystallized from acetone to yield additional white crystals (1.012 g
total, 88% yield), mp 191 - 193 C. 'H NMR (300 MHz, CDCI3) 6: 6.96 (s, 2H), 6.85 (d, J= 9.0
Hz, 1 H), 6.78 (d, J = 9.0 Hz, 1 H), 3.82 (s, 3H), 3.56 (s, 3H), 2.93 (septet, J = 7.0 Hz, 1 H), 2.42
(septet, J = 7.0 Hz, 2H), 2.19 (m, 2H), 1.82 - 1.60 (m, 8H), 1.41 - 0.90 (m, 12H), 1.31 (d, J =
7.0 Hz, 6H), 1.16 (d, J= 7.0 Hz, 6H), 0.92 (d, J= 7.0 Hz, 6H) ppm. 13C NMR (75 MHz, CDC 3)
6: 156.5, 156.5, 152.5, 152.4, 147.1, 146.2, 146.1, 139.5, 139.0, 132.9, 132.8, 127.0, 126.6,
120.4, 120.3, 110.9, 108.8, 55.3, 54.9, 54.8, 36.9, 36.7, 34.0, 33.3, 32.9, 31.2, 31.0, 30.7, 28.2,
28.1, 27.9, 27.7, 26.7, 25.3, 24.2, 23.8 ppm (Observed complexity is due to P-C splitting). 31p
NMR (121 MHz, CDC13) 6: -1.62 ppm. IR (neat, cm~1): 3378, 2849, 1654, 1654, 1457, 1423,
1384, 1249, 1053. Anal. Calcd. for C35H530 2 P: C, 78.32; H, 9.95. Found: C, 78.44; H, 10.09.
Synthesis of 4
Me
Br Me Me Me
i-Pr i-Pr Me Br 1) Mg, THF, 75 C Me PCy2
Me Br 2) CuCI, CIPCy 2  i-Pr i-Pr
i-Pr Me
i-Pr
Ligand 4. An oven-dried three-neck 250 mL round bottom flask, which was equipped
with a magnetic stir bar and charged with magnesium shavings (559 mg, 24.3 mmol), was fitted
with a reflux condenser, addition funnel, and glass stopper. The flask was purged with argon
and then THF (15 mL) and 2,4,6-triisopropylbromobenzene (2.83 g, 10 mmol) were added via
syringe. The reaction mixture was heated to reflux and 1,2-dibromethane (40 uL) was added via
syringe. The reaction was allowed to stir at reflux for 1 h and then the addition funnel, which
was charged with 1,2-dibromo-3,4,5,6-tetramethylbenzene (2.92 g, 10 mmol) in 40 mL of THF,
was opened and the solution was added over a 1 h period. The mixture was stirred for 5 h at
reflux and then cooled to room temperature where CuCl (1.0 g, 10 mmol) was added quickly to
the reaction mixture. Next, CIPCy 2 (2.65 mL, 10 mmol) was then added in a dropwise fashion
and the reaction mixture was heated to 75 0C for 60 h. The reaction mixture was then cooled to
room temperature, diluted with EtOAc, washed 3 times with 30% NH40H, dried over MgSO4,
and concentrated under reduced pressure. The crude material was recrystallized from
benzene to yield the product as a white solid (1.507 g, 28% yield). H NMR (300 MHz, CDCl3) 6:
7.36 (s, 5H), 7.15 (s, 2H), 2.99 (septet, J = 7.0 Hz, 1H), 2.44 (s, 3H), 2.35-2.14 (m, 11H), 1.98
(s, 2H), 1.80-1.44 (m, 14H), 1.39-1.04 (m, 22H), 0.91 (d, J = 6.5 Hz, 6H) ppm. 13C NMR (75
MHz, CDC13) 6: 150.9, 145.8, 145.4, 144.6, 140.0, 138.5, 135.8, 135.6, 135.5, 135.5, 128.6,
124.3, 40.2, 39.9, 35.4, 35.2, 34.5, 30.7, 29.5, 27.8, 27.7, 27.4, 27.2, 25.9, 25.0, 24.6, 21.2,
20.8, 17.7, 17.3 ppm (Observed complexity is due to P-C splitting). 31P NMR (121 MHz, CDC 3 )
6: 16.33 ppm.
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Synthesis of 5
OMe OWe
1) n-BuLi
2) CIPCy 2  PCy 2
OMe OMe
Ligand 5. To a 0 0C solution of 1,3-dimethoxybenzene (2.0 mL, 15.3 mmol) in THF (35
mL) was added n-BuLi (6.20 mL, 2.5 M in hexanes, 15.5 mmol) via syringe over a 10 min
period. The mixture was then allowed to warm to room temperature and stirred for 5 h. The
mixture was re-cooled to 0 0C and CIPCy 2 (3.07 mL, 13.9 mmol) was added via syringe over a
10 min period. The reaction mixture was allowed to warm to room temperature where it was
stirred for 12 h. The solution was then filtered through a plug of silica, eluting with EtOAc, and
concentrated under reduced pressure to yield the product as a white solid (4.89 g, 96% yield).
H NMR (300 MHz, CDC13 ) 6: 7.21 (t, J = 8.0 Hz, 1 H), 6.46 (d, J = 8.0 Hz, 2H), 3.74 (s, 6H),
2.26 (m, 2H), 1.86 (m, 2H), 1.70 (m, 2H), 1.56 (m, 4H), 1.42-0.89 (m, 12H) ppm. 13C NMR (75
MHz, CDC13) 6: 164.5, 164.4, 131.1, 111.6, 111.2, 104.1, 55.8, 34.3, 34.1, 32.5, 32.2, 30.5,
30.4, 27.6, 27.5, 27.5, 27.3, 26.7 ppm (Observed complexity is due to P-C splitting). 31P NMR
(121 MHz, CDC13) 6: -11.8 ppm. IR (neat, cm-1): 2921, 2847, 1581, 1463, 1428, 1242, 1103,
777.
Synthesis of 6
OMe
MeO PCy 2  NH2
i-Pr i-Pr ci
i- + Me 2 Pd(tmeda) CIN NH 2
MTBE, 55 *c 1 CI
i-Pr 6
1
Precatalyst 6. An oven-dried schlenk tube, which was equipped with a magnetic stir bar
and fitted with a rubber septum, was charged with Me2Pd(TMEDA) (253 mg, 1 mmol) and 1
(537 mg, 1 mmol). The vessel was evacuated and backfilled with argon (this process was
repeated a total of 3 times) and the 2-(2-chorophenyl)ethylamine (156 mg, 1 mmol) and MTBE
(8 mL) were added via syringe and the reaction mixture was heated to 55 0C for 5 h. The
reaction mixture was then cooled to 0 0C and a white precipate was filtered and washed with
cold MTBE. The white product was then taken up in CH2Cl2 and concentrated under reduced
pressure (done to remove any remaining MTBE) to yield the product as a white solid (645 mg,
93% yield). 1H NMR (300 MHz, CDC13) 6: 7.17 (s, 2H), 7.09-6.84 (m, 6H), 3.85 (s, 3H), 3.38 (s,
3H), 3.17-0.00 (m, 49 H) ppm. 31P NMR (121 MHz, CDC13) 6: 42.2 ppm. IR (neat, cm'): 3303,
2929,1658,1462,1384,1256,1010,755.
Experimental Procedures for Examples Described in Table 1
General Procedure Using the Precatalysts: An oven-dried test tube, which was
equipped with a magnetic stir bar and fitted with a teflon septum, was charged with the
precatalyst (1 mol%), ligand (1 mol%), 4-t-butylphenyl methanesulfonate (0.5 mmol, 114 mg),
and K2 CO3 (97 mg, 0.7 mmol). The vessel was evacuated and backfilled with argon (this
process was repeated a total of 3 times) and then the aniline (55 tL, 0.6 mmol) and tert-butanol
(6 mL) were added via syringe. The solution was heated to 110 0C for 4 h, cooled to room
temperature, diluted with Ethyl acetate, and washed with water. Dodecane was then added as
an internal standard and the reaction was analyzed by GC.
General Procedure for Water-Mediated Catalyst Preactivation: An oven-dried test
tube, which was equipped with a magnetic stir bar and fitted with a teflon septum, was charged
with Pd(OAc)2 (1 mol%) and ligand (3 mol%). The vessel was evacuated and backfilled with
argon (this process was repeated a total of 3 times) and the tert-butanol (1 mL) and degassed
H20 (8 mol%) were added via syringe. After addition of the water, the solution was heated to
110 Cfor 1 min.
A second oven-dried test tube, which was equipped with a magnetic stir bar and fitted
with a Teflon septum, was charged with 4-t-butylphenyl methanesulfonate (0.5 mmol, 114 mg)
and K2CO 3 (97 mg, 0.7 mmol). The vessel was evacuated and backfilled with argon (this
process was repeated a total of 3 times) and then the aniline (55 tL, 0.6 mmol) and tert-butanol
(5 mL) were added via syringe and the activated catalyst solution was transferred from the first
reaction vessel into the second via cannula. The solution was heated to 110 0C for 4 h, cooled
to room temperature, diluted with Ethyl acetate, and washed with water. Dodecane was then
added as an internal standard and the reaction was analyzed by GC.
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Experimental Procedures for Examples Described in Table 2
General Procedure A: An oven-dried test tube, which was equipped with a magnetic
stir bar and fitted with a teflon septum, was charged with 5 (1 mol%) 1 (1 mol%) and K2CO3 (97
mg, 0.7 mmol). The vessel was evacuated and backfilled with argon (this process was repeated
a total of 3 times) and then the aryl mesylate (0.5 mmol), amine (0.6 mmol), and tert-butanol (6
mL) were added via syringe (aryl chlorides or amines that were solids at room temperature were
added with the catalyst and base). The solution was heated to 110 0C until the starting material
was completely consumed as monitored by GC. The reaction mixture was then cooled to room
temperature, diluted with ethyl acetate, washed with water, concentrated in vacuo, and purified
via the Biotage SP4 (silica-packed 25+M cartridge).
H Me
N
ci~e
N-(4-(1H-Pyrrol-1-yl)phenyl)-2,5-dimethylaniline (Table 2). Following general
procedure A, a mixture of 4-(1H-pyrrol-1-yl)phenylmethanesulfonate (119 mg, 0.5 mmol), 2,5-
dimethylaniline (75 [tL, 0.6 mmol), K2CO3 (97 mg, 0.7 mmol), 5 (4 mg, 1 mol%), 1 (2.5 mg, 1
mol%), and t-BuOH (6 mL) was heated to 110 0C for 16 h. The crude product was purified via
the Biotage SP4 (silica-packed 25+M; 0-30% EtOAc/hexanes) to provide the title compound as
a white solid (138 mg, 95%), mp 97-98 *C. 1H NMR (300 MHz, CDCl3) 6: 7.31 (d, J = 9.0 Hz,
2H), 7.14 (d, J = 7.5 Hz, 1H), 7.04 (m, 5H), 6.82 (d, J = 7.5 Hz, 1H), 6.37 (t, J = 2.5 Hz, 2H),
5.40 (s, 1H), 2.33 (s, 3H), 2.27 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 142.4, 141.1, 136.9,
134.4, 131.2, 125.6, 123.3, 122.3, 119.9, 119.8, 118.5, 110.0, 21.5, 17.8 ppm. IR (neat, cm 1):
3386, 2920, 1519, 1310, 1072, 829, 726. Anal. Calcd. for C18H18N2 : C, 82.41; H, 6.92. Found:
C, 82.03; H, 7.03.
HCO2Et
F
Ethyl 2-(4-Fluorophenylamino)benzoate (Table 2). Following general procedure A, a
mixture of 4-fluorophenylmethanesulfonate (95 mg, 0.5 mmol), ethyl 2-aminobenzoate (89 [tL,
0.6 mmol), K2CO3 (97 mg, 0.7 mmol), 5 (4 mg, 1 mol%), 1 (2.5 mg, 1 mol%), and t-BuOH (6 mL)
was heated to 110 0C for 16 h. The crude product was purified via the Biotage SP4 (silica-
packed 25+M; 0-20% EtOAc/hexanes) to provide the title compound as a yellow oil (118 mg,
91%). 1H NMR (300 MHz, CDC13) 6: 9.44 (s, 1H), 7.99 (d, J= 8.0 Hz, 1H), 7.30 (t, J = 7.5 Hz,
1 H), 7.21 (m, 2H), 7.07 (m, 3H), 6.73 (t, J = 7.5 Hz, 1 H), 4.37 (q, J = 7.5 Hz, 2H), 1.42 (t, J = 7.5
Hz, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 168.8, 161.3, 158.1, 148.8, 136.9, 136.9, 134.4,
131.9, 125.4, 125.3, 117.1, 116.5, 116.2, 113.6, 112.0, 60.9, 14.6 ppm. IR (neat, cm(): 3316,
2982, 1683, 1583, 1513, 1455, 1260, 1233, 1082, 749. Anal. Calcd. for C15H14FN0 2: C, 69.49;
H, 5.44. Found: C, 70.14; H, 5.64.
H
MeO N
MeO F
OMe
N-(4-Fluorophenyl)-3,4,5-trimethoxyaniline (Table 2). Following general procedure A,
a mixture of 3,4,5-trimethoxyphenylmethanesulfonate (131 mg, 0.5 mmol), 4-fluoroaniline (57
tL, 0.6 mmol), K2CO3 (97 mg, 0.7 mmol), 5 (4 mg, 1 mol%), 1 (2.5 mg, 1 mol%), and t-BuOH (6
mL) was heated to 110 0C for 16 h. The crude product was purified via the Biotage SP4 (silica-
packed 25+M; 5-40% EtOAc/hexanes) to provide the title compound as a yellow oil (120 mg,
87%). 'H NMR (300 MHz, CDCI3) 6: 6.99 (m, 4H), 6.22 (s, 2H), 5.57 (s, 1H), 3.80 (s, 3H), 3.78
(s, 6H) ppm. 13C NMR (75 MHz, CDC13) 6: 159.7, 156.5, 154.1, 140.5, 139.6, 132.5, 120.4,
120.3, 116.4, 116.1, 95.2, 61.3, 56.2 ppm. IR (neat, cm'): 3360, 2937, 1597, 1499, 1454, 1216,
1129, 1007, 785. Anal. Calcd. for C15H16FN0 3: C, 64.97; H, 5.82. Found: C, 65.24; H, 6.00.
MeO H
CO2Et
Ethyl 4-(2-methoxyphenylamino)benzoate 21 (Table 2). Following general procedure
A, a mixture of 2-methoxyphenylmethanesulfonate (101 mg, 0.5 mmol), ethyl 4'-aminobenzoate
(99 mg, 0.6 mmol), K2CO3 (97 mg, 0.7 mmol), 5 (4 mg, 1 mol%), 1 (2.5 mg, 1 mol%), and t-
BuOH (6 mL) was heated to 110 0C for 16 h. The crude product was purified via the Biotage
SP4 (silica-packed 25+M; 0-30% EtOAc/hexanes) to provide the title compound as a clear oil
(117 mg, 87%). 'H NMR (300 MHz, CDC13) 6: 7.96 (d, J = 9.0 Hz, 2H), 7.41 (d, J = 7.0 Hz, 1 H),
7.09 (d, J = 9.0 Hz, 2H), 6.97 (m, 3H), 6.42 (s, 1 H), 4.35 (q, J = 7.0 Hz, 2H), 3.87 (s, 3H), 1.39
(t, J= 7.0 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3) 5: 166.8, 149.7, 147.7,131.6, 130.8,122.4,
121.7, 121.0, 117.9, 115.4, 111.1, 60.7, 55.8, 14.7 ppm. IR (neat, cm-1): 3354, 2979, 1704,
1593, 1526, 1276, 1175, 1105,1027, 746.
H
Ph N Ac
1-(4-(Biphenyl-4-ylamino)phenyl)ethanone (Table 2). Following general procedure A,
a mixture of 4-biphenylmethanesulfonate (124 mg, 0.5 mmol), 4'-aminoacetophenone (81 mg,
0.6 mmol), K2CO 3 (97 mg, 0.7 mmol), 5 (4 mg, 1 mol%), 1 (2.5 mg, 1 mol%), and t-BuOH (6 mL)
was heated to 110 *C for 16 h. The crude product was purified via the Biotage SP4 (silica-
packed 25+M; 15-50% EtOAc/hexanes) to provide the title compound as a white solid (139 mg,
97%), mp 136-139 0C. 'H NMR (300 MHz, CDC13) 6: 7.90 (d, J = 9.0 Hz, 2H), 7.59 (m 4H),
7.45 (t, J = 7.0 Hz, 2H), 7.35 (t, J = 7.0 Hz, 1 H), 7.25 (d, J = 9.0 Hz, 2H), 7.05 (d, J = 9.0 Hz,
2H), 6.35 (s 1H), 2.55 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 196.8, 148.4, 140.7, 140.2,
136.2, 130.9, 129.3, 129.1, 128.4, 127.3, 127.0, 120.9, 114.9, 26.5 ppm. IR (neat, cm-1): 3324,
1656,1586,1524,1487,1339,1278,1178,827,763.
H
N CF 3
CO 2Et
Ethyl 3-(4-(trifluoromethyl)phenylamino)benzoate (Table 2). Following general
procedure A, a mixture of ethyl 3-(methylsulfonyloxy)benzoate (122 mg, 0.5 mmol), 4-
(trifluoromethyl)aniline (75 [L, 0.6 mmol), K2CO3 (97 mg, 0.7 mmol), 5 (4 mg, 1 mol%), 1 (2.5
mg, 1 mol%), and t-BuOH (6 mL) was heated to 110 0C for 16 h. The crude product was
purified via the Biotage SP4 (silica-packed 25+M; 0-30% EtOAc/hexanes) to provide the title
compound as a white solid (144 mg, 93%), mp 106-108 OC. 'H NMR (300 MHz, CDC13 ) 6: 7.81
(s, 1 H), 7.71 (d, J = 7.0 Hz, 1 H), 7.49 (d, J = 8.5 Hz, 2H), 7.36 (m, 2H), 7.07 (d, J = 8.5 Hz, 2H),
6.13 (s 1H), 4.38 (q, J= 7.0 Hz, 2H), 1.39 (t, J= 7.0 Hz, 3H) ppm. 13C NMR (75 MHz, CDC13 ) 6:
166.7, 146.3, 141.8, 132.1, 130.1, 129.8, 127.1, 127.0, 127.0, 126.9, 126.6, 123.8, 123.8, 123.0,
122.6, 122.2, 120.6, 116.0, 61.5, 14.5 ppm. IR (neat, cm-"): 3358, 1701, 1620, 1543, 1333,
1158, 1108, 1070, 751. Anal. Calcd. for C16H14F30 2N: C, 62.13; H, 4.56. Found: C, 61.97; H,
4.46.
Synthesis of Aryl Mesylates
All known aryl mesylates were synthesized using literature procedures.sb22
OMs
Co2Et
Ethyl 3-(methylsulfonyloxy)benzoate. To a stirred solution of ethyl 3-hydroxybenzoate
(3.32 g, 20 mmol) in dichloromethane (20 mL) cooled to 0 *C was added triethylamine (4.17 mL,
30 mmol). To this was added mesyl chloride (1.94 mL, 25 mmol) dropwise over 15 min. The
reaction was stirred at 0 0C for 15 min then quenched with water and the phases separated. The
aqueous layer was extracted with dichloromethane and the combined organics were dried over
MgSO 4 and concentrated in vacuo. The crude material was purified via the Biotage SP4 (silica-
packed 25+M; 0-50% EtOAc/hexanes) to provide the title compound as a white solid (2.698 g,
55%). 'H NMR (300 MHz, CDC13) 5: 7.98 (m, 1H), 7.89 (s, 1H), 7.47 (m, 2H), 4.35 (q, J = 7.0
Hz, 2H), 3.16 (s, 3H), 1.37 (t, J = 7.0 Hz, 3H) ppm. 13C NMR (75 MHz, CDC13) 5: 165.3, 149.3,
132.9, 130.3, 128.7, 126.9, 123.2, 61.8, 37.8, 14.5 ppm. IR (neat, cm-1): 1721, 1384, 1369 1268,
1194,1168,1098, 936,840,798.
Experimental Procedures for Examples Described in Table 4
General Procedure B: An oven-dried test tube, which was equipped with a magnetic
stir bar and fitted with a teflon septum, was charged with the precatalyst (0.01 equiv.) and NaOt-
Bu (120 mg, 1.2 mmol). The vessel was evacuated and backfilled with argon (this process was
repeated a total of 3 times) and then the aryl chloride (1.0 mmol), 2M methylamine solution in
THF (1 mL, 2.0 mmol), and t-BuOH (1 mL) were added in succession via syringe (aryl chlorides
that were solids at room temperature were added with the precatalyst and base). The solution
was allowed to stir at room temperature until starting aryl chloride was completely consumed as
monitored by GC. The reaction mixture was then diluted with ethyl acetate, washed with
aqueous NH4 CI, dried over Na2SO4 concentrated in vacuo, and purified via column
chromatography on silica gel.
Procedure C: General procedure B was used with the following modification: 2M
methylamine solution in THF (1 mL, 2.0 mmol), and t-BuOH (4 mL) were premixed and added to
the reaction vessel.
MeO
/ N(H)Me
4-Methoxy-N-methylaniline2 3 (Table 4). Following general procedure A, a mixture of 4-
chloroanisole (123 [L, 1.0 mmol), 2M methylamine (1 mL, 2.0 mmol), NaOt-Bu (120 mg, 1.2
mmol), BrettPhos precatalyst (8 mg, 0.01 mmol), and t-BuOH (1 mL) was stirred at room
temperature for 2 h. The crude product was purified via column chromatography (20:1
CH2Cl2/MeOH) to provide the title compound as a yellow liquid that turned into a tan solid upon
standing (126 mg, 92%). 'H NMR (400 MHz, CDC13) 6: 6.80 (dt, J= 9.0, 2.3 Hz, 2H), 6.59 (dt, J
= 9.0, 2.3 Hz, 2H), 3.76 (s, 3H), 3.46 (bs, 1 H), 2.81 (s, 3H) ppm. 13C NMR (75 MHz, CDC13 ) 6:
152.2, 143.9, 115.1, 113.8, 56.1, 31.8 ppm.
OMe
MeO N(H)Me
3,5-Dimethoxy-N-methylaniline24 (Table 4). Following general procedure A, a mixture
of 3,5-dimethoxychlorobenzene (173 mg, 1.0 mmol), 2M methylamine (1 mL, 2.0 mmol), NaOt-
Bu (120 mg, 1.2 mmol), BrettPhos precatalyst (8 mg, 0.01 mmol), and t-BuOH (1 mL) was
stirred at room temperature for 2 h. The crude product was purified via column chromatography
(80:20 to 50:50 Hexanes/EtOAc gradient) to provide the title compound as a pale yellow liquid
(150 mg, 90%). 1H NMR (400 MHz, CDC13) 6: 5.89 (t, J= 2.2 Hz, 1H), 5.80 (t, J= 2.2 Hz, 2H),
3.76 (s, 7H), 2.81 (s, 3H) ppm. 13C NMR (75 MHz, CDC 3) 6: 161.9, 151.5, 91.4, 89.7, 55.3,
30.9 ppm.
N, : N(H)Me
N-Methylpyridin-3-amine25 (Table 4). Following general procedure B, a mixture of 3-
chloropyridine (95 pL, 1.0 mmol), 2M methylamine (1 mL, 2.0 mmol), NaOt-Bu (120 mg, 1.2
mmol), BrettPhos precatalyst (8 mg, 0.01 mmol), and t-BuOH (4 mL) was stirred at room
temperature for 2 h. The crude product was purified via column chromatography (20:1
CH2Cl2/MeOH) to provide the title compound as a pale yellow liquid (97 mg, 90%). The isolated
product was a 35:1 mixture of mono:diarylation methylamine. 'H NMR (400 MHz, CDC13) 6:
8.02 (d, J = 2.9, 1 H), 7.95 (dd, J = 4.7, 1.3, 1 H), 7.09 (dd, J = 8.3, 4.7, 1 H), 6.86 (ddd, J = 8.2,
2.9, 1.3, 1H), 3.79 (bs, 1H), 2.85 (d, J = 5.1, 3H) ppm. 13C NMR (75 MHz, CDCl3) 6: 145.3,
138.9, 136.0, 123.9, 118.2, 30.5 ppm.
N(H)Me
N-Methylquinolin-6-amine (Table 4). Following general procedure A, a mixture of 6-
chloroquinoline (164 mg, 1.0 mmol), 2M methylamine (1 mL, 2.0 mmol), NaOt-Bu (120 mg, 1.2
mmol), BrettPhos precatalyst (8 mg, 0.01 mmol), and t-BuOH (1 mL) was stirred at room
temperature for 17 h. The crude product was purified via column chromatography (99:1 to 97:3
CH2Cl2/MeOH gradient) to provide the title compound as a yellow oil (150 mg, 95%). 'H NMR
(400 MHz, CDC13) 6: 8.62 (dd, J = 4.2, 1.7 Hz, 1 H), 7.94 (d, J = 8.3 Hz, 1 H), 7.88 (d, J = 9.1 Hz,
1 H), 7.26 (dd, J = 8.3, 4.2 Hz, 1 H), 7.09 (dd, J = 9.1, 2.6 Hz, 1 H), 6.68 (d, J = 2.6 Hz, 1 H), 4.19
(bs, 1H), 2.93 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 147.4, 146.1, 143.3, 133.9, 130.3,
130.2, 121.5, 102.4, 30.8 ppm.
Experimental Procedures for Examples Described in Table 5
General Procedure D: An oven-dried test tube, which was equipped with a magnetic
stir bar and fitted with a teflon septum, was charged with 5 (0.05 mol%) 1 (0.05 mol%) and NaO-
t-Bu (1.15 g, 12 mmol). The vessel was evacuated and backfilled with argon (this process was
repeated a total of 3 times) and then the aryl chlorodie (10 mmol), amine (14 mmol), and Bu2 0
(3 mL) were added via syringe. The solution was heated to 85 0C until the starting material was
completely consumed as monitored by GC. The reaction mixture was then cooled to room
temperature, diluted with ethyl acetate, washed with water, concentrated in vacuo, and purified
via the Biotage SP4 (silica-packed 100 g snap cartridge).
General Procedure E: An oven-dried test tube, which was equipped with a magnetic
stir bar, was taken into a nitrogen filled dry-box and charged with NaOt-Bu (115 mg, 1.2 mmol),
amine (1.2 mmol), aryl chloride (1.0 mmol), and Bu2O (1 mL). A solution of 1 and 5 in toluene
(50 [tL, 0.02M, 0.01 mol% 1, 0.01 mol% 5) was added and then the reaction vessel was sealed,
removed from the dry-box and heated to 110 *C until the starting material was completely
consumed as monitored by GC. The reaction mixture was then cooled to room temperature,
diluted with ethyl acetate, washed with water, concentrated in vacuo, and purified via the
Biotage SP4 (silica-packed 25+M cartridge).
M N(H)Hex
MeO
N-Hexyl-4-methoxyaniline (Table 5). Following general procedure D, a mixture of 4-
chloroanisole (1.23 mL, 10 mmol), hexylamine (1.83 mL, 14 mmol), NaOt-Bu (1.15 g, 12 mmol),
5 (4 mg, 0.05 mol%), 1 (2.5 mg, 0.05 mol%), and Bu2O (3 mL) was heated to 85 0C for 1 h. The
crude product was purified via the Biotage SP4 (silica-packed 100 g; 0-50% EtOAc/hexanes) to
provide the title compound as a yellow oil (1.828 g, 88%). 1H NMR (300 MHz, CDC13) 6: 6.84
(d, J = 9.0 Hz, 2H), 6.62 (d, J = 9.0 Hz, 2H), 3.78 (s, 3H), 3.40 (s, 1 H), 3.09 (t, J = 7.0 Hz, 2H),
1.64 (pentet, J = 7.5 Hz, 2H), 1.42 (m, 6H), 0.97 (t, J = 7.0 Hz, 3H) ppm. 13C NMR (75 MHz,
CDC13 ) 6: 152.2, 143.2, 115.1, 114.2, 56.0, 45.3, 32.0, 30.0, 27.2, 23.0, 14.4 ppm. IR (neat,
cm1): 3394, 2929, 2857, 2831, 1513, 1466, 1237, 1180, 1040, 819. 520.
N N(H)Bn
MeO
N-Benzyl-4-methoxyaniline (Table 5). Following general procedure D, a mixture of 4-
chloroanisole (1.23 mL, 10 mmol), benzylamine (1.52 mL, 14 mmol), NaOt-Bu (1.15 g, 12
mmol), 5 (4 mg, 0.05 mol%), 1 (2.5 mg, 0.05 mol%), and Bu2O (3 mL) was heated to 85 0C for 1
h. The crude product was purified via the Biotage SP4 (silica-packed 25+M; 0-50%
EtOAc/hexanes) to provide the title compound as a yellow oil (2.059 g, 97%). 'H NMR (300
MHz, CDCl3 ) 6: 7.63 - 7.52 (m, 5H), 7.06 (d, J = 9.0 Hz, 2H), 6.81 (d, J = 9.0 Hz, 2H), 4.46 (s,
2H), 4.05 (s, 1H), 3.92 (s, 3H) ppm. 13C NMR (75 MHz, CDCl3) 6: 152.6, 143.1, 140.5, 129.2,
128.1, 127.7, 115.4, 114.6, 56.1, 49.5 ppm. IR (neat, cm 1): 3414, 3029, 2832, 1513, 1453,
1235, 1036, 820, 743, 698. Anal. Calcd. for C 4H15NO: C, 78.84; H, 7.09. Found: C, 78.61; H,
7.10.
OVN(H)Hex
N-Hexylaniline (Table 5). Following general procedure D, a mixture of chlorobenzene
(1.02 mL, 10 mmol), hexylamine (1.83 mL, 14 mmol), NaOt-Bu (1.15 g, 12 mmol), 5 (4 mg, 0.05
mol%), 1 (2.5 mg, 0.05 mol%), and Bu2O (3 mL) was heated to 85 0C for 1 h. The crude
product was purified via the Biotage SP4 (silica-packed 50 g; 0-50% EtOAc/hexanes) to provide
the title compound as a clear oil (1.607 g, 91%). 1H NMR (300 MHz, CDC13) 6: 7.33 (t, J= 7.5
Hz, 2H), 6.85 (t, J = 7.5 Hz, 1 H), 6.74 (d, J = 7.5 Hz, 2H), 3.70 (s, 1 H), 3.23 (t, J = 7.0 Hz, 2H),
1.74 (pentet, J = 7.0 Hz, 2H), 1.51 (m, 6H), 1.09 (t, J = 7.0 Hz, 3H) ppm. 13C NMR (75 MHz,
CDC13) 6: ppm 148.9, 129.6, 117.4, 113.0, 44.4, 32.1, 29.9, 27.3, 23.1, 14.5. IR (neat, cm-1):
3412, 2956, 2928, 1603, 1507, 1321, 1259, 748, 692. Anal. Calcd. for C12H19N: C, 81.30; H,
10.80. Found: C, 81.37; H, 10.73.
N(H)Bn
N-benzylaniline (Table 5). Following general procedure D, a mixture of chlorobenzene
(1.02 mL, 10 mmol), benzylamine (1.52 mL, 14 mmol), NaOt-Bu (1.15 g, 12 mmol), 5 (4 mg,
0.05 mol%), 1 (2.5 mg, 0.05 mol%), and Bu20 (3 mL) was heated to 85 0C for 1 h. The crude
product was purified via the Biotage SP4 (silica-packed 25+M; 0-50% EtOAc/hexanes) to
provide the title compound as a yellow oil (1.646 g, 90%). 1H NMR (300 MHz, CDC13) 6: 7.69 -
7.61 (m, 5H), 7.53 (t, J = 7.5 Hz, 2H), 7.09 (t, J = 7.5 Hz, 1 H), 6.92 (d, J = 7.5 Hz, 2H), 4.57 (s,
2H), 4.22 (s, 1H) ppm. 13C NMR (75 MHz, CDC13) 6: 148.8, 140.2, 129.9, 129.3, 128.1, 127.8,
118.1, 113.5, 48.7 ppm. IR (neat, cm~1): 3419, 3052, 3026, 2841, 1603, 1506, 1453, 1325, 750,
693. Anal. Calcd. for C13H13N: C, 85.21; H, 7.15. Found: C, 85.04; H, 7.15.
C (N(H)Hex
Me
N-Hexyl-2-methylaniline (Table 5, entry 5). Following general procedure D, a mixture
of 2-chlorotoluene (1.17 mL, 10 mmol), hexylamine (1.82 mL, 14 mmol), NaOt-Bu (1.15 g, 12
mmol), 5 (4 mg, 0.05 mol%), 1 (2.5 mg, 0.05 mol%), and Bu20 (3 mL) was heated to 85 0C for 1
h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap; 0-50%
EtOAc/hexanes) to provide the title compound as a clear oil (1.732 g, 91%). 1H NMR (300 MHz,
CDC13) 6: 7.33 (t, J = 7.5 Hz, 1 H), 7.25 (d, J = 7.5 Hz, 1 H), 6.83 (m, 2H), 3.61 (s, 1 H), 3.33 (t, J
= 7.0 Hz, 2H), 2.32 (s, 3H), 1.85 (septet, J = 7.0 Hz, 2H), 1.58 (m, 6H), 1.14 (t, J = 7.0 Hz, 3H)
ppm. 13C NMR (75 MHz, CDC13) 6: 146.8, 130.4, 127.6, 122.0, 117.0, 110.0, 44.4, 32.2, 30.0,
27.4, 23.2, 17.9, 14.5 ppm. IR (neat, cm'): 3430, 2956, 2924, 2856, 1607, 1514, 1473, 1317,
1260, 745. Anal. Calcd. for C3H21N: C, 81.61; H, 11.06. Found: C, 81.81; H, 11.02.
Me H
N ,a CF 3
Me
2,5-Dimethyl-N-(3-(trifluoromethyl)phenyl)aniline (Table 5). Following general
procedure E, a mixture of 2-chloro-p-xylene (134 tL, 1.0 mmol), 3-(trifluoromethyl)aniline (150
ptL, 1.2 mmol), NaOt-Bu (115 mg, 1.2 mmol), 5 (0.08 mg, 0.01 mol%), 1 (0.05 mg, 0.01 mol%),
and Bu2O (1 mL) was heated to 110 *C for 1 h. The crude product was purified via the Biotage
SP4 (silica-packed 25+M; 0-30% EtOAc/hexanes) to provide the title compound as a clear oil
(248 mg, 94%). 'H NMR (300 MHz, CDC13) 6: 7.38 (t, J= 8.0 Hz, 1H), 7.22 (d, J= 8.0 Hz, 1H),
7.16 (m, 3H), 7.08 (d, J = 8.0 Hz, 1H), 6.95 (d, J = 8.0 Hz, 1H), 5.53 (s, 1H), 2.39 (s, 3H), 2.28
(s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 145.5, 139.8, 137.1, 132.6, 132.2, 131.8, 131.8,
131.4, 130.1, 130.0, 127.5, 126.4, 124.9, 124.9, 124.8, 122.8, 122.1, 122.0, 119.2, 119.1, 116.3,
116.3, 112.8, 21.4, 17.7 ppm. IR (neat, cm'): 3391, 3021, 2924, 1613, 1485, 1337, 1165,
1124, 787, 699. Anal. Calcd. for C15H4F3N: C, 67.91; H, 5.32. Found: C, 68.02; H, 5.31.
Me H
I ~ OEt
Me
N-(4-Ethoxyphenyl)-2,5-dimethylaniline (Table 5). Following general procedure E, a
mixture of 2-chloro-p-xylene (134 tL, 1.0 mmol), 4-ethoxyaniline (154 tL, 1.2 mmol), NaOt-Bu
(115 mg, 1.2 mmol), 5 (0.08 mg, 0.01 mol%), 1 (0.05 mg, 0.01 mol%), and Bu2 0 (1 mL) was
heated to 110 0C for 1 h. The crude product was purified via the Biotage SP4 (silica-packed
25+M; 0-30% EtOAc/hexanes) to provide the'title compound as a white solid (235 mg, 98%), mp
56-58 C. 'H NMR (300 MHz, CDC13) 6: 7.10 (m, 3H), 6.95 (m, 3H), 6.72 (d, J = 7.5 Hz, 1H),
5.26 (s, 1 H), 4.09 (q, J = 7.0 Hz, 2H), 2.33 (s, 3H), 2.29 (s, 3H), 1.51 (t, J = 7.0 Hz, 3H) ppm.
13C NMR (75 MHz, CDCI3) 6: 154.7, 143.5, 136.8, 136.5, 130.9, 122.5, 121.0, 116.1, 116.1,
115.6, 64.1, 21.6, 17.7, 15.3 ppm. IR (neat, cm 1): 3402, 2978, 2923, 1511, 1478, 1292, 1238,
1117, 1049, 798. Anal. Calcd. for C16H19NO: C, 79.63; H, 7.94. Found: C, 79.70; H, 8.01.
H
MeO N F
4-Fluoro-N-(4-methoxyphenyl)aniline (Table 5). Following general procedure E, a
mixture of 4-chloroanisole (123 [tL, 1.0 mmol), 4-fluoroaniline (114 [tL, 1.2 mmol), NaOt-Bu (115
mg, 1.2 mmol), 5 (0.08 mg, 0.01 mol%), 1 (0.05 mg, 0.01 mol%), and Bu20 (1 mL) was heated
to 110 0C for 1 h. The crude product was purified via the Biotage SP4 (silica-packed 25+M; 0-
30% EtOAc/hexanes) to provide the title compound as a white solid (209 mg, 94%), mp 59-60
C. 1H NMR (300 MHz, CDC13) 5: 7.03 - 6.86 (m, 8H), 5.41 (s, 1H), 3.81 (s, 3H) ppm. 13C
NMR (75 MHz, CDC13 ) 5: 159.0, 155.8, 155.2, 141.4, 136.8, 121.4, 118.0, 117.9, 116.2, 115.9,
115.0, 55.8 ppm. IR (neat, cm 1): 3391, 3007, 1508, 1314, 1243, 1221, 1027, 814, 772, 591.
Anal. Calcd. for C13H12FNO: C, 71.87; H, 5.57. Found: C, 71.89; H, 5.62.
H
N
MeO OEt
4-Ethoxy-N-(4-methoxyphenyl)aniline (Table 5). Following general procedure E, a
mixture of 4-chloroanisole (123 [tL, 1.0 mmol), 4-ethoxyaniline (154 [tL, 1.2 mmol), NaOt-Bu
(115 mg, 1.2 mmol), 5 (0.08 mg, 0.01 mol%), 1 (0.05 mg, 0.01 mol%), and Bu20 (1 mL) was
heated to 110 0C for 1 h. The crude product was purified via the Biotage SP4 (silica-packed
25+M; 0-30% EtOAc/hexanes) to provide the title compound as a white solid (229 mg, 94%), mp
73-75 *C. 'H NMR (300 MHz, CDC13 ) 6: 6.95 (m, 4H), 6.84 (m, 4H), 5.34 (s, 1H), 4.01 (q, J =
7.0 Hz, 2H), 3.80 (s, 3H), 1.43 (t, J = 7.0 Hz, 3H) ppm. 13C NMR (75 MHz, CDC13 ) 6: 154.4,
153.8, 138.2, 138.1, 119.8, 119.7, 115.7, 114.9, 64.1, 55.9, 15.3 ppm. IR (neat, cm 1): 3421,
2983, 2956, 1513, 1298, 1253, 1116, 1052, 1037, 814. Anal. Calcd. for C15H17NO2: C, 74.05; H,
7.04. Found: C, 73.95; H, 7.06.
H Me
N
MeO
Me
N-(4-Methoxyphenyl)-2,5-dimethylaniline (Table 5). Following general procedure E, a
mixture of 4-chloroanisole (123 [tL, 1.0 mmol), 2,5-dimethylaniline (149 [AL, 1.2 mmol), NaOt-Bu
(115 mg, 1.2 mmol), 5 (0.08 mg, 0.01 mol%), 1 (0.05 mg, 0.01 mol%), and Bu2 0 (1 mL) was
heated to 110 0C for 1 h. The crude product was purified via the Biotage SP4 (silica-packed
25+M; 0-30% EtOAc/hexanes) to provide the title compound as a white solid (220 mg, 97%), mp
40-41 C. 1H NMR (300 MHz, CDC13) 6: 7.11 (m, 3H), 6.96 (m, 3H), 6.75 (d, J = 7.5 Hz, 1H),
5.27 (s, 1H), 3.88 (s, 3H), 2.33 (s, 3H), 2.30 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 155.3,
143.5, 136.8, 136.7, 131.0, 122.7, 122.5, 121.1, 116.2, 115.0, 55.9, 21.7, 17.7 ppm. IR (neat,
cm1): 3400, 2921, 1579, 1511, 1463, 1292, 1241, 1037, 828, 800. Anal. Calcd. for C15H17NO:
C, 79.26; H, 7.54. Found: C, 79.11; H, 7.59.
Experimental Procedures for Examples Described in Table 6
General Procedure F: An oven-dried test tube, which was equipped with a magnetic stir
bar and fitted with a teflon septum, was charged with 5 (1 mol%) 1 (1 mol%) and NaOt-Bu (2.0
equiv). The vessel was evacuated and backfilled with argon (this process was repeated a total
of 3 times) and then the aryl chlorodie (1.0 equiv), amine (1.2 equiv), and dioxane (1 mL/mmol)
were added via syringe. The solution was heated to 80 0C until the starting material was
completely consumed as monitored by GC. The reaction mixture was then cooled to room
temperature, diluted with ethyl acetate, washed with water, concentrated in vacuo, and purified
via the Biotage SP4 (silica-packed 50 g snap cartridge).
N
H
N',N4-Diphenylbutane-1,4-diamine (Table 6). Following general procedure F, a
mixture of chlorobenzene (51 [AL, 0.5 mmol), N-phenylbutane-1,4-diamine (98 mg, 0.6 mmol),
NaOt-Bu (97 mg, 1.0 mmol), 5 (4 mg, 1 mol%), 1 (2.5 mg, 1 mol%), and dioxane (0.5 mL) was
heated to 80 *C for 2 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g
snap; 0-75% EtOAc/hexanes) to provide the title compound as a clear oil (108 mg, 91%). 'H
NMR (300 MHz, CDC13) 6: 7.28 (t, J = 7.0 Hz, 4H), 6.80 (t, J = 7.0 Hz, 2H), 6.68 (d, J = 7.0 Hz,
4H), 3.68 (s, 2H), 3.22 (m, 4H), 1.78 (m, 4H) ppm. 13C NMR (75 MHz, CDC13 ) 6: 148.6, 129.6,
117.6, 113.1, 44.0, 27.4 ppm. IR (neat, cm 1): 3407, 3050, 2934, 2861, 1603, 1507, 1477,
1321, 1257, 1179, 749, 693. Anal. Calcd. for C16H20 N2: C, 79.96; H, 8.39. Found: C, 80.20; H,
8.48.
HN _O
HN
N-(Piperidin-4-ylmethyl)aniline (Table 6). Following general procedure F, a mixture of
chlorobenzene (102 [tL, 1.0 mmol), 4-(aminomethyl)piperidine (137 mg, 1.2 mmol), NaOt-Bu
(192 mg, 2.0 mmol), 5 (8 mg, 1 mol%), 1 (5 mg, 1 mol%), and dioxane (1 mL) was heated to 80
0C for 15 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap; 7 -
9% MeOH/CH 2CI2) to provide the title compound as a white solid (159 mg, 84%), mp 60 - 61
C. 1H NMR (300 MHz, DMSO) 6: 7.02 (t, J= 7.5 Hz, 2H), 6.52 (d, J= 8.0 Hz, 2H), 6.46 (t, J=
8.0 Hz, 1 H), 5.58 (s, 1 H), 3.11 (s, 1 H), 2.92 (d, J = 11.5 Hz, 2H), 2.82 (t, J = 6.0 Hz, 2H), 2.41 (t,
J= 10 Hz, 2H), 1.64 (m, 3H), 1.02 (m 2H) ppm. 13C NMR (75 MHz, DMSO) 6: 149.8, 129.5,
115.8, 112.5, 50.0, 46.5, 36.2, 31.7 ppm. IR (neat, cm-1): 3326, 2919, 1602, 1509, 1427, 1325,
1263, 749, 694.
H
N NN
H
N',-Diphenylbenzene-1,4-diamine (Table 5). Following general procedure F, a
mixture of chlorobenzene (102 [tL, 1.0 mmol), N'-phenylbenzene-1,4-diamine (221 mg, 1.2
mmol), NaOt-Bu (192 mg, 2.0 mmol), 5 (8 mg, 1 mol%), 1 (5 mg, 1 mol%), and dioxane (1 mL)
was heated to 80 0C for 2 h. The crude product was purified via the Biotage SP4 (silica-packed
50 g snap; 0-50% EtOAc/Hexane) to provide the title compound as a off-white solid (260 mg,
99%), mp 152-154 *C. 1H NMR (300 MHz, CDC13) 6: 7.27 (t, J= 7.5 Hz, 4H), 7.08 (s, 4H), 7.00
(d, J = 8.0 Hz, 4H), 6.90 (t, J = 7.5 Hz, 2H), 5.59 (s, 2H) ppm. 13C NMR (75 MHz, CDC13) 6:
144.7, 137.4, 129.6, 121.2, 120.2, 116.5 ppm. IR (neat, cm-1): 3389, 1601, 1512, 1496, 1382,
1313, 1271, 820, 742, 695. Anal. Calcd. for C18H16N2: C, 83.04; H, 6.19. Found: C, 82.81; H,
6.22.
Synthesis of 12, 13 and 14
BrettPhosPdPhBr 12. In a nitrogen filled glovebox, a solution of BrettPhos (1, 23.6 mg,
44 pmol), bromobenzene (30 pL) and THF 26 (2 mL) was added to solid
(COD)Pd(CH 2SiPhMe 2)227 ,28 (20.4 mg, 40 pmol) in an oven-dried 20 mL vial. The vial was
capped, and the resulting yellow solution was allowed to stand for 48 h at rt. After this time,
pentane29 (8 mL) was layered on top of the THF solution and the vial was allowed to stand for
24 h resulting in the formation of crystals. After 24 h, the crystals were collected via vacuum
filtration in the glovebox, and dried under vacuum to provide 2 (24 mg, 75%) as light-yellow
needles as a THF mono-solvate: 'H NMR (400 MHz, CD2 Cl2, mixture of rotomers) 8 7.26-7.29
(m, 2H - minor), 7.00-7.06 (m, major and minor), 6.82-6.92 (m, major and minor), 6.75-6.79
(m, 1 H - minor, 1 H - major), 4.33 (s, 3H - minor), 3.79 (s, 3H -major), 3.59 (s, 3H - minor),
3.33 (s, 3H - major), 3.00-3.08 (m, 1 H - major), 2.88-2.92 (m, 1 H - major), 2.72-2.82 (m, 2H -
major), 2.46-2.53 (m, 2H - major), 2.32-2.37 (m, 2H -minor), 1.50-1.90 (m, major and minor),
1.05-1.45 (m), 0.75-0.90 (m, 12H - major and minor), 0.55-0.65 (m, 2H - minor); 31P NMR
(162 MHz, CD2CI2 , mixture of rotomers) 8 44.9 (minor), 36.9 (major).
OMe
MeO PCy2
'Pr ,Pr Pd-
CI
'Pr
BrettPhosPdPhCl 13. In a nitrogen filled glovebox, a solution of BrettPhos (1, 51.0 mg,
96 pmol), chlorobenzene (100 pL) and THF (4 mL) was added to solid (COD)Pd(CH 2SiPhMe2)2
(40.8 mg, 80 pmol) in an oven-dried 20 mL vial. The vial was capped, and the resulting yellow
solution was allowed to stand for 48 h at rt. After this time, pentane (14 mL) was layered on top
of the THF solution and the vial was allowed to stand for 24 h resulting in the formation of
crystals. After 24 h, the crystals were collected via vacuum filtration in the glovebox, and dried
under vacuum to provide 3 (42 mg, 69%) as light-yellow microcrystalline powder: 'H NMR (400
MHz, CD2CI2 , mixture of rotomers) 6 7.28-7.30 (m, 2H - minor), 7.07-7.10 (m, 2H - minor),
7.04 (s, 2H - major), 7.02 (s, 2H - minor), 6.82-6.92 (m, major and minor), 6.76-6.82 (m, 1 H -
minor, 1 H - major), 4.29 (s, 3H - minor), 3.79 (s, 3H -major), 3.59 (s, 3H - minor), 3.34 (s, 3H -
major), 2.96-3.03 (m, 1H - major), 2.88-2.95 (m, 1H - major), 2.71-2.80 (m, 2H - major),
2.46-2.53 (m, 2H - major), 2.32-2.37 (m, 2H -minor), 1.50-1.90 (m, major and minor), 1.08-
1.45 (m), 0.78-0.92 (m, major and minor), 0.55-0.65 (m, 2H - minor); 31P NMR (162 MHz,
CD2CI2, mixture of rotomers) 8 46.8 (minor), 38.6 (major). Anal Calc for C41H58CIO 2PPd: C,
65.16; H, 7.74;. Found: C, 65.42; H, 7.53.
OMe
MeO PCy2  Me
'Pr ,iPr Pd
Me
Br
'Pr
BrettPhosPd(3,5-dimethylphenyl)Br 14. In a nitrogen filled glovebox, a solution of
BrettPhos (1, 172 mg, 321 pmol), 3,5-dimethylbromobenzene (225 pL) and THF (15 mL) was
added to solid (COD)Pd(CH 2SiPhMe2)2 (150 mg, 292 pmol) in an oven-dried 100 mL round
bottom flask. The flask was capped, and the resulting yellow solution was allowed to stand for
48 h at rt. After this time, pentane (60 mL) was layered on top of the THF solution and the vial
was allowed to stand for 24 h resulting in the formation of crystals. After 24 h, the crystals were
collected via vacuum filtration in the glovebox, and dried under vacuum to provide 3 (185 mg,
77%) as light-yellow microcrystalline powder as a THF mono-solvate: 'H NMR (400 MHz,
CD2CI2 , mixture of rotomers) 6 7.01-7.08 (m, 2H - major, 4H - minor), 6.90 (s, 2H - minor),
6.89 (dd, J = 9.2, 2.8, 1 H - major), 6.83 (d, J = 8.8 Hz, 1 H -major), 6.64 (s, 2H -major), 6.41 (s,
1 H - minor, 2H - major), 4.31 (s, 3H - minor), 3.78 (s, 3H -major), 3.59 (s, 3H - minor), 3.32 (s,
3H - major), 3.03-3.06 (m, 1 H - major), 2.88-2.92 (m, 1 H - major), 2.70-2.79 (m, 2H - major),
2.45-2.51 (m, 2H - major), 2.32-2.37 (m, 2H -minor), 2.14 (s, 6H -major), 2.12 (s, 6H - minor),
1.50-1.90 (m, major and minor), 1.05-1.45 (m), 0.75-0.90 (m, 12H - major and minor), 0.55-
0.65 (m, 2H - minor); 31P NMR (162 MHz, CD2CI2 , mixture of rotomers) 8 45.0 (minor), 37.5
(major). Anal Calc C43H62BrO 2PPd: C, 62.36; H, 7.55. Found: C, 62.52; H, 7.68.
X-ray Crystal Structure Data for 1:
Table 1. Crystal data and structure refinement for 1.
Identification code bf2049
Empirical formula 035 H53 02 P
Formula weight 536.74
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P2(1)/c
Unit cell dimensions a = 19.3663(7) A a= 90
b14.5216(5) A9.
34.4249(12) A =9
Volume 9679.4(6) A3
Z 12
Density (calculated) 1.105 Mg/i 3
Absorption coefficient 0.113 mm 1
F(000) 3528
Crystal size 0.50 x 0.40 x 0.25 mm3
Theta range for data collection 1.05 to 29.130.
Index ranges -26<=h<=26, -19<=k<=1 9, -47<=
Reflections collected 246274
Independent reflections 26043 [R(int) = 0.0445]
Completeness to theta = 25.000 100.0%
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.9723 and 0.9457
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 26043 / 0 / 1051
Goodness-of-fit on F2  1.091
Final R indices [l>2sigma(l)] R1 = 0.0408, wR2 = 0.1284
R indices (all data) R1 = 0.0574, wR2 = 0.1467
Largest diff. peak and hole 0.435 and -0.250 e.A
.
1480(10)0.
0
l<=47
Table 2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (A2x
103)
for BF2049. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
x y z U(eq)
P(1)
0(1)
0(2)
C(1)
C(2)
C(3)
C(4)
C(5)
C(6)
C(7)
C(8)
C(9)
C(10)
C(11)
C(12)
C(13)
C(14)
C(15)
C(16)
C(17)
C(18)
C(19)
C(20)
C(21)
C(22)
C(23)
C(24)
C(25)
C(26)
1432(1)
2474(1)
3291(1)
2276(1)
2696(1)
3305(1)
3514(1)
3118(1)
2497(1)
2106(1)
2323(1)
1969(1)
1409(1)
1202(1)
1542(1)
2950(1)
3527(1)
2768(1)
1027(1)
1332(1)
998(1)
1324(1)
1619(1)
543(1)
3927(1)
2866(1)
1011(1)
262(1)
-130(1)
2799(1)
2629(1)
840(1)
2213(1)
2155(1)
1655(1)
1200(1)
1261(1)
1770(1)
1816(1)
2412(1)
2419(1)
1851(1)
1259(1)
1222(1)
3039(1)
2720(1)
4046(1)
1853(1)
2522(1)
888(1)
497(1)
-444(1)
435(1)
342(1)
2514(1)
2489(1)
2831(1)
2590(1)
2647(1)
3332(1)
2002(1)
2672(1)
3011(1)
3015(1)
2683(1)
2343(1)
2332(1)
1949(1)
1655(1)
1297(1)
1216(1)
1512(1)
1873(1)
1697(1)
1427(1)
1608(1)
824(1)
534(1)
644(1)
2164(1)
2049(1)
2208(1)
2006(1)
3682(1)
3114(1)
3096(1)
3466(1)
16(1)
21(1)
21(1)
15(1)
17(1)
20(1)
20(1)
17(1)
14(1)
15(1)
15(1)
16(1)
17(1)
18(1)
16(1)
19(1)
28(1)
29(1)
19(1)
27(1)
28(1)
19(1)
31(1)
29(1)
25(1)
28(1)
19(1)
24(1)
31(1)
C(27)
C(28)
C(29)
C(30)
C(31)
C(32)
C(33)
C(34)
C(35)
P(1A)
O(1A)
O(2A)
C(1A)
C(2A)
C(3A)
C(4A)
C(5A)
C(6A)
C(7A)
C(8A)
C(9A)
C(1OA)
C(11A)
C(12A)
C(13A)
C(14A)
C(15A)
C(16A)
C(17A)
C(18A)
C(19A)
C(20A)
C(21A)
C(22A)
C(23A)
C(24A)
-101(1)
642(1)
1026(1)
1640(1)
1186(1)
1290(1)
2045(1)
2508(1)
2401(1)
4824(1)
5901(1)
6634(1)
5677(1)
6103(1)
6697(1)
6886(1)
6489(1)
5892(1)
5514(1)
4938(1)
4590(1)
4802(1)
5378(1)
5742(1)
4697(1)
3928(1)
4856(1)
4408(1)
4427(1)
4663(1)
6387(1)
6303(1)
7010(1)
6296(1)
7282(1)
4410(1)
1559(1)
1216(1)
1449(1)
4049(1)
4624(1)
5658(1)
5921(1)
5358(1)
4320(1)
2461(1)
2237(1)
4764(1)
3003(1)
2895(1)
3416(1)
4057(1)
4154(1)
3615(1)
3661(1)
4242(1)
4230(1)
3680(1)
3122(1)
3106(1)
4899(1)
4788(1)
5897(1)
3705(1)
4670(1)
3000(1)
2507(1)
1567(1)
3009(1)
2180(1)
5233(1)
2416(1)
3547(1)
3566(1)
3194(1)
2739(1)
2461(1)
2525(1)
2477(1)
2750(1)
2697(1)
4293(1)
4978(1)
3859(1)
4381(1)
4716(1)
4769(1)
4489(1)
4151(1)
4091(1)
3705(1)
3646(1)
3288(1)
2981(1)
3043(1)
3399(1)
3960(1)
4042(1)
3849(1)
2593(1)
2416(1)
2301(1)
3433(1)
3235(1)
3262(1)
5332(1)
3885(1)
4776(1)
34(1)
33(1)
27(1)
19(1)
25(1)
31(1)
30(1)
27(1)
22(1)
16(1)
24(1)
22(1)
16(1)
18(1)
21(1)
21(1)
17(1)
15(1)
15(1)
17(1)
19(1)
19(1)
17(1)
15(1)
21(1)
28(1)
31(1)
25(1)
39(1)
36(1)
18(1)
23(1)
29(1)
35(1)
24(1)
18(1)
C(25A)
C(26A)
C(27A)
C(28A)
C(29A)
C(30A)
C(31A)
C(32A)
C(33A)
C(34A)
C(35A)
P(1B)
O(1B)
O(2B)
C(1B)
C(2B)
C(3B)
C(4B)
C(5B)
C(6B)
C(7B)
C(8B)
C(9B)
C(1OB)
C(1 1 B)
C(12B)
C(13B)
C(14B)
C(15B)
C(16B)
C(17B)
C(18B)
C(19B)
C(20B)
C(21B)
C(22B)
3654(1)
3252(1)
3281(1)
4026(1)
4436(1)
5052(1)
4623(1)
4819(1)
4740(1)
5179(1)
5002(1)
1848(1)
793(1)
-13(1)
999(1)
570(1)
-40(1)
-243(1)
160(1)
785(1)
1221(1)
1737(1)
2130(1)
2038(1)
1525(1)
1107(1)
1871(1)
2642(1)
1584(1)
2450(1)
1979(1)
3052(1)
523(1)
-17(1)
781(1)
493(1)
2130(1)
2103(1)
3034(1)
3345(1)
3357(1)
1241(1)
960(1)
5(1)
-713(1)
-458(1)
502(1)
7425(1)
7556(1)
9389(1)
8000(1)
8040(1)
8537(1)
8999(1)
8956(1)
8458(1)
8486(1)
9162(1)
9208(1)
8596(1)
7930(1)
7870(1)
9884(1)
9956(1)
10820(1)
8639(1)
8873(1)
9313(1)
7170(1)
7456(1)
6193(1)
7805(1)
4704(1)
5082(1)
5283(1)
5355(1)
4979(1)
4164(1)
3802(1)
3653(1)
3971(1)
4327(1)
4482(1)
3948(1)
3273(1)
4594(1)
3928(1)
3591(1)
3585(1)
3917(1)
4255(1)
4266(1)
4635(1)
4679(1)
5023(1)
5328(1)
5279(1)
4945(1)
4369(1)
4279(1)
4498(1)
5708(1)
6048(1)
5700(1)
4946(1)
5244(1)
5038(1)
2908(1)
23(1)
28(1)
30(1)
28(1)
22(1)
18(1)
21(1)
27(1)
27(1)
25(1)
22(1)
17(1)
20(1)
21(1)
15(1)
16(1)
18(1)
18(1)
16(1)
15(1)
15(1)
17(1)
18(1)
17(1)
17(1)
16(1)
21(1)
29(1)
32(1)
20(1)
29(1)
26(1)
18(1)
25(1)
27(1)
27(1)
4575(1) 23(1)C(23B)
C(24B)
C(25B)
C(26B)
C(27B)
C(28B)
C(29B)
C(30B)
C(31B)
C(32B)
C(33B)
C(34B)
C(35B)
2254(1)
3017(1)
3397(1)
3328(1)
2573(1)
2202(1)
1638(1)
2121(1)
2020(1)
1273(1)
784(1)
885(1)
7704(1)
7411(1)
7609(1)
8620(1)
8914(1)
8726(1)
6172(1)
5602(1)
4567(1)
4292(1)
4850(1)
5891(1)
Table 3. Bond lengths [A] and angles [0] for BF2049.
1.8431(11)
1.8700(12)
1.8847(12)
1.3761(13)
1.4223(14)
1.3703(13)
1.4275(13)
1.4089(15)
1.4145(14)
1.3846(15)
1.3897(16)
1.3872(15)
1.4106(15)
1.5087(14)
1.4030(15)
1.4117(15)
1.3996(14)
1.5224(15)
1.3866(15)
3472(1)
3499(1)
3122(1)
3006(1)
2980(1)
3360(1)
3867(1)
4130(1)
4069(1)
4136(1)
3873(1)
3929(1)
21(1)
27(1)
34(1)
36(1)
31(1)
26(1)
22(1)
30(1)
38(1)
35(1)
30(1)
23(1)
P(1)-C(1)
P(1)-C(24)
P(1)-C(30)
0(1)-C(2)
0(1)-C(23)
0(2)-C(5)
0(2)-C(22)
C(1)-C(6)
C(1)-C(2)
C(2)-C(3)
C(3)-C(4)
C(4)-C(5)
C(5)-C(6)
C(6)-C(7)
C(7)-C(8)
C(7)-C(1 2)
C(8)-C(9)
C(8)-C(1 3)
C(9)-C(1 0)
-591(1) 10001(1)
C(10)-C(1 1)
C(1 0)-C(l 6)
C(11)-C(12)
C(1 2)-C(l 9)
C(1 3)-C(1 5)
C(1 3)-C(l 4)
C(1 6)-C(l 7)
C(1 6)-C(1 8)
C(1 9)-C(21)
C(1 9)-C(20)
C(24)-C(29)
C(24)-C(25)
C(25)-C(26)
C(26)-C(27)
C(27)-C(28)
C(28)-C(29)
C(30)-C(31)
C(30)-C(35)
C(31)-C(32)
C(32)-C(33)
C(33)-C(34)
C(34)-C(35)
P(1 A)-C(1 A)
P(1 A)-C(24A)
P(1 A)-C(30A)
0(1 A)-C(2A)
0(1 A)-C(22A)
O(2A)-C(5A)
O(2A)-C(23A)
C(1 A)-C(6A)
C(1 A)-C(2A)
C(2A)-C(3A)
C(3A)-C(4A)
C(4A)-C(5A)
C(5A)-C(6A)
C(6A)-C(7A)
1.3983(16)
1.5256(15)
1.3950(15)
1.5197(15)
1.5343(17)
1.5387(17)
1.5210(17)
1.5328(16)
1.5257(16)
1.5358(17)
1.5343(17)
1.5345(16)
1.5361(17)
1.523(2)
1.5225(19)
1.5332(17)
1.5332(16)
1.5342(16)
1.5302(18)
1.5249(19)
1.5239(19)
1.5328(17)
1.8494(11)
1.8611(11)
1.8807(12)
1.3736(13)
1.4299(14)
1.3727(13)
1.4292(13)
1.4064(15)
1.4136(15)
1.3853(16)
1.3951(16)
1.3879(15)
1.4072(15)
1.5051(14)
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C(7A)-C(1 2A)
C(7A)-C(8A)
C(8A)-C(9A)
C(8A)-C(1 3A)
C(9A)-C(1 OA)
C(1OA)-C(1 1A)
C(10A)-C(1 6A)
C(11 A)-C(1 2A)
C(1 2A)-C(1 9A)
C(1 3A)-C(1 4A)
C(1 3A)-C(1 5A)
C(1 6A)-C(1 8A)
C(1 6A)-C(1 7A)
C(1 9A)-C(20A)
C(1 9A)-C(21 A)
C(24A)-C(29A)
C(24A)-C(25A)
C(25A)-C(26A)
C(26A)-C(27A)
C(27A)-C(28A)
C(28A)-C(29A)
C(30A)-C(31 A)
C(30A)-C(35A)
C(31 A)-C(32A)
C(32A)-C(33A)
C(33A)-C(34A)
C(34A)-C(35A)
P(1 B)-C(1 B)
P(1 B)-C(24B)
P(1 B)-C(30B)
0(1 B)-C(2B)
0(1 B)-C(22B)
O(2B)-C(5B)
0(2B)-C(23B)
C(1 B)-C(6B)
C(1 B)-C(2B)
1.4055(15)
1.4101(15)
1.3941(15)
1.5223(15)
1.3936(16)
1.3911(16)
1.5249(15)
1.4013(14)
1.5245(15)
1.5298(17)
1.5321(17)
1.5252(19)
1.5292(19)
1.5328(15)
1.5352(16)
1.5350(16)
1.5372(16)
1.5311(17)
1.5203(19)
1.5279(17)
1.5311(17)
1.5374(15)
1.5390(15)
1.5307(17)
1.5210(17)
1.5249(17)
1.5339(17)
1.8449(11)
1.8760(12)
1.8839(12)
1.3771(13)
1.4222(13)
1.3724(13)
1.4302(13)
1.4116(15)
1.4121(14)
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C(2B)-C(3B)
C(3B)-C(4B)
C(4B)-C(5B)
C(5B)-C(6B)
C(6B)-C(7B)
C(7B)-C(8B)
C(7B)-C(1 2B)
C(8B)-C(9B)
C(8B)-C(l 3B)
C(9B)-C(l OB)
C(10B)-C(l 1 B)
C(1 OB)-C(l 6B)
C(11 B)-C(12B)
C(1 2B)-C(1 9B)
C(1 3B)-C(1 4B)
C(1 3B)-C(1 5B)
C(1 6B)-C(1 8B)
C(1 6B)-C(1 7B)
C(1 9B)-C(21 B)
C(1 9B)-C(20B)
C(24B)-C(29B)
C(24B)-C(25B)
C(25B)-C(26B)
C(26B)-C(27B)
C(27B)-C(28B)
C(28B)-C(29B)
C(30B)-C(35B)
C(30B)-C(31 B)
C(31 B)-C(32B)
C(32B)-C(33B)
C(33B)-C(34B)
C(34B)-C(35B)
C(1)-P(1)-C(24)
C(1)-P(1)-C(30)
C(24)-P(1)-C(30)
1.3846(15)
1.3899(15)
1.3883(14)
1.4100(15)
1.5094(14)
1.4069(15)
1.4136(15)
1.3988(14)
1.5208(15)
1.3882(16)
1.3941(15)
1.5203(15)
1.3947(14)
1.5213(15)
1.5340(17)
1.5367(18)
1.5237(17)
1.5349(16)
1.5342(16)
1.5372(17)
1.5351(17)
1.5378(17)
1.5324(18)
1.527(2)
1.525(2)
1.5312(17)
1.5326(17)
1.5334(17)
1.5287(19)
1.521(2)
1.529(2)
1.5353(17)
104.52(5)
104.51(5)
100.64(5)
C(2)-O(1)-C(23)
C(5)-O(2)-C(22)
C(6)-C(1)-C(2)
C(6)-C(1)-P(1)
C(2)-C(1)-P(1)
0(1)-C(2)-C(3)
0(1)-C(2)-C(1)
C(3)-C(2)-C(1)
C(2)-C(3)-C(4)
C(5)-C(4)-C(3)
O(2)-C(5)-C(4)
O(2)-C(5)-C(6)
C(4)-C(5)-C(6)
C(1)-C(6)-C(5)
C(1)-C(6)-C(7)
C(5)-C(6)-C(7)
C(8)-C(7)-C(1 2)
C(8)-C(7)-C(6)
C(1 2)-C(7)-C(6)
C(9)-C(8)-C(7)
C(9)-C(8)-C(1 3)
C(7)-C(8)-C(1 3)
C(1 0)-C(9)-C(8)
C(9)-C(1 0)-C(1 1)
C(9)-C(1 0)-C(1 6)
C(11)-C(10)-C(16)
C(1 2)-C(11 )-C(1 0)
C(11)-C(12)-C(7)
C(11 )-C(1 2)-C(1 9)
C(7)-C(1 2)-C(1 9)
C(8)-C(1 3)-C(1 5)
C(8)-C(1 3)-C(14)
C(1 5)-C(1 3)-C(1 4)
C(1 7)-C(1 6)-C(1 0)
C(1 7)-C(1 6)-C(1 8)
C(1 0)-C(1 6)-C(1 8)
116.81(9)
116.42(9)
118.58(10)
117.30(8)
124.08(8)
122.30(10)
116.65(9)
121.04(10)
120.18(10)
119.96(10)
123.52(10)
115.70(9)
120.78(10)
119.42(9)
123.20(9)
117.37(9)
118.97(10)
120.34(9)
120.58(9)
119.48(10)
117.03(9)
123.44(9)
122.68(10)
116.97(10)
122.70(10)
120.33(10)
122.43(10)
119.44(10)
118.76(10)
121.67(9)
111.79(10)
110.57(9)
109.38(10)
113.17(9)
109.18(10)
111.66(9)
C(12)-C(19)-C(21)
C(1 2)-C(l 9)-C(20)
C(21)-C(l 9)-C(20)
C(29)-C(24)-C(25)
C(29)-C(24)-P(1)
C(25)-C(24)-P(1)
C(24)-C(25)-C(26)
C(27)-C(26)-C(25)
C(28)-C(27)-C(26)
C(27)-C(28)-C(29)
C(28)-C(29)-C(24)
C(31)-C(30)-C(35)
C(31)-C(30)-P(1)
C(35)-C(30)-P(1)
C(32)-C(31)-C(30)
C(33)-C(32)-C(3 1)
C(34)-C(33)-C(32)
C(33)-C(34)-C(35)
C(34)-C(35)-C(30)
C(1A)-P(1A)-C(24A)
C(1 A)-P(1 A)-C(30A)
C(24A)-P(1 A)-C(30A)
C(2A)-O(1 A)-C(22A)
C(5A)-O(2A)-C(23A)
C(6A)-C(1 A)-C(2A)
C(6A)-C(1 A)-P(1 A)
C(2A)-C(1 A)-P(1 A)
0(1 A)-C(2A)-C(3A)
0(1 A)-C(2A)-C(1 A)
C(3A)-C(2A)-C(1A)
C(2A)-C(3A)-C(4A)
C(5A)-C(4A)-C(3A)
O(2A)-C(5A)-C(4A)
O(2A)-C(5A)-C(6A)
C(4A)-C(5A)-C(6A)
C(1A)-C(6A)-C(5A)
113.26(10)
109.72(10)
110.39(10)
109.88(10)
112.59(8)
108.33(8)
111.99(10)
111.08(11)
111.14(11)
111.49(11)
111.07(11)
110.00(10)
107.59(8)
115.72(8)
111.85(11)
110.70(11)
110.52(11)
112.25(11)
111.61(10)
105.49(5)
103.09(5)
106.61(5)
116.47(9)
117.05(9)
118.26(10)
115.39(8)
126.26(8)
122.72(10)
116.28(10)
120.98(10)
120.26(10)
119.80(10)
124.05(10)
115.51(9)
120.43(10)
120.09(10)
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C(1 A)-C(6A)-C(7A)
C(5A)-C(6A)-C(7A)
C(1 2A)-C(7A)-C(8A)
C(1 2A)-C(7A)-C(6A)
C(8A)-C(7A)-C(6A)
C(9A)-C(8A)-C(7A)
C(9A)-C(8A)-C(1 3A)
C(7A)-C(8A)-C(1 3A)
C(1 OA)-C(9A)-C(8A)
C(11 A)-C(1 OA)-C(9A)
C(11 A)-C(1 OA)-C(1 6A)
C(9A)-C(1 OA)-C(1 6A)
C(1 OA)-C(1 1 A)-C(1 2A)
C(11 A)-C(1 2A)-C(7A)
C(11 A)-C(1 2A)-C(1 9A)
C(7A)-C(1 2A)-C(1 9A)
C(8A)-C(1 3A)-C(1 4A)
C(8A)-C(1 3A)-C(1 5A)
C(1 4A)-C(1 3A)-C(1 5A)
C(1 OA)-C(1 6A)-C(1 8A)
C(1 OA)-C(1 6A)-C(1 7A)
C(1 8A)-C(1 6A)-C(1 7A)
C(1 2A)-C(1 9A)-C(20A)
C(1 2A)-C(1 9A)-C(21 A)
C(20A)-C(1 9A)-C(21 A)
C(29A)-C(24A)-C(25A)
C(29A)-C(24A)-P(1 A)
C(25A)-C(24A)-P(1 A)
C(26A)-C(25A)-C(24A)
C(27A)-C(26A)-C(25A)
C(26A)-C(27A)-C(28A)
C(27A)-C(28A)-C(29A)
C(28A)-C(29A)-C(24A)
C(31 A)-C(30A)-C(35A)
C(31 A)-C(30A)-P(1 A)
C(35A)-C(30A)-P(1 A)
120.59(9)
119.22(9)
119.64(10)
118.78(9)
121.58(9)
119.15(10)
119.09(10)
121.73(10)
122.25(10)
117.68(10)
122.36(10)
119.97(10)
122.16(10)
119.08(10)
118.26(10)
122.63(9)
112.24(10)
110.42(10)
110.41(10)
113.45(10)
110.89(11)
109.86(11)
113.21(9)
110.46(9)
109.27(10)
109.64(10)
111.45(8)
106.93(8)
111.69(10)
110.42(11)
111.25(11)
111.78(10)
111.26(10)
110.55(9)
108.39(8)
118.01(8)
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C(32A)-C(31 A)-C(30A)
C(33A)-C(32A)-C(31 A)
C(32A)-C(33A)-C(34A)
C(33A)-C(34A)-C(35A)
C(34A)-C(35A)-C(30A)
C(1 B)-P(1 B)-C(24B)
C(1 B)-P(1 B)-C(30B)
C(24B)-P(1 B)-C(30B)
C(2B)-O(1 B)-C(22B)
C(5B)-O(2B)-C(23B)
C(6B)-C(1 B)-C(2B)
C(6B)-C(1 B)-P(1 B)
C(2B)-C(1 B)-P(1 B)
0(1 B)-C(2B)-C(3B)
0(1 B)-C(2B)-C(1 B)
C(3B)-C(2B)-C(1 B)
C(2B)-C(3B)-C(4B)
C(5B)-C(4B)-C(3B)
O(2B)-C(5B)-C(4B)
0(2B)-C(5B)-C(6B)
C(4B)-C(5B)-C(6B)
C(5B)-C(6B)-C(1 B)
C(5B)-C(6B)-C(7B)
C(1 B)-C(6B)-C(7B)
C(8B)-C(7B)-C(12B)
C(8B)-C(7B)-C(6B)
C(1 2B)-C(7B)-C(6B)
C(9B)-C(8B)-C(7B)
C(9B)-C(8B)-C(13B)
C(7B)-C(8B)-C(13B)
C(1 OB)-C(9B)-C(8B)
C(9B)-C(1 OB)-C(1 1 B)
C(9B)-C(1 OB)-C(1 6B)
C(11 B)-C(1OB)-C(16B)
C(1OB)-C(1 1 B)-C(12B)
C(11 B)-C(12B)-C(7B)
112.22(10)
110.52(10)
110.44(10)
112.14(10)
111.60(10)
104.94(5)
103.98(5)
99.92(5)
116.47(9)
116.72(8)
118.73(10)
117.25(8)
123.96(8)
122.26(10)
116.30(9)
121.45(10)
119.63(10)
120.22(10)
123.26(10)
115.75(9)
120.98(10)
118.96(9)
118.37(9)
122.56(9)
118.72(9)
119.56(9)
121.67(9)
119.93(10)
117.56(10)
122.47(9)
122.20(10)
117.09(10)
123.35(10)
119.53(10)
122.87(10)
119.14(10)
C(11 B)-C(l 2B)-C(l 9B)
C(7B)-C(1 2B)-C(l 9B)
C(8B)-C(1 3B)-C(1 4B)
C(8B)-C(l 3B)-C(l 1B)
C(14B)-C(13B)-C(15B)
C(1 OB)-C(l 6B)-C(l 8B)
C(1 OB)-C(l 6B)-C(l 7B)
C(1 8B)-C(1 6B)-C(1 7B)
C(12B)-C(19B)-C(21 B)
C(1 2B)-C(1 9B)-C(20B)
C(21 B)-C(1 9B)-C(20B)
C(29B)-C(24B)-C(25B)
C(29B)-C(24B)-P(1 B)
C(25B)-C(24B)-P(1 B)
C(26B)-C(25B)-C(24B)
C(27B)-C(26B)-C(25B)
C(28B)-C(27B)-C(26B)
C(27B)-C(28B)-C(29B)
C(28B)-C(29B)-C(24B)
C(35B)-C(30B)-C(31 B)
C(35B)-C(30B)-P(1 B)
C(31 B)-C(30B)-P(1 B)
C(32B)-C(31 B)-C(30B)
C(33B)-C(32B)-C(31 B)
C(32B)-C(33B)-C(34B)
C(33B)-C(34B)-C(35B)
C(30B)-C(35B)-C(34B)
117.33(10)
123.44(9)
111.75(10)
109.86(10)
110.97(10)
113.55(10)
110.91(9)
109.78(10)
112.29(10)
109.68(9)
109.59(10)
109.94(10)
113.68(8)
107.84(8)
111.94(11)
111.14(12)
111.35(11)
111.41(11)
110.97(11)
110.15(10)
116.11(8)
107.82(9)
112.04(12)
110.94(11)
110.54(12)
111.86(11)
111.34(10)
Symmetry transformations used to generate equivalent atoms:
Table 4. Anisotropic displacement parameters (A2x 103 )for BF2049. The anisotropic
displacement factor exponent takes the form: -2n 2 [ h2 a*2 Ul + ... + 2 h k a* b* U12 ]
Uii U22 U33 U23 U13 U12
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P(1)
0(1)
0(2)
C(1)
C(2)
C(3)
C(4)
C(5)
C(6)
C(7)
C(8)
C(9)
C(10)
C(11)
C(12)
C(13)
C(14)
C(15)
C(16)
C(17)
C(18)
C(19)
C(20)
C(21)
C(22)
C(23)
C(24)
C(25)
C(26)
C(27)
C(28)
C(29)
C(30)
C(31)
C(32)
C(33)
13(1)
21(1)
18(1)
13(1)
17(1)
19(1)
17(1)
16(1)
13(1)
13(1)
14(1)
17(1)
14(1)
13(1)
13(1)
20(1)
18(1)
41(1)
14(1)
21(1)
29(1)
17(1)
40(1)
19(1)
18(1)
35(1)
16(1)
18(1)
22(1)
26(1)
30(1)
25(1)
17(1)
19(1)
29(1)
34(1)
20(1)
30(1)
26(1)
17(1)
20(1)
24(1)
22(1)
18(1)
16(1)
16(1)
15(1)
17(1)
19(1)
19(1)
16(1)
23(1)
45(1)
22(1)
24(1)
40(1)
31(1)
19(1)
21(1)
33(1)
29(1)
31(1)
25(1)
35(1)
47(1)
49(1)
39(1)
28(1)
20(1)
23(1)
22(1)
22(1)
15(1)
14(1)
19(1)
16(1)
15(1)
18(1)
21(1)
18(1)
15(1)
16(1)
16(1)
15(1)
18(1)
21(1)
19(1)
15(1)
22(1)
24(1)
19(1)
19(1)
25(1)
22(1)
32(1)
36(1)
28(1)
17(1)
16(1)
21(1)
25(1)
28(1)
29(1)
28(1)
19(1)
32(1)
40(1)
36(1)
0(1)
-4(1)
-6(1)
1(1)
-1(1)
1(1)
1(1)
-1(1)
1(1)
-2(1)
-2(1)
0(1)
-3(1)
-3(1)
-1(1)
0(1)
-1(1)
2(1)
-2(1)
3(1)
-8(1)
1(1)
6(1)
7(1)
-9(1)
-4(1)
0(1)
4(1)
4(1)
9(1)
13(1)
6(1)
-1(1)
4(1)
4(1)
1(1)
0(1)
-4(1)
-2(1)
-1(1)
-1(1)
-4(1)
-2(1)
0(1)
-1(1)
-1(1)
-2(1)
0(1)
-2(1)
-2(1)
-1(1)
-2(1)
1(1)
-5(1)
-4(1)
-5(1)
-10(1)
0(1)
3(1)
2(1)
-2(1)
-9(1)
1(1)
3(1)
8(1)
6(1)
3(1)
5(1)
2(1)
-1(1)
0(1)
6(1)
2(1)
7(1)
8(1)
1(1)
1(1)
4(1)
5(1)
1(1)
-1(1)
3(1)
1(1)
2(1)
4(1)
0(1)
2(1)
-6(1)
-8(1)
-11(1)
2(1)
-1(1)
4(1)
-3(1)
4(1)
-6(1)
9(1)
11(1)
1(1)
4(1)
3(1)
-7(1)
-3(1)
1(1)
3(1)
4(1)
7(1)
0(1)
C(34)
C(35)
P(1A)
O(1 A)
O(2A)
C(1A)
C(2A)
C(3A)
C(4A)
C(5A)
C(6A)
C(7A)
C(8A)
C(9A)
C(1OA)
C(11A)
C(12A)
C(13A)
C(14A)
C(15A)
C(16A)
C(17A)
C(18A)
C(19A)
C(20A)
C(21A)
C(22A)
C(23A)
C(24A)
C(25A)
C(26A)
C(27A)
C(28A)
C(29A)
C(30A)
C(31A)
24(1)
18(1)
13(1)
20(1)
19(1)
13(1)
16(1)
18(1)
17(1)
16(1)
14(1)
13(1)
14(1)
13(1)
14(1)
16(1)
14(1)
18(1)
20(1)
35(1)
15(1)
34(1)
24(1)
17(1)
24(1)
17(1)
26(1)
20(1)
16(1)
17(1)
20(1)
22(1)
24(1)
19(1)
16(1)
21(1)
23(1)
22(1)
20(1)
33(1)
24(1)
20(1)
23(1)
28(1)
25(1)
18(1)
16(1)
16(1)
19(1)
24(1)
25(1)
21(1)
16(1)
24(1)
34(1)
24(1)
43(1)
53(1)
63(1)
19(1)
19(1)
24(1)
55(1)
26(1)
22(1)
29(1)
39(1)
44(1)
37(1)
27(1)
21(1)
25(1)
35(1)
26(1)
16(1)
19(1)
23(1)
15(1)
16(1)
16(1)
20(1)
17(1)
15(1)
16(1)
17(1)
21(1)
17(1)
16(1)
17(1)
20(1)
30(1)
33(1)
17(1)
28(1)
20(1)
18(1)
27(1)
46(1)
23(1)
27(1)
17(1)
23(1)
25(1)
24(1)
22(1)
21(1)
16(1)
18(1)
-4(1)
-3(1)
3(1)
12(1)
7(1)
1(1)
3(1)
2(1)
0(1)
2(1)
0(1)
3(1)
2(1)
6(1)
5(1)
0(1)
2(1)
-1(1)
-2(1)
-4(1)
4(1)
16(1)
-7(1)
0(1)
-2(1)
-2(1)
19(1)
6(1)
1(1)
-3(1)
-1(1)
-5(1)
-8(1)
-2(1)
1(1)
2(1)
3(1)
1(1)
-1(1)
-4(1)
-5(1)
0(1)
1(1)
-4(1)
-4(1)
-1(1)
-1(1)
-1(1)
0(1)
-1(1)
-2(1)
-1(1)
0(1)
-1(1)
4(1)
-1(1)
-3(1)
-8(1)
-6(1)
-2(1)
1(1)
2(1)
-6(1)
-4(1)
1(1)
2(1)
5(1)
6(1)
2(1)
1(1)
-1(1)
-3(1)
-2(1)
2(1)
-1(1)
-5(1)
-9(1)
0(1)
0(1)
-1(1)
-5(1)
-1(1)
1(1)
-3(1)
-1(1)
1(1)
-5(1)
-4(1)
-2(1)
4(1)
6(1)
-1(1)
-1(1)
2(1)
-1(1)
1(1)
0(1)
-1(1)
-7(1)
-10(1)
-3(1)
-5(1)
-7(1)
-2(1)
-3(1)
-5(1)
-2(1)
-7(1)
208
C(32A)
C(33A)
C(34A)
C(35A)
P(1B)
O(1B)
O(2B)
C(1B)
C(2B)
C(3B)
C(4B)
C(5B)
C(6B)
C(7B)
C(8B)
C(9B)
C(10B)
C(1 1 B)
C(12B)
C(13B)
C(14B)
C(15B)
C(16B)
C(17B)
C(18B)
C(19B)
C(20B)
C(21B)
C(22B)
C(23B)
C(24B)
C(25B)
C(26B)
C(27B)
C(28B)
C(29B)
32(1)
28(1)
25(1)
24(1)
14(1)
21(1)
20(1)
14(1)
18(1)
17(1)
17(1)
17(1)
15(1)
14(1)
16(1)
14(1)
14(1)
16(1)
15(1)
23(1)
26(1)
42(1)
15(1)
19(1)
19(1)
19(1)
21(1)
34(1)
34(1)
22(1)
16(1)
17(1)
20(1)
27(1)
31(1)
26(1)
27(1)
24(1)
23(1)
24(1)
21(1)
26(1)
24(1)
16(1)
17(1)
22(1)
20(1)
15(1)
14(1)
16(1)
18(1)
20(1)
21(1)
19(1)
15(1)
20(1)
35(1)
23(1)
28(1)
48(1)
39(1)
20(1)
34(1)
19(1)
31(1)
24(1)
26(1)
37(1)
47(1)
47(1)
35(1)
27(1)
22(1)
29(1)
29(1)
19(1)
17(1)
14(1)
17(1)
15(1)
15(1)
15(1)
18(1)
16(1)
15(1)
15(1)
18(1)
20(1)
16(1)
16(1)
17(1)
20(1)
27(1)
31(1)
17(1)
19(1)
20(1)
17(1)
20(1)
29(1)
15(1)
22(1)
20(1)
29(1)
35(1)
33(1)
28(1)
25(1)
-3(1)
0(1)
3(1)
3(1)
0(1)
-4(1)
-4(1)
0(1)
-1(1)
1(1)
1(1)
0(1)
1(1)
-2(1)
1(1)
-3(1)
-3(1)
1(1)
-1(1)
3(1)
8(1)
3(1)
-2(1)
-3(1)
-3(1)
2(1)
1(1)
2(1)
-2(1)
-5(1)
0(1)
4(1)
6(1)
7(1)
8(1)
2(1)
0(1)
2(1)
-2(1)
-3(1)
-1(1)
-4(1)
-4(1)
-2(1)
-1(1)
-4(1)
-3(1)
-2(1)
-2(1)
-4(1)
-2(1)
-3(1)
-4(1)
-3(1)
-2(1)
-6(1)
-3(1)
-10(1)
-5(1)
-4(1)
-6(1)
-4(1)
-1(1)
-8(1)
-5(1)
-4(1)
1(1)
3(1)
9(1)
5(1)
2(1)
1(1)
-11(1)
-7(1)
0(1)
1(1)
2(1)
5(1)
8(1)
-1(1)
0(1)
1(1)
3(1)
0(1)
-2(1)
2(1)
-1(1)
-2(1)
3(1)
1(1)
1(1)
-6(1)
-13(1)
1(1)
2(1)
0(1)
-4(1)
-4(1)
-5(1)
-4(1)
9(1)
9(1)
-1(1)
0(1)
-2(1)
-12(1)
-7(1)
-3(1)
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C(30B)
C(31B)
C(32B)
C(33B)
C(34B)
C(35B)
22(1)
21(1)
37(1)
40(1)
33(1)
22(1)
19(1)
26(1)
25(1)
20(1)
21(1)
20(1)
24(1)
42(1)
53(1)
44(1)
35(1)
26(1)
0(1)
7(1)
9(1)
3(1)
-5(1)
-2(1)
5(1)
3(1)
9(1)
9(1)
6(1)
1(1)
4(1)
7(1)
11(1)
2(1)
-2(1)
1(1)
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 103)
for BF2049.
x y z U(eq)
H(3)
H(4)
H(9)
H(11)
H(13)
H(14A)
H(14B)
H(14C)
H(15A)
H(1 5B)
H(15C)
H(1 6)
H(17A)
H(17B)
H(17C)
H(18A)
H(18B)
H(18C)
H(19)
H(20A)
H(20B)
H(20C)
3581
3927
2118
816
3128
3355
3671
3922
2661
3162
2366
540
1805
1336
1051
708
803
1466
1530
1430
1493
2124
1622
847
2831
868
3001
2725
2095
3139
4113
4440
4228
2051
2335
3144
2517
902
455
692
667
-624
-905
-403
3246
2687
1101
1466
1971
1157
1498
1453
1329
1678
1758
871
477
645
294
407
830
578
2423
1794
2243
2037
210
H(21A)
H(21B)
H(21C)
H(22A)
H(22B)
H(22C)
H(23A)
H(23B)
H(23C)
H(24)
H(25A)
H(25B)
H(26A)
H(26B)
H(27A)
H(27B)
H(28A)
H(28B)
H(29A)
H(29B)
H(30)
H(31A)
H(31B)
H(32A)
H(32B)
H(33A)
H(33B)
H(34A)
H(34B)
H(35A)
H(35B)
H(3A)
H(4A)
H(9A)
H(11A)
H(13A)
359
436
332
4309
3995
3912
2895
2641
3332
1260
21
259
77
-617
-326
-359
643
885
809
1511
1503
1299
695
999
1143
2179
2106
2409
2996
2684
2559
6975
7286
4195
5530
4961
1046
9
211
763
64
-144
1858
2846
2760
2811
2550
3507
2928
2785
1429
1225
540
1500
1119
1240
4199
4469
4467
6006
5825
5811
6585
5527
5512
3985
4135
3337
4426
4611
2740
4755
2267
2419
1964
2066
1750
2203
3747
3893
3648
3332
2868
3059
3689
3435
3797
3340
3605
3791
2971
3220
3010
2190
2501
2336
2790
2204
2533
3022
2701
2893
2436
4997
4529
3251
2838
4205
44
44
44
37
37
37
42
42
42
23
29
29
37
37
41
41
39
39
32
32
23
30
30
37
37
37
37
33
33
26
26
25
25
23
21
25
H(14D)
H(14E)
H(1 4F)
H(15D)
H(15E)
H( 15F)
H(1 6A)
H(17D)
H(17E)
H(1 7F)
H(18D)
H(18E)
H( 18F)
H(1 9A)
H(20D)
H(20E)
H(20F)
H(21D)
H(21 E)
H(21F)
H(22D)
H(22E)
H(22F)
H(23D)
H(23E)
H(23F)
H(24A)
H(25C)
H(25D)
H(26C)
H(26D)
H(27C)
H(27D)
H(28C)
H(28D)
H(29C)
3655
3806
3830
5355
4705
4611
3914
4256
4134
4903
5141
4370
4644
6488
6272
5881
6702
7427
7069
6931
6778
6109
6271
7294
7339
7657
4649
3431
3641
2765
3452
3042
3036
4254
4027
4923
4975
5175
4142
5967
6311
6051
3558
5118
4685
4824
3144
3022
2383
2398
1651
1270
1179
2636
3606
3103
2042
1689
2768
5625
5615
4781
1946
2572
1514
1936
1626
2995
3496
2923
3970
3520
3813
4264
4103
3814
4055
3606
2646
2603
2180
2349
2234
2066
2415
3715
2953
3325
3301
3304
3391
2983
5274
5495
5471
4117
3653
3902
4943
4522
4581
5024
5257
5534
5120
5544
5469
5040
42
42
42
46
46
46
30
58
58
58
54
54
54
21
35
35
35
44
44
44
52
52
52
36
36
36
22
28
28
33
33
36
36
34
34
27
212
H(29D)
H(30A)
H(31C)
H(31D)
H(32C)
H(32D)
H(33C)
H(33D)
H(34C)
H(34D)
H(35C)
H(35D)
H(3B)
H(4B)
H(9B)
H(11B)
H(13B)
H(1 4G)
H(14H)
H(141)
H(1 5G)
H(15H)
H(151)
H(16B)
H(1 7G)
H(17H)
H(171)
H(18G)
H(18H)
H(181)
H(1 9B)
H(20G)
H(20H)
H(201)
H(21G)
H(21H)
4243
5545
4127
4692
4519
5304
4885
4249
5673
5105
5324
4528
-319
-659
2472
1457
1619
2894
2703
2820
1083
1684
1800
2645
1776
2251
1610
3365
3303
2877
297
197
-399
-195
1166
405
3833
1251
963
1419
-158
12
-1323
-755
-475
-919
659
496
8561
9347
9674
7498
9695
10197
10372
9345
10772
11286
10998
8012
9485
8871
8414
9140
9295
9937
7165
7468
7012
8070
6042
5752
4802
4083
3867
3594
3427
3566
3873
4043
4259
4534
4700
4584
3355
3913
5050
5481
4126
4506
4058
4214
4528
4301
4746
5758
6007
6291
6062
5491
5950
5653
4682
5504
5239
5178
4869
4993
27
21
26
26
32
32
32
32
30
30
27
27
22
22
22
21
25
44
44
44
48
48
48
24
43
43
43
39
39
39
22
37
37
37
41
41
213
H(211) 937 6162 5310 41
H(22G) 9 7609 2896 40
H(22H) 746 7502 2699 40
H(221) 519 8474 2875 40
H(23G) -521 10457 4369 34
H(23H) -636 10317 4824 34
H(231) -1013 9649 4517 34
H(24B) 2020 7332 3264 25
H(25E) 3248 7746 3716 33
H(25F) 3044 6745 3557 33
H(26E) 3891 7452 3157 41
H(26F) 3203 7216 2911 41
H(27E) 3576 9007 3200 43
H(27F) 3545 8716 2751 43
H(28E) 2337 8576 2766 38
H(28F) 2547 9580 2919 38
H(29E) 1710 8901 3331 31
H(29F) 2411 9107 3570 31
H(30B) 1750 6023 3591 26
H(31E) 2606 5764 4075 36
H(31F) 2034 5756 4405 36
H(32E) 2147 4400 3801 46
H(32F) 2327 4225 4252 46
H(33E) 1159 4400 4411 42
H(33F) 1214 3628 4081 42
H(34E) 301 4687 3932 36
H(34F) 867 4689 3599 36
H(35E) 582 6227 3742 27
H(35F) 750 6066 4195 27
Table 6. Torsion angles [0] for BF2049.
C(24)-P(1)-C(1)-C(6) 137.31(9)
C(30)-P(1)-C(1)-C(6) -117.39(9)
C(24)-P(1)-C(1)-C(2) -40.28(11)
C(30)-P(1)-C(1)-C(2)
C(23)-O(1)-C(2)-C(3)
C(23)-0(1)-C(2)-C(1)
C(6)-C(1)-C(2)-O(1)
P(1)-C(1)-C(2)-O(1)
C(6)-C(1)-C(2)-C(3)
P(1)-C(1)-C(2)-C(3)
0(1)-C(2)-C(3)-C(4)
C(1)-C(2)-C(3)-C(4)
C(2)-C(3)-C(4)-C(5)
C(22)-0(2)-C(5)-C(4)
C(22)-0(2)-C(5)-C(6)
C(3)-C(4)-C(5)-0(2)
C(3)-C(4)-C(5)-C(6)
C(2)-C(1)-C(6)-C(5)
P(1)-C(1)-C(6)-C(5)
C(2)-C(1)-C(6)-C(7)
P(1)-C(1)-C(6)-C(7)
0(2)-C(5)-C(6)-C(1)
C(4)-C(5)-C(6)-C(1)
0(2)-C(5)-C(6)-C(7)
C(4)-C(5)-C(6)-C(7)
C(1)-C(6)-C(7)-C(8)
C(5)-C(6)-C(7)-C(8)
C(1)-C(6)-C(7)-C(1 2)
C(5)-C(6)-C(7)-C(12)
C(1 2)-C(7)-C(8)-C(9)
C(6)-C(7)-C(8)-C(9)
C(1 2)-C(7)-C(8)-C(1 3)
C(6)-C(7)-C(8)-C(1 3)
C(7)-C(8)-C(9)-C(10)
C(1 3)-C(8)-C(9)-C(1 0)
C(8)-C(9)-C(1 0)-C(1 1)
C(8)-C(9)-C(1 0)-C(1 6)
C(9)-C(1 0)-C(11 )-C(1 2)
C(16)-C(10)-C(11)-C(12)
65.02(10)
-5.70(16)
175.27(10)
177.44(10)
-5.00(15)
-1.60(16)
175.95(9)
-178.94(11)
0.06(18)
1.24(18)
-1.90(16)
178.41(10)
179.38(11)
-0.95(17)
1.86(16)
-175.86(8)
-177.54(10)
4.73(14)
179.08(9)
-0.62(16)
-1.48(14)
178.82(10)
101.22(13)
-78.19(13)
-82.60(13)
97.98(12)
1.29(15)
177.53(9)
-176.15(10)
0.09(16)
-0.60(16)
177.00(10)
0.36(16)
-179.50(10)
-0.87(16)
179.00(10)
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C(1 0)-C( 11)-C(l 2)-C(7)
C(1 0)-C( 11)-C(1 2)-C(1 9)
C(8)-C(7)-C(l 2)-C(1 1)
C(6)-C(7)-C(l 2)-C(l 1)
C(8)-C(7)-C(l 2)-C(1 9)
C(6)-C(7)-C(1 2)-C(l 9)
C(9)-C(8)-C(1 3)-C(1 5)
C(7)-C(8)-C(1 3)-C(1 5)
C(9)-C(8)-C(1 3)-C(1 4)
C(7)-C(8)-C(1 3)-C(1 4)
C(9)-C(1 0)-C(1 6)-C(1 7)
C(11 )-C(1 0)-C(1 6)-C(1 7)
C(9)-C(1 0)-C(1 6)-C(1 8)
C(11 )-C(1 0)-C(1 6)-C(1 8)
C(11 )-C(1 2)-C(1 9)-C(21)
C(7)-C(1 2)-C(1 9)-C(21)
C(11 )-C(1 2)-C(1 9)-C(20)
C(7)-C(1 2)-C(1 9)-C(20)
C(1)-P(1)-C(24)-C(29)
C(30)-P(1)-C(24)-C(29)
C(1)-P(1)-C(24)-C(25)
C(30)-P(1)-C(24)-C(25)
C(29)-C(24)-C(25)-C(26)
P(1)-C(24)-C(25)-C(26)
C(24)-C(25)-C(26)-C(27)
C(25)-C(26)-C(27)-C(28)
C(26)-C(27)-C(28)-C(29)
C(27)-C(28)-C(29)-C(24)
C(25)-C(24)-C(29)-C(28)
P(1)-C(24)-C(29)-C(28)
C(1)-P(1)-C(30)-C(31)
C(24)-P(1)-C(30)-C(31)
C(1)-P(1)-C(30)-C(35)
C(24)-P(1)-C(30)-C(35)
C(35)-C(30)-C(31)-C(32)
P(1)-C(30)-C(31)-C(32)
1.60(16)
-174.37(10)
-1.78(15)
-178.00(9)
174.07(10)
-2.16(15)
56.31(13)
-126.19(11)
-65.81(13)
111.69(12)
1.23(15)
-178.63(10)
124.91(12)
-54.95(14)
-46.81(14)
137.32(11)
77.03(13)
-98.85(12)
-50.20(10)
-158.38(9)
-171.93(8)
79.89(9)
55.64(14)
179.02(9)
-55.40(15)
54.82(15)
-55.89(16)
56.77(15)
-55.95(13)
-176.80(9)
139.44(8)
-112.38(8)
16.01(10)
124.20(9)
-55.96(13)
177.19(9)
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C(30)-C(31)-C(32)-C(33)
C(31)-C(32)-C(33)-C(34)
C(32)-C(33)-C(34)-C(35)
C(33)-C(34)-C(35)-C(30)
C(31)-C(30)-C(35)-C(34)
P(1)-C(30)-C(35)-C(34)
C(24A)-P(1 A)-C(1 A)-C(6A)
C(30A)-P(1 A)-C(1 A)-C(6A)
C(24A)-P(1 A)-C(1 A)-C(2A)
C(30A)-P(1 A)-C(1 A)-C(2A)
C(22A)-O(1 A)-C(2A)-C(3A)
C(22A)-O(1 A)-C(2A)-C(1 A)
C(6A)-C(1 A)-C(2A)-O(1 A)
P(1 A)-C(1 A)-C(2A)-O(1 A)
C(6A)-C(1 A)-C(2A)-C(3A)
P(1 A)-C(1 A)-C(2A)-C(3A)
0(1 A)-C(2A)-C(3A)-C(4A)
C(1 A)-C(2A)-C(3A)-C(4A)
C(2A)-C(3A)-C(4A)-C(5A)
C(23A)-O(2A)-C(5A)-C(4A)
C(23A)-O(2A)-C(5A)-C(6A)
C(3A)-C(4A)-C(5A)-O(2A)
C(3A)-C(4A)-C(5A)-C(6A)
C(2A)-C(1 A)-C(6A)-C(5A)
P(1 A)-C(1 A)-C(6A)-C(5A)
C(2A)-C(1 A)-C(6A)-C(7A)
P(1 A)-C(1 A)-C(6A)-C(7A)
O(2A)-C(5A)-C(6A)-C(1 A)
C(4A)-C(5A)-C(6A)-C(1 A)
O(2A)-C(5A)-C(6A)-C(7A)
C(4A)-C(5A)-C(6A)-C(7A)
C(1A)-C(6A)-C(7A)-C(1 2A)
C(5A)-C(6A)-C(7A)-C(1 2A)
C(1 A)-C(6A)-C(7A)-C(8A)
C(5A)-C(6A)-C(7A)-C(8A)
C(1 2A)-C(7A)-C(8A)-C(9A)
57.55(15)
-56.20(15)
55.27(15)
-54.67(14)
54.00(13)
176.16(8)
-141.44(8)
106.90(9)
35.00(11)
-76.65(11)
6.55(17)
-174.78(11)
-175.02(10)
8.63(15)
3.68(17)
-172.67(9)
178.27(11)
-0.34(18)
-1.77(18)
8.56(17)
-171.78(10)
-179.90(11)
0.46(17)
-4.94(16)
171.80(8)
171.50(10)
-11.76(13)
-176.71(10)
2.96(17)
6.80(15)
-173.53(10)
-92.01(13)
84.46(13)
87.55(13)
-95.98(13)
2.09(16)
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C(6A)-C(7A)-C(8A)-C(9A)
C(1 2A)-C(7A)-C(8A)-C(1 3A)
C(6A)-C(7A)-C(8A)-C(1 3A)
C(7A)-C(8A)-C(9A)-C(1 OA)
C(1 3A)-C(8A)-C(9A)-C(1 OA)
C(8A)-C(9A)-C(1OA)-C(1 1 A)
C(8A)-C(9A)-C(1 OA)-C(1 6A)
C(9A)-C(1 OA)-C(1 1 A)-C(1 2A)
C(1 6A)-C(1 OA)-C(1 1 A)-C(1 2A)
C(1 OA)-C(1 1 A)-C(1 2A)-C(7A)
C(1 OA)-C(1 1 A)-C(1 2A)-C(1 9A)
C(8A)-C(7A)-C(1 2A)-C(1 1 A)
C(6A)-C(7A)-C(1 2A)-C(1 1 A)
C(8A)-C(7A)-C(1 2A)-C(1 9A)
C(6A)-C(7A)-C(1 2A)-C(1 9A)
C(9A)-C(8A)-C(1 3A)-C(1 4A)
C(7A)-C(8A)-C(1 3A)-C(1 4A)
C(9A)-C(8A)-C(13A)-C(1 5A)
C(7A)-C(8A)-C(1 3A)-C(1 5A)
C(11 A)-C(1 OA)-C(1 6A)-C(1 8A)
C(9A)-C(10A)-C(1 6A)-C(1 8A)
C(11 A)-C(10A)-C(1 6A)-C(1 7A)
C(9A)-C(1 OA)-C(1 6A)-C(1 7A)
C(11 A)-C(1 2A)-C(1 9A)-C(20A)
C(7A)-C(1 2A)-C(1 9A)-C(20A)
C(11 A)-C(1 2A)-C(1 9A)-C(21 A)
C(7A)-C(1 2A)-C(1 9A)-C(21 A)
C(1 A)-P(1 A)-C(24A)-C(29A)
C(30A)-P(1 A)-C(24A)-C(29A)
C(1 A)-P(1 A)-C(24A)-C(25A)
C(30A)-P(1 A)-C(24A)-C(25A)
C(29A)-C(24A)-C(25A)-C(26A)
P(1 A)-C(24A)-C(25A)-C(26A)
C(24A)-C(25A)-C(26A)-C(27A)
C(25A)-C(26A)-C(27A)-C(28A)
C(26A)-C(27A)-C(28A)-C(29A)
-177.46(10)
-176.27(10)
4.18(16)
-1.55(17)
176.85(10)
0.59(17)
-179.16(10)
-0.19(16)
179.55(10)
0.76(16)
-177.06(10)
-1.70(15)
177.86(9)
176.02(10)
-4.42(15)
53.92(14)
-127.72(11)
-69.73(13)
108.63(12)
5.59(16)
-174.68(11)
-118.60(13)
61.13(14)
-41.46(14)
140.80(11)
81.44(12)
-96.30(12)
50.37(9)
159.52(8)
170.18(8)
-80.67(9)
-57.04(13)
-178.01(9)
57.42(14)
-55.71(15)
55.19(15)
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C(27A)-C(28A)-C(29A)-C(24A)
C(25A)-C(24A)-C(29A)-C(28A)
P(1 A)-C(24A)-C(29A)-C(28A)
C(1 A)-P(1 A)-C(30A)-C(31 A)
C(24A)-P(1 A)-C(30A)-C(31 A)
C(1 A)-P(1 A)-C(30A)-C(35A)
C(24A)-P(1 A)-C(30A)-C(35A)
C(35A)-C(30A)-C(31 A)-C(32A)
P(1 A)-C(30A)-C(31 A)-C(32A)
C(30A)-C(31 A)-C(32A)-C(33A)
C(31 A)-C(32A)-C(33A)-C(34A)
C(32A)-C(33A)-C(34A)-C(35A)
C(33A)-C(34A)-C(35A)-C(30A)
C(31 A)-C(30A)-C(35A)-C(34A)
P(1 A)-C(30A)-C(35A)-C(34A)
C(24B)-P(1 B)-C(1 B)-C(6B)
C(30B)-P(1 B)-C(1 B)-C(6B)
C(24B)-P(1 B)-C(1 B)-C(2B)
C(30B)-P(1 B)-C(1 B)-C(2B)
C(22B)-O(1 B)-C(2B)-C(3B)
C(22B)-O(1 B)-C(2B)-C(1 B)
C(6B)-C(1 B)-C(2B)-O(1 B)
P(1 B)-C(1 B)-C(2B)-O(1 B)
C(6B)-C(1 B)-C(2B)-C(3B)
P(1 B)-C(1 B)-C(2B)-C(3B)
0(1 B)-C(2B)-C(3B)-C(4B)
C(1 B)-C(2B)-C(3B)-C(4B)
C(2B)-C(3B)-C(4B)-C(5B)
C(23B)-O(2B)-C(5B)-C(4B)
C(23B)-O(2B)-C(5B)-C(6B)
C(3B)-C(4B)-C(5B)-O(2B)
C(3B)-C(4B)-C(5B)-C(6B)
O(2B)-C(5B)-C(6B)-C(1 B)
C(4B)-C(5B)-C(6B)-C(1 B)
O(2B)-C(5B)-C(6B)-C(7B)
C(4B)-C(5B)-C(6B)-C(7B)
-55.27(15)
55.49(13)
173.69(8)
-133.93(8)
115.24(8)
99.50(9)
-11.33(10)
-54.30(13)
174.92(8)
57.05(13)
-57.22(14)
56.58(14)
-54.43(14)
52.40(13)
177.92(8)
-137.83(9)
117.69(9)
39.43(10)
-65.05(10)
18.74(16)
-161.55(10)
-177.89(10)
4.89(14)
1.82(16)
-175.40(9)
178.94(10)
-0.75(17)
-0.73(17)
-8.03(16)
171.47(10)
-179.42(10)
1.10(17)
-179.51(9)
0.00(16)
-3.24(14)
176.27(10)
C(2B)-C(1 B)-C(6B)-C(5B)
P(1 B)-C(1 B)-C(6B)-C(5B)
C(2B)-C(1 B)-C(6B)-C(7B)
P(1 B)-C(1 B)-C(6B)-C(7B)
C(5B)-C(6B)-C(7B)-C(8B)
C(1 B)-C(6B)-C(7B)-C(8B)
C(5B)-C(6B)-C(7B)-C(1 2B)
C(1 B)-C(6B)-C(7B)-C(1 2B)
C(1 2B)-C(7B)-C(8B)-C(9B)
C(6B)-C(7B)-C(8B)-C(9B)
C(1 2B)-C(7B)-C(8B)-C(1 3B)
C(6B)-C(7B)-C(8B)-C(1 3B)
C(7B)-C(8B)-C(9B)-C(10B)
C(1 3B)-C(8B)-C(9B)-C(1 OB)
C(8B)-C(9B)-C(10B)-C(1 1 B)
C(8B)-C(9B)-C(1OB)-C(1 6B)
C(9B)-C(10B)-C(1 1 B)-C(1 2B)
C(16B)-C(1OB)-C(1 1 B)-C(12B)
C(1OB)-C(1 1 B)-C(12B)-C(7B)
C(1 OB)-C(1 1 B)-C(1 2B)-C(1 9B)
C(8B)-C(7B)-C(1 2B)-C(1 1 B)
C(6B)-C(7B)-C(1 2B)-C(1 1 B)
C(8B)-C(7B)-C(12B)-C(1 9B)
C(6B)-C(7B)-C(12B)-C(1 9B)
C(9B)-C(8B)-C(1 3B)-C(1 4B)
C(7B)-C(8B)-C(1 3B)-C(1 4B)
C(9B)-C(8B)-C(13B)-C(1 5B)
C(7B)-C(8B)-C(1 3B)-C(1 5B)
C(9B)-C(1 OB)-C(1 6B)-C(1 8B)
C(11 B)-C(1 OB)-C(1 6B)-C(1 8B)
C(9B)-C(10B)-C(1 6B)-C(1 7B)
C(11 B)-C(10B)-C(16B)-C(17B)
C(11 B)-C(1 2B)-C(1 9B)-C(21 B)
C(7B)-C(1 2B)-C(1 9B)-C(21 B)
C(11 B)-C(12B)-C(19B)-C(20B)
C(7B)-C(1 2B)-C(1 9B)-C(20B)
-1.42(15)
175.99(8)
-177.53(10)
-0.12(14)
-91.43(13)
84.70(13)
86.16(13)
-97.71(13)
0.65(16)
178.31(10)
-176.84(10)
0.81(16)
0.91(17)
178.53(10)
-0.81(17)
-178.89(10)
-0.89(16)
177.27(10)
2.44(16)
-174.29(10)
-2.25(16)
-179.86(10)
174.26(10)
-3.35(16)
51.01(14)
-131.44(12)
-72.62(13)
104.93(12)
-9.63(16)
172.32(11)
114.54(13)
-63.50(14)
-55.29(14)
128.14(11)
66.81(13)
-109.76(12)
C(1 B)-P(1 B)-C(24B)-C(29B)
C(30B)-P(1 B)-C(24B)-C(29B)
C(1 B)-P(1 B)-C(24B)-C(25B)
C(30B)-P(1 B)-C(24B)-C(25B)
C(29B)-C(24B)-C(25B)-C(26B)
P(1 B)-C(24B)-C(25B)-C(26B)
C(24B)-C(25B)-C(26B)-C(27B)
C(25B)-C(26B)-C(27B)-C(28B)
C(26B)-C(27B)-C(28B)-C(29B)
C(27B)-C(28B)-C(29B)-C(24B)
C(25B)-C(24B)-C(29B)-C(28B)
P(1 B)-C(24B)-C(29B)-C(28B)
C(1 B)-P(1 B)-C(30B)-C(35B)
C(24B)-P(1 B)-C(30B)-C(35B)
C(1 B)-P(1 B)-C(30B)-C(31 B)
C(24B)-P(1 B)-C(30B)-C(31 B)
C(35B)-C(30B)-C(31 B)-C(32B)
P(1 B)-C(30B)-C(31 B)-C(32B)
C(30B)-C(31 B)-C(32B)-C(33B)
C(31 B)-C(32B)-C(33B)-C(34B)
C(32B)-C(33B)-C(34B)-C(35B)
C(31 B)-C(30B)-C(35B)-C(34B)
P(1 B)-C(30B)-C(35B)-C(34B)
C(33B)-C(34B)-C(35B)-C(30B)
Symmetry transformations used to generate equivalent atoms:
46.86(10)
154.34(9)
169.02(8)
-83.49(9)
-55.79(14)
179.77(10)
55.07(16)
-54.46(16)
55.67(16)
-56.87(15)
56.30(13)
177.30(8)
-17.81(10)
-126.06(9)
-141.90(8)
109.85(9)
55.54(14)
-176.85(9)
-56.81(16)
56.00(17)
-55.76(15)
-54.38(14)
-177.25(9)
55.38(14)
3.5 References and Notes
1) a) Schlummer, B.; Scholz, U. Adv. Synth. Catal. 2004, 346, 1599. b) Jiang, L.; Buchwald, S.
L. In Metal-Catalyzed Cross-Coupling Reactions (Eds.: de Meijere, A.; Diederich, F.), 2nd ed.,
Wiley-VCH, Weinheim, 2004. c) Hartwig, J. F. Synlett 2006, 1283.
2) a) Marion, N.; Navarro, 0.; Mei, J.; Stevens, E. D.; Scott, N. M.; Nolan, S. P. J. Am. Chem.
Soc. 2006, 128, 4101. b) Shen, Q.; Shekhar, S.; Stambuli, J. P.; Hartwig, J. F. Angew. Chem.
Int. Ed. 2005, 44, 1371. c) Rataboul, F.; Zapf, A.; Jackstell, R.; Harkal, S.; Riermeier, T.;
Monsees, A.; Dingerdissen, U.; Beller, M. Chem. Eur. J. 2004, 10, 2983.
3) Amination of aryl tosylates, benzenesulfonates, and nonaflates are known. See: a) Anderson,
K. W.; Mendez-Perez, M.; Priego, J.; Buchwald, S. L. J. Org. Chem. 2003, 68, 9563. b) Roy, A.
H.; Hartwig, J. F. J. Am. Chem. Soc. 2003, 125, 8704. c) Huang, X.; Anderson, K. W.; Zim, D.;
Jiang, L.; Klapars, A.; Buchwald, S. L. J. Am. Chem. Soc. 2003, 125, 6653.
4) A paper disclosing the amination of aryl mesylates was released after this work was
completed; So, C. M.; Zhou, Z.; Lau, C.; Kwong, F. Angew. Chem. Int. Ed. 2008, 47, 6402.
5) a) Percec, V.; Golding, G. M.; Smidrkal, J.; Weichold, 0. J. Org. Chem. 2004, 69, 3447. b)
Munday, R. H.; Martinelli, J. R.; Buchwald, S. L. J. Am. Chem. Soc. 2008, 130, 2754.
6) Ikawa, T.; Barder, T. E.; Biscoe, M. R.; Buchwald S. L. J. Am. Chem. Soc. 2007, 129,13001.
7) Details of the synthesis of 1 are in the experimental section.
8) Biscoe, M. R.; Fors, B. P.; Buchwald, S. L. J. Am. Chem. Soc. 2008, 130, 6686.
9) a) Ozawa, F.; Kubo, A.; Hayashi, T. Chem. Lett. 1992, 2177. b) Amatore, C.; Carre, E.;
Jutand, A.; M'Barki, M. A. Organometallics 1995, 14, 1818. c) Fors, B. P.; Krattiger, P.; Strieter,
E.; Buchwald, S. L. Org. Lett. 2008, 10, 3505.
10) Hartwig, J. F. /norg. Chem. 2007, 46,1936.
11) a) An extra equivalent of ligand was added to reactions at temperatures above 80 0C to help
stability. No attempt has been made to minimize the quantity of additional ligand. b)Attempts to
use primary aliphatic amines or amides in cross couplings reactions with mesylates have been
unsuccessful due to sulfonyl transfer side reactions.
12) Wolfe, J. P.; Buchwald, S. L. J. Org. Chem. 2000, 65,1144.
13) a) Shen, Q.; Ogata, T.; Hartwig, J. F. J. Am. Chem. Soc. 2008, 130, 6586.
14) Anderson, K. W.; Tundel, R. E.; Ikawa, T.; Altman, R. A.; Buchwald, S. L. Angew. Chem. Int.
Ed. 2006, 45, 6523.
15) For these reactions conducted at room temperature, an extra equivalent of 1 was not
required in order to create the most stable catalytic system.
16) Biscoe, M. R.; Barder, T. E.; Buchwald, S. L. Angew. Chem. Int. Ed. 2007, 46, 7232.
17) Cabello-Sanchez, N.; Jean, L.; Maddaluno, J.; Lasne, M.; Rouden, J. J. Org. Chem. 2007,
72, 2030.
18) Pan, Y.; Young, G. B. J. Organomet. Chem. 1999, 577, 257.
19) Concentrations measured versus an internal standard.
20) In particular, the methoxy and isopropyl resonances are diagnostic in this assessment, see
Supporting Information
21) Sapountzis, I.; Knochel, P. J. Am. Chem. Soc. 2002, 124, 9390.
22) a) Ritter, T.; Stanek, K.; Larrosa, I.; Carreira, E. M. Org. Lett. 2004, 6, 1513. b) Fujikawa, N.;
Ohta, T.; Yamaguchi, T.; Fukuda, T.; Ishibashi, F.; Iwao, M. Tetrahedron 2006, 62, 594.
23) Ali, H. I.; Tomita, K.; Akaho, E.; Kambara, H.; Miura, S.; Hayakawa, H.; Ashida, N.;
Kawashima, Y.; Yamagishi, T.; Ikeya, H.; Yoneda, F.; Nagamatsu, T. Bioorg. Med. Chem. 2007,
15, 242.
24) Brown, F. J.; Bernstein, P. R.; Cronk, L. A.; Dosset, D. L.; Hebbel, K. C.; Maduskuie, T. P.;
Shapiro, H. S.; Vacek, E. P.; Yee, Y. K.; Willard, A. K.; Krell, R. D.; Snyder, D. W. J. Med.
Chem. 1989, 32, 807.
25) Watanabe, T.; Tanaka, Y.; Sekiya, K.; Akita, Y.; Ohta, A. Synthesis 1980, 39.
26) THF used in this experiment was prepared as described in the general procedures, then
sparged with N2 for 30 min and stored over activated 3A molecular sieves in a glovebox prior to
use.
27) Pan, Y.; Young, G. B. J. Organomet. Chem. 1999, 577, 257.
28) COD = 1,5-cycloocatadiene
29) Aldrich Sure-Seal, N2 sparged and stored over activated 3A molecular sieves in a glovebox.
223
224
3.6 Spectra
wdd e s 9 L !R
-- -- -- -- --
d-\
wdd 0 02 Oz t 09 09 OT 02T OT 09T 09T 00z 
02 -L.J I ...L L L LLLL L J AL I.. I I I I J I IJ ~ I II UL I I I I I I 1 I 1 I ]r j-Lj-LjjIA AJ JL~ I0 t2 092
I ..L I I I
-Twmrn T L.U~
CID
JPO.
to .
(A)
C W, -- Oj+ N 0 N ccsN
CA)
"* cn
0n
0.
ii) r r~ cn CO C O Q CI .
wdd t7
J r
9
id-I
09N\
I I -- I I I I I I -I I- .- I I I I I I I I
wdd
iudd 09- 017-00z02 at02 ~ 0 01
I I, I ~ Ii I
.Jd-I
O j-
oc
z
-
\ 7
00
-
-
M
0-
-
=
-
D
N
-
C
JD
-
'0
\/ 
\ 
/
-
-
 
CO
7
7
.7
0
4
28
1 76
.8
58
55
.3
38
54
.8
51
54
.8
21
33
6.
93
1
3
6
.7
4
6
34
.0
20
33
.2
60
32
.9
49
31
.1
86
3
1
.0
5
1
30
.7
35
28
.2
30
-
2
8
.1
1
4
-
_
27
 
.
8
5
3
2
7
.6
7
4
26
.7
32
25
.3
21
24
.2
23
23
.7
90
15
6.
54
0
15
6.
49
8
1
5
2
.5
3
0
15
2.
39
0
-
1
4
7
.1
0
9 1
46
.1
62
14
6.
13
9
13
9.
45
0
\-
1
3
8
.9
7
7
13
2.
93
1
1
3
2
.8
1
7
12
6.
95
7
12
6 
.
58
6
12
0.
37
4
1
2
0
.3
4
4
1
2
0
.3
1
6
11
0.
91
3
10
8.
75
6
wdd T
Jd-!'
Aed gW
eW~ NW
9
I I I
wdd 09- 01- 02-
S .. .. .09 09 'I I I I I
IT
...........
0 0T .
wdd9
.......
WOVY MAob
wdd 09- 0V- 02- 0 02 017 09 09 00T
GaNo
wdd a 0
ID I
?'
wdd 09- 017-
1 1
02- 0 02 0 t 09
| [
10 
~Pd
.-r~~~ I
-i1 i-1 Iigiig 4pptfgU 1 1 ww ll km 1 m i W O O V 0-06 loop' 0 " s m|11' SUi 90lim 1110finpsgilo iiI i I IiusIg p i -g igpgigii i UN M p pg( pI 9 ig g p
e 
|
II
N
H
wdd 0 09V 09 09 00T 02T0tT 09T
N)
N) L )
Sco C
I 
N
N
GAi H
09T00 zO2 o 2 0 92z
co-~-
co
coCO CO
" N
----------------------------------------------------
TF7 Twrr,-77r, 'Tr;rr! 7,';R.Fyr
ILI I i0lifli A Jull,,J.LjIt
H CO 2Et
N
9 8 7 6 5 2 1 PPM
I
I i I I I I I I I I I I I I II I E
4 3
ot~
z
D
O
-
N
: 0-
m
-
O
l 
-
00
-
C
2 Dco
 
-
77
.7
39
7
7
.3
1
6
\ 
76
.8
92
60
.9
03
-
-
_
 
1
4
.6
0
0
-
n
16
8.
83
0
-
16
1.
28
4
15
8.
06
5 1
48
.8
33
13
6.
92
1
1
3
6
.8
8
2
_
 
_
 
_
13
4.
36
8
-
-
-
-
-
-
 
-
13
1.
86
5
-
3 
12
5.
41
3
25
.3
05
11
7 
.
09
8
E
11
6.
48
0
-
1
1
6
.1
8
3
-
11
3.
64
6
11
1.
98
3
ZI
r
m
uiddT1? S 9
eirhOO8VN
N OaV
H
I
wdd 0 02 0 09 09 00 T OZ 09T 09T 0T 02 z 022 0V2 092
*D W
ton
Ca
cn c
eWO
-1' 001 61
H
wdd 2
H N
wdd 0 02 017 09 09 00T 02T 07?T 09T 091 002 022 0 V2 092
* Io
U, , 0
coK
I ~J 0
NH
wddd
oN
H
wdd 0 02 01t 09 09 00T 02T 01T 09T 09T 002 022 01V2 092
-o o
o -
e n
(0
0,
coI-
-JI
coI
N N to " 
H
.
wdd T 9
Nb-
H
wdd 0 02 0t? 09 09 00T O2T O VT 091 09T 0G2 022 0 092z
I T F 17 r- ' qp
Z-. co
m2 0
Cb
00
c<: co30
c-~a -N
00 L
CO M
N
H ,-. r'3f~o
00 -r
999668S 
9
8009 
9
99099 
109 
9
L09 
9
V6L 
9
0
0
8
 
9
9T
89 
~
-
8E6L 9
966L
 
9
q
9
8
' 
-
-
 
~
 
8
0~
C)
j~DL
J1
C)
0t
z,
-
r~
04
in Ln0 
6
-L
fl
r)* 
f
I 
o
 
l
46 
I
TST
249
tf) (3). . .
-IV CC Ll~)- Lfl
'A'
Me ~ N(H)Me
MeO
10 80Q 170 160 150 140 130 120 110 1CO 90 80 70 60 50 40 30 20 10 ppn
jn
C
O
-
.
i 
00
-
20
0 
4
7 3 
.
02
9
u
lP cn-
/ 
O
C
'
.
00
0 
~
-
u
i-
2 
00
4
C
D 0
0- CD
/ I
7.
 (1
41
LP
4
5.
89
92
-
5.
89
38
-
-
5.
88
84
S5
. 80
82
5.
80
23 5.
89
9
5.
 8
94
5.
88
8
5.
8C
8
5 
.
80
3
z CD
-
-
3.
76
4
2
.8
0
9
.
3 
.
76
36
-
-
co co' C.)--
ca4 -4c
k D
MeO ~.N(H)Me
OMe
170 160 150 140
I I I' I
90 80 70 60 50 40 30 20 10 ppn1.30 120 110 100190 180
Nt
'M '~N(H)Me
'7 10
A I ii
I J{
4.0~ 3~U _ 1 0
C n n CN
LOCN O 00 Or LC
N
N(H)Me
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 pp
Coupling of 3-Chloropyridine and methylamine -- CDCl-
-(7' Q M 0 7-%oo
-4 cr -i n mw n on omzo w %.D oc r- Ic 1-1
N(H)Me
N
2.095 F CC 7.995 ppn,
-4h
9 O 2. E D 7.0 6. 5 6(.0 .: 5.0 4.3 4 .7 C 3 3. 2.$ 2. .5 10 c 05 PI
/V\i
7 0 q.05 7.0 6. 95) .9c 6, n p
Er
2 2. pp
cc CC o
L, cc
14 r4 4
N(H)Me
N
II
- ~~~~~~~~ . .~.. S .L It.L . ~li.~
190 180 170 160 150 140 130 120 110 100 60 50 40 30 20 10 ppi
C~) C'n LnL-) r  -i
Ln CN 03
\//
90C 80 70
ii S
oir N
XeH(H)N '
uiddzL
I I I
01V 09 09 I I I0 0T0 2T 01V71
~ I ~ -~ -~
uidd0 (I.,0 9T0 9T00017Z09z
r-J -
jr(rl I-. j~.-~ r'.~ (A,
XBH(H)N 
~c 
oe'
N(H)Bn
MeO
I i i 6 5 4 I 2 1 p
4 3 2 1 PPM
tn
CD
4 ~
20 0 ppm
cn mq
mn C"
N., 04,
N(H)Bn
MeO
260 240 220 200 180 160 140 120 100 80 60 40
(D
CD
C
wdd Tt7 S
I I I I
XeH(H)N o
wdd 0
I i l 1 1 1 r i i i 102 07 09 09 00T 02T OT 09T 09T 002 02 01VZ 092  | II I 1 1 s i I i r i i ii [| 1 i t l i 1 i i l I Ii 1 i I i 1i I i l : .4 ., 1 ..l .., ., ..., .I ..i .I. i ..I ..I .
01
01 ~
XGH(H)N
wddL 9 z c
I 1
F
Ue(H)N j
00 q-
N(H)Bn (' '
c'J
CD c
260 40 2  20 10 16 14 12 10080 0 4020 pp
wdd e 7I I/ 9
p
/I/
xGH(H)N 
"
I I I I
wdd 017 09 09 00 OT 0 1T 09T 09T 02 0 zz 0z 09z
i~~~~~~~I i1 1 1 I -L L -- 1 i1 1 i1 1 1 1 1 1 i1 1 1i 1 ] 1 f i l 1 1 1 1 1 1 [ 1 i iI Iie | | i i i I i e i lI i, , , I
LJ C D -
* .-
j C
XGH(H)N N
O O
0n P
wdd Ts9 19 6
I
N
H
I f
wdd 2 .......1 ....1 ...01 09 S .1 ,09 00T ....,
CD @ 0Mn Jcc-J Kj CD. c 3n 0e O Cfli '. e /
, dOja N~" H 
y
(13
N
N
02T09To09T I ..I ..00201t7z 0, 21092.1.1
cn
(A
0 VTO22
17
130l
la N '
H
.dd9L
wdd 0 2 017 09 09 00T 02T 07T 09T 09T 02 0 z o 2Vz o92
F-W-n
cne "J r
Ln -j rx
CD. c
0o CD -
-U3-~
KC:
0<1 N
H
1 9 L |
NH
wddI
wdd 0
| I I I I I Il A i I 4i i i 02 01 09 09 00T i I I I J1 I I i i| I L L t iJIAI A I i ] I I i i i i I 1 L I 
i|i
02T OVT 09T 091 002 022 02 092
I | I I I I | |I I I I I | I I I I I [ .I I I
00 cn
CII~
CDn 'Ji
.mk
co I-
to L
M
cn
w 0 o
H
I I I I
,
9 l IL9
Ce)
N
H
wdd
I , --I I I I I
wdd 0 02 017 09 09 00T OZT OtT 09T 09T 002z 0ZZ 02
! (AWl
020
cc 0
L0 0o
t,
092
Sr]
ND2
rr
roco
I |I |
N
H
wdd 17 9 L SI I 
I I II9
wdd
9L
Z
00
C
D
00
0
F-
I-
15
5.
32
3 14
3 
.
48
1 1
36
 .
69
0
-
13
0 
.
93
9
1
3
0
.9
2
1
12
2 
.
5 
9 9
12
2.
45
3
12
1.
08
5
2
1
.0
6
0
2 
-
1
1
6
7
.1
7
4
-
11
6 
.
12
8
11
4.
 9
 84
00
 _
77
.8
78
7 .
45
5 77
 .0
30
-
55
.8
73
-
l 
21
.6
52
C2
 
17
 .
71
5
3
17 s
I? I I I A I I -I I I I I ----I I I I I I I I I I I .I I rII I I
N H
wdd£L
wdd 0 02 0V 0999 00T02T0V109T09T 002ozz 0tpz 092
CO Pj
A I--
DCD
H
HN
H
1~~~~~~ ~~ ~ ~   .
wdd T 29 L
NH
NH
f 1 1
I -I I
...........I I I I I
wdd 0 02 0V 09 09 00109T0020z 0172 092
.0,
CA "
0 O
o O
CD
NH
" \ NH
02T 0 VT 0 9 T
tuddV
I ~ IsL
I I I 11111,11, J
H
N
~ NJ N N
H
wdd 0 02 017 09 09
1 1 1 1 | 1  | : : : i I i | | 1 i i 1 , , , , | , , , , i001 OOT2TIOVT 09T 09T 0 0027Z 09z I I I ii i i a I I I I i I * .I ..I I I
-0 N
--
~ N) C, e -
C,-'J. 0 )
-~
C, CA) CA) CD b CD -
H
H
...I ...I .....I I .1 .1 1 1 1 1 1 1 1 1
I-
H-- r- c0 N co0
Ln (Y N H- 00
C CO OD C 00r o -: \ ] co
a- (Y 00 N r- LO
00 LO) , CN 00
00 00 co 00 00
D D O tD
r i- LO N N p j ['- -i m (Y ig m LC) LC)t oo -i H r- H, r-- H 3 N w9 00 (c) O- cD O - (H mo OD cD p m 0m 0m Ng Ln d- O) [- (Y (q LC) ON - ) Ln ,. z LC) (0) (Y) CN , N H-- M N r-- 0) Esr( c) (Y) ce) (Y,) r- L-) (Y,) OD r- if) 3 qT [- r- 16 Q6 i) tr) (Y) (Y) (N N9 (N Ng r- r- C 00 000O r
C ( , ( r r r H , ( Q C(N CDCDC
Im4o
MAJOR MINOR
BRUKER
Current Data Parameters
NAME DAW4229aH
EXPNO
PROCNO
F2 - Acquisition Parameters
Date 20080625
Time 14.20
INSTRUM spect
PROBHD 5 mm BBO BB-1H
PULPROG zg30
TD 65536
SOLVENT CD2Cl2
NS 8
DS 0
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 256
DW 60.400 use
DE 6.00 use
TE 293.2 K
Dl 1.00000000 sec
TDO 1
NUC 1
P1
PL1
SFO1
F2 - Pro
SI
SF
WDW
SSB
CHANNEL fl ========
1H
15.07
0.00
400.1324710
usec
dB
MHz
cessing parameters
65536
400.1300212 MHz
EM
0
0.30 Hz
0
1.00
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 PPM
I I I I I , , I I I I . I
c
c
/I
Pd Cy
mrh-- ~ ~ -M,-0 X ,
, I. Pi
MINO
MINOR
BRUKER
Current Data Parameters
NAME DAW4239aP
EXPNO
PROCNO
F2 - Acquisition Parameters
Date 20080701
Time 11.43
INSTRUM spect
PROBHD 5 mm QNP 1H/13
PULPROG zgpg30
TD 65536
SOLVENT CD2Cl2
NS 32
DS 0
SWH 64935.066 Hz
FIDRES 0.990830 Hz
AQ 0.5046772 sec
RG 11585.2
DW 7.700 usec
DE 6.00 usec
TE 292.2 K
Dl 2.00000000 sec
dll 0.03000000 sec
DELTA 1.89999998 sec
TDO 1
======== CHANNEL fl ========
NUCl 31P
P1 9.25 usec
PL1 3.00 dB
SFO1 161.9674940 MHz
CPDPRG2
NUC2
PCPD2
PL2
PL12
PL13
1111 1,91ik lL ikl~kk SFO2
Tr~rIF 2 - Pr oSI
-SF
55 50 45 40 35 30 25 20 15 10 5 0 -5 -10 ppmSSB
GB
PC
CHA' NNEL f2 ========
waltz16
1H
90.00 usec
0.00 dB
16.10 dB
19.00 dB
400.1316000 MHz
cessing parameters
65536
161.9755024 MHz
EM
0
1.00 Hz
0
1.40
WO
MAJOR
1,00:1
M LO LfC o N Q0 Q0
m m0 r- Ln 31 m o
CO OC 00 O M0 0D 0
00 O zl -' O m N N -o ,o 00 m N Ln H-- CD X '4 N M I-- WO H CD M M d-- L0 H-- W N N (Y r-jr C)
X CD OD C) W0 0W M ' M0 O M ) M3 r- N M LC) N M [- L) I(Y) LC) M d-- LC) N CO OD M Ln N OD M
SM m m N r L m or) [- r- Ln v il ['- t- 0 - LC) LO LC) (Y) (Y) N N N~ H -H H3 C 00 00 00 66 obr-
LnL NN Cr CcC), D, C, CD
CI\ /
Pd
-P
MINOR
BRUKER
Current Data Parameters
NAME DAW4239aH
EXPNO 1
PROCNO 1
F2 - Acquisition Parameters
Date 20080701
Time 11.46
INSTRUM spect
PROBHD 5 mm QNP 1H/13
PULPROG zg30
TD 65536
SOLVENT CD2C12
NS 8
DS 0
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 322.5
DW 60.400 use
DE 6.00 use
TE 292.2 K
Dl 1.00000000 sec
TDO 1
NUC1
P1
PL1
SF01
F2 -
SI
SF
WDW
SSB
LB
- GB
PC
CHANNEL fl ========
1H
14.00 usec
0.00 dB
400.1324710 MHz
Processing parameters
65536
400.1300220 MHz
EM
0
0.30 Hz
0
1.00
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5
rCO Ln 04 04 w IRr 04 LO  01 r: 0! q Cl
Cli C; C; 6 0 0 C4 0
C(i '" *l
n0) M 0 P- 0ii O coiTr le CI
MAJOR
ppm
I ~ ~ ~  I . I I I I I I . I r I I I . . . 1 I . I I . I  . . . . . . . .
Cy,
c
c
BRUKER
J akAl11 U- ITF1 NFII w 1I11 - r w -7--q ' '10 1 '1"1T iII'" 11
MAJOR
Pd Lq
mq.&- LA oO -,, e :y
-I. P
MI-O
MINOR
Current
NAME
EXPNO
PROCNO
Data Parameters
DAW4229aP
1
F2 - Acquisition Parameters
Date 20080625
Time 14.14
INSTRUM spect
PROBHD 5 mm BBO BB-1H
PULPROG zgpg30
TD 65536
SOLVENT CD2C12
NS 32
DS
SWH
FIDRES
AQ
RG
DW
DE
TE
D1
d1l
DELTA
TDO
NUC 1
P1
PL1
SFO1
L A 1" 1 i k.h'kJ i.i~ h.L Ifi '11 'J'1 L 11 . IIJ6-1 A11j ' ''
CPDPRG2
NUC2
PCPD2
PL2
PL12
PL13
SF02
j t 1 .1  .. A L.aI ill ki iI. jl I I., 1 lII . I. J1111 .1-ikhiI. Ji.jiojb.ik Llhi~ j i A I
55 50 45 40 35 30 25 20 15 10 5 0 -5 -10
qC,'
9-
-SF
iqi
WDW
ppm B
GB
PC
0
64935.066
0.990830
0.5046772
20642.5
7.700
6.00
293.2
2.00000000
0.03000000
1.89999998
1
Hz
Hz
sec
usec
usec
K
sec
sec
sec
CHANNEL fl ========
31P
10.00 usec
0.00 dB
161.9674942 MHz
======== CHANNEL f2 ========
waltz16
1H
400.13
90.00 usec
-1.00 dB
14.52 dB
18.00 dB
16005 MHz
- Processing parameters
32768
161.9755930 MHz
EM
1.00 Hz
0
1.40
A, - 11. , LIL 11
7"I"r"T" F "r r"7rr--,fT rrrrT Tv"TIF-IT
0M CD M H1 W0 t H- M H- M OD N E M N (,0 00 L r- 0M CO N H- N Ln WO rH CW Mr CD W0 r_,c)O 0H
M 0W r- ZT H M H-- D OD O W0 k0 N v 0M W00 M cr 30 0 Y C OOT0 ' O()HCj
O 0 c 0 0 toe MM r OM ZT 'I -4 00 0M r Q0 LO LO LO) M M N N N N HI H 0M M0C C  N - - C q r I>r r O
I I I I
time <3 min
N (c) Ln) O (Y)
ZT (n) N M3 r-
co 0 cO r-
00000 ),CDBRUKER
Current Data Parameters
NAME DAW4241aH30secinsoln
EXPNO 2
PROCNO 1
F2 - Acquisition Parameters
Date 20080701
Time 12.07
INSTRUM spect
PROBHD 5 mm QNP 1H/13
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 1
DS 0
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 322.5
DW 60.400 usec
DE 6.00 usec
TE 292.2 K
Dl 1.00000000 sec
TDO
NUCl
P1
PL1
SF01
F2 - Pro
SI
SF
WDW
SSB
CHANNEL fl ========
1H
14.00 usec
0.00 dB
400.1324710 MHz
cessing parameters
65536
400.1300220 MHz
EM
0
0.30 Hz
0
1.00
I I I , , , , I , , I I I III I1
7.5 7.0 6.5 6.0 5.5
R' 00 n o 0O
0)-OI
5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 PPM
0'- ~ ~ 0 (N L0 N ON(
ONCr- 0 0 0 0 LQ C i tle Nll
V; Cq o wCNC 01 CONoO R
I I I I . I
1Y,
BRUKER
Current Data Parameters
NAME DAW424laP30secinsoln
EXPNO 1
PROCNO 1
F2 - Acquisition Parameters
Date 20080701
Time 12.10
INSTRUM spect
PROBHD 5 mm QNP 1H/13
PULPROG zgpg30
TD 65536
SOLVENT CD2Cl2
NS 35
DS 0
SWH 64935.066 Hz
FIDRES 0.990830 Hz
AQ 0.5046772 sec
RG 9195.2
DW 7.700 usec
DE 6.00 usec
TE 300.0 K
D1 2.00000000 sec
dl 0.03000000 sec
DELTA 1.89999998 sec
TDO 1
======== CHANNEL fl ========
NUCl
P 1
PL1
SFO1
CPDPR
NUC2
PCPD2
PL2
PL12
PL13
SF02
2 -
SI
SF
WDW
' SSB
LB10 ppmGB
PC
31P
9.25 usec
3.00 dB
161.9674940 MHz
======== CHANNEL f2 ========
waltz16
1H
90.00
0.00
16.10
19.00
400.1316000
usec
dB
dB
dB
MHz
Processing parameters
65536
161.9755024 MHz
EM
1. 00 Hz
0
1.40
kk 1
time <3 mjn
55 50 45 40 35 30 25 20 15 10 5 0 -5 -
N\JLnOc co 0 0r-i () to
00o n rH Q0 Lto III
PZI Tr_4 _H Ln L() Y"
Cf')
(y>
00 C
77
M~i Al o
WAo 4R.±Pd 
-X
PP
Me
X
' d C
o M NO R
M IN O
BRUKER
C2'<,M)
Current
NAME
EXPNO
PROCNO
Data Parameters
DAW424laH30mininsoln
1
1
F2 - Acquisition Parameters
Date 20080701
Time 12.04
INSTRUM spect
PROBHD 5 mm QNP 1H/13
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 8
DS
SWH
FIDRES
AQ
RG
DW
DE
TE
D1
TDO
NUCl
P1
PL1
SF01
F2 -
SI
SF
WDW
SSB
0
8278.146 Hz
0.126314 Hz
3.9584243 sec
322.5
60.400 use
6.00 use
292.2 K
1.00000000 sec
c
c
CHANNEL fl ========
1H
14.00 usec
0.00 dB
400.1324710 MHz
Processing parameters
65536
400.1300220 MHz
EM
0
0.30 Hz
-PC 1.40
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5
wotoI
6
ppm
V4T LO 0 -qr - T 4 0IRT ( Cl) 04 C 04 ,- o 04
D Y)C)
000) C
LOy) Y(Y
time =30 min
(0i rCoC4
C"
I I I I I I
I /
BRUKER
Current
NAME
EXPNO
PROCNO
MINOR
time = 30 min
Data Parameters
DAW424laP30mininsoln
F2 - Acquisition Parameters
Date 20080701
Time 12.00
INSTRUM spect
PROBHD 5 mm QNP 1H/13
PULPROG zgpg30
TD 65536
SOLVENT CD2C12
NS 32
DS
SWH
FIDRES
AQ
RG
DW
DE
TE
Dl
dll
DELTA
TDO
0
64935.066
0.990830
0.5046772
9195.2
7.700
6.00
292.2
2.00000000
0.03000000
1.89999998
1
Hz
Hz
sec
usec
usec
K
sec
sec
sec
======== CHANNEL f1 ========
NUCl 31P
P1 9.25 usec
PL1 3.00 dB
SF01 161.9674940 MHz
======== CHANNEL f2 ========
CPDPRG2
NUC2
PCPD2
PL2
PL12
PL13
SF02
IF2 -
B
waltz16
1H
90.00 usec
0.00 dB
16.10 dB
19.00 dB
400.1316000 MHz
Processing parameters
65536
161.9755024 MHz
EM
0
1.00 Hz
0
1.40
M AJ OR
1. 111.1 mI.
LB55 50 45 40 35 30 25 20 15 10 5 0 -5 -10 ppmGB
I JL PC
Chapter 4.
An Efficient Process for Pd-Catalyzed C-N Cross-Coupling Reactions of Aryl
lodides: Insight Into Controlling Factors
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4.1 Introduction
In Pd-catalyzed C-C cross-coupling reactions aryl iodides have generally been better
substrates than the corresponding aryl bromides or chlorides.' However, this has not been the
case for Pd-catalyzed C-N bond-forming processes,2 in which aryl iodides have traditionally
been the least successful substrates of these three aryl halides. Recent advances in this field
have allowed for reactions of aryl chlorides to reach the same efficiencies as aryl bromides,3 but
relatively little progress has been made in increasing the proficiency of Pd-catalyzed C-N cross-
coupling processes using aryl iodides.3b'4
Herein, we describe an investigation into the cause of the modest results obtained with
aryl iodides as substrates. We also report that catalysts using certain biarylphosphine ligands
allow for the C-N cross-coupling reactions of aryl iodides to be accomplished with the same (or
better) efficiencies as with other aryl halides.
OMe
MeO Pcy2  PCY2  PC'9
2 PCy2  i-Pr Y2  NH 2
Me2N i-PrO O-Pr L PC
i-Pr i-Pr 6;L=2
7;L=31 2 DavePhos 3 XPhos 4 RuPhos 8; L = 4
4.2 Results and Discussion
Oxidative addition complexes, using P(o-tol) 3 as the ligand, exist as stable bridging
halide dimers in solution.5 While the bridging bromide dimers are readily converted to [(o-
tol)3P]2Pd(amine)Br upon treatment with an amine, the process with the corresponding bridging
iodide dimers is endergonic.sa It was proposed that the stability of the bridging iodide dimers
could be the cause of the lower observed efficiency in reactions involving aryl iodides.
Preventing dimer formation would be expected to render amine binding more favorable,
resulting in comparable reactivity between aryl iodides, bromides, and chlorides.
Recently we disclosed a catalyst system, comprised of ligand 1, which showed excellent
reactivity for the C-N cross-coupling reactions of aryl chlorides.sa We found that the aryl
bromide and aryl chloride oxidative addition complexes, 1-Pd(Ar)X, existed as monomers in
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solution. Based on this, we hypothesized that the use of 1 could retard the formation of the
bridging dimers in the couplings of aryl iodides and improve the overall efficiency of these
reactions.
We began our studies by examining several biarylphosphine ligands for the reaction of
4-iodoanisole and aniline (Figure 1). Using a precatalyst based on ligand 1 (5), the reaction
gave a 99% yield (GC) after 10 minutes at room temperature. When a precatalyst of 2 (6),
which was previously our best biarylphosphine ligand for the coupling of aryl iodides, was
employed, a 7% yield of product was detected. Two other precatalysts, with ligands 3 (7) and 4
(8), which have been shown to yield highly active catalysts for the Pd-catalyzed C-N cross-
coupling reactions of aryl bromides and aryl chlorides, each gave <14% of the desired
product. These results show that for the amination reactions of aryl iodides, the catalyst derived
from 1 is highly active and displays marked differences from catalysts based on other
biarylphosphine ligands.
H
H2N 1% Pd, Ligand N
MeO toluene, rt, 10 min MeO
100
25 --
0
Ligand: 1 2 3 4
Figure 1. Results observed for the coupling of aniline and 4-iodoanisole in toluene using 1 mol
% Pd at room temperature for 10 minutes with various ligands.
Given that Pd-catalyzed C-N bond-forming reactions are carried out in a variety of
solvents, we investigated the coupling of aniline with 4-bromanisole and 4-iodoanisole in three
of those most commonly employed (toluene, dioxane and DME) to probe the effect of this
parameter. In toluene, the coupling of the two aryl halides with aniline proceeded at roughly the
same rate (Table 1). In dioxane and DME, however, the reactions with 4-bromoanisole were 2
and 7 times faster than the reactions with 4-iodoanisole. We would not expect the bridging
dimers to be more reactive in toluene than in DME or dioxane. Moreover, kinetic studies
indicated that the reaction in toluene is first order in 5. Taken together, these results indicate
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that the bridging iodide dimers are not playing a critical role in the overall process and that there
must be another cause for the observed solvent dependence and iodide effect. It is possible that
bridging dimers are important when other ligands are used (vide supra).
Table 1. Solvent effects on the coupling of aniline and 4-haloanisolea
X H2N 1 mol % 5, NaOt-Bu H
MeO I Solvent, 22 0C MeO
Solvent Halide Reaction Time (min) Solubility of Nal (mM)
Toluene Br 6 0.33
Toluene 1 6 0.33
Dioxane Br 10 0.8
Dioxane I 23 0.8
DME Br 10 797
DME I 70 797
[a] ArX (1 mmol), aniline (1.2 mmol), NaOt-Bu (1.2 mmol), solvent (2 mL/mmol), 5 (1 mol %).
It has previously been shown that Nal can inhibit the C-N cross-coupling reactions of
aryl bromides in DME.3b We postulated that the solvent dependence that we were detecting for
the cross-coupling of aryl iodides could be due to the solubility of the Nal byproduct in the
reaction medium. To test this hypothesis, we first determined the solubility of Nal in the three
solvents used in our study.6 As expected, the greater the solubility of Nal in the solvent, the
slower the reaction proceeded (Table 1). In toluene, where Nal is sparingly soluble, there is not
enough of the salt in solution to inhibit the reaction. This is consistent with our observation that
the rates of reaction for both the aryl iodide and aryl bromide are comparable. These solvent
effects are opposite of what has been seen for C-N cross-coupling reactions using a catalyst
system based on a bidentate ligand;3b this suggests that these results are only relevant for
catalysts based on biarylphosphine ligands.
To further understand the mechanism of iodide inhibition, reaction calorimetry7 was used
to study the effect of added Nal on the initial rates for the reaction of aniline and 4-bromoanisole
in DME. As expected, an inverse order in Nal was observed, which showed saturation at ca.
10% added iodide (Figure 2). We believe that these results suggest that the iodide could be
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Br H2N
+
MeO'C
1 mol % 5, NaOt-Bu
DME, 22 *C
Nal
N
MeO
0
0.02r
0 5
Figure 2. Effect of added Nal on the
1 mol % 5.
10
Added Nal (mol%)
cross-coupling of aniline and 4-bromoanisole in DME with
inhibiting the reaction by binding to a Pd(II) intermediate and forming a Pd ate complex (Scheme
1). This inhibition could occur at two different points on the catalytic cycle. First, the iodide could
compete with the amine for binding to the Pd(lI) oxidative addition complex (9). Second, the
iodide could bind to the Pd(ll) amido complex (10), slowing the rate of reductive elimination.8
Ar I Ar E)
L Pd-R L Pd-R
9; R = I or Br
10; R = NR 2
Scheme 1. Iodide inhibition pathways.
We also wanted to further verify our postulate that these reactions were most efficient in
toluene due to the lack of solubility of the Nal byproduct. Using reaction calorimetry the
coupling of aniline and 4-iodoanisole in toluene was shown to be zeroth order in added Nal
(Figure 3, A). The same reaction, with added tetrahexylammonium iodide, showed an inverse
order in added iodide (Figure 3, 9).9 This supports our hypothesis that the reactions are most
effective in toluene because the Nal byproduct precipitates and is not available to inhibit the
reaction.
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0.06
C
'.0 04
Br H2N 1 mol % 5, NaOt-Bu N
MeO toluene, 22 *C
Nal or (Hex) 4NI MeO
0.15
_ 1 A A A
C
E
-0.12
z
0.09
0 (Hex) 4NI
£4A Nal
0.06
0 2 4 6 8
Added Iodide (mol%)
Figure 3. Effect of different iodide sources on the cross-coupling of aniline and 4-iodoanisole in
toluene with I mol % 5.
Having found a catalyst and conditions that showed high activities for the cross-coupling
reactions of amines with aryl iodides, the scope of this system was next examined (Table 2).
The reaction of aniline with 4-iodoanisole was successfully performed in high yield at 0.01 mol
% catalyst loading in as little as 5 minutes. This rate is >10 fold faster than we previously
reported for the reaction of 4-chloroanisole and aniline under identical conditions.a It is also
notable that this is the first reported C-N cross-coupling reaction using 4-iodoanisole to be
carried out below 0.5 mol% catalyst loading.3b Ortho substitution on the aryl iodide and electron-
withdrawing groups on the aniline were also well tolerated. The coupling of linear and branched
primary aliphatic amines could also be carried out at low catalyst loadings and in high yields
with <1% diarylation observed. This system also showed high chemoselectivity for the coupling
of an iodide over a chloride. By switching to Cs2CO3 as the base, a number of functional groups
were all well tolerated. These substrates could be transformed using 0.1-0.2 mol % catalyst;
these are the first examples of C-N cross-coupling reactions to be reported with a weak base
using <0.5 mol % catalyst (most of the examples reported in the literature use 1 mol % or more
catalyst).s3
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Table 2. Cross-coupling of primary amines and aryl iodides
Ari + H 2NR
0.005 - 0.2 mol % 1, 0.005 - 0.2 mol % 5
B,
Base, toluene, 80 - 110 *C
H
MeO N
98% (0.005% Pd)a
97% (0.01% Pd)a,b
MeO' 
r N(H)Bn
87% (0.01% Pd)a
H
NNN
Cl
4-Cl, 97% (0.05% Pd)c
3-Cl, 96% (0.05% Pd)c
H
N. N(H)Cy Me N 
2E Me
Me
H CN
90% (0.2% Pd)d
H
ON 'N2
91% (0.05% Pd)a 92% (0.1% Pd)a 91% (0.1% Pd)d 96% (0.1% Pd)d
[a] Arl (1.0 equiv), amine (1.4 equiv), NaOt-Bu (1.4 equiv), 1 (0.005 - 0.2 mol%), 5 (0.005 - 0.2
mol%), toluene, 80-110 C. [b] 5 min reaction time. [c]1.0 equiv of amine was used. [d] Cs2CO3
was used as the base.
We next set out to extend the efficiency we had seen for the coupling of aryl iodides with
primary amines to reactions of secondary amines. We found that the precatalyst 8, based on
RuPhos (4), showed similar reactivity for the coupling of aryl iodides and aryl bromides with
secondary amines.3c 0 Further, for the coupling of 4-iodoanisole and morpholine precatalyst 8
gave a 99% yield, whereas catalyst systems based on other biarylphosphine ligands gave a
maximum of only 36% of the desired product (Figure 4).
+
MeO
HN \ O 1% Pd, Ligand
HN 0 tnMeOe N 0
\-/ toluene, 80 0C, 3 min -& \-
100
75
0
u 25
0 -
Ligand: 1 2 3 4
Figure 4. Results observed for the coupling of morpholine and 4-iodoanisole in toluene using I
mol % Pd at 80 *C for 3 min with various ligands.
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ArN(H)R
Using 8, both cyclic and acyclic secondary aliphatic amines in combination with aryl
iodides gave products in excellent yields with 0.025 - 0.1 mol % catalyst. N-Methylaniline and
diphenylamine were also successfully coupled with aryl iodides with higher turnover numbers
than any previously reported system. Functional group tolerance was also achieved by using
Cs2CO3 as the base with 0.1 mol % 8. Also, as shown for the reaction of piperidine with 4-
iodoanisole, these couplings proceed efficiently in dioxane as well as in toluene, although a
slightly higher quantity of catalyst is required.
Table 3. Cross-coupling of secondary amines and aryl iodidesa
0.01 - 0.1 mol % 4, 0.01 - 0.1 mol % 8
Ar + HN(R)R' ArN(R)R'
Base, toluene, 80 - 110 *C
Me Me
N 0 MeO N NBu2 N NMe
Me Me
85% (0.05% Pd)
99% (0.025% Pd) 89% (0.1% Pd)b 91% (0.05% Pd) 89% (0.1% Pd)
Me Me NPh2 Me
N
MeO Me EtO 2C CN
80% (0.01% Pd) 90% (0.05% Pd) 95% (0.1% Pd)C
[a] Art (1.0 equiv), amine (1.4 equiv), NaOt-Bu (1.4 equiv), 4 (0.01 - 0.1 mol %), 8 (0.01 - 0.1
mol %), toluene, 80-110 *C. [b] Dioxane was used as the solvent. [c] Cs2 CO3 was used as the
base.
Finally, we broadened the scope of this process to include the reactions of
heteroarylamines and heteroaryliodides (Table 4). The lack of solubility of these very polar
substrates in toluene necessitated a switch to t-BuOH. In this solvent aminopyrazine, 2-
aminopyrimidine, and 2-aminopyridine were all coupled with aryl iodides for the first time in good
to excellent yields." An array of heteroaryliodides, which have been poor coupling partners in
the past, were also effectively transformed to product (Table 4 ).3,12
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Table 4. Cross-coupling of heteroaryliodides and heteroarylaminesa
1 mol%1, 1 mol%5
Arl + H2NR ArN(H)R
K2CO 3, t-BuOH, 110 *C
HH Me N N H HK N~
Me N N N NMe
9 5 %b 90% 94% 90%
HH H
NTN N~ N.;N N NN
N N N N N
76% 73% 86%
[a] Arl (1.0 equiv), amine (1.4 equiv), K2CO 3 (1.4 equiv), 1 (1 mol %), 5 (1 mol %), t-BuOH (2
mL/mmol), 110 *C. [b] 0.5 mol % Pd was used.
4.3 Conclusion
In summary, precatalysts 5 and 8 have been shown to be highly active in Pd-catalyzed
amination reactions of aryl iodides. With ligand 1 (a component of 5) the formation of the
bridging iodide dimers was retarded, enhancing the reactivity of the system. Inhibition by Nal
was also shown to have a strong effect on these reactions. By switching to a solvent in which
the iodide salt was insoluble no inhibition was observed and the reactions of aryl iodides
became as efficient as other aryl halides. These catalyst systems were then applied to the
coupling of aryl iodides in high yields and with low catalyst loadings with an array of both
primary and secondary amines. Finally, reactions of heteroarylamines and heteroaryliodides
were performed in high yields. This system is complimentary to previously reported Cu based
catalysts13 and allows the synthetic chemist to choose from aryl chlorides, bromides, or iodides,
depending on their availability or ease of synthesis, for use in Pd-catalyzed C-N cross-coupling
processes.
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4.4 Experimental
General Reagent Information: All reactions were carried out under an argon
atmosphere. The 1,4-dioxane, DME, and tert-butanol were purchased from Aldrich Chemical
Co. in Sure-Seal bottles and were used as received. Toluene was purchased from J.T. Baker in
CYCLE-TAINER* solvent-delivery kegs and vigorously purged with argon for 2 h. The solvent
was further purified by passing it under argon pressure through two packed columns of neutral
alumina and copper (II) oxide. Aryl halides and amines were purchased from Aldrich Chemical
Co., Alfa Aesar, Acros Organics or TCI America. All amines, aryl bromides, and aryl iodides that
were liquids were distilled from calcium hydride and stored under argon. Amines and aryl
halides that were a solid were used as purchased without further purification. Cesium carbonate
(fine) was a gift from Chemetall and sodium tert-butoxide was purchased from Aldrich Chemical
Co. The bulk of the bases were stored in an N2 glovebox. Small portions were taken outside the
box in glass vials and weighed in the air. Anhydrous sodium iodide was purchased from Aldrich
Chemical Co. and stored in an N2 glovebox. Ligands 1,3a 2,14 and 410 were synthesized using
literature procedures. Ligand 3 was purchased from Strem Chemicals. Precatalysts 5,3a 6, 7,
and 8 3c were synthesized using literature procedures. Flash chromatography was performed
using a Biotage SP4 instrument with prepacked silica cartridges.
General Analytical Information: All compounds were characterized by 1H NMR, 13C
NMR, IR spectroscopy, as well as, in most instances, elemental analysis. Copies of the 1H and
13C spectra can be found at the end of the Supporting Information. Nuclear Magnetic Resonance
spectra were recorded on a Varian 300 MHz instrument and Varian 500 MHz instruments. All 1H
NMR experiments are reported in 6 units, parts per million (ppm), and were measured relative
to the signals for residual chloroform (7.26 ppm) in the deuterated solvent, unless otherwise
stated. All 13C NMR spectra are reported in ppm relative to deuterochloroform (77.23 ppm),
unless otherwise stated, and all were obtained with 'H decoupling. All IR spectra were taken on
a Perkin - Elmer 2000 FTIR. All GC analyses were performed on a Agilent 6890 gas
chromatograph with an FID detector using a J & W DB-1 column (10 m, 0.1 mm I.D.). Elemental
analyses were performed by Atlantic Microlabs Inc., Norcross, GA.
General Procedure for Figure 1
An oven-dried test tube, which was equipped with a magnetic stir bar and fitted with a teflon
septum, was charged with the precatalyst (1 mol%), 4-iodoanisole (234 mg, 1.0 mmol), and
NaOt-Bu (115 mg, 1.2 mmol). The vessel was evacuated and backfilled with argon (this process
was repeated a total of 3 times) and then the aniline (110 pL, 1.2 mmol) and toluene (1 mL)
were added via syringe. The solution was stirred at room temperature for 10 min, diluted with
Ethyl acetate, and washed with water. Dodecane was then added as an internal standard and
the reaction was analyzed by GC.
General Procedure for Table 1
An oven-dried 16 mL vial was equipped with a magnetic stir bar, fitted with a screw-cap
Teflon septum, and taken into the glovebox. Once in the glovebox, the vial was charged with 4-
haloanisole (1.0 mmol), aniline (55 pL, 0.6 mmol), NaOt-Bu (58 mg, 0.6 mmol), and solvent (1.7
mL). The reaction was then taken out of the glovebox and placed in an Omnical CRC reaction
calorimeter along with a syringe containing a solution of the Pd source in the solvent (300 pL
solvent, 1 mol% Pd precatalyst). The calorimeter was set to 22.4 *C and allowed to thermally
equilibrate. After equilibration, the solution of Pd precatalyst was injected and the reaction was
stirred until the heat flow on the calorimeter returned to the baseline. A correction was then
applied to the raw data due to the delay between the moment that the heat is given off of the
reaction and the moment that it is detected. The corrected heat flow curve was then converted
to fractional conversion by dividing the area under the curve to any point by the total area under
the curve (equation 1). Dodecane was then added as to the reaction as an internal standard and
it was analyzed by GC.
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Equation 1
t
fractional conversion = q-dt
tfinal
q-dt
General Procedure for Figure 2
An oven-dried 16 mL vial was equipped with a magnetic stir bar, fitted with a screw-cap
Teflon septum, and taken into the glovebox. Once in the glovebox, the vial was charged with 2
mL of a solution of 4-bromoanisole (63 pL, 0.5 mmol), aniline (55 pL, 0.6 mmol), NaOt-Bu (58
mg, 0.6 mmol), and Nal (0 - 20 mol%) in DME, which was prepared in a 2 mL volumetric flask.
The reaction was then taken out of the glovebox and placed in an Omnical CRC reaction
calorimeter along with a syringe containing a solution of 8 (4 mg, 1 mol%) in 1,4-dioxane (300
pL). The calorimeter was set to 22.4 0C and allowed to thermally equilibrate. After equilibration,
the solution containing 8 was injected and the reaction was stirred until the heat flow on the
calorimeter returned to the baseline. A correction was then applied to the raw data due to the
delay between the moment that the heat is given off of the reaction and the moment that it is
detected. The corrected heat flow curve was then converted to rate by using the equation q =
AHan - V - r, where q is the heat flow, AHrn is the heat of reaction, V is the reaction volume, and
r is the reaction rate. The heat of reaction was found by integrating the heat flow vs. time
curves.
General Procedure for Figure 3
An oven-dried 16 mL vial was equipped with a magnetic stir bar, fitted with a screw-cap
Teflon septum, and taken into the glovebox. Once in the glovebox, the vial was charged with 4-
iodoanisole (117 mg, 0.5 mmol), aniline (55 pL, 0.6 mmol), NaOt-Bu (58 mg, 0.6 mmol), Nal or
tetrahexylammonium iodide (0 - 20 mol%), and toluene (1.7 mL). The reaction was then taken
out of the glovebox and placed in an Omnical CRC reaction calorimeter along with a syringe
containing a solution of 8 (4 mg, 1 mol%) in toluene (300 pL). The calorimeter was set to 22.4
0C and allowed to thermally equilibrate. After equilibration, the solution containing 8 was
injected and the reaction was stirred until the heat flow on the calorimeter returned to the
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baseline. A correction was then applied to the raw data due to the delay between the moment
that the heat is given off of the reaction and the moment that it is detected. The corrected heat
flow curve was then converted to rate by using the equation q = AHrxn - V - r, where q is the heat
flow, AHrxn is the heat of reaction, V is the reaction volume, and r is the reaction rate. The heat
of reaction was found by integrating the heat flow vs. time curves.
General Procedure for Figure 4
An oven-dried test tube, which was equipped with a magnetic stir bar and fitted with a
teflon septum, was charged with the precatalyst (1 mol%), 4-iodoanisole (234 mg, 1.0 mmol),
and NaOt-Bu (115 mg, 1.2 mmol). The vessel was evacuated and backfilled with argon (this
process was repeated a total of 3 times) and then the morpholine (105 pL, 1.2 mmol) and
toluene (1 mL) were added via syringe. The solution was heated to 80 0C for 3 min, then cooled
to room temperature, diluted with Ethyl acetate, and washed with water. Dodecane was then
added as an internal standard and the reaction was analyzed by GC.
General Procedures for Tables 2, 3, and 4
General Procedure A: An oven-dried test tube, which was equipped with a magnetic
stir bar and fitted with a teflon septum, was charged with NaOt-Bu (1.2 equiv). The vessel was
evacuated and backfilled with argon (this process was repeated a total of 3 times) and then the
aryl iodide (1 equiv), amine (1.2 equiv), and toluene (0.3 - 1.0 mL/mmol) were added via syringe
(aryl iodides or amines that were solids at room temperature were added with the and base). A
solution of the ligand and precatalyst in toluene (0.002 M, 0.005 - 0.2 mol % 1, 0.005 - 0.2 mol
% 5) was added and the reaction was heated to 110 OC until the starting material was
completely consumed as monitored by GC. The reaction mixture was then cooled to room
temperature, diluted with ethyl acetate, washed with water, concentrated in vacuo, and purified
via the Biotage SP4 (silica-packed 50 or100 g snap cartridge).
General Procedure B: An oven-dried test tube, which was equipped with a magnetic
stir bar and fitted with a teflon septum, was charged with the ligand (0.05 - 0.2 mol%), the
precatalyst (0.05 - 0.2 mol%), and NaOt-Bu (1.2 - 1.4 equiv). The vessel was evacuated and
backfilled with argon (this process was repeated a total of 3 times) and then the aryl iodide (1
equiv), amine (1.2 - 1.4 equiv), and toluene (0.3 mL/mmol) were added via syringe (aryl iodides
or amines that were solids at room temperature were added with the precatalyst and base). The
solution was heated to 85 0C until the starting material was completely consumed as monitored
by GC. The reaction mixture was then cooled to room temperature, diluted with ethyl acetate,
washed with water, concentrated in vacuo, and purified via the Biotage SP4 (silica-packed 50 or
100 g snap cartridge).
General Procedure C: General procedure A was used with the following modification:
1.4 equiv of Cs2CO3 was used as the base.
General Procedure D: An oven-dried test tube, which was equipped with a magnetic
stir bar and fitted with a teflon septum, was charged with the ligand (0.5 - 1 mol%), the
precatalyst (0.5 - 1 mol%), and K2CO 3 (1.4 equiv). The vessel was evacuated and backfilled
with argon (this process was repeated a total of 3 times) and then the aryl iodide (1 equiv),
amine (1.4 equiv), and t-BuOH (2 mL/mmol) were added via syringe (aryl iodides or amines that
were solids at room temperature were added with the precatalyst and base). The solution was
heated to 110 0C until the starting material was completely consumed as monitored by GC. The
reaction mixture was then cooled to room temperature, diluted with ethyl acetate, washed with
water, concentrated in vacuo, and purified via the Biotage SP4 (silica-packed 50 g snap
cartridge).
Experimental Procedures for Examples Described in Table 2
H
MeO
4-Methoxy-N-phenylaniline 3c (Table 2). Following general procedure A, a mixture of 4-
iodoanisole (468 mg, 2.0 mmol), aniline (256 pL, 2.8 mmol), NaOt-Bu (269 mg, 2.8 mmol), 5
and 1 (50 pL, 0.002 M in toluene, 0.005 mol%), and toluene (2 mL) was heated to 110 0C for 24
h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-45%
EtOAc/hexanes) to provide the title compound as a white solid (390 mg, 98%), mp 104 - 105 *C
(lit. 104 - 106 C). 1H NMR (300 MHz, CDC13) 6: 7.31 (t, J = 7.5 Hz, 2H), 7.15 (d, J = 9.0 Hz,
2H), 6.97 (m, 5H), 5.58 (bs, 1H), 3.87 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 155.5, 145.5,
136.1, 129.7, 122.5, 119.9, 115.9, 115.0, 55.9 ppm. IR (neat, cm-1): 3384, 2837, 1597, 1513,
1298, 1250, 1182, 1034, 752, 696. Anal. Calcd. for C13H13NO: C, 78.36; H, 6.58. Found: C,
78.07; H, 6.62.
H
MeON
4-Methoxy-N-phenylanilinec (Table 2). Following general procedure A, a mixture of 4-
iodoanisole (468 mg, 2.0 mmol), aniline (256 pL, 2.8 mmol), NaOt-Bu (269 mg, 2.8 mmol), 5
and 1 (100 pL, 0.002 M in toluene, 0.01 mol%), and toluene (900 pL) was heated to 110 0C for 5
min. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-
45% EtOAc/hexanes) to provide the title compound as a white solid (388 mg, 97%), mp 104 -
105 0C (lit. 104 - 106 CC). 1H NMR (300 MHz, CDC13) 6: 7.31 (t, J = 7.5 Hz, 2H), 7.15 (d, J =
9.0 Hz, 2H), 6.97 (m, 5H), 5.58 (bs, 1H), 3.87 (s, 3H) ppm. 13C NMR (75 MHz, CDC13 ) 6: 155.5,
145.5, 136.1, 129.7, 122.5, 119.9, 115.9, 115.0, 55.9 ppm. IR (neat, cm-1): 3384, 2837, 1597,
1513, 1298, 1250, 1182, 1034, 752, 696. Anal. Calcd. for C 13H13NO: C, 78.36; H, 6.58. Found:
C, 78.38; H, 6.68.
Me H
N N 
N
CF 3
2-Methyl-N-(3-(trifluoromethyl)phenyl)aniline (Table 2). Following general procedure
A, a mixture of 2-iodotoluene (350 pL, 2.0 mmol), 3-aminobenzotrifluoride (350 pL, 2.8 mmol),
NaOt-Bu (269 mg, 2.8 mmol), 5 and 1 (100 pL, 0.002 M in toluene, 0.01 mol%), and toluene
(900 pL) was heated to 110 0C for 24 h. The crude product was purified via the Biotage SP4
(silica-packed 50 g snap column; 0-45% EtOAc/hexanes) to provide the title compound as a
yellow oil (438 mg, 87%). 'H NMR (300 MHz, CDC13) 6: 7.42 - 7.28 (m, 4H), 7.23 - 7.10 (m,
4H), 5.58 (bs, 1H), 2.35 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 145.4, 140.1, 132.1, 131.9,
131.6, 130.5, 130.1, 127.3, 125.7, 124.0, 123.5, 121.2, 119.4, 116.6, 116.5, 116.5, 113.0, 112.9,
112.9, 18.1 ppm (observed complexity due to C-F splitting). IR (neat, cm-1): 3398, 3034, 2926,
1585, 1496, 1338, 1165, 1124, 1069, 699. Anal. Calcd. for C14H12F3N: C, 66.93; H, 4.81. Found:
C, 66.98; H, 4.80.
H
cl N
cia
4-Chloro-N-phenylaniline1 5 (Table 2). Following general procedure A, a mixture of 4-
chloroiodobenzene (477 mg, 2.0 mmol), aniline (182 pL, 2.0 mmol), NaOt-Bu (269 mg, 2.8
mmol), 5 and 1 (500 pL, 0.002 M in toluene, 0.05 mol%), and toluene (500 pL) was heated to 80
0C for 2 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column;
0-25% EtOAc/hexanes) to provide the title compound as a white solid (397 mg, 97%), mp 67 -
68 0C (lit. 72 *C). 1H NMR (500 MHz, CDC13) 6: 7.38 (t, J = 7.5 Hz, 2H), 7.29 (d, J = 6.5 Hz,
2H), 7.12 (d, J = 7.5 Hz, 2H), 7.05 (m, 3H), 5.70 (bs, 1H) ppm. 13C NMR (75 MHz, CDCl3) 6:
143.0, 142.2, 129.8, 129.6, 125.7, 121.8, 119.1, 118.4 ppm. IR (neat, cm- 1): 3403, 1590, 1505,
1485, 1384, 1312, 1090, 750, 692, 504. Anal. Calcd. for C12H10CIN: C, 70.77; H, 4.95. Found: C,
70.57; H, 5.03.
H
CI N
3-Chloro-N-phenylaniline (Table 2). Following general procedure A, a mixture of 3-
chloroiodobenzene (247 pL, 2.0 mmol), aniline (182 pL, 2.0 mmol), NaOt-Bu (269 mg, 2.8
mmol), 5 and 1 (500 pL, 0.002 M in toluene, 0.05 mol%), and toluene (500 pL) was heated to 80
0C for 2 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column;
0-25% EtOAc/hexanes) to provide the title compound as a yellow oil (395 mg, 96%). 1H NMR
(500 MHz, CDC13) 6: 7.38 (t, J = 7.5 Hz, 2H), 7.22 (t, J = 8.0 Hz, 1H), 7.15 (d, J = 7.5 Hz, 2H),
7.09 (m, 2H), 6.95 (dd, J = 8.0 Hz, J = 2.0 Hz, 2H), 5.73 (bs, 1H) ppm. 13C NMR (125 MHz,
CDC13) 6: 145.1, 142.2, 135.3, 130.7, 129.8, 122.4, 120.8, 119.3, 117.0, 115.4 ppm. IR (neat,
cm-1): 3403, 3059, 1589, 1496, 1480, 1314, 993, 916, 752, 681. Anal. Calcd. for C12H10CIN: C,
70.77; H, 4.95. Found: C, 71.05; H, 4.91.
H
MeO
N-Benzyl-4-methoxyaniline 3a (Table 2). Following general procedure B, a mixture of 4-
iodoanisole (2.33 g, 10 mmol), benzylamine (1.31 mL, 12 mmol), NaOt-Bu (1.34 g, 14 mmol), 5
(4 mg, 0.05 mol%) and 1 (2.5 mg, 0.05 mol%), and toluene (3 mL) was heated to 85 0C for 24 h.
The crude product was purified via the Biotage SP4 (silica-packed 100 g snap column; 0-40%
EtOAc/hexanes) to provide the title compound as a yellow oil (1.761 g, 83%). 1H NMR (300
MHz, CDC13) 6: 7.46 (m, 5H), 6.91 (d, J = 9.0 Hz, 2H), 6.71 (d, J = 9.0 Hz, 2H), 4.37 (s, 2H),
3.90 (bs, 1H), 3.84 (s, 3H) ppm. 13C NMR (75 MHz, CDCl3 ) 6: 152.5, 142.9, 140.2, 129.0,
127.9, 127.5, 115.3, 114.5, 56.1, 49.5 ppm. IR (neat, cm-1): 3415, 3028, 2831, 1511, 1452,
1234, 1036, 819, 742, 697.
H
MeO N
N-Cyclohexyl-4-methoxyaniline16 (Table 2). Following general procedure B, a mixture
of 4-iodoanisole (2.33 g, 10 mmol), cyclohexylamine (1.603 mL, 14 mmol), NaOt-Bu (1.34 g, 14
mmol), 5 (8 mg, 0.1 mol%) and 1 (5 mg, 0.1 mol%), and toluene (3 mL) was heated to 85 0C for
24 h. The crude product was purified via the Biotage SP4 (silica-packed 100 g snap column; 0-
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50% EtOAc/hexanes) to provide the title compound as a white solid (1.875 g, 92%), mp 44 - 46
*C. 1H NMR (300 MHz, CDC13) 6: 6.80 (d, J= 9.0 Hz, 2H), 6.60 (J= 9.0 Hz, 2H), 3.76 (s, 3H),
3.26 (bs, 1 H), 3.20 (m, 1 H), 2.07 (m, 2H), 1.78 (m, 2H), 1.68 (m, 1 H), 1.48 - 1.05 (m, 5H) ppm.
13C NMR (75 MHz, CDC13) 6: 152.1, 141.9, 115.1, 115.0, 56.0, 53.0, 33.9, 26.3, 25.4 ppm. IR
(neat, cm 1): 3388, 2929, 2852, 1511, 1450, 1240, 1040, 819, 756, 515.
H ON
N
2-(Phenylamino)benzonitrile (Table 2). Following general procedure C, a mixture of
iodobenzene (112 pL, 1.0 mmol), 2-aminobenzonitrile (165 mg, 1.2 mmol), Cs2CO3 (456 mg, 1.4
mmol), and 5 and 1 (1 mL, 0.002 M in toluene, 0.2 mol%) was heated to 110 0C for 24 h. The
crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-45%
EtOAc/hexanes) to provide the title compound as a white solid (175 mg, 90%), mp 50 - 51 C.
'H NMR (300 MHz, CDC13) 6: 7.51 (d, J = 7.8 Hz, 1H), 7.39 (m, 3H), 7.21 (m, 3H), 7.15 (t, J =
7.2 Hz, 1H), 6.85 (t, J = 7.5 Hz, 1H), 6.54 (bs, 1H) ppm. 13C NMR (75 MHz, CDCl3) 6: 147.6,
140.3, 134.2, 133.4, 129.9, 124.4, 121.9, 119.5, 118.0, 114.5, 98.8 ppm. IR (neat, cm 1): 3338,
2217, 1592, 1575, 1517, 1457, 1319, 1293, 745, 695. Anal. Calcd. for C13H10 N2: C, 80.39; H,
5.19. Found: C, 80.09; H, 5.12.
H
Me 
N 
Et
Me
Ethyl 4-(3,5-dimethylphenylamino)benzoate17 (Table 2). Following general procedure
C, a mixture of 3,5-dimethyliodobenzene (144 pL, 1.0 mmol), ethyl 4-aminobenzoate (231 mg,
1.4 mmol), Cs 2CO3 (456 mg, 1.4 mmol), 5 and 1 (500 pL, 0.002 M in toluene, 0.1 mol%), and
toluene (0.5 mL) was heated to 110 0C for 24 h. The crude product was purified via the Biotage
SP4 (silica-packed 50 g snap column; 0-50% EtOAc/hexanes) to provide the title compound as
a white solid (244 mg, 91%), mp 117 - 119 0C (lit. 119 *C). 1H NMR (300 MHz, CDC13) 6: 7.94
(d, J = 8.4 Hz, 2H), 6.99 (d, J = 8.4, 2H), 6.81 (s, 2H), 6.73 (s, 1 H), 6.12 (bs, 1 H), 4.36 (q, J =
7.2 Hz, 2H), 2.32 (s, 6H), 1.40 (t, J = 7.2 Hz, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 166.9,
148.5, 141.1, 139.4, 131.7, 125.0, 121.3, 118.3, 114.9, 60.7, 21.6, 14.7 ppm. IR (neat, cm 1):
309
3343, 1698, 1595, 1510, 1352, 1282, 1170, 1109, 831, 769. Anal. Calcd. for C17 H,9NO2: C,
75.81; H, 7.11. Found: C, 75.54; H, 7.13.
H
N
Me N NO 2
4-Methyl-N-(4-nitrophenyl)aniline (Table 2). Following general procedure C, a mixture
of 4-iodotoluene (218 mg, 1.0 mmol), 4-nitroaniline (193 mg, 1.4 mmol), Cs2 CO 3 (456 mg, 1.4
mmol), 5 and 1 (500 pL, 0.002 M in toluene, 0.1 mol%), and toluene (0.5 mL) was heated to 110
0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap
column; 0-40% EtOAc/hexanes) to provide the title compound as an orange solid (220 mg,
96%), mp 138 - 139 0C. 'H NMR (300 MHz, CDC13) 6: 8.09 (d, J= 9.0 Hz, 2H), 7.20 (d, J= 7.8
Hz, 2H), 7.12 (d, J= 7.8 Hz, 2H), 6.88 (d, J= 9.0 Hz, 2H), 6.38 (bs, 1H), 2.37 (s, 3H) ppm. 13C
NMR (75 MHz, CDC13) 6: 151.2, 139.4, 136.9, 135.0, 130.5, 126.6, 122.9, 113.4, 21.2 ppm. IR
(neat, cm 1): 3342, 1595, 1524, 1481, 1298, 1187, 1111, 829, 749, 499. Anal. Calcd. for
C13 H12 N20 2: C, 68.41; H, 5.30. Found: C, 68.35; H, 5.22.
Experimental Procedures for Examples Described in Table 3
N O
4-Phenylmorpholinel" (Table 3). Following general procedure A, a mixture of
iodobenzene (1.119 mL, 10 mmol), morpholine (1.223 mL, 14 mmol), NaOt-Bu (1.34 g, 14
mmol), 4 and 8 (1.25 mL, 0.002 M in toluene, 0.025 mol%), and toluene (1.75 mL) was heated
to 85 OC for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 100 g snap
column; 0-50% EtOAc/hexanes) to provide the title compound as a white solid (1.632 g, 99%),
mp 53 - 55 *C. 'H NMR (500 MHz, CDC13 ) 6: 7.39 (t, J= 7.0 Hz, 2H), 7.00 (m, 3H), 3.91 (t, J=
5.0 Hz, 4H), 3.19 (t, J = 5.0 Hz, 4H) ppm. 13C NMR (125 MHz, CDCl3) 6: 151.7, 129.6, 120.3,
116.0, 67.2, 49.6 ppm. IR (neat, cm1): 2888, 2856, 2826, 1599, 1496, 1449, 1231, 1120, 926,
773. Anal. Calcd. for ClOH 13NO: C, 73.59; H, 8.03. Found: C, 73.53; H, 8.19.
MeO /' N
1-(4-Methoxyphenyl)piperidine' 8 (Table 3). Following general procedure B, a mixture
of 4-iodoanisole (2.33 g, 10 mmol), piperidine (1.381 mL, 14 mmol), NaOt-Bu (1.34 g, 14 mmol),
8 (3.5 mg, 0.05 mol%) and 4 (2.5 mg, 0.05 mol%), and toluene (3 mL) was heated to 85 0C for
24 h. The crude product was purified via the Biotage SP4 (silica-packed 100 g snap column; 0-
40% EtOAc/hexanes) to provide the title compound as a yellow oil (1.633 g, 85%). 'H NMR (500
MHz, CDC13) 6: 6.96 (d, J = 9.0 Hz, 2H), 6.88 (d, J = 9.0 Hz, 2H), 3.79 (s, 3H), 3.07 (t, J = 5.5
Hz, 4H), 1.77 (m, 4H), 1.59 (m, 2H) ppm. 13C NMR (125 MHz, CDC13 ) 6: 153.8, 147.2, 119.0,
114.6, 55.7, 52.6, 26.5, 24.5 ppm. IR (neat, cm-1): 2934, 2792, 1511, 1453, 1244, 1041, 919,
823, 700, 539.
MeO N
1-(4-Methoxyphenyl)piperidine' 8 (Table 3). Following general procedure B, a mixture
of 4-iodoanisole (2.33 g, 10 mmol), piperidine (1.381 mL, 14 mmol), NaOt-Bu (1.34 g, 14 mmol),
8 (3.5 mg, 0.05 mol%) and 4 (2.5 mg, 0.05 mol%), and dioxane (3 mL) was heated to 85 0C for
24 h. The crude product was purified via the Biotage SP4 (silica-packed 100 g snap column; 0-
40% EtOAc/hexanes) to provide the title compound as a yellow oil (1.711 g, 89%). 'H NMR (500
MHz, CDC13 ) 6: 6.96 (d, J = 9.0 Hz, 2H), 6.88 (d, J = 9.0 Hz, 2H), 3.79 (s, 3H), 3.07 (t, J = 5.5
Hz, 4H), 1.77 (m, 4H), 1.59 (m, 2H) ppm. 1C NMR (125 MHz, CDC13 ) 6: 153.8, 147.2, 119.0,
114.6, 55.7, 52.6, 26.5, 24.5 ppm. IR (neat, cm'): 2934, 2792, 1511, 1453, 1244, 1041, 919,
823, 700, 539.
Me
/ \NBu2
Me
N,N-Dibutyl-3,5-dimethylaniline (Table 3). Following general procedure A, a mixture of
3,5-dimethyliodobenzene (1.44 mL, 10 mmol), dibutylamine (2.35 mL, 14 mmol), NaOt-Bu (1.34
g, 14 mmol), 4 and 8 (2.50 mL, 0.002 M in toluene, 0.05 mol%), and toluene (0.5 mL) was
heated to 85 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 100
g snap column; 0-50% EtOAc/hexanes) to provide the title compound as a yellow oil (2.127 g,
91%). 'H NMR (300 MHz, CDC13) 6: 6.66 (s, 3H), 3.60 (t, J = 7.5 Hz, 4H), 2.64 (s, 6H), 1.93
(pentet, J = 8.1 Hz, 4H), 1.72 (sextet, J = 7.5 Hz, 4H), 1.33 (t, J = 7.5 Hz, 6H) ppm. 1C NMR (75
MHz, CDC13 ) 6: 148.9, 139.1, 117.9, 110.3, 51.4, 30.1, 22.5, 21.0, 14.6 ppm. IR (neat, cm'):
2957, 2872, 1597, 1486, 1367, 1304, 1196, 1064, 814, 691. Anal. Calcd. for C16H27N: C, 82.34;
H, 11.66. Found: C, 82.17; H, 11.91.
Me
e 
\ NNMe
Me
1-(3,5-Dimethylphenyl)-4-methylpiperazine (Table 3). Following general procedure B,
a mixture of 3.5-dimethyliodobenzene (1.443 mL, 10 mmol), N-methylpiperazine (1.550 mL, 14
mmol), NaOt-Bu (1.34 g, 14 mmol), 8 (7 mg, 0.1 mol%) and 4 (4.5 mg, 0.1 mol%), and toluene
(3 mL) was heated to 85 *C for 24 h. The crude product was purified via the Biotage SP4 (silica-
packed 100 g snap column; 75-100% EtOAc/hexanes) to provide the title compound as a yellow
oil (1.808 g, 89%). 1H NMR (300 MHz, CDC13) 6: 6.61 (s, 2H), 6.56 (s, 1H), 3.22 (t, J= 5.1 Hz,
4H), 2.59 (t, J = 5.1 Hz, 4H), 2.38 (s, 3H), 2.32 (s, 6H) ppm. 13C NMR (75 MHz, CDCl3) 6:
151.7, 138.8, 121.9, 114.3, 55.5, 49.5, 46.5, 22.0 ppm. IR (neat, cm'): 2937, 2794, 1597, 1452,
1376, 1291, 1265, 1143,1009,828.
Me
'I r I
MeON
4-Methoxy-N-methyl-N-phenylaniline (Table 3). Following general procedure A, a
mixture of 4-iodoanisole (468 mg, 2.0 mmol), N-methylaniline (303 pL, 2.8 mmol), NaOt-Bu (269
mg, 2.8 mmol), 4 and 8 (100 pL, 0.002 M in toluene, 0.01 mol%), and toluene (0.9 mL) was
heated to 85 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g
snap column; 0-40% EtOAc/hexanes) to provide the title compound as a yellow oil (342 mg,
80%). 'H NMR (500 MHz, CDC13 ) 6: 7.25 (t, J= 9.0 Hz, 2H), 7.15 (d, J= 9.0 Hz, 2H), 6.95 (d, J
= 9.5 Hz, 2H), 6.85 (m, 3H), 3.86 (s, 3H), 3.31 (s, 3H) ppm. 13C NMR (125 MHz, CDC13 ) 6:
156.6, 150.0, 142.5, 129.2, 126.6, 118.6, 116.0, 115.0, 55.8, 40.8, 39.8 ppm. IR (neat, cm'):
2951, 2834, 1597, 1508, 1344, 1244, 1035, 835, 751, 695. Anal. Calcd. for C 4H15NO: C, 78.84;
H, 7.09. Found: C, 79.07; H, 7.24.
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Me
3,5-Dimethyl-N,N-diphenylaniline (Table 3). Following general procedure A, a mixture
of 3.5-dimethyliodobenzene (289 pL, 2.0 mmol), diphenylamine (473 mg, 2.8 mmol), NaOt-Bu
(269 mg, 2.8 mmol), 4 and 8 (500 pL, 0.002 M in toluene, 0.05 mol%), and toluene (0.5 mL) was
heated to 110 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50
g snap column; 0-40% EtOAc/hexanes) to provide the title compound as a white solid (489 mg,
90%), mp 135 - 136 0C. 'H NMR (300 MHz, CDC13) 6: 7.34 (t, J= 7.2 Hz, 4H), 7.20 (J= 7.5 Hz,
4H), 7.09 (t, J = 7.2 Hz, 2H), 6.86 (s, 2H), 6.80 (s, 1 H), 2.34 (s, 6H) ppm. 13C NMR (75 MHz,
CDC13) 6: 148.4, 148.1, 139.2, 129.5, 125.2, 125.2, 124.4, 122.7, 21.7 ppm. IR (neat, cm-1):
3035, 1589, 1492, 1338, 1294, 1273, 1230, 1029, 753, 693. Anal. Calcd. for C20H19N: C, 87.87;
H, 7.01. Found: C, 87.62; H, 7.11.
Me
EtO 2C N cN
3,5-Dimethyl-N,N-diphenylaniline (Table 3). Following general procedure C, a mixture
of ethyl 4-iodobenzoate (152 pL, 1.0 mmol), 4-cyano-N-methylaniline (185 mg, 1.4 mmol),
Cs 2CO3 (456 mg, 1.4 mmol), 4 and 8 (500 pL, 0.002 M in toluene, 0.1 mol%), and toluene (0.5
mL) was heated to 110 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-
packed 50 g snap column; 0-30% EtOAc/hexanes) to provide the title compound as a clear oil
(266 mg, 95%). 1H NMR (300 MHz, CDC13) 6: 7.99 (d, J = 8.4 Hz, 2H), 7.45 (d, J = 9.0 Hz, 2H),
7.15 (d, J= 8.7 Hz, 2H), 6.96 (d, J= 8.7 Hz, 2H), 4.33 (q, J= 6.9 Hz, 2H), 3.38 (s, 3H), 1.36 (t, J
= 7.2 Hz, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 166.2, 151.4, 151.0, 133.6, 131.5, 125.9,
122.6, 119.9, 118.0, 102.7, 61.1, 40.2, 14.6 ppm. IR (neat, cm-1): 2982, 2218, 1710, 1595,
1508, 1347, 1278, 1179, 1107, 773. Anal. Calcd. for C17H16N202: C, 72.84; H, 5.75. Found: C,
72.90; H, 5.76.
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Experimental Procedures for Examples Described in Table 4
Note: All heteroaryliodides that were not commercially available were synthesized using
literature procedures. 9
H
Me N N
N-p-Tolylpyrazin-2-amine (Table 4). Following general procedure D, a mixture of 4-
iodotoluene (218 mg, 1.0 mmol), aminopyrazine (133 mg, 1.4 mmol), K2CO3 (197 mg, 1.4
mmol), 5 (4 mg, 0.5 mol%) and 1 (2.5 mg, 0.5 mol%), and t-BuOH (2 mL) was heated to 110 0C
for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column;
0-50% EtOAc/hexanes) to provide the title compound as a white solid (167 mg, 95%), mp 112 -
113 OC. 1H NMR (300 MHz, CDC13 ) 6: 8.19 (s, 1H), 8.06 (s, 1H), 7.92 (d, J = 2.7 Hz, 1H), 7.62
(bs, 1 H), 7.30 (d, J = 8.4 Hz, 2H), 7.14 (J = 8.1 Hz, 2H), 2.33 (s, 3H) ppm. 13C NMR (75 MHz,
CDC13) 6: 153.2, 142.2, 136.9, 134.3, 133.6, 133.0, 130.2, 121.2, 21.1 ppm. IR (neat, cm-1):
3289, 3100, 1626, 1524, 1385, 1142, 1004, 814, 506, 413. Anal. Calcd. for C11H11N3: C, 71.33;
H, 5.99. Found: C 71.06; H, 6.03.
H
Me N N
- N-
Me
N-(3,5-Dimethylphenyl)pyrimidin-2-amine (Table 4). Following general procedure D, a
mixture of 3,5-dimethyliodobenzene (144 pL, 1.0 mmol), 2-aminopyrimidine (133 mg, 1.4 mmol),
K2C0 3 (197 mg, 1.4 mmol), 5 (8 mg, 1 mol%) and 1 (5 mg, 1 mol%), and t-BuOH (2 mL) was
heated to 110 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50
g snap column; 0-40% EtOAc/hexanes) to provide the title compound as a yellow oil (161 mg,
81%). 1H NMR (300 MHz, CDC13 ) 6: 8.44 (d, J= 4.8 Hz, 2H), 8.26 (s, 1H), 7.28 (s, 2H), 6.74 (s,
1H), 6.69 (t, J = 4.8 Hz, 1H), 2.53 (s, 6H) ppm. 13C NMR (75 MHz, CDC13 ) 6: 160.8, 158.3,
139.6, 138.8, 125.0, 118.0, 112.3, 21.8 ppm. IR (neat, cm- 1): 3274, 3014, 1580, 1539, 1449,
1404, 1246, 838, 797, 631. Anal. Calcd. for C12H13N3: C, 72.33; H, 6.58. Found: C 72.23; H,
6.65.
HK N NN
N N
N-(Pyridin-3-yl)pyrazin-2-amine (Table 4) Following general procedure D, a mixture of
3-iodopyridine (205 mg, 1.0 mmol), aminopyrazine (133 mg, 1.4 mmol), K2CO3 (197 mg, 1.4
mmol), 5 (8 mg, 1 mol%) and 1 (5 mg, 1 mol%), and t-BuOH (2 mL) was heated to 110 0C for 24
h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-10%
MeOH/EtOAc) to provide the title compound as a white solid (160 mg, 93%), mp 181 - 182 *C.
1H NMR (300 MHz, DMSO) 6: 9.70 (s, 1H), 8.61 (s, 1H), 8.25 (s, 1H), 8.15 (m, 3H), 7.95 (s,
1H), 7.30 (m, 1H) ppm. 13C NMR (75 MHz, DMSO) 6: 152.7, 142.8, 141.7,140.8, 138.0, 135.8,
134.9, 125.3, 124.2 ppm. IR (neat, cm-1): 3305, 2317, 1643, 1585, 1528, 1485, 1462, 1359,
1006, 702. Anal. Calcd. for CH 8 N4 : C, 62.78; H, 4.68. Found: C 62.54; H, 4.72.
HN N KN
N-(Pyridin-4-yl)pyrazin-2-amine (Table 4). Following general procedure D, a mixture of
iodopyrazine (98 pL, 1.0 mmol), 4-amnopyridine (132 mg, 1.4 mmol), K2CO3 (197 mg, 1.4
mmol), 5 (8 mg, 1 mol%) and 1 (5 mg, 1 mol%), and t-BuOH (2 mL) was heated to 110 0C for 24
h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-10%
MeOH/EtOAc) to provide the title compound as a brown solid (155 mg, 90%), decomposed
above 200 *C. 'H NMR (500 MHz, DMSO) 6: 9.97 (s, 1H), 8.33 (m, 3H), 8.23 (s, 1H), 8.06 (s,
1H), 7.66 (m, 2H) ppm. 13C NMR (125 MHz, DMSO) 6: 152.2, 150.7, 147.8, 141.8, 136.3,
136.0, 112.7 ppm. IR (neat, cm-1): 3444, 1617, 1522,1425,1400,1356,1145,1008, 815, 517.
H
N N
N N
N-(Pyrazin-2-yl)isoquinolin-4-amine (Table 4). Following general procedure D, a
mixture of 4-iodoisoquinoline (128 mg, 0.5 mmol), aminopyrazine (67 mg, 0.7 mmol), K2CO3 (99
mg, 0.7 mmol), 5 (4 mg, 1 mol%) and 1 (2.5 mg, 1 mol%), and t-BuOH (1 mL) was heated to
110 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap
column; 0-10% MeOH/EtOAc) to provide the title compound as a white solid (88 mg, 80%), mp
214 - 216 C. 'H NMR (300 MHz, DMSO) 6: 9.42 (s, 1H), 9.07 (s, 1H), 8.97 (s, 1H), 8.41 (s,
315
1H), 8.14 (t, J= 8.4 Hz, 2H), 8.05 (s, 1H), 7.95 (s, 1H), 7.77 (t, J = 7.2 Hz, 1H), 7.69 (t, J = 7.2
Hz, 1H) ppm. 13C NMR (75 MHz, DMSO) 6: 153.9, 148.3, 141.9, 137.0, 135.3, 135.0, 131.1,
130.7, 130.6, 129.3, 128.5, 128.1, 122.6 ppm. IR (neat, cm-1): 3391, 1628, 1580, 1521, 1477,
1384, 784, 762, 446, 436.
H
N
N-(Pyridin-2-yl)quinolin-3-amine (Table 4). Following general procedure D, a mixture
of 3-iodoquinoline (128 mg, 0.5 mmol), 2-aminopyridine (66 mg, 0.7 mmol), K2C0 3 (99 mg, 0.7
mmol), 5 (4 mg, 1 mol%) and 1 (2.5 mg, 1 mol%), and t-BuOH (1 mL) was heated to 110 0C for
24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-
10% MeOH/EtOAc) to provide the title compound as a white solid (80 mg, 73%), mp 224 - 226
C. 1H NMR (300 MHz, DMSO) 6: 9.60 (bs, 1H), 8.92 (s, 2H), 8.27 (s, 1H), 7.86 (m, 1H), 7.64
(t, J = 7.2 Hz, 1 H), 7.50 (m, 2H), 6.96 (d, J = 8.1 Hz, 1 H), 6.84 (t, J = 6.0 Hz, 1 H) ppm. 13C NMR
(75 MHz, DMSO) 6: 156.2, 148.0, 145.6, 143.4, 138.2, 136.2, 129.2, 127.8, 127.5, 126.8,
118.4, 115.9, 112.1 ppm. IR (neat, cm 1): 3285, 2919, 1633, 1580, 1483, 1431, 1384, 1349,
1156, 768.
H
N N
N-(Pyrazin-2-yl)pyrimidin-5-amine (Table 4). Following general procedure D, a mixture
of 5-iodopyrimidine (103 mg, 0.5 mmol), aminopyrazine (67 mg, 0.7 mmol), K2C03 (99 mg, 0.7
mmol), 5 (4 mg, 1 mol%) and 1 (2.5 mg, 1 mol%), and t-BuOH (1 mL) was heated to 110 0C for
24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-
10% MeOH/EtOAc) to provide the title compound as a white solid (76 mg, 88%), sublimed
above 200 *C. 1H NMR (300 MHz, DMSO) 6: 9.88 (s, 1H), 9.11 (s, 2H), 8.76 (s, 1H), 8.27 (s,
1H), 8.18 (s, 1H), 8.02 (s, 1H) ppm. 13C NMR (75 MHz, DMSO) 6: 152.1, 151.8, 146.5, 141.7,
136.7, 135.8, 135.6 ppm. IR (neat, cm-1): 3388, 2918, 1579, 1529, 1443, 1384, 1055, 1005,
833, 716.
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Chapter 5.
An Efficient System For the Pd-Catalyzed Cross-Coupling of Amides and Aryl Chlorides
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5.1 Introduction
Metal-catalyzed amidation reactions of aryl halides or pseudo halides are an attractive
method for synthesizing N-arylamides. These reactions were traditionally performed with aryl
iodides under Goldberg-modified Ullman cross-coupling conditions using stoichiometric Cu and
high reaction temperatures.' Recent advances in this area have allowed for the reactions of
amides and aryl iodides or aryl bromides to be performed using catalytic amounts of Cu under
milder conditions.2 Pd-based catalyst systems using phosphine ligands have also been
developed, which allow for the coupling of amides with aryl sulfonates,3 aryl bromides,4 and
most recently, aryl chlorides.5 These methods have proven to be useful to synthetic chemists
and have been widely used in both industrial and academic laboratories. 6
Me
Me M Me OMe OMe
Me P(t-Bu)2  MeO PCy 2  MeO P(t-Bu) 2  P(t-Bu) 2  Pcy 2Me P B i-Pr i-Pr i-Pr i-Pr i-Pr i-Pr i-Pr i-Pr
i-Pr i-Pr i-Pr i-Pr i-Pr
1 2 3 4 5
(t-BuXPhos) (XPhos)
Figure 1. Biarylphosphine ligands.
Of the aryl halides, aryl chlorides are generally the most attractive substrates for cross-
coupling reactions because they are less expensive and more readily available. Our group
previously reported a catalyst system, based on ligand 1, that effectively promoted the cross-
coupling of amides and unhindered aryl chloridessa but was less effective with ortho-substituted
aryl chlorides. Mechanistic studies and DFT calculations indicated to us that the methyl
substituent ortho to the di-tert-butylphosphino group in ligand 1 prohibited rotation around the P-
CAr bond, forcing the Pd(ll) center of the resulting oxidative addition complex to position itself
over the non-phosphine-containing ring (Figure 2). It was postulated that this confirmation
inhibited the formation of the K2-amidate complex, accelerating reductive elimination. On the
other hand, DFT calculations have also indicated that the amine binding step of the catalytic
cycle using biarylphosphine ligands is slower when the Pd(II) is positioned over the non-
phosphine containing ring Having an ortho substituent on the arene in these complexes
compounds this effect by increasing the crowding around the Pd(II) center, hence, further
slowing "transmetallation" (amide binding/deprotonation). Herein, we report a catalyst system,
which displays high activity for the amidation of aryl chlorides, including those with ortho
substitution, by facilitating transmetallation while still inhibiting the formation of a K2-amidate
intermediate.
t-Bu Ar
Me t-Bu I
Me Pd-Xi-Pr
Me i-Pr
i-Pr
Me Me
Figure 2. Pd(ll) oxidative addition complex based on ligand 1.
5.2 Results and Discussion
Our group recently disclosed a catalyst system, based on 2, that was highly active and
selective for the monoarylation of primary amines.3 In this study we observed that, in solution,
the oxidative addition complexes of 2 existed as two rotamers; for one of which the environment
around the Pd center was less sterically demanding. We hypothesized that the substitution of a
methoxy substituent ortho to the di-tert-butylphosphino group in 1 (see ligand 3) would allow for
more freedom of rotation around the P-CAr bond and help promote transmetallation with
relatively hindered substrates. This new ligand (3) was easily synthesized in 2 steps from
commercially available starting materials (see experimental section).
Initial studies employing the supporting ligand 3 focused on the coupling of acetamide
and 2-chlorotoluene in the presence of various Pd sources, bases, and solvents. We found that
when the catalyst was formed using our recently reported water-mediated catalyst preactivation
method9 with 3, Pd(OAc) 2, and K3 P04 as the base in t-BuOH, the reaction gave a 99% GC yield
after 40 minutes at 110 0C (Table 1, entry 1). This initial result was very promising as it
represented the highest turnover frequency observed to date for the Pd-catalyzed amidation
reactions of aryl chlorides bearing an ortho substituent.a Switching the Pd source to Pd2(dba)3
or Pd(dba)2 resulted in a dramatic reduction in yield (Table 1, entries 2 and 3). This loss of
activity is likely caused by. coordination of the dba ligands to the Pd, which is a well known effect
of dba in cross-coupling reactions.10 The use of Pd(II) salts (e.g., [(allyl)PdC] 2, (H3CCN) 2PdC 2,
or Pd(OAc)2) without preactivation, all of which need to be reduced quickly and efficiently in
order to generate an active catalyst, leads to yields below 60%." These results demonstrated
the importance of forming the active monoligated Pd(0) complex in these reactions. The use of
carbonate bases showed similar results for this coupling reaction,' 2 but a substantial decline in
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yield was observed with all bases examined when other common solvents were used (Table 1,
entries 9 and 10).
Table 1. Screen of reaction parameters for the cross-coupling of acetamide and 2-
chlorotoluenea
CI+ 1 mol % Pd, 1.2 mol % 3 N M
Me H2N Me Solvent, Base, 110 C, 40 min HMe MeH
Entry Pd Source Base Solvent Yield (GC)
1 Pd(OAc)2/H20 Act. K3P0 4  t-BuOH 99%
2 Pd2(dba)3  K3P04  t-BuOH 27%
3 Pd(dba)2  K3PO4 t-BuOH 25%
4 [(allyl)PdCI] 2  K3P0 4  t-BuOH 48%
5 (H3CCN) 2PdCI 2  K3P04  t-BuOH 46%
6 Pd(OAc)2  K3P0 4  t-BuOH 57%
7 Pd(OAc) 2/H20 Act. Cs2CO3  t-BuOH 99%
8 Pd(OAc)2/H20 Act. K2 C0 3  t-BuOH 96%
9 Pd(OAc)2/H20 Act. K3P04  Toluene 10%
10 Pd(OAc)2/H20 Act. K3P0 4  1,4-Dioxane 0%
[a] Reaction conditions: ArCI (1.0 equiv), amide (1.2 equiv), base (1.4 equiv), Pd (1 mol %), 3
(2.2 mol %), solvent (2 mL/mmol), 110 'C, 40 min.
Encouraged by our initial results, we set out to compare reactions with ligand 3 directly
with those employing other biarylphosphine ligands that had previously been used for Pd-
catalyzed amidation reactions. Using a catalyst based on 1 for the cross-coupling of acetamide
and 2-chlorotoluene resulted in a 12% yield (GC), whereas using a catalyst supported by 3
afforded the product in a 99% yield (Figure 3). This result demonstrates that changing the
substituent ortho to the di-tert-butylphosphino group in 1 from a methyl to a methoxy group, as
in 3, has a dramatic effect on the activity of these systems. We believe this increase in activity is
due to the increased freedom of rotation around the P-CAr bond in 3, which may accelerate
transmetallation. With 2, the dicyclohexylphosphino analogue of 3, a 65% yield of product was
realized. With the ligand lacking the two methoxy substituents, t-BuXPhos (4), only a 15% yield
of the desired product was formed.sals These results reveal that both the methoxy group ortho
to the di-tert-butylphosphino group and the di-tert-butyl groups on the phosphorus center in 3
are important to the high activity observed when this ligand is employed. Finally, with ligand 5
(XPhos), which had previously been reported to be suitable ligand for Pd-catalyzed amidation
reactions of aryl tosylates, only a trace of product was observed. 3e
0
H2N Me
1 mol % Pd, 2.2 mol % L
t-BuOH, K3P0 4, 4 mol % H20110 *C, 40 min
2 3
Figure 3. Results observed
ligands.
for the coupling of acetamide and 2-chlorotoluene with various
We next explored the scope of the Pd-catalyzed cross-coupling reactions of aryl
chlorides and amides with our new catalyst system. We began by examining the effect of the
ortho substituent on the aryl chloride. As we had already observed, 2-chlorotoluene was
successfully coupled with acetamide in high yield (Table 2, entry 1). When the methyl
substituent was replaced with the larger ethyl group the coupling still proceeded in good yield
(Table 2, entry 2). When the ortho substituent was changed to an electron-donating methoxy
group the rate of the coupling decreased slightly, the reaction took 3 hours to proceed to
completion, but still gave 91% of the desired product (Table 2, entry 3). Aryl chlorides with ortho
substitution were also coupled with benzamide in excellent yields (Table 2, entries 4 and 5).
These examples show the superior reactivity of this system over previously reported catalysts.
Unfortunately, the reactions of aryl chlorides with two ortho substituents failed to provide product
under these conditions.
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N Me
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Table 2. Pd-catalyzed cross-coupling of amides and aryl chlorides'
Entry ArCI Amide Product Time Yieldb
N0
N Me
Me
N Me
Et H
N0
N Me
OMe H
40 min 83%
1.5 h 78%
3 h 91%
Me
N
~~CIci
Me
OMe
5 IN
ci
OMe
6 Me
MeO 2C Ci
Me
0
H2N ON Kk N N
Me H
OMe
H2N NI4 
__N N
OMe
H0 Me ) N 0
H2N CF3  CF3
H2N Me0 2C N1 v H"
[a] Reaction conditions: ArCl (1.0 equiv), amide (1.2 equiv), K3P04 (1.4 equiv), Pd(OAc) 2 (1
mol%), 3 (2.2 mol %), H20 (4 mol %), t-BuOH (2 mL/mmol), 110 *C. [b] Isolated yields, average
of two runs.
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1 C
Me
2Cl
Et
3 O e
OMe
0
H2N Me
0
H2N 'KMe
0
H2N 1 Me
3 h 93%
1.5 h 92%
2 h 80%
5 h 83%
Table 2. (continued) Pd-catalyzed cross-coupling of amides and aryl chloridesa
Entry ArCI Amide Product Time Yieldb
8 C1
OMe
9 C1
Et
10 MeO 
CI
11 C1
Et
12 I
Me0 2C " ci
MeO N
13 
:: c
14 aCI
15 N CI
16 NN C I
0
H
2N
0
H2N
H2N
H2N "
0
H2N 11 O
0
H2N
H2N N
H2N N
0
H2N 15
0
N 0
N
Et HM
MeO N 0 S\
N
H
N s
N
EtH
MeO2Ca N0H_'T
MeO N 0
HI
N
N N
H
N0
N N
H
0
' NH 1
2 h 98%
3 h 85%
1.5 h 90%
3 h 84%
1.5 h 96%
5 h 90%
4 h 70%
12 h 61%
1.5 h 93%
[a] Reaction conditions: ArCI (1.0 equiv), amide (1.2 equiv), K3 P04 (1.4 equiv), Pd(OAc) 2 (1
mol%), 3 (2.2 mol %), H20 (4 mol %), t-BuOH (2 mL/mmol), 110 C. [b] Isolated yields, average
of two runs.
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We next examined the reactions of aryl chlorides that lacked an ortho substituent.
Utilizing 3 as the ligand, the reaction of 4-chlorotoluene with 4-trifluoromethylbenzamide gave
the desired product in good yield with 1 mol % Pd in only 2 h (Table 2, entry 6). The reactions
of similar substrates with the best previously reported catalyst system required times between
12 - 24 h.
Due to the ubiquity of heterocycles in many biologically active molecules, we next
wanted to extend the scope of this system to heteroaryl substrates. Amides containing furans,
pyridines, and thiophenes were all well tolerated in these reactions. These could be
successfully coupled with a variety of aryl chlorides in good to excellent yields, all with reaction
times that were <5 h using 1 mol% Pd (Table 2, entries 8 - 14). For example, the coupling of
furan-2-carboxamide with 2-chloroanisole gave a 98% yield of the desired product in 2 h (Table
2, entry 8). Additonally, a heteroaryl chloride, 3-chloropyridine, was also an excellent coupling
partner for this reaction (Table 2, entries 15 and 16).
5.3 Conclusion
In summary, a catalyst based on the new ligand 3 was developed for the Pd-catalyzed
cross-coupling of amides and aryl chlorides. This system was much more active than previous
catalyst systems that have been used for these reactions, particularly for the coupling of amides
with aryl chlorides bearing an ortho substituent. An array of amides were successfully combined
with aryl chlorides in good to excellent yields using 1 mol % Pd and with reaction times <5 h.
5.4 Experimental
General Reagent Information: All reactions were set up in the air and carried out
under an atmosphere of argon. Flash chromatography was performed using a) silica gel from
American International Chemical or b) a Biotage SP4 instrument with prepacked silica
cartridges. The tert-butanol was purchased from Aldrich Chemical Co. in Sure-Seal bottles and
was used as received. Pd(OAc)2 was a gift from BASF. Aryl halides and amides were
purchased from Aldrich Chemical Co., Alfa Aesar, Acros Organics, or Oakwood Products and
were used as purchased without further purification. Deionized water was degassed by brief (30
sec) sonication under vacuum and then evacuated and backfilled with argon (this procedure
was repeated three times). Anhydrous tribasic potassium phosphate was purchased from Fluka
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Chemical Co., stored in a nitrogen filled glovebox and removed in small quantities and stored on
the bench for up to two weeks. Ligands 1 ,5a 2,7 and 43e were synthesized using literature
procedures and ligand 5 was purchased from Strem Chemicals Inc.
General Analytical Information: Yields refer to isolated yields of compounds greater
than 95% purity as determined by gas chromatography (GC) and 1H NMR. All yields reported in
Table 2 are for an average of two experiments. All compounds were characterized by 1H NMR,
13C NMR, IR spectroscopy, melting point, and in most cases, elemental analysis. Nuclear
Magnetic Resonance spectra were recorded on a Varian 300 MHz instrument or a Bruker 400
MHz instruement. All 1H NMR experiments are reported in 8 units, parts per million (ppm), and
were measured relative to the solvent residual peak. All 13C NMR spectra are reported in ppm
relative to solvent residual peak and were obtained with 1H decoupling. All IR spectra were
made on a Perkin - Elmer 2000 FTIR. All GC analyses were performed on a Agilent 6890 gas
chromatograph with an FID detector using a J & W DB-1 column (10 m, 0.1 mm I.D.). Elemental
analyses were performed by Atlantic Microlabs Inc., Norcross, GA. HRMS spectra were
performed on a Bruker APEXIV 4.7t FT-ICR mass spectrometer.
OMe OMe 
-
MeO 1) t-BuLi P(t-B) 2
i-Pr i-Pr 2) CIP(t-Bu) 2  i-Pr i-Pr
cuci
i-Pr i-Pr
Synthesis of 3. An oven-dried 300 mL round bottom Schlenk flask, which was equipped
with a magnetic stir bar, fitted with a rubber septum, and charged with 2-iodo-2',4',6'-triisopropyl-
3,6-dimethoxybipheny 7 (3.78 g, 8.11 mmol), was evacuated and backfilled with argon (this
process was repeated a total of 3 times). THF (40 mL) was added via syringe, the reaction was
cooled to -78 0C, and t-BuLi (1.7 M in Hexane, 9.54 mL, 16.22 mmol) was added in a dropwise
fashion over a 20 min period. The solution was stirred for 30 min and then under a positive
pressure of argon the septum was removed from the Schlenk flask and anhydrous CuCl (804
mg, 8.11 mmol), which was weighed out in nitrogen filled glovebox, was added rapidly. The
flask was refitted with the rubber septum and CIP(t-Bu) 2 (1.70 mL, 8.92 mmol) was added in a
dropwise fashion over a 10 minute period. The reaction was warmed from -78 *C to room
376
temperature at which point the flask was sealed with a Teflon screw cap and heated to 70 0C for
60 h. The solution was cooled to room temperature, diluted with ethyl acetate, washed with
aqueous NH40H (this process was repeated a total of three times), washed with brine, dried
over MgSO 4, and concentrated in vacuo. The crude material was recrystallized from hot
methanol to yield the desired product as white crystals (2.081 g, 53%). 'H NMR (300 MHz,
CDC13) 6: 6.96 (s, 2H), 6.87 (d, J = 8.7 Hz, 1 H), 6.83 (d, J = 9.0 Hz, 1 H), 3.78 (s, 3H), 3.56 (s,
3H), 2.95 (septet, J = 6.9 Hz, 1 H), 2.49 (septet, J = 6.6 Hz, 2H), 1.32 (d, J = 6.9 Hz, 6H), 1.21
(d, J= 6.6 Hz, 6H), 1.14 (s, 9H), 1.10 (s, 9H), 0.93 (d, J= 6.6 Hz, 6H) ppm. 13C NMR (75 MHz,
CDC13) 6: 155.9, 152.6, 152.5, 147.2, 146.7, 140.5, 140.0, 133.0, 127.6, 127.0, 120.1, 110.9,
108.2, 54.4, 54.0, 34.2, 34.1, 33.8, 32.1, 31.8, 31.3, 25.7, 24.3, 23.6 ppm (Observed complexity
is due to P-C splitting). 31P NMR (121 MHz, CDC13) 6: 34.78 ppm. IR (neat, cm-1): 2958, 2864,
1581, 1486, 1421, 1250, 1086, 1020, 799, 715. HRMS (ESI) Calcd. for C3 1H 00 2P [M+H*]:
485.3543; Found: 485.3537.
General procedure for Table 2. An oven-dried test tube, which was equipped with a
magnetic stir bar and fitted with a teflon screwcap septum, was charged with Pd(OAc) 2 (1 mol%)
and 3 (2.2 mol%). The vessel was evacuated and backfilled with argon (this process was
repeated a total of 3 times) and t-BuOH (2.0 mL) and degassed H20 (4 mol%) were added via
syringe. After addition of the water, the solution was heated to 110 0C for 1.5 min. A second
oven-dried test tube equipped with a magnetic stir bar and fitted with a Teflon screwcap septum,
was charged with amide (1.2 mmol) and K3P0 4 (1.4 mmol) (aryl chlorides that were solids at
room temperature were added with the base). The vessel was evacuated and backfilled with
argon (this process was repeated a total of 3 times) and then the aryl chloride (1.0 mmol) was
added via syringe and the activated catalyst solution was transferred from the first reaction
vessel into the second via cannula. The solution was heated to 110 0C until the aryl chloride had
been completely consumed as judged by GC analysis. The reaction mixture was then cooled to
room temperature, diluted with ethyl acetate and washed with water. The layers were separated
and the organic layer was dried over anhydrous MgSO 4, filtered and concentrated in vacuo. The
crude product was purified via flash chromatography on silica gel.
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N-o-Tolylacetamide 5a (Table 2, entry 1). Following the general procedure, a mixture of
2-chlorotoluene (117 [tL, 1.0 mmol), acetamide (71 mg, 1.2 mmol), K3PO4 (297 mg, 1.4 mmol),
Pd(OAc) 2 (2.3 mg, 0.010 mmol), 3 (11 mg, 0.022 mmol), H20 (0.7 CL, 0.04 mmol) and t-BuOH
(2.0 mL) was heated to 110 *C for 40 minutes. The crude product was purified by flash
chromatography on silica gel (40% hexanes in EtOAc) to provide the title compound as a white
solid (119 mg, 80%). Mp = 109 - 109 0C (lit. 108 - 109). 1H NMR (300 MHz, CDC13 ) 6: 7.68 (d, J
= 7.8 Hz, 1H), 7.23 - 7.15 (m, 3H) 7.07 (t, J = 7.5 Hz, 1H), 2.23 (s, 3H), 2.17 (s, 3H) ppm. 13c
NMR (75 MHz, CDCl3) 6: 168.8, 135.7, 130.5, 130.1, 126.6, 125.5, 124.0, 24.1, 17.9 ppm. IR
(neat, cm~1): 3290, 3028, 2981, 1654, 1588, 1531, 1486, 1460, 1369, 1288, 1272, 1118, 1039,
1018, 756, 714, 700, 653, 608, 562, 534, 446. Anal. Calcd. for C9H11NO: C, 72.46; H, 7.43.
Found: C, 72.25, H, 7.59.
N Me
Et H
N-(2-Ethylphenyl)acetamide 14 (Table 2, entry 2). Following the general procedure, a
mixture of 1-chloro-2-ethylbenzene (132 L, 1.0 mmol), acetamide (71 mg, 1.2 mmol), K3 P04
(297 mg, 1.4 mmol), Pd(OAc)2 (2.3 mg, 0.010 mmol), 3 (11 mg, 0.022 mmol), H20 (0.7 L, 0.04
mmol) and t-BuOH (2.0 mL) was heated to 110 *C for 1.5 h. The crude product was purified by
flash chromatography on silica gel (50% EtOAc in hexanes) to provide the title compound as a
white solid (129 mg, 79%). Mp = 115 - 116 OC (lit. 111 - 111.8 *C). 1H NMR (300 MHz, CDC 3)
6: 7.63 (d, J = 7.2 Hz, 1H), 7.33 (bs, 1 H), 7.21 - 7.10 (m, 3H), 2.57 (q, J = 7.5 Hz, 2H), 2.15 (s,
3H), 1.20 (t, J = 7.8 Hz, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 168.9, 136.0, 135.0, 128.6,
126.6, 125.9, 124.6, 24.27, 24.19, 14.0 ppm. IR (neat, cm1): 3271, 3037, 2964, 2929, 2869,
1653, 1588, 1540, 1448, 1373, 1296, 1053, 1018, 971, 749, 717, 610, 487. HRMS (ESI) Calcd.
for C10H14NO [M+H*]: 164.1070; Found: 164.1077.
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N-(2-Methoxyphenyl)acetamide 5a (Table 2, entry 3). Following the general procedure,
a mixture of 2-chloroanisole (127 tL, 1.0 mmol), acetamide (71 mg, 1.2 mmol), K3P0 4 (297 mg,
1.4 mmol), Pd(OAc) 2 (2.3 mg, 0.010 mmol), 3 (11 mg, 0.022 mmol), H20 (0.7 [tL, 0.04 mmol)
and t-BuOH (2.0 mL) was heated to 110 0C for 3 h. The crude product was purified by flash
chromatography on silica gel (40% EtOAc in hexanes) to provide the title compound as a white
solid (150 mg, 91%). Mp = 87 - 88 0C (lit. 87 - 88). 'H NMR (300 MHz, CDCl3) 6: 8.35 (dd, J=
8.1, 1.7 Hz, 1H), 7.78 (bs, 1H), 7.03 (td, J= 7.5, 1.8 Hz, 1H), 6.95 (td, J= 7.8, 1.5 Hz, 1H), 6.86
(dd, J = 8.1, 1.5 Hz, 1H), 3.87 (s, 3H), 2.19 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 168.3,
147.7, 127.8, 123.7, 121.1, 119.8, 109.9, 55.7, 25.0. ppm. IR (neat, cm 1): 3249, 3195, 3137,
3063, 3021, 2964, 1659, 1596, 1544, 1496, 1468, 1459, 1436, 1368, 1323, 1291, 1272, 1252,
1025, 751. Anal. Calcd. for CHi1NO2: C, 65.44; H, 6.71. Found: C, 65.89, H, 6.90.
Me
N~0
Me q
N-(2,5-Dimethylphenyl)benzamide (Table 2, entry 4). Following the general procedure,
a mixture of 2-chloro-p-xylene (133 [tL, 1.0 mmol), benzamide (145 mg, 1.2 mmol), K3PO4 (297
mg, 1.4 mmol), Pd(OAc) 2 (2.3 mg, 0.010 mmol), 3 (11 mg, 0.022 mmol), H20 (0.7 L, 0.04
mmol) and t-BuOH (2.0 mL) was heated to 110 0C for 3 h. The crude product was purified by
flash chromatography on silica gel (20% EtOAc in hexanes) to provide the title compound as a
white solid (215 mg, 95%). Mp = 151 - 152 OC. 1H NMR (300 MHz, CDCi3) 6: 7.88 (dt, J= 6.6,
1.5 Hz, 2H), 7.78 (s, 1 H), 7.71 (bs, 1 H), 7.56 (tt, J = 6.9, 1.8 Hz, 1 H), 7.49 (tt, J = 6.6, 1.5 Hz,
2H), 7.11 (d, J = 7.8 Hz, 1 H), 6.94 (dd, J = 7.5, 0.9 Hz, 1 H), 2.34 (s, 3H), 2.28 (s, 3H) ppm. 13C
NMR (75 MHz, CDC13) 6: 136.7, 135.6, 135.1, 131.9, 130.43, 130.41, 128.9, 127.1, 126.2,
123.8, 21.3, 17.5 ppm. IR (neat, cm 1): 3253, 2922, 1644, 1618, 1580, 1530, 1489, 1501, 1308,
1290, 1029, 875, 808, 708, 602, 450. Anal. Calcd. for C15H15NO: C, 79.97; H, 6.71. Found: C,
79.81; H, 6.78.
OMe
O
OMe
N-(2,5-Dimethoxyphenyl)benzamide1 5 (Table 2, entry 5). Following the general
procedure, a mixture of 2,5-dimethoxychlorobenzene (143 tL, 1.0 mmol), benzamide (145 mg,
1.2 mmol), K3 P04 (297 mg, 1.4 mmol), Pd(OAc)2 (2.3 mg, 0.010 mmol), 3 (11 mg, 0.022 mmol),
H20 (0.7 cL, 0.04 mmol) and t-BuOH (2.0 mL) was heated to 110 0C for 1.5 h. The crude
product was purified by flash chromatography on silica gel (10% EtOAc in hexanes) to provide
the title compound as a white-tan solid (242 mg, 94%). Mp = 87 - 88 0C (lit. 82 - 84 C). 1H NMR
(300 MHz, CDC13 ) 6: 8.60 (bs, 1 H), 8.30 (d, J = 3.0 Hz, 1 H), 7.89 (dt, J = 6.6, 1.8 Hz, 2H), 7.58 -
7.46 (m, 3H), 6.83 (d, J = 9.0 Hz, 1 H), 6.61 (dd, J = 9.0, 3.0 Hz, 1 H), 3.87 (s, 3H), 3.82 (s, 3H)
ppm. 13C NMR (75 MHz, CDCl3) 6: 165.3, 154.0, 142.4, 135.2, 131.9, 128.9, 128.5, 127.1,
110.7, 108.9, 105.9, 56.3, 55.9 ppm. IR (neat, cm 1): 3427, 3335, 3057, 3000, 2937, 2955, 2833,
1668, 1601, 1532, 1498, 1478, 1464, 1423, 1268, 1220, 1202, 1179, 1164, 1047, 1024, 862,
797, 704, 679. Anal. Calcd. for C15H15NO3: C, 70.02; H, 5.88. Found: C, 69.89; H, 6.03.
Me 
.a 0
N
H
CF 3
N-p-Tolyl-4-(trifluoromethyl)benzamide 6 (Table 2, entry 6). Following the general
procedure, a mixture of 4-chlorotoluene (118 L, 1.0 mmol), 4-trifluoromethylbenzamide (227
mg, 1.2 mmol), K3PO4 (297 mg, 1.4 mmol), Pd(OAc)2 (2.3 mg, 0.010 mmol), 3 (11 mg, 0.022
mmol), H20 (0.7 tL, 0.04 mmol) and t-BuOH (2.0 mL) was heated to 110 *C for 2 h. The crude
product was dissolved in acetone, evaporated on to a small amount of silica gel, and purified by
flash chromatography on silica gel (gradient eluent: 10 - 30% EtOAc in hexanes) to provide the
title compound as a white solid (222 mg, 80%). Mp = 235 - 236 0C (lit. 236 - 238 C). 1H NMR
(300 MHz, (CD3)2SO) 6:10.4 (s, 1H), 8.14 (d, J= 7.8 Hz, 2H), 7.90 (d, J= 8.4 Hz, 2H), 7.66 (dd,
J = 8.4 Hz, 2H), 7.17 (d, J = 8.1 Hz, 2H), 2.28 (s, 3H) ppm. 13C NMR (75 MHz, (CD3)2 SO) 6:
164.2, 138.9, 136.4, 133.1, 131.5, 131.1, 129.5, 129.1, 128.6, 125.8, 125.4, 125.4, 120.5, 20.5
ppm (complexity is due to CF3-group). IR (neat, cm'): 3333, 2919, 1649, 1599, 1580, 1530,
1407, 1160, 1125, 861, 815, 770. Anal. Calcd. for C15H12 F3 NO: C, 64.51; H, 4.33. Found: C,
65.00; H, 4.68.
380
MeO 2C N
H
Methyl 3-(cyclopropanecarboxamido)benzoate (Table 2, entry 7). Following the
general procedure, a mixture of methyl 3-chlorobenzoate (139 tL, 1.0 mmol),
cyclopropanecarboxamide (102 mg, 1.2 mmol), K3PO 4 (297 mg, 1.4 mmol), Pd(OAc) 2 (2.3 mg,
0.010 mmol), 3 (11 mg, 0.022 mmol), H20 (0.7 1iL, 0.04 mmol) and t-BuOH (2.0 mL) was heated
to 110 *C for 5 h. The crude product was purified by flash chromatography on silica gel (gradient
eluent: 20 - 30% EtOAc in hexanes) to provide the title compound as a white solid (169 mg,
77%). Mp = 129 - 130 C. 1H NMR (300 MHz, CDC13) 6: 8.10 - 8.07 (m, 2H), 7.86 (d, J= 7.8 Hz,
1 H), 7.74 (d, J = 7.8 Hz, 1 H), 7.35 (t, J = 8.1 Hz, 1 H), 3.87 (s, 3H), 1.55 (sep, J = 3.9 Hz, 1 H),
1.08 (dt, J = 6.9, 3.9 Hz, 2H), 0.85 - 0.79 (m, 2H) ppm. 13C NMR (75 MHz, CDC 3) 6: 172.6,
167.0, 138.5, 130.8, 129.2, 125.1, 124.4, 120.7, 52.4, 15.7, 8.3 ppm. IR (neat, cm-1): 3294,
3013, 2952, 1724, 1663, 1596, 1548, 1488, 1431, 1395, 1302, 1273, 1241, 1197, 1178, 1107,
1082, 956, 755, 688. Anal. Calcd. for C12H13NO3: C, 65.74; H, 5.98. Found: C, 65.47; H, 6.10.
0
HIOMe /
N-(2-Methoxyphenyl)furan-2-carboxamide (Table 2, entry 8). Following general procedure A,
a mixture of 2-chloroanisole (127 [tL, 1.0 mmol), 2-furamide (133 mg, 1.2 mmol), K3PO 4 (297
mg, 1.4 mmol), Pd(OAc)2 (2.3 mg, 0.010 mmol), 3 (11 mg, 0.022 mmol), H20 (0.7 1tL, 0.04
mmol) and t-BuOH (2.0 mL) was heated to 110 0C for 2 h. The crude product was purified by
flash chromatography on silica gel (10% EtOAc in hexanes) to provide the title compound as a
white solid (208 mg, 96%). Mp = 123 - 124 *C. 1H NMR (300 MHz, CDC13) 6: 8.78 (bs, 1H), 8.50
(dd, J = 7.8, 1.8 Hz, 1 H), 7.52 (dd, J = 1.5, 0.6 Hz, 1 H), 7.22 (dd, J = 3.6, 0.9 Hz, 1 H), 7.08 (td, J
= 7.8, 1.8 Hz, 1H), 7.00 (tdd, J= 7.7, 1.5, 0.3 Hz, 1H), 6.91 (dd, J= 8.1, 1.5 Hz, 1H), 6.54 (dd, J
= 3.6, 1.8 Hz, 1 H) 3.93 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 156.0, 148.3, 148.1, 144.28,
144.26, 127.3, 124.0, 121.2, 119.8, 115.03, 114.98, 112.57, 112.53, 110.0, 55.9 ppm
(complexity of 13C NMR data is due to detection of rotamers). IR (neat, cm 1): 3410, 3141, 3118,
3019, 2979, 2943, 2843, 1672, 1606, 1584, 1534, 1524, 1462, 1437, 1251, 1226, 1216, 1105,
1020, 1012, 765, 750, 653, 604, 593. Anal. Calcd. for C12H11NO3: C, 66.35; H, 5.10,. Found: C,
66.16; H, 5.19.
S0
N
N-(2-Ethylphenyl)nicotinamide (Table 2, entry 9). Following the general procedure, a
mixture of 1-chloro-2-ethylbenzene (132 [L, 1.0 mmol), nicotinamide (147 mg, 1.2 mmol),
K3P04 (297 mg, 1.4 mmol), Pd(OAc) 2 (2.3 mg, 0.010 mmol), 3 (11 mg, 0.022 mmol), H20 (0.7
tL, 0.04 mmol) and t-BuOH (2.0 mL) was heated to 110 0C for 3 h. The crude product was
purified by flash chromatography on silica gel (80% EtOAc in hexanes) to provide the title
compound as a white solid (189 mg, 83%). Mp = 101 - 102.5 0C. 1H NMR (300 MHz, (CD3)2SO)
6: 10.1 (s, 1H), 9.13 (d, J= 2.1 Hz, 1H), 8.77 (dd, J= 4.8, 1.2 Hz, 1H), 8.31 (d, J= 7.8 Hz, 1H),
7.58 (dd, J = 8.1, 4.8 Hz, 1 H), 7.33 - 7.23 (m, 4H), 2.63 (q, J = 7.8 Hz, 2H), 1.13 (t, J = 7.8 Hz,
3H) ppm. 13C NMR (75 MHz, (CD3)2SO) 6: 164.3, 152.2, 148.7, 139.9, 135.4, 130.1, 128.6,
127.6, 126.8, 126.2, 123.6, 24.0, 14.2 ppm. IR (neat, cm-1): 3262, 3035, 2968, 2934, 2875,
1651, 1591, 1525, 1491, 1473, 1452, 1418, 1306, 1275, 1026, 759, 749, 706. HRMS (ESI)
Calcd. for C14H15N20 [M+H*]: 227.1179; Found: 227.1176.
MeO 0 S
N
H
N-(4-Methoxyphenyl)-2-(thiophen-2-yl)acetamide (Table 2, entry 10). Following the general
procedure, a mixture of 4-chloroanisole (122 tL, 1.0 mmol), 2-thiopheneacetamide (169 mg, 1.2
mmol), K3P04 (297 mg, 1.4 mmol), Pd(OAc) 2 (2.3 mg, 0.010 mmol), 3 (11 mg, 0.022 mmol),
H20 (0.7 [tL, 0.04 mmol) and t-BuOH (2.0 mL) was heated to 110 *C for 1.5 h. The crude
product was purified via the Biotage SP4 (silica-packed 25+M; 0 - 100% EtOAc/hexanes) to
provide the title compound as a pale yellow solid (223 mg, 90%). Mp = 122 - 123 C. 1H NMR
(400 MHz, CD3CN) 6: 8.35 (bs, 1 H), 7.43 (dt, J = 9.0, 3.4 Hz, 2H), 7.29 (dd, J = 4.4, 2.0 Hz, 1 H),
6.99 - 6.97 (m, 2H), 6.86 (dt, J = 9.0, 3.3 Hz, 2H), 3.82 (s, 2H), 3.75 (s, 3H) ppm. 13C NMR (100
MHz, CD3CN) 6: 168.9, 157.1, 138.1, 132.7, 127.7, 127.6, 125.9, 122.3, 114.8, 55.9, 38.4. IR
(neat, cm~1): 3329, 3106, 2960, 2834, 1659, 1609, 1544, 1511, 1454, 1407, 1310, 1242, 1173,
1025, 831, 702. HRMS (ESI) Calcd. for C13H14NO2S [M+H*]: 248.0740; Found: 248,0740.
0 S\
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N-(2-Ethylphenyl)-2-(thiophen-2-yl)acetamide (Table 2, entry 11). Following the
general procedure, a mixture of 1-chloro-2-ethylbenzene (132 [LL, 1.0 mmol), 2-
thiopheneacetamide (169 mg, 1.2 mmol), K3PO4 (297 mg, 1.4 mmol), Pd(OAc) 2 (2.3 mg, 0.010
mmol), 3 (11 mg, 0.022 mmol), H2 0 (0.7 [L, 0.04 mmol) and t-BuOH (2.0 mL) was heated to
110 0C for 3 h. The crude product was purified by flash chromatography on silica gel (20%
EtOAc in hexanes) to provide the title compound as a white solid (207 mg, 84%). Mp = 120.5 -
121.5 0C. 'H NMR (300 MHz, CDC13 ) 6: 7.92 (d, J = 7.8 Hz, 1H), 7.35- 7.33 (m, 1H), 7.20 (td, J
= 8.1, 2.1 Hz, 1H), 7.14 - 7.05 (m, 4H), 3.99 (s, 3H), 2.31 (q, J= 7.5 Hz, 2H), 0.99 (t, J= 7.5 Hz,
3H) ppm. 13C NMR (75 MHz, CDC13) 6: 168.0, 136.0, 134.8, 134.3, 128.8, 128.2, 127.8, 126.9,
126.4, 125.4, 122.6, 38.5, 24.5, 14.1 ppm. IR (neat, cm-1): 3257, 3034, 2963, 2930, 2871, 1655,
1585, 1532, 1447, 1405, 1342, 1256, 967, 752, 689. HRMS (ESI) Calcd. for C14H16NOS [M+H*]:
246.0947; Found: 246.0949.
MeO 2C NH ~
Methyl 3-(furan-2-carboxamido)benzoate (Table 2, entry 12). Following the general
procedure, a mixture of methyl 3-chlorobenzoate (139 [tL, 1.0 mmol), 2-furamide (133 mg, 1.2
mmol), K3PO4 (297 mg, 1.4 mmol), Pd(OAc) 2 (2.3 mg, 0.010 mmol), 3 (11 mg, 0.022 mmol),
H20 (0.7 [L, 0.04 mmol) and t-BuOH (2.0 mL) was heated to 110 0C for 1.5 h. The crude
product was purified by flash chromatography on silica gel (30% EtOAc in hexanes) to provide
the title compound as a white solid (237 mg, 97%). Mp = 83 - 85 C. 1H NMR (300 MHz, CDC 3)
6: 8.39 (bs, 1H), 8.19 (t, J= 1.8 Hz, 1H), 8.02 (ddd, J = 8.1, 2.4, 1.2 Hz, 1H), 7.78 (ddd, J = 7.8,
1.5, 0.9 Hz, 1 H), 7.45 (dd, J = 1.8, 0.8 Hz, 1 H), 7.39 (t, J = 8.1 Hz, 1 H), 7.21 (dd, J = 4.2, 0.8
Hz, 1H), 6.51 (dd, J = 3.6, 1.8 Hz, 1H), 3.87 (s, 3H) ppm. 13C NMR (75 MHz, CDC 3) ,6:166.7,
156.3, 147.5, 144.54, 144.51, 137.7, 130.9, 129.3, 125.5, 124.5, 120.9, 115.7, 115.6, 112.71,
112.67, 52.3 ppm (complexity of 13C NMR data is due to detection of rotamers). IR (neat, cm-1):
3325, 3130, 2952, 2845, 1722, 1668, 1598, 1583, 1542, 1489, 1473, 1441, 1323, 1294, 1265,
383
1230, 1165, 1118, 1083, 1012, 884, 755, 684, 594. HRMS (ESI) Calcd. for C13H12NO4 [M+H']:
246.0761; Found: 246.0771.
MeO 0
H
N
N-(4-Methoxyphenyl)nicotinamide (Table 2, entry 13). Following the general
procedure, a mixture of 4-chloroanisole (122 [tL, 1.0 mmol), nicotinamide (147 mg, 1.2 mmol),
K3 P0 4 (297 mg, 1.4 mmol), Pd(OAc) 2 (2.3 mg, 0.010 mmol), 3 (11 mg, 0.022 mmol), H20 (0.7
tL, 0.04 mmol) and t-BuOH (2.0 mL) was heated to 110 0C for 5 h. The crude product was
purified by flash chromatography on silica gel with EtOAc as eluent to provide the title
compound as a white solid (192 mg, 84%). Mp = 152 - 154 0C. 1H NMR (300 MHz, (CD3)2 SO) 6:
10.3 (s, 1H), 9.11 (dd, J = 2.1, 0.8 Hz, 1H), 8.75 (dd, J = 4.8, 1.5 Hz, 1H), 8.28 (ddd, J = 7.8,
2.1, 1.5 Hz, 1 H), 7.69 (d, J = 9.0 Hz, 2H), 7.55 (ddd, J = 7.8, 4.8, 0.9 Hz, 1 H), 6.95 (d, J = 9.0
Hz, 2H), 3.75 (s, 3H) ppm. 13C NMR (75 MHz, (CD3)2SO) 6: 163.6, 155.8, 152.0, 148.7, 135.4,
131.9, 130.7, 123.5, 122.0, 113.8, 55.2 ppm. IR (neat, cm~1): 3321, 3010, 2952, 2838, 1672,
1643, 1614, 1546, 1510, 1485, 1423, 1409, 1276, 1248, 1177, 1124, 1030, 824, 706. Anal.
Calcd. for C13H12N202: C, 68.41; H, 5.30. Found: C, 67.86; H, 5.26.
NN 3 N
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N-Phenyl-2-(pyridin-2-yl)acetamide (Table 2, entry 14). Following the general
procedure, a mixture of chlorobenzene (102 tL, 1.0 mmol), pyridine-2-acetamide (163 mg, 1.2
mmol), K3 P04 (297 mg, 1.4 mmol), Pd(OAc) 2 (2.3 mg, 0.010 mmol), 3 (11 mg, 0.022 mmol),
H20 (0.7 [L, 0.04 mmol) and t-BuOH (2.0 mL) was heated to 110 0C for 4 h. The crude product
was purified via the Biotage SP4 (silica-packed 25+M; 0 - 100% EtOAc/hexanes) to provide the
title compound as a white solid (178 mg, 84%). Mp = 135 - 136 *C. 'H NMR (400 MHz,
(CD 3)2SO) 6: 10.3 (s, 1 H), 8.45 (d, J = 4.4 Hz, 1 H), 7.75 (td, J = 7.6, 1.8 Hz, 1 H), 7.62 (d, J = 7.7
Hz, 2H), 7.40 (d, J = 7.8 Hz, 1 H), 7.32 - 7.25 (m, 3H), 7.04 (t, J = 7.4 Hz, 1 H), 3.85 (s, 2H) ppm.
1C NMR (100 MHz, (CD3)2 SO) 6: 168.2, 156.1, 149.0, 139.2, 136.6, 128.7, 124.0, 123.2, 121.9,
119.1, 45.9. IR (neat, cm-1): 3228, 3185, 3011, 2973, 1676, 1593, 1545, 1496, 1476, 1444,
1343, 1326, 1274, 1209, 1150, 1002, 780, 747, 685. HRMS (ESI) Calcd. for C13H13N20 [M+H*]:
213.1022; Found: 213.1025.
",N. 0
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N-(Pyridin-3-yl)cyclohexanecarboxamide 1 7 (Table 2, entry 15). Following the general
procedure, a mixture of 3-chloropyridine (95 tL, 1.0 mmol), cyclohexanecarboxamide (153 mg,
1.2 mmol), K3PO4 (297 mg, 1.4 mmol), Pd(OAc) 2 (2.3 mg, 0.010 mmol), 3 (11 mg, 0.022 mmol),
H20 (0.7 [tL, 0.04 mmol) and t-BuOH (2.0 mL) was heated to 110 *C for 12 h. The crude product
was purified by flash chromatography on silica gel with EtOAc as eluent followed by a second
purification via the Biotage SP4 (silica-packed 25+M; 70 - 100% EtOAc in hexanes) to provide
the title compound as a white solid (133 mg, 65%). Mp = 128.5 - 130.5 *C (lit. 134 - 135 C). 1H
NMR (300 MHz, (CD3)2SO) 6: 10.0 (s, 1H), 8.75 (d, J = 2.4 Hz, 1H), 8.22 (dd, J = 4.8, 1.5 Hz,
1 H), 8.05 (dt, J = 8.4, 1.8 Hz, 1 H), 7.30 (dd, J = 8.1, 1.5 Hz, 1 H), 2.34 (tt, J = 11.4, 3.3 Hz, 1 H),
1.82 - 1.62 (m, 5H), 1.46 - 1.14 (m, 5H) ppm. 13C NMR (75 MHz, CDC13) 6: 174.9, 143.9, 140.7,
136.1, 125.9, 123.5, 44.8, 29.1, 25.4, 25.2 ppm. IR (neat, cm-1): 3299, 3180, 3121, 3047, 2931,
2855, 1667,1600,1587,1543,1483,1450,1422,1335,1278,1196,1173,1131, 949, 896, 804,
761, 707, 635. HRMS (ESI) Calcd. for C12H17N20 [M+H*]: 205.1335; Found: 205.1326.
N 0
H I
N-(Pyridin-3-yl)furan-2-carboxamide (Table 2, entry 16). Following general procedure
A, a mixture of 3-chloropyridine (95 tL, 1.0 mmol), 2-furamide (133 mg, 1.2 mmol), K3P04 (297
mg, 1.4 mmol), Pd(OAc)2 (2.3 mg, 0.010 mmol), 3 (11 mg, 0.022 mmol), H20 (0.7 tL, 0.04
mmol) and t-BuOH (2.0 mL) was heated to 110 0C for 1.5 h. The crude product was purified by
flash chromatography on silica gel (gradient eluent: 50 - 100% EtOAc in CH2Cl 2) to provide the
title compound as a white-tan solid (181 mg, 96%). Mp = 142 - 143 0C. 1H NMR (300 MHz,
CD3OD) 6: 8.88 (dd, J = 2.4, 0.8 Hz, 1 H), 8.27 (dd, J = 4.5, 1.4 Hz, 1 H), 8.22 (ddd, J = 8.4, 2.4,
1.5 Hz, 1 H), 7.74 (dd, J = 1.8, 0.9 Hz, 1 H), 7.41 (ddd, J = 8.4, 4.8, 0.6 Hz, 1 H), 7.29 (dd, J = 3.6,
0.8 Hz, 1H), 6.63 (dd, J = 3.5, 1.7 Hz, 1H) ppm. 13C NMR (75 MHz, CD30D) b: 159.0, 148.5,
147.0, 145.5, 142.6, 137.0, 129.8, 125.2, 116.8, 113.4 ppm. IR (neat, cm~1): 3248, 3118, 3044,
385
1670, 1601, 1578, 1538, 1483, 1470, 1423, 1332, 1298, 1229, 1167, 1012, 884, 802, 756, 706,
595. HRMS (ESI) Calcd. for Cj0H9N202 [M+H*]: 189.0659; Found: 189.0661.
X-ray Crystal Structure Data for 3:
Table 1. Crystal data and structure refinement for BF2147.
Identification code bf2l 47
Empirical formula C31 H49 02 P
Formula weight 484.67
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Orthorhombic
Space group Pbca
Unit cell dimensions a = 18.3122(6)
b = 13.7633(4)
c = 22.7718(7),
Volume 5739.3(3) A3
a= 900.
@= 90*.
y = 900 .
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 25.000
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(l)]
R indices (all data)
Largest diff. peak and hole
1.122 Mg/m3
0.120 mm-1
2128
0.25 x 0.20 x 0.15 mm3
1.79 to 30.03*.
-25<=h<=25, -19<=k<=1 9, -32<=<=32
149587
8399 [R(int) = 0.0501]
100.0 %
Semi-empirical from equivalents
0.9822 and 0.9706
Full-matrix least-squares on F2
8399/0/321
1.045
R1 = 0.0360, wR2 = 0.0901
R1 = 0.0469, wR2 = 0.0985
0.444 and -0.237 e.A-3
386
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x
103)
for BF2147. U(eq) is defined as one third of the trace of the orthogonalized UUi tensor.
x y z U(eq)
P(1)
0(1)
0(2)
C(1)
C(2)
C(3)
C(4)
C(5)
C(6)
C(7)
C(8)
C(9)
C(10)
C(11)
C(12)
C(13)
C(14)
C(15)
C(16)
C(17)
C(18)
C(19)
C(20)
C(21)
C(22)
C(23)
C(24)
C(25)
C(26)
C(27)
1071(1)
-508(1)
-354(1)
176(1)
-506(1)
-1136(1)
-1100(1)
-438(1)
196(1)
860(1)
896(1)
1516(1)
2101(1)
2045(1)
1433(1)
277(1)
-153(1)
546(1)
2782(1)
2782(1)
2899(1)
1367(1)
2087(1)
1045(1)
1051(1)
1766(1)
396(1)
1063(1)
1120(1)
832(1)
8411(1)
8541(1)
9460(1)
8633(1)
8714(1)
8966(1)
9209(1)
9165(1)
8820(1)
8653(1)
7828(1)
7688(1)
8328(1)
9155(1)
9338(1)
7090(1)
7293(1)
6030(1)
8165(1)
7206(1)
9004(1)
10303(1)
10666(1)
11072(1)
7082(1)
6836(1)
6698(1)
6564(1)
9179(1)
8771(1)
2507(1)
1992(1)
4345(1)
2875(1)
2585(1)
2887(1)
3480(1)
3773(1)
3488(1)
3868(1)
4236(1)
4586(1)
4587(1)
4234(1)
3886(1)
4302(1)
4868(1)
4318(1)
4959(1)
5298(1)
5391(1)
3567(1)
3307(1)
3983(1)
2304(1)
1982(1)
1957(1)
2901(1)
1809(1)
1225(1)
12(1)
18(1)
17(1)
12(1)
14(1)
15(1)
15(1)
13(1)
12(1)
12(1)
14(1)
15(1)
15(1)
15(1)
13(1)
17(1)
24(1)
22(1)
17(1)
24(1)
29(1)
16(1)
24(1)
21(1)
15(1)
21(1)
21(1)
20(1)
16(1)
19(1)
C(28)
C(29)
C(30)
C(31)
Table 3. Bond lengths [A] and angles [0] for BF2147.
P(1)-C(1)
P(1)-C(22)
P(1)-C(26)
0(1)-C(2)
0(1)-C(30)
0(2)-C(5)
O(2)-C(31)
C(1)-C(2)
C(1)-C(6)
C(2)-C(3)
C(3)-C(4)
C(4)-C(5)
C(5)-C(6)
C(6)-C(7)
C(7)-C(1 2)
C(7)-C(8)
C(8)-C(9)
C(8)-C(1 3)
C(9)-C(1 0)
C(10)-C(1 1)
C(1 0)-C(1 6)
C(1 1)-C(12)
C(1 2)-C(1 9)
C(1 3)-C(1 4)
C(1 3)-C(1 5)
C(1 6)-C(1 7)
C(1 6)-C(1 8)
C(1 9)-C(20)
1.8660(10)
1.8877(10)
1.9113(10)
1.3716(11)
1.4244(12)
1.3741(11)
1.4324(12)
1.4164(13)
1.4207(13)
1.3882(13)
1.3914(14)
1.3852(13)
1.4117(13)
1.5104(12)
1.4117(13)
1.4123(13)
1.4010(13)
1.5282(13)
1.3873(14)
1.3962(14)
1.5237(13)
1.3944(13)
1.5198(13)
1.5361(15)
1.5402(15)
1.5290(15)
1.5331(15)
1.5289(14)
760(1)
1948(1)
-1178(1)
-898(1)
10168(1)
9355(1)
8658(1)
10107(1)
1928(1)
1731(1)
1682(1)
4571(1)
19(1)
20(1)
19(1)
19(1)
388
C(1 9)-C(21)
C(22)-C(24)
C(22)-C(25)
C(22)-C(23)
C(26)-C(27)
C(26)-C(28)
C(26)-C(29)
C(1)-P(1)-C(22)
C(1)-P(1)-C(26)
C(22)-P(1)-C(26)
C(2)-O(1)-C(30)
C(5)-O(2)-C(31)
C(2)-C(1)-C(6)
C(2)-C(1)-P(1)
C(6)-C(1)-P(1)
0(1)-C(2)-C(3)
0(1)-C(2)-C(1)
C(3)-C(2)-C(1)
C(2)-C(3)-C(4)
C(5)-C(4)-C(3)
0(2)-C(5)-C(4)
0(2)-C(5)-C(6)
C(4)-C(5)-C(6)
C(5)-C(6)-C(1)
C(5)-C(6)-C(7)
C(1)-C(6)-C(7)
C(1 2)-C(7)-C(8)
C(1 2)-C(7)-C(6)
C(8)-C(7)-C(6)
C(9)-C(8)-C(7)
C(9)-C(8)-C(13)
C(7)-C(8)-C(13)
C(1 0)-C(9)-C(8)
C(9)-C(1 0)-C(1 1)
C(9)-C(1 0)-C(1 6)
1.5365(15)
1.5309(14)
1.5355(14)
1.5389(14)
1.5358(14)
1.5359(14)
1.5453(14)
104.56(4)
108.94(4)
109.46(4)
118.07(8)
116.49(8)
117.74(8)
125.30(7)
116.70(7)
121.91(9)
116.58(8)
121.50(9)
120.04(9)
119.90(9)
122.90(9)
116.24(8)
120.86(9)
119.45(8)
116.79(8)
123.76(8)
119.00(8)
120.97(8)
119.95(8)
119.06(9)
116.97(8)
123.89(8)
122.61(9)
117.44(9)
122.55(9)
C(1 1)-C(10)-C(1 6) 120.01(9)
C(12)-C(11)-C(10) 122.16(9)
C(1 1)-C(12)-C(7) 119.59(9)
C(11 )-C(1 2)-C(1 9) 119.55(8)
C(7)-C(1 2)-C(19) 120.71(8)
C(8)-C(13)-C(14) 110.00(8)
C(8)-C(1 3)-C(1 5) 113.26(9)
C(1 4)-C(1 3)-C(1 5) 108.46(9)
C(1 0)-C(1 6)-C(1 7) 114.11(9)
C(1 0)-C(1 6)-C(1 8) 111.14(9)
C(1 7)-C(1 6)-C(1 8) 109.04(9)
C(1 2)-C(1 9)-C(20) 113.71(9)
C(12)-C(19)-C(21) 109.78(8)
C(20)-C(19)-C(21) 110.23(9)
C(24)-C(22)-C(25) 107.89(8)
C(24)-C(22)-C(23) 110.19(8)
C(25)-C(22)-C(23) 107.96(8)
C(24)-C(22)-P(1) 118.43(7)
C(25)-C(22)-P(1) 103.49(7)
C(23)-C(22)-P(1) 108.28(7)
C(27)-C(26)-C(28) 109.23(8)
C(27)-C(26)-C(29) 107.20(8)
C(28)-C(26)-C(29) 107.57(9)
C(27)-C(26)-P(1) 120.10(7)
C(28)-C(26)-P(1) 108.83(7)
C(29)-C(26)-P(1) 103.15(6)
Symmetry transformations used to generate equivalent atoms:
Table 4. Anisotropic displacement parameters (A2 x 103 )for BF2147. The anisotropic
displacement factor exponent takes the form: -2n2 [ h2 a*2 Ul1 + ... + 2 h k a* b* U1 2 ]
U1i U22 U33 U23 U13 U12
P(1)
0(1)
0(2)
C(1)
C(2)
C(3)
C(4)
C(5)
C(6)
C(7)
C(8)
C(9)
C(10)
C(11)
C(12)
C(13)
C(14)
C(15)
C(16)
C(17)
C(18)
C(19)
C(20)
C(21)
C(22)
C(23)
C(24)
C(25)
C(26)
C(27)
C(28)
10(1)
14(1)
16(1)
11(1)
13(1)
11(1)
11(1)
13(1)
10(1)
11(1)
13(1)
15(1)
12(1)
12(1)
12(1)
16(1)
17(1)
28(1)
12(1)
17(1)
25(1)
16(1)
22(1)
25(1)
16(1)
20(1)
20(1)
23(1)
14(1)
18(1)
22(1)
15(1)
29(1)
24(1)
14(1)
16(1)
19(1)
18(1)
16(1)
13(1)
16(1)
16(1)
17(1)
20(1)
18(1)
15(1)
19(1)
29(1)
18(1)
24(1)
31(1)
33(1)
16(1)
27(1)
17(1)
15(1)
22(1)
19(1)
17(1)
20(1)
27(1)
19(1)
11(1)
12(1)
12(1)
13(1)
13(1)
16(1)
16(1)
12(1)
13(1)
10(1)
12(1)
13(1)
12(1)
15(1)
12(1)
17(1)
25(1)
22(1)
15(1)
23(1)
28(1)
15(1)
25(1)
22(1)
16(1)
22(1)
22(1)
20(1)
13(1)
13(1)
17(1)
0(1)
-3(1)
-3(1)
0(1)
-1(1)
-1(1)
0(1)
0(1)
1(1)
-1(1)
-1(1)
1(1)
-2(1)
-1(1)
-1(1)
4(1)
7(1)
4(1)
0(1)
7(1)
-9(1)
2(1)
7(1)
0(1)
-1(1)
-2(1)
-4(1)
2(1)
2(1)
1(1)
3(1)
0(1)
-4(1)
0(1)
0(1)
-1(1)
-2(1)
2(1)
1(1)
-1(1)
0(1)
0(1)
-1(1)
-1(1)
0(1)
1(1)
-3(1)
3(1)
-5(1)
-3(1)
-4(1)
-13(1)
-2(1)
3(1)
-2(1)
0(1)
3(1)
-2(1)
0(1)
1(1)
1(1)
1(1)
1(1)
4(1)
5(1)
1(1)
0(1)
0(1)
1(1)
0(1)
-1(1)
1(1)
0(1)
1(1)
2(1)
-2(1)
0(1)
-4(1)
-3(1)
-5(1)
2(1)
3(1)
4(1)
-2(1)
-6(1)
1(1)
2(1)
5(1)
-1(1)
2(1)
1(1)
3(1)
4(1)
C(29)
C(30)
C(31)
16(1)
18(1)
18(1)
26(1)
24(1)
22(1)
19(1)
17(1)
17(1)
5(1)
-4(1)
-3(1)
2(1)
-7(1)
2(1)
-1(1)
3(1)
4(1)
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 103)
for BF2147.
x y z U(eq)
H(3)
H(4)
H(9)
H(11)
H(13)
H(14A)
H(14B)
H(14C)
H(15A)
H(15B)
H(15C)
H(1 6)
H(17A)
H(17B)
H(17C)
H(18A)
H(1 8B)
H(18C)
H(19)
H(20A)
H(20B)
H(20C)
H(21A)
H(21B)
H(21 C)
-1593
-1529
1537
2436
-61
175
-547
-363
877
127
805
3210
2383
3249
2712
2931
3353
2488
1016
2417
1992
2314
572
978
1378
8972
9404
7132
9608
7166
7246
6815
7948
5915
5590
5911
8153
7209
7129
6665
9617
8898
9034
10213
10860
11225
10145
10846
11683
11176
2689
3683
4833
4231
3960
5206
4908
4850
3987
4289
4687
4687
5585
5502
5023
5174
5610
5666
3236
3625
3052
3077
4131
3769
4313
18
18
18
18
21
35
35
35
34
34
34
20
35
35
35
43
43
43
19
37
37
37
32
32
32
H(23A)
H(23B)
H(23C)
H(24A)
H(24B)
H(24C)
H(25A)
H(25B)
H(25C)
H(27A)
H(27B)
H(27C)
H(28A)
H(28B)
H(28C)
H(29A)
H(29B)
H(29C)
H(30A)
H(30B)
H(30C)
H(31A)
H(31B)
H(31C)
1820
2181
1754
444
379
-55
606
1475
1115
307
1087
918
864
956
231
2197
2141
2031
-1537
-1096
-1361
-980
-731
-1355
6129
7107
7115
5994
7015
6839
6695
6803
5862
8645
8164
9244
10610
10442
10082
8731
9683
9764
8191
8542
9320
10635
10379
9751
1954
2199
1586
1905
1572
2173
3110
3134
2840
1259
1133
911
1601
2292
1966
1679
2080
1385
1832
1263
1740
4290
4946
4632
31
31
31
31
31
31
30
30
30
29
29
29
29
29
29
30
30
30
29
29
29
28
28
28
Table 6. Torsion angles [0] for BF2147.
C(22)-P(1)-C(1)-C(2)
C(26)-P(1)-C(1)-C(2)
C(22)-P(1)-C(1)-C(6)
C(26)-P(1)-C(1)-C(6)
C(30)-O(1)-C(2)-C(3)
C(30)-O(1)-C(2)-C(1)
C(6)-C(1)-C(2)-O(1)
P(1)-C(1)-C(2)-O(1)
C(6)-C(1)-C(2)-C(3)
P(1)-C(1)-C(2)-C(3)
0(1)-C(2)-C(3)-C(4)
C(1)-C(2)-C(3)-C(4)
C(2)-C(3)-C(4)-C(5)
C(31)-O(2)-C(5)-C(4)
C(31)-0(2)-C(5)-C(6)
C(3)-C(4)-C(5)-O(2)
C(3)-C(4)-C(5)-C(6)
O(2)-C(5)-C(6)-C(1)
C(4)-C(5)-C(6)-C(1)
O(2)-C(5)-C(6)-C(7)
C(4)-C(5)-C(6)-C(7)
C(2)-C(1)-C(6)-C(5)
P(1)-C(1)-C(6)-C(5)
C(2)-C(1)-C(6)-C(7)
P(1)-C(1)-C(6)-C(7)
C(5)-C(6)-C(7)-C(1 2)
C(1)-C(6)-C(7)-C(1 2)
C(5)-C(6)-C(7)-C(8)
C(1)-C(6)-C(7)-C(8)
C(1 2)-C(7)-C(8)-C(9)
C(6)-C(7)-C(8)-C(9)
C(1 2)-C(7)-C(8)-C(1 3)
C(6)-C(7)-C(8)-C(13)
C(7)-C(8)-C(9)-C(1 0)
-75.34(9)
41.59(9)
110.53(8)
-132.53(7)
2.04(14)
-177.33(9)
179.28(8)
5.21(13)
-0.10(14)
-174.16(8)
-174.98(9)
4.36(15)
-2.38(15)
-20.28(14)
158.89(9)
175.26(9)
-3.87(15)
-171.07(8)
8.11(14)
10.02(13)
-170.79(9)
-6.02(13)
168.56(7)
172.81(9)
-12.61(12)
-100.67(11)
80.48(12)
75.89(12)
-102.96(11)
-3.20(14)
-179.83(8)
173.64(9)
-2.99(14)
-0.08(15)
C(1 3)-C(8)-C(9)-C(1 0)
C(8)-C(9)-C(10)-C(1 1)
C(8)-C(9)-C(1 0)-C(1 6)
C(9)-C(1 0)-C(11 )-C(l 2)
C(1 6)-C(l 0)-C( 11)-C(l 2)
C(1 0)-C( 11)-C(l 2)-C(7)
C(1 0)-C( 11)-C(l 2)-C(l 9)
C(8)-C(7)-C(l 2)-C(l 1)
C(6)-C(7)-C(12)-C(1 1)
C(8)-C(7)-C(l 2)-C(l 9)
C(6)-C(7)-C(1 2)-C(1 9)
C(9)-C(8)-C(1 3)-C(1 4)
C(7)-C(8)-C(1 3)-C(1 4)
C(9)-C(8)-C(1 3)-C(1 5)
C(7)-C(8)-C(1 3)-C(1 5)
C(9)-C(1 0)-C(1 6)-C(1 7)
C(11)-C(10)-C(1 6)-C(1 7)
C(9)-C(1 0)-C(1 6)-C(1 8)
C(11 )-C(1 0)-C(1 6)-C(1 8)
C(11)-C(12)-C(1 9)-C(20)
C(7)-C(1 2)-C(1 9)-C(20)
C(11 )-C(1 2)-C(1 9)-C(21)
C(7)-C(1 2)-C(1 9)-C(21)
C(1)-P(1)-C(22)-C(24)
C(26)-P(1)-C(22)-C(24)
C(1)-P(1)-C(22)-C(25)
C(26)-P(1)-C(22)-C(25)
C(1)-P(1)-C(22)-C(23)
C(26)-P(1)-C(22)-C(23)
C(1)-P(1)-C(26)-C(27)
C(22)-P(1)-C(26)-C(27)
C(1)-P(1)-C(26)-C(28)
C(22)-P(1)-C(26)-C(28)
C(1)-P(1)-C(26)-C(29)
C(22)-P(1)-C(26)-C(29)
-177.14(9)
2.07(14)
-178.79(9)
-0.77(14)
-179.93(9)
-2.49(14)
173.03(9)
4.45(14)
-178.96(8)
-171.01(9)
5.58(13)
76.81(11)
-100.09(11)
-44.73(12)
138.36(10)
3.73(14)
-177.15(9)
-120.06(11)
59.06(12)
39.86(13)
-144.68(9)
-84.14(11)
91.32(11)
52.33(9)
-64.25(9)
-66.96(7)
176.47(6)
178.63(7)
62.05(8)
-88.88(8)
24.90(9)
37.99(8)
151.76(7)
152.02(7)
-94.21(7)
Symmetry transformations used to generate equivalent atoms:
Table 7. Hydrogen bonds for BF2147 [A and 0].
D-H... A d(D-H) d(H.. .A) d(D... A) <(DHA)
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Chapter 6.
The Pd-Catalyzed Conversion of Aryl
Chlorides, Triflates, and Nonaflates to Nitroaromatics
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6.1 Introduction
Aromatic nitro compounds are of great importance to a variety of disciplines. They can
be found in an array of pharmaceuticals,' dyes, 2 and materials.3 Moreover, they are an
important entity in synthesis and can participate in a range of useful transformations. 4 Most
commonly, nitrobenzenes are synthesized via electrophilic aromatic substitution using HNO 3
and a strong acid or with dinitrogen pentoxide4 However, these methods suffer from issues of
poor regioselectivity and imperfect functional group tolerance. Further, the application of these
reactions is particularly problematic for the nitration of heteroaromatics. More recently, Prakash
and Olah disclosed a method for the conversion of aryl boronic acids to aryl nitro compounds.5
This was followed by a report from Saito disclosing a copper catalyst for the transformation of
aryl iodides to nitrobenzenes.6 These processes were important advances in this field and
provided complimentary nitration protocols to known chemistry; however, the substrate scope of
these reactions was limited and did not include heterocycles.
Herein, we report a general Pd catalyst for the conversion of aryl chlorides, triflates, and
nonaflates to nitroaromatics.7 This protocol circumvents issues of regioselectivity and proceeds
efficiently under weakly basic conditions, allowing for excellent functional group compatibility.
Moreover, it enables the formation of nitroarenes that cannot be accessed effectively by other
means, most notably heteroaryl nitro-substituted compounds. Mechanistic insight into the
"transmetallation" step of this catalytic process is also provided.
Me
OMe OMe Me Me
MeO P(t-Bu)2  MeO PCy2  Me P(t-Bu) 2  P(t-Bu) 2  PCy 2
i-Pr i-Pr i-Pr i-Pr i-Pr i-Pr i-Pr i-Pr i-Pr i-Pr
i-Pr i-Pr i-Pr i-Pr i-Pr
1 2 3 4 5
(t-BuXPhos) (XPhos)
Figure 1. Biarylphosphine ligands.
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6.2 Results and Discussion
We began our studies by examining the reaction of 4-chloro-n-butylbenzene with
commercially available nitrite sources. We hypothesized that a catalyst based on ligand 1
(Figure 1), which we have shown to be effective in amidation reactions of aryl chlorides,5 would
be useful for this transformation as we felt that N-Pd bond formation would be difficult as in the
latter transformation. Using 0.5 mol % Pd2(dba)3, 1.2 mol % 1, and sodium nitrite in t-BuOH 26%
of the desired 4-nitro-n-butylbenzene was obtained (Table 1). Due to the fact that the sodium
nitrite is sparingly soluble in t-BuOH, we reasoned that use of a phase transfer catalyst might be
beneficial. Adding 5 mol % tris(3,6-dioxaheptyl)amine (TDA) improved the yield to 52%,
whereas the use of other phase transfer catalysts did not have a positive influence on the
outcome of the reaction.
Catalysts based on other biarylphosphine ligands (2,8 3,9 4, and 5)10 gave little to no
desired product in these reactions. This demonstrates that in ligand 1 the di-t-butylphosphino
group, as well as the methoxy substituent ortho to the phosphine are critical to the reactivity of
this catalyst system.
Table 1. Pd-catalyzed formation of 4-nitro-n-butylbenzene
CI + NN 2  0.5 mol % Pd2(dba)3  N
n-u I + NaNO2 1. 0o 1 Ligand n-uoO
n-Buj:: t-BuoH, 110 'C n-Buj:
Entry L 5% PTC Yielda Entry L 5% PTC Yielda
1 1 -- 26% 6 3 TDA 10%
2 1 TDA 52% 7 4 TDA 0%
3 1 TBACI 3% 8 5 TDA 0%
4 1 15-C-5 33% 9 1 -- 2
5 2 TDA 0% 10 1 TDA 99%C
[a] 4-chloro-n-butylbenzene (1 mmol), NaNO 2 (2.0 mmol), Pd2(dba) 3 (0.5 mol %), ligand (1.2 mol
%), t-BuOH (2 mL), 110 *C, 24 h; GC yields. [b] (TBA)N0 2 was used. [c] Reaction temperature
was 130 *C.
We observed that as the amount of TDA was increased from 0 - 5 mol% the yield of the
reaction also increased. However, the amount of product generated in these reactions dropped
quickly when more than 5% of the TDA was used (Figure 2).11 We reasoned that higher
concentrations of nitrite in solution could oxidize the Pd(0) or ligand, which would explain the
lower yields at higher loadings of TDA. To test this postulate we ran the reaction with a soluble
source of nitrite (tetrabutylammonium nitrite) and obtained only 2% 4-nitro-n-butylbenzene
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(Table 1, entry 9). These studies show that having the optimal amount of nitrite in solution is
essential to the outcome of the reaction.
NaNO2 0.5 mol % Pd2(dba)3  N
n-Buj c + NaNO2 t-DA o n-Bu NO
60
40
>' 20fU
0 -
0
0 25 50 75
TDA (moll%)
Figure 2. Effect of TDA on the yield for the Pd-catalyzed formation of 4-nitro-n-butylbenzene.
By increasing the reaction temperature, we were able to convert 4-chloro-n-
butylbenzene to the desired nitro product in virtually quantitative yield (Table 1, entry 11). Using
these conditions we set out to explore the scope of the Pd-catalyzed transformation of aryl
chlorides to nitro aromatics using a catalyst based on ligand 1 (Table 2). Ortho substituents, as
well as acid-sensitive functional groups, such as an acetal, pyrrole, and free alcohol, were all
well tolerated. Nitro arenes containing electron-withdrawing groups or amines in the para
position and electron-donating substituents in the meta position were synthesized in high yields
with this method; these compounds cannot be efficiently formed through traditional nitration
protocols. Nitro heteroaromatics could also be prepared in good to excellent yields. For
example, 5- and 7-chloroindole were transformed to the corresponding nitroindoles in good
yields without the need of a protecting group. This catalyst system is complimentary to current
nitration protocols and allows for the synthesis of nitro aromatic compounds that are not readily
accessible via other means.
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Table 2. Conversion of aryl chlorides nitro aromatics.a
C1 0.5 mol % Pd2(dba)3  N
R + NaNO2 1.2 mol % 1 R
5 mol % TDA, t-BuOH
130 *C, 24 h
NO2  Me N O
N O2 N 2  O NO2  NO 2  NO 2
I Me 0
n-Bu Me CN Ph 0
87% 75% 99% 9 9 %b 76%b 98%
HO NO2 NO2 MeO ? NO2  r NO2
(N
NMe 2  OMe 0
71%b 98% 84% 99%
NO2  N NO2  NO2 N2
(N )_lH N
97% 74% 7 7 %b 81 %b
[a] ArCI (1 mmol), NaNO 2 (2.0 mmol), Pd2(dba)3 (0.5 mol %), 1 (1.2 mol %), t-BuOH (2 mL), 130
0C, 24 h; isolated yields, average of 2 runs. [b] Pd2(dba)3 (2.5 mol %), 1 (6 mol %).
Based on the broad scope this catalyst displayed for the nitration of aryl chlorides, we
decided to explore nitrations of aryl bromides and iodides. Under the optimized reaction
conditions 3,5-dimethylbromobenzene (6) and 3,5-dimethyliodobenzene (7) gave 44% and 0%
of the desired product, respectively (Figure 3). In order to aid our interpretation of this result a
competition experiment between the aryl bromide or iodide and aryl chloride were performed. In
experiment A, where a 1:1 mixture of 6 and 8 was subjected to the reaction conditions, 44% of
the aryl bromide-derived and none of the aryl chloride-derived coupling products were observed.
In experiment B, where a 1:1 mixture of 7 and 8 was used, no nitroaromatic products were
formed. These results demonstrate that the catalyst is undergoing oxidative addition with the
aryl iodide or bromide faster than with the aryl chloride and that transmetallation is the slow
(problematic) step for these processes.'2 Moreover, this establishes that the rate of
transmetallation follows the order of CI>Br>l in these reactions.
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Me 0.5 mol % Pd2(dba)31.2 mol % 1
5 mol % TDA, t-BuOH
Me 130 *C, 24 h
x
Me Me
6, X = Br
7, X = I
cI
+ K
n-Bu
8
Me
NO2  X = Br; 44%X=I; 0%
Me
NaNO 20.5 mol % Pd2(dba)3  NO21.2 mol % 1
5 mol % TDA, t-BuOH
130 *C, 24 h Me Me
Experiment A, X = Br; 44%
Experiment B, X = I; 0%
NO2
n-Bu
0%
0%
Figure 3. Reactions of aryl bromides and iodides.
Based on these results and previous findings in our group,10 we postulated that reactions
of aryl triflates and nonaflates would proceed with an accelerated rate of transmetallation and be
suitable substrates for these reactions. Using a catalyst comprised of 1 and Pd2(dba)3, an array
of aryl nonaflates and triflates were converted to product in good to excellent yields (Table 3),
including those containing esters and nitriles; heteroaryl triflates were also transformed in high
efficiencies.
Table 3. Conversion of aryl triflates and nonaflates to nitro aromatics.a
X 0.5 mol % Pd2(dba)3  NO2
R- + NaNO2 1.2 mol % 1 R
5 mol % TDA, t-BuOH
130 *C, 24 h
Me NO2  N MeO NO2
Me t-Bu NON2
Me OMe
95% 94% 97% 87%
(X = OTf) (X = ONf) (X = OTf) (X = OTf)
N NO2
NCO 
0
76%b
(X = OTf)
NeONO2MeO
0
85%(X = ONf)
N02
N
94%
(X = OTf)
NO 2
/ \NH
7 6 %b
(X = OTf)
[a] ArX (1 mmol), NaNO2 (2.0 mmol), Pd2(dba)3 (0.5 mol %), 1 (1.2 mol %), t-BuOH (2 mL), 130
0C, 24 h; isolated yields, average of 2 runs. [b] Pd2(dba)3 (2.5 mol %), 1 (6 mol %).
6.3 Conclusion
In summary, an effective catalyst for the conversion of aryl chlorides, triflates, and
nonaflates to nitroaromatics has been developed. This method is complimentary to previous
nitration protocols and evades issues of regioselectivity and functional group compatibility. It
was also shown that the rate of transmetallation follows the order of CI>Br>l in these reactions.
Further studies to better understand the mechanism of the reaction and extend its scope to aryl
iodides, bromides, and tosylates are currently underway in our laboratories.
6.4 Experimental
General Reagent Information: All reactions were carried out under an argon
atmosphere. The tert-butanol was purchased from Aldrich Chemical Company in Sure-Seal
bottles and were used as received. Aryl halides and aryl triflates were purchased from Aldrich
Chemical Co., Alfa Aesar, Acros Organics or TCI America and used as received without further
purification. Aryl triflates and aryl nonaflates that were not commercially available were
synthesized using literature procedures.13 Sodium nitrite and tetrabutylammonium nitrite were
purchased from Aldrich Chemical Company. Tris(3,5-dioxaheptyl)amine was purchased from
Alfa Aesar and was used as received. Ligands 1,9 2, and 310 were synthesized using literature
procedures. Ligands 4 and 5 were purchased from Strem Chemicals and the Pd2(dba)3 was
purchased from Aldrich Chemical Company. Flash chromatography was performed using a
Biotage SP4 instrument with prepacked silica cartridges.
General Analytical Information: All compounds were characterized by 'H NMR, 13C
NMR, IR spectroscopy, as well as, in most instances, elemental analysis. Copies of the 1H and
13C spectra can be found at the end of the Supporting Information. Nuclear Magnetic Resonance
spectra were recorded on a Varian 300 MHz instrument and a Varian 500 MHz instrument. All
1H NMR experiments are reported in 6 units, parts per million (ppm), and were measured
relative to the signals for residual chloroform (7.26 ppm) in the deuterated solvent, unless
otherwise stated. All 13C NMR spectra are reported in ppm relative to deuterochloroform (77.23
ppm), unless otherwise stated, and all were obtained with 'H decoupling. All IR spectra were
taken on a Perkin - Elmer 2000 FTIR. All GC analyses were performed on a Agilent 6890 gas
chromatograph with an FID detector using a J & W DB-1 column (10 m, 0.1 mm l.D.). Elemental
analyses were performed by Atlantic Microlabs Inc., Norcross, GA.
General Procedure for Table 1 and Figure 1: An oven-dried sealable Schlenk tube,
which was equipped with a magnetic stir bar and fitted with a rubber septum, was charged with
the Pd2(dba)3 (0.5 mol %), ligand (1.2 mol %), and nitrite source (2.0 mmol). The vessel was
evacuated and backfilled with argon (this process was repeated a total of 3 times) and then the
4-chloro-n-butylbenzene (169 pL, 1.0 mmol), phase transfer catalyst (0-100 mol%), and t-BuOH
(2 mL) were added via syringe. The Schlenk tube was sealed with a Teflon screw cap and the
solution was heated to 110 *C for 24 h. The reaction mixture was then cooled to room
temperature, diluted with EtOAc, and washed with water. Dodecane was then added as an
internal standard and the reaction was analyzed by GC.
Note: Use of KNO 2 under optimal conditions gave a 10% GC yield for the above reaction.
General Procedure for Tables 2 and 3: An oven-dried sealable Schlenk tube, which
was equipped with a magnetic stir bar and fitted with a rubber septum, was charged with the
Pd2(dba)3 (0.5 - 2.5 mol %), 1 (1.2 - 6 mol %), and sodium nitrite (138 mg, 2.0 mmol). The
vessel was evacuated and backfilled with argon (this process was repeated a total of 3 times)
and then the aryl halide or pseudo halide (1.0 mmol), tris(3,5-dioxaheptyl)amine (16 pL, 5
mol%), and t-BuOH (2 mL) were added via syringe (aryl chlorides, triflates, or nonaflates that
were solids at room temperature were added with the catalyst and sodium nitrite). The Schlenk
tube was sealed with a Teflon screw cap and the solution was heated to 130 0C for 24 h. The
reaction mixture was then cooled to room temperature, diluted with ethyl acetate, washed with
water, concentrated in vacuo, and purified via the Biotage SP4 (silica-packed 50 or 100 g snap
cartridge).
Experimental Procedures for Examples Described in Table 2
NO2
n-Bu
1-Butyl-4-nitrobenzene (Table 2). Following the general procedure, a mixture of 4-
chloro-n-butylbenzene (169 pL, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3 (4.5
mg, 0.5 mol%), 1 (6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-BuOH (2
mL) was heated to 130 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-
packed 50 g snap column; 0-25% EtOAc/hexanes) to provide the title compound as a yellow oil
(155 mg, 87%). 'H NMR (300 MHz, CDC13) 6: 8.11 (d, J= 8.7 Hz, 2H), 7.31 (d, J= 8.7 Hz, 2H),
2.70 (t, J = 7.5 Hz, 2H), 1.61 (pentet, J = 7.5 Hz, 2H), 1.36 (sextet, J = 7.5 Hz, 2H), 0.92 (t, J =
7.2 Hz, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 151.1, 146.4, 129.4, 123.8, 35.8, 33.3, 22.5,
14.1 ppm. IR (neat, cm-1): 3439, 2932, 2862, 1605, 1518, 1345, 1110, 856, 746, 697. Anal.
Calcd. for C10H13NO2: C, 67.02; H, 7.31. Found: C, 67.00; H, 7.40.
q NO2
NMe 2
N,N-Dimethyl-3-nitroaniline 4 (Table 2). Following the general procedure, a mixture of
N,N-dimethylamino-3-chlorobenzene (156 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol),
Pd2(dba)3 (4.5 mg, 0.5 mol%), 1 (6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%),
and t-BuOH (2 mL) was heated to 130 0C for 24 h. The crude product was purified via the
Biotage SP4 (silica-packed 50 g snap column; 0-50% EtOAc/hexanes) to provide the title
compound as a red solid (166 mg, 99%), mp = 53-56 'C (lit 56 - 58 C). 'H NMR (500 MHz,
CDC13) 6: 7.51 (d, J = 8.0 Hz, 1 H), 7.48 (s, 1 H), 7.33 (t, J = 8.0 Hz, 1 H), 6.96 (d, J = 8.0 Hz, 1 H),
3.04 (s, 6H) ppm. 13C NMR (75 MHz, CDC13 ) 6:151.0,129.8,117.8,110.8, 106.2, 40.5 ppm. IR
(neat, cm-1): 2908, 1620, 1568, 1529, 1342, 1232, 1067, 994, 875, 837, 732.
MeO NO2
OMe
1,3-Dimethoxy-5-nitrobenzene (Table 2). Following the general procedure, a mixture of
1,3-dimethoxy-5-chlorobenzene (172 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol),
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Pd2(dba)3 (4.5 mg, 0.5 mol%), 1 (6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%),
and t-BuOH (2 mL) was heated to 130 0C for 24 h. The crude product was purified via the
Biotage SP4 (silica-packed 50 g snap column; 0-40% EtOAc/hexanes) to provide the title
compound as a yellow solid (155 mg, 84%), mp = 87 - 89 *C. 1H NMR (300 MHz, CDC13) 6:
7.31 (d, J = 2.4 Hz, 2H), 6.70 (t, J = 2.4 Hz, 1 H), 3.83 (s, 6H) ppm. 13C NMR (75 MHz, CDCl3) 6:
161.1, 150.0, 107.3, 101.6, 56.1 ppm. IR (neat, cm 1): 2961, 1589, 1535, 1452, 1356, 1210,
1044, 854, 745, 665. Anal. Calcd. for C8H9NO4: C, 52.46; H, 4.95. Found: C, 52.90; H, 4.98.
Ph 
NO2
0
(4-Nitrophenyl)(phenyl)methanone (Table 2). Following the general procedure, a
mixture of 4-chlorobenzophenone (217 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol),
Pd2(dba)3 (4.5 mg, 0.5 mol%), 1 (6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%),
and t-BuOH (2 mL) was heated to 130 0C for 24 h. The crude product was purified via the
Biotage SP4 (silica-packed 50 g snap column; 0-50% EtOAc/hexanes) to provide the title
compound as a white solid (214 mg, 94%), mp = 132 - 135 C. 1H NMR (300 MHz, CDC13) 6:
8.31 (d, J = 8.1 Hz, 2H), 7.91 (d, J = 8.4 Hz, 2H), 7.78 (d, J = 8.1 Hz, 2H), 7.64 (t, J = 7.8 Hz,
1H), 7.50 (t, J = 7.8 Hz, 2H) ppm. 13C NMR (75 MHz, CDC13) 6: 195.0, 150.0, 143.1, 136.5,
133.7, 131.0, 130.3, 128.9, 123.8 ppm. IR (neat, cm-1): 3101, 1651, 1594, 1514, 1359, 1318,
1107, 872, 705, 692. Anal. Calcd. for C13HqNO 3: C, 68.72; H, 3.99. Found: C, 69.19; H, 3.99.
Me
NO2
Me
1,4-Dimethyl-2-nitrobenzene (Table 2). Following the general procedure, a mixture of
2-chloro-p-xylene (134 pL, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba) 3 (4.5 mg, 0.5
mol%), 1 (6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-BuOH (2 mL) was
heated to 130 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50
g snap column; 0-40% EtOAc/hexanes) to provide the title compound as a yellow oil (106 mg,
70%). 1H NMR (300 MHz, CDC 3) 6: 7.76 (s, 1 H), 7.28 (d, J = 7.8 Hz, 1 H), 7.19 (d, J = 7.8 Hz,
1H), 2.53 (s, 3H), 2.38 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 137.3, 134.1, 132.8, 125.1,
445
20.9, 20.3 ppm. IR (neat, cm~'): 2930, 1654, 1527, 1346, 1293, 1156, 917, 810. Anal. Calcd. for
C8H9NO2 : C, 63.56; H, 6.00. Found: C, 63.15; H, 6.04.
NO2
Me
Ph
2-Methyl-3-nitrobiphenyl (Table 2). Following the general procedure, a mixture of 3-
chloro-2-methylbiphenyl (203 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3 (4.5
mg, 0.5 mol%), 1 (6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-BuOH (2
mL) was heated to 130 *C for 24 h. The crude product was purified via the Biotage SP4 (silica-
packed 50 g snap column; 0-40% EtOAc/hexanes) to provide the title compound as a yellow oil
(212 mg, 99%). 'H NMR (300 MHz, CDC13 ) 6: 7.80 (d, J = 8.10 Hz, 1H), 7.49 - 7.27 (m, 7H),
2.37 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 151.5, 145.2, 140.2, 134.2, 130.3, 129.5, 128.7,
128.0, 126.4, 123.3, 17.2 ppm. IR (neat, cm-1): 3075, 1536, 1464, 1366, 869, 812, 760, 733,
706, 575. Anal. Calcd. for C13H,,NO2: C, 73.23; H, 5.20. Found: C, 73.48; H, 5.16.
NO2
0)
\--o
5-Nitro-1,3-benzodioxole15 (Table 2). Following the general procedure, a mixture of 5-
chloro-1,3-benzodioxole (117 pL, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3 (23
mg, 2.5 mol%), 1 (30 mg, 6 mol%), tris(3,5-dioxaheptyl)amine (16 PL, 5 mol%), and t-BuOH (2
mL) was heated to 130 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-
packed 50 g snap column; 0-50% EtOAc/hexanes) to provide the title compound as a white
solid (166 mg, 99%), mp = 144 - 146 0C (literature 146 - 147 OC). 'H NMR (300 MHz, CDC13) 6:
7.87 (dd, J = 2.4 Hz, J = 8.7 Hz, 1H), 7.64 (d, J= 2.4 Hz, 1H), 6.85 (d, J= 8.7 Hz, 1H), 6.14 (s,
2H) ppm. 13C NMR (75 MHz, CDC13) 6: 153.4, 148.4, 120.1, 107.8, 104.7, 103.3 ppm. IR (neat,
cm-1): 1504,1488, 1343, 1274, 1239, 1036, 919, 870, 825, 742.
NC NO 2
NC~a 
0
4-Nitrobenzonitrile'6 (Table 2). Following the general procedure, a mixture of 4-
chlorobenzonitrile (138 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3 (23 mg, 2.5
mol%), 1 (30 mg, 6 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-BuOH (2 mL) was
heated to 130 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50
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g snap column; 0-50% EtOAc/hexanes) to provide the title compound as a white solid (112 mg,
77%), mp = 141 - 145 0C (literature 143 - 144 0C). 'H NMR (300 MHz, CDC13) 6: 8.35 (d, J =
8.7 Hz, 2H), 7.89 (d, J = 8.4 Hz, 2H) ppm. 13C NMR (75 MHz, CDC13) 6: 133.7, 124.5, 118.6,
117.1 ppm. IR (neat, cm-1): 2233, 1601, 1526, 1489, 1349, 1295, 860, 748, 683, 540.
HO NO2
2-(3-Nitrophenyl)ethanol (Table 2). Following the general procedure, a mixture of 3-
chlorophenethylalcohol (133 pL, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3 (23
mg, 2.5 mol%), 1 (30 mg, 6 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-BuOH (2
mL) was heated to 130 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-
packed 50 g snap column; 0-50% EtOAc/hexanes) to provide the title compound as a white
solid (135 mg, 80%), mp = 47 - 49 *C. 'H NMR (300 MHz, CDCi3) 6: 8.06 (m, 2H), 7.55 (d, J=
7.8 Hz, 1 H), 7.44 (t, J = 7.8 Hz, 1 H), 3.87 (t, J = 6.3 Hz, 2H), 2.93 (t, J = 6.3 Hz, 2H), 2.23 (s,
1H) ppm. 13C NMR (75 MHz, CDC13) 6: 148.5, 141.2, 135.7, 129.6, 124.1, 121.8, 63.1, 38.8
ppm. IR (neat, cm-1): 3427, 1640, 1525, 1351, 1047, 735, 688. Anal. Calcd. for C8 H9NO3 : C,
57.48; H, 5.43. Found: C, 57.73; H, 5.40.
J NO2
N
4-(4-Nitrophenyl)morpholine (Table 2). Following the general procedure, a mixture of
4-(4-chlorophenyl)morpholine (198 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3
(4.5 mg, 0.5 mol%), 1 (6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-
BuOH (2 mL) was heated to 130 0C for 24 h. The crude product was purified via the Biotage
SP4 (silica-packed 50 g snap column; 0-50% EtOAc/hexanes) to provide the title compound as
a red solid (207 mg, 99%), mp = 148 - 150 *C. 'H NMR (300 MHz, CDC13) 6: 8.05 (d, J = 9.0
Hz, 2H), 6.77 (d, J = 9.3 Hz, 2H), 3.82 (t, J = 4.8 Hz, 4H), 3.34 (t, J = 4.8 Hz, 4H) ppm. 13C NMR
(75 MHz, CDC13 ) 6: 155.2, 138.9, 126.1, 112.7, 66.6, 47.2 ppm. IR (neat, cm-1): 1602, 1511,
1490, 1331, 1243, 1119, 1109, 1052, 927, 825. Anal. Calcd. for C1OH12N20 3: C, 57.68; H, 5.81.
Found: C, 57.82; H, 5.82.
NO2
N
6-Nitroquinoline'7 (Table 2). Following the general procedure, a mixture of 6-
chloroquinoline (164 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3 (4.5 mg, 0.5
mol%), 1 (6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-BuOH (2 mL) was
heated to 130 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50
g snap column; 25-75% EtOAc/hexanes) to provide the title compound as a white solid (168 mg,
98%), mp = 149 - 151 0C (literature 150 C). 1H NMR (300 MHz, CDC13) 6: 9.06 (s, 1H), 8.76
(s, 1 H), 8.45 (d, J = 9.3 Hz, 1 H), 8.33 (d, J = 9.6 Hz, 1 H), 8.19 (d, J = 9.3 Hz, 1 H), 7.5 (dd, J =
5.4 Hz, J = 8.4 Hz, 1H) ppm. 13C NMR (75 MHz, CDC13) 6: 154.1, 150.4, 145.7, 138.1, 131.6,
127.2, 124.9, 123.1, 123.1 ppm. IR (neat, cm-1): 1606, 1519, 1492, 1385, 1344, 1324, 903, 853,
809, 791, 777.
N, 
N02
1-(4-Nitropheny)-1H-pyrrole 1 8 (Table 2). Following the general procedure, a mixture of
1-(4-chlorophenyl)-1H-pyrrole (177 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3
(4.5 mg, 0.5 mol%), 1 (6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-
BuOH (2 mL) was heated to 130 0C for 24 h. The crude product was purified via the Biotage
SP4 (silica-packed 50 g snap column; 0-50% EtOAc/hexanes) to provide the title compound as
an off-white solid (141 mg, 75%), mp = 179 - 180 'C (literature 178 - 180 *C). 1H NMR (300
MHz, DMSO) 6: 8.25 (d, J = 9.3 Hz, 2H), 7.85 (d, J = 9.3 Hz, 2H), 7.56 (m, 2H), 6.35 (s, 2H)
ppm. 13C NMR (75 MHz, DMSO) 6: 145.3, 144.5,126.1, 120.1, 119.6,112.9 ppm. IR (neat, cm-
'): 8438, 1598, 1507,1334,1110,1063, 847, 737.
NO2
HN
5-Nitro-1 H-indole (Table 2). Following the general procedure, a mixture of 5-
chloroindole (151 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3 (23 mg, 2.5
mol%), 1 (30 mg, 6 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-BuOH (2 mL) was
heated to 130 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50
g snap column; 0-75% EtOAc/hexanes) to provide the title compound as a yellow solid (134 mg,
83%), mp = 140 - 141 *C. 1H NMR (300 MHz, DMSO) 6: 11.82 (s, 1 H), 8.55 (s, 1 H), 7.97 (dd, J
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= 2.4 Hz, J = 9.0 Hz, 1 H), 7.60 (t, J = 2.7 Hz, 1 H), 7.54 (d, J = 9.0 Hz, 1 H), 6.71 (s, 1 H) ppm. 1C
NMR (75 MHz, DMSO) 6: 141.7,139.7,130.0, 127.7,118.0, 117.1, 112.5, 104.6 ppm. IR (neat,
cm-1): 3337, 1504, 1476, 1347, 1334, 1100, 892, 765, 744, 422. Anal. Calcd. for C8H6N20 2: C,
59.26; H, 3.73. Found: C, 59.34; H, 3.68.
NH
NO2
7-Nitro-1H-indole (Table 2). Following the general procedure, a mixture of 7-
chloroindole (151 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3 (23 mg, 2.5
mol%), 1 (30 mg, 6 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-BuOH (2 mL) was
heated to 130 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50
g snap column; 0-75% EtOAc/hexanes) to provide the title compound as a yellow solid (116 mg,
72%), mp = 96 - 98 *C. 1H NMR (300 MHz, CDC13) 6: 9.96 (s, 1H), 8.16 (d, J = 8.4 Hz, 1H),
7.97 (d, J = 7.8 Hz, 1 H), 7.40 (m, 1 H), 7.20 (t, J = 8.1 Hz, 1 H), 6.71 (m, 1 H) ppm. 13C NMR (75
MHz, CDC13) 6: 131.9, 129.5, 129.2, 126.9, 119.5, 119.4, 104.3, 104.2 ppm. IR (neat, cm-1):
3395, 1502, 1479, 1337, 1321, 1272, 1098, 1066, 736, 719. Anal. Calcd. for C8H6N20 2: C,
59.26; H, 3.73. Found: C, 59.38; H, 3.65.
Experimental Procedures for Examples Described in Table 3
Me NO 2
Me
Me
1,2,3-Trimethyl-5-nitrobenzene (Table 2). Following the general procedure, a mixture
of 3,4,5-trimethylphenyl triflate (268 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol),
Pd2(dba)3 (4.5 mg, 0.5 mol%), 1 (6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%),
and t-BuOH (2 mL) was heated to 130 0C for 24 h. The crude product was purified via the
Biotage SP4 (silica-packed 50 g snap column; 0-40% EtOAc/hexanes) to provide the title
compound as a yellow solid (156 mg, 95%), mp = 69 - 71 C. 'H NMR (300 MHz, CDC13) 6:
7.81 (s, 2H), 2.34 (s, 6H), 2.23 (s, 3H) ppm. 13C NMR (75 MHz, CDCI3) 6: 145.5, 143.6, 138.1,
122.4, 20.9, 16.2 ppm. IR (neat, cm-1): 2962, 1536, 1453, 1357, 1211, 1159, 1044, 919, 855,
746. Anal. Calcd. for CqHjjN0 2: C, 65.44; H, 6.71. Found: C, 65.54; H, 6.69.
449
NO 2
t-Bu
1-tert-Butyl-4-nitrobenzene (Table 2). Following the general procedure, a mixture of 4-
tert-butylphenyl nonaflate (433 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3 (4.5
mg, 0.5 mol%), 1 (6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-BuOH (2
mL) was heated to 130 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-
packed 50 g snap column; 0-40% EtOAc/hexanes) to provide the title compound as a yellow oil
(161 mg, 90%). 'H NMR (300 MHz, CDC13) 6: 8.13 (d, J= 9.0 Hz, 2H), 7.53 (d, J= 9.0 Hz, 2H),
1.35 (s, 9H) ppm. 13C NMR (75 MHz, CDC13) 6: 159.1, 146.1, 126.5, 123.6, 35.6, 31.3 ppm. IR
(neat, cm-1): 2966, 1604, 1520, 1343, 1268, 1103, 853, 758, 727, 700. Anal. Calcd. for
C10H13NO2 : C, 67.02; H, 7.31. Found: C, 66.86; H, 7.32.
MeO ) NO2
OMe
1,3-Dimethoxy-5-nitrobenzene (Table 2). Following the general procedure, a mixture of
3,5-dimethoxyphenyl triflate (286 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3
(4.5 mg, 0.5 mol%), 1 (6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-
BuOH (2 mL) was heated to 130 *C for 24 h. The crude product was purified via the Biotage
SP4 (silica-packed 50 g snap column; 0-40% EtOAc/hexanes) to provide the title compound as
a yellow solid (179 mg, 98%), mp = 88 - 90 *C. 'H NMR (300 MHz, CDC13) 6: 7.30 (s, 2H), 6.70
(s, 1H), 3.83 (s, 6H) ppm. 13C NMR (75 MHz, CDC13) 6: 161.0, 150.0, 107.3, 101.6, 56.1 ppm.
IR (neat, cm~'): 2961, 1589, 1535, 1452, 1356, 1210, 1044, 854, 745, 665. Anal. Calcd. for
C8 H9NO 4 : C, 52.46; H, 4.95. Found: C, 52.98; H, 4.97.
W NO2
2-Nitronaphthalene (Table 2). Following the general procedure, a mixture of 2-napthyl
triflate (276 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3 (4.5 mg, 0.5 mol%), 1
(6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-BuOH (2 mL) was heated to
130 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap
column; 0-40% EtOAc/hexanes) to provide the title compound as a yellow solid (150 mg, 87%),
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mp = 74 - 76 *C. 'H NMR (300 MHz, CDC13) 6: 8.72 (s, 1 H), 8.18 (d, J = 9.0 Hz, 1 H), 7.96 (d, J
= 8.4 Hz, 1 H), 7.90 (d, J =8.7 Hz, 2H), 7.64 (m, 2H) ppm. 13C NMR (75 MHz, CDC13) 6: 136.0,
132.1, 130.2, 130.0, 129.7, 128.2, 128.2, 124.8, 124.8, 119.4 ppm. IR (neat, cm'): 1603, 1530,
1501, 1351, 1081, 903, 869, 820, 766, 466. Anal. Calcd. for Cj0H7NO2: C, 69.36; H, 4.07.
Found: C, 69.88; H, 4.13.
NC NO2NCa 
2
4-Nitrobenzonitrile16 (Table 2). Following the general procedure, a mixture of 4-
cyanophenyl triflate (251 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3 (23 mg,
2.5 mol%), 1 (30 mg, 6 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-BuOH (2 mL)
was heated to 130 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-
packed 50 g snap column; 0-40% EtOAc/hexanes) to provide the title compound as a white
solid (112 mg, 75%), mp = 141 - 145 0C (literature 143 - 144 C). 'H NMR (300 MHz, CDC13) 6:
8.36 (d, J = 8.4 Hz, 2H), 7.89 (d, J = 8.4 Hz, 2H) ppm. 13C NMR (75 MHz, CDC13) 6: 133.7,
124.5, 118.6, 117.1 ppm. IR (neat, cm'): 2233, 1603, 1533, 1526, 1489, 1349, 1296, 860, 748,
683.
N 02
MeO NO
0
Methyl 4-nitrobenzoate'9 (Table 2). Following the general procedure, a mixture of
methyl 4-(perfluorobutoxy)benzoate (434 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol),
Pd2(dba)3 (4.5 mg, 0.5 mol%), 1 (6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%),
and t-BuOH (2 mL) was heated to 130 0C for 24 h. The crude product was purified via the
Biotage SP4 (silica-packed 50 g snap column; 0-50% EtOAc/hexanes) to provide the title
compound as a white solid (153 mg, 85%), mp = 94 - 95 0C (literature 95 - 96 *C). 'H NMR
(300 MHz, CDC13) 6: 8.25 (d, J = 9.0 Hz, 2H), 8.18 (d, J = 9.0 Hz, 2H), 3.95 (s, 3H) ppm. 1c
NMR (75 MHz, CDC13 ) 6: 165.4, 150.7, 135.7, 130.9, 123.8, 53.1 ppm. IR (neat, cm'): 1719,
1609, 1526, 1434,1351,1282,1104, 956, 872, 717.
NO2
6-Nitroquinoline1 7 (Table 2). Following the general procedure, a mixture of quinolin-6-yl
trifluoromethanesulfonate (277 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol), Pd2(dba)3 (4.5
mg, 0.5 mol%), 1 (6 mg, 1.2 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%), and t-BuOH (2
mL) was heated to 130 *C for 24 h. The crude product was purified via the Biotage SP4 (silica-
packed 50 g snap column; 25-75% EtOAc/hexanes) to provide the title compound as a white
solid (152 mg, 94%), mp = 150 - 151 *C. 'H NMR (300 MHz, CDC13) 6: 9.06 (s, 1H), 8.76 (s,
1 H), 8.45 (d, J = 9.3 Hz, 1 H), 8.33 (d, J = 9.6 Hz, 1 H), 8.19 (d, J = 9.3 Hz, 1 H), 7.5 (dd, J = 5.4
Hz, J = 8.4 Hz, 1H) ppm. 13C NMR (75 MHz, CDC13) 6: 154.1, 150.4, 145.7, 138.1, 131.6,
127.2, 124.9, 123.1, 123.1 ppm. IR (neat, cm): 1606, 1519, 1492, 1344, 1324, 903, 853, 809,
791, 777. Anal. Calcd. for CH 6N20 2 : C, 62.07; H, 3.47. Found: C, 61.97; H, 3.36.
; NO2
NH
2-Nitro-9H-carbazole (Table 2). Following the general procedure, a mixture of 9H-
carbazol-2-yl trifluoromethanesulfonate (315 mg, 1.0 mmol), sodium nitrite (138 mg, 2.0 mmol),
Pd2(dba)3 (23 mg, 2.5 mol%), 1 (30 mg, 6 mol%), tris(3,5-dioxaheptyl)amine (16 pL, 5 mol%),
and t-BuOH (2 mL) was heated to 130 OC for 24 h. The crude product was purified via the
Biotage SP4 (silica-packed 50 g snap column; 25-75% EtOAc/hexanes) to provide the title
compound as a off-white solid (162 mg, 76%), mp = 172 - 174 *C. 1H NMR (300 MHz, DMSO)
6: 11.82 (s, 1 H), 8.34 (s, 1 H), 8.26 (d, J = 8.4 Hz, 1 H), 8.20 (d, J = 7.8 Hz, 1 H), 7.99 (d, J = 8.7
Hz, 1H), 7.60 (d, J = 8.1 Hz, 1H), 7.50 (t, J = 7.2 Hz, 1H), 7.22 (d, J = 7.5 Hz, 1H) ppm. 13C
NMR (75 MHz, DMSO) 6: 145.6, 142.8, 139.1, 128.7, 128.2, 122.3, 121.7, 121.2, 120.4, 114.2,
112.4, 107.5 ppm. IR (neat, cm-1): 3374, 1632, 1513, 1455, 1384, 1343, 1324, 874, 734, 719.
Anal. Calcd. for C12H8N202: C, 67.92; H, 3.80. Found: C, 68.23; H, 3.89.
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Chapter 7.
A Multiligand Based Pd Catalyst for C-N Cross-Coupling Reactions
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7.1 Introduction
Palladium-catalyzed C-N cross-coupling reactions have become an important
technology with widespread use across a variety of disciplines.' We have traditionally
approached research in this field by identifying an interesting substrate class and then
developing a catalytic system that efficiently couples these substrates. Because of this strategy
there are currently a large number of catalysts for such processes, 1b,2 which often makes it
difficult for the practitioner to decide what system to employ in a specific case. This can lead to a
significant amount of effort spent screening various possibilities in order to find the optimum
system. This is time consuming and costly, especially for researchers using these reactions to
make libraries of compounds (e.g., medicinal chemists).3 On this basis, it has been a long-
standing goal in our laboratory to find a single catalyst system that would work for all Pd-
catalyzed amination reactions. To take a step toward this goal we elected to use an approach to
catalyst development, where the focus was to find a catalyst, or catalyst mixture, that
incorporates the best features displayed by some, if not all, of our previous systems.
Herein, we disclose a Pd based catalyst comprised of two biarylphosphine ligands that
allows for unparalleled substrate scope and reactivity in C-N cross-coupling reactions. This
system not only encompasses the reactivity that each of the catalysts based on these two
ligands possess separately but also transforms reactions that are inefficient for either of the two
systems alone into high yielding processes. We anticipate this multiligand approach to catalyst
design will be applicable to other cross-coupling methodologies and will enable the development
of more comprehensive catalyst systems.4
7.2 Results and Discussion
We have reported that a catalyst based on 15 works well for the monoarylation of primary
amines but is inefficient for reactions involving secondary amines (Figure 1). Further, a catalyst
based on RuPhos (2)6 is highly efficient for the arylation of secondary amines but is ineffective
for cross-coupling reactions of primary amines and gives significant quantities of the undesired
diarylation by-product. Because these two catalysts are complementary we sought a system
that would manifest the best properties that each possessed separately.7
J- e_ P C Y 2i-r , Wr i-PrO 01-Pr NHPd
I-Pr
3; L = 1
1 2 RuPhos 4; L = 2
Figure 1. Biarylphosphine ligands and Pd precatalysts.
We began our studies by examining the coupling of 3-bromoanisole and morpholine. As
expected, using 1 mol % of the precatalyst 4, which is based on 2, a 99% yield of the desired
product was obtained after 10 minutes at 100 *C (Table 1 a, entry 1). When this same reaction
was run using a mixture of 1 and 4 as the catalyst full conversion to product was also observed
after 10 minutes (Table 1a, entry 2). This demonstrated that 1 does not inhibit reactions of
secondary amines when using a catalyst based on 2. Next, by replacing 4 with precatalyst 3,
which is based on 1, the yield of the reaction dropped to 17% (Table la, entry 3). This was
anticipated, as it is well known that a catalyst based on 1 is unproductive for the arylation of
secondary amines. However, it was found that by using a mixture of 2 and 3 as the catalyst the
yield was increased to 99%, showing that the efficiency of the reaction did not depend on which
ligand began bound to the Pd as long as 2 was in the mixture (Table 1a, entry 4). This result
was promising as it suggested that it was possible for a catalyst comprised of multiple ligands to
display the same reactivity as a catalyst made up of a single ligand.
Table 1. Effect of multiple ligands on Pd-Catalyzed C-N cross-coupling reactions.
MeO HN 0 MeO H2NOct MeO
N O 1% Pd,1% L / \ Br 1% Pd, 1% L / \ N(H)OctNaOt-Bu NaOt-Bu
100 *C, 10 min 100 *C, 10 min
Pd GC Yield b) Pd Mono: GC Yield
Entry Source Ligand (%)a Entry Source Ligand Diarylation (%)a
1 4 -- 99
2 4 1 99
3 3 -- 17
4 3 2 99
1 3 -- 99:1 99
2 3 2 97:3 94
3 4 1 96:4 92
4 4 -- 97:3 30
5 b 4 -- 89:11 77
[a] Reaction conditions: Pd source (1.0 mol %), ligand (1.0 mol %), 3-bromoanisole (1.0 equiv),
amine (1.4 mmol), NaOt-Bu (1.4 mmol), 1,4-dioxane (1 mL/mmol), 100 *C for 10 minutes. [b]
Reaction time of 4 h.
The results described above revealed that the presence of 1 did not affect the
productivity of a catalyst based on 2 for the arylation of secondary amines. Of equal importance
was that the presence of 2 does not have a deleterious effect on a reaction of a primary amine
utilizing a catalyst based on 1. The reaction of 3-bromoanisole and octylamine using the
precatalyst, 3, gave a 99% yield after 10 minutes at 100 0C with >99:1 selectivity for
monoarylation to diarylation (Table 1b, entry 1). Performing the same reaction using a mixture
of 2 and 3 as the catalyst provided a 94% yield of the desired product with an excellent
selectivity of 97:3 for monoarylation:diarylation (Table 1 b, entry 2). This indicated that 2 not only
had little influence on the yield and rate of the reaction but also led to only minimal degradation
in the selectivity for monoarylation. By substituting the combination of 2 and 3 with a mixture of 1
and 4 a nearly identical result was obtained for this transformation, again showing that the
success of the process was not dependent on which ligand began bound to the Pd and
suggesting that ligand exchange is rapid under the reaction conditions (Table 1 b, entry 3).
Further, based on the high selectivities observed for monoarylation using this mixed-ligand
system we can conclude that the coupling of primary amines with a catalyst based on 1 is faster
than the coupling of secondary N-aryl alkylamines with a catalyst based on 2. It is worth noting
that when the control reaction was carried out using 4 without any added 1 the yield of the
reaction dropped to 30% (after 10 minutes) demonstrating that 1 had to be present for the
catalyst to be effective (Table 1 b, entry 4). Combined, these results show that a catalyst based
on a mixture of 1 and 2 can take the form of either of the two catalysts and incorporates the best
properties from each individual system allowing for the highly efficient arylation of both primary
and secondary amines.
We next set out to explore the scope of the mixed ligand catalyst system for C-N cross-
coupling reactions (Table 2). Employing a 1:1 mixture of 2 and 3, anilines were coupled with
aryl chlorides, bromides, iodides, and mesylates in good to excellent yields. Moreover, only
ppm levels of Pd (0.005 - 0.01 mol %) were used for the reactions of the aryl halides,
demonstrating that the mixed ligand system displayed the same catalyst activity and lifetime as
the catalyst based solely on 1 for these reactions.5' S A variety of primary aliphatic amines also
proved to be excellent substrates using this catalyst system. For example, n-hexylamine was
successfully combined with 2-chloro-p-xylene in 95% yield using only 0.05 mol % Pd. Further,
more sterically hindered branched aliphatic amines (e.g., 1-aminoadamantane) were arylated in
high yields. These results prompted us to employ methylamine as a substrate. Methylamine is
the smallest primary aliphatic amine and has typically been a difficult substrate to selectively
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monoarylate.5 Utilizing the mixed ligand system the reaction of methylamine and 4-n-
butylchlorobenzene provided an 89% yield of the desired product with 98:2 selectivity of
monoarylation to diarylation, again confirming that the presence of 2 has little effect on the
reactivity or selectivity of a catalyst based on 1 for the coupling of primary amines. Lastly, the
reaction of a primary amide with 4-chloroanisole yielded the desired product in a nearly
quantitative yield, further highlighting the diverse range of substrates that can be successfully
coupled with this new catalyst system.8
Table 2. Cross-coupling reactions using a multiligand based Pd catalysta
0.005 - 1 mol % 2, 0.005 - 1 mol % 3
AX.V NIRDR' '
NaOt-Bu, dioxane, 80 - 110 *C
H
N
Me
X CI, 99% (0.01% Pd)
X = Br, 99% (0.005% Pd)
X = 1, 78% (0.005% Pd)b
Me
N(H)Hex
Me
x = CI, 95%
(0.05% Pd)
Me
N Q
X = CI, 98%
(0.01% Pd)
MeO N 
X = Br, 99% (1% Pd)c
H
N qCF3
CF3
X = CI, 87% (0.01% Pd)
MeO ' K0
X = CI, 84%
(0.1% Pd)
MeO N NPh2
X = Ci, 99%
(0.05% Pd)
H
n-Bu
X = CI, 81%
(1% Pd)
MeO N
OMe
X = CI, 80%
(0.05% Pd)
Me
INN(
t-Bu
X = OMs, 94% (1% Pd)0
ArN(R)R
H
t-Bu
X = OMs, 99% (1% Pd)C
H
n-Bu 'Me
X = CI, 89%
(1% Pd)d
NNBu2
n-Bu
X = CI, 96%
(0.1% Pd)
H
NN YPh
MeO N P
X = CI, 83% (1% Pd)*
[a] Reaction conditions: 2 (0.005 - 1.0 mol %), 3 (0.005 - 1.0 mol %), aryl halide/pseudohalide
(1.0 equiv), amine (1.4 mmol), NaOt-Bu (1.4 mmol), 1,4-dioxane (1 mL/mmol), 110 *C. [b] The
reaction was run in toluene. [c] Cs2CO3 was used as the base in t-BuOH as the solvent. [d] A
commercial 2 M solution of methylamine in THF was used at 80 *C. [e] K3PO4 was used as the
base in t-BuOH as the solvent.
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The scope for the arylation of secondary amines was next investigated (Table 2).
Utilizing the same combination of 2 and 3 as above, an array of secondary amines were
successfully coupled with aryl halides. For example, N-methylaniline was arylated with
chlorobenzene in 98% yield using only 0.01 mol % Pd, the same catalyst loading required when
a catalyst based only on 2 is used. This further verifies that the presence of 1 has little to no
effect on reactions of secondary amines when the multiligand catalyst is employed.
Additionally, a secondary biarylamine, cyclic aliphatic amine, and acyclic aliphatic amine could
all be combined with aryl chlorides to give the desired products in good to excellent yields
utilizing relatively low levels of Pd in all cases. Finally, with this catalyst system we were able to
efficiently N-arylate indole, as well as couple N-methylaniline with an aryl mesylate. It is
noteworthy that this is the first example of the reaction of a secondary amine with an aryl
mesylate using a catalyst based on our biarylphosphine ligands.9
We next wanted to extend the scope of this catalyst system to heteroaryl substrates, as
well as those containing base-sensitive functional groups (Table 3). Use of Cs2CO3 as the base
in t-BuOH allowed for substrates with esters, nitriles, ketones, as well as nitroaromatics to be
converted to product in high yield. For example, under these conditions the reaction of ethyl 4-
aminobenzoate and chlorobenzene gave a 98% yield of the desired product using only 0.1 mol
% of the catalyst mixture. Additionally, this catalyst system allowed for the efficient coupling of
an array of aminoheterocycles (i.e, aminopyrazine, aminopyrimidine, aminopyridine, amino-
pyrazole, N-methylamino-pyridine, furan-2-carboxamide), as well as heteroaryl halides all in
excellent yields. These structural components are of particular importance because of their
prevalence in pharmaceutically interesting molecules.
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Table 3. Cross-coupling reactions
functional groupsa
ArX + HN(R)R'.
of substrates containing heterocycles and base sensitive
1 mol%2,1 mol%3
ArNRyk)ms1
Cs2CO3, t-BuOH, 110 *C
H
X = CI, 88% (0.1% Pd)
H
N N
X = CI, 98%
H
EtO N N
0
X = Br, 96%
N NPh2
F3C
X = Ci, 90%
H
NNN N
N N
X = CI, 99%
H
N N
S N Me
0
X=Br, 94%
H
X =CI, 9 7 %b
H
N N YMe
(N 0
X = OTf, 9 2 %c
H
S N NN
X = Br, 94%
H Me
02N Na N I
'/N
Me
x = CI, 97%
Me
NC NUAJ
X = 1, 97%
H j
Me NN
- 0
Me
X= 1, 99%C
[a] Reaction conditions: 2 (1.0 mol %), 3 (1.0 mol %), aryl halide/pseudohalide (1.0 equiv),
amine (1.4 mmol), Cs2 CO 3 (1.4 mmol), t-BuOH (2 mL/mmol), 110 0C. [b] 1 M LHMDS in THF
was used as the base and solvent. [c] K3P04 was used as the base.
Although this new catalyst system has permitted greater substrate scope and reactivity
for these reactions than any of our previous ones, we wanted to further broaden its generality by
exploring transformations that could only be done efficiently with the catalyst mixture. We
postulated that the synthesis of unsymmetrical triarylamines, 7clo which are commonly used in
optoelectronic applications," would be one case where the mixed ligand system could be more
effective than catalysts based on either of the two ligands separately. First, we were able to
make triarylamines from 2 different aryl chlorides and an aniline via a sequential addition
protocol (Figure 2). For example, allowing 3-aminobenzotrifluoride to react with 1-(4-
chlorophenyl)-1H-pyrrole at 110 OC for 15 minutes followed by the addition of chlorobenzene
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resulted in a 92% yield of the desired unsymmetrical triarylamine (Figure 2a). Next, by utilizing
the 2/3 combination and taking advantage of the innate relative reactivity of aryl halides we were
able to selectively couple 4-tert-butylbromobenzene, chlorobenzene, and 4-fluoroaniline to make
the desired unsymmetrical triarylamine in 97% yield (Figure 2b). In comparison, when the
identical reaction was run with either 3 or 4 as the catalyst source only 69% and 41 %,
respectively, of the product was obtained. These results illustrate that a catalyst based on the
1/2 combination is more effective for this process than a system based on either of the ligands
separately. Finally, by employing this protocol we were able to synthesize TPD, a hole transport
agent, in 98% yield from simple starting materials in a single step using only 0.2 mol % Pd
(Figure 2c).a This result corresponds to a 99.5% average yield for each of the four C-N
couplings that have taken place.
a) ci
NH2  a) 1% 2,1% 3, NaOt-Bu
I dioxane, 110 -B F3C N
F3c b) cl 92*I N
b) Br t-Bu
NH2  Cl Cat Yield
16 1% Catalyst2,97
FNaOt-Bu, dioxane N 3 69%
F t-Bu 110 0 C,25min 4 41%
C) NH2  Me Me
Br C1
0.2% 2, 0.2% 3-- -
N + I Me+ NaOt-Bu, dioxane
110 OCTPD; 98%
NH2
Figure 2. Synthesis of triarylamines using a catalyst comprised of 2 and 3.
It is worth mentioning that although this system shows the highest activity and the
broadest substrate scope of any single catalyst system we have developed to date, there are
still some limitations. For example, substrates that require catalysts based on highly
specialized ligands have not proven to be proficient coupling partners utilizing our mixed-ligand
system. Specifically, imidazoles, benzimidazoles, pyrazoles,12 or secondary acyclic amides13
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have not been successfully employed using the 2/3 combination. Further, this catalyst system
does not work well for the monoarylation of ammonia.
We next set out to gain insight into why the mixed-ligand catalyst system was so
effective for C-N cross-coupling reactions. Based on the fact that the reactivity of our system
did not depend on which ligand began coordinated to the Pd, we hypothesized that ligand
exchange under the catalytic conditions must be facile. To investigate this we conducted
studies to elucidate where interchange of the ligands was occurring in the catalytic cycle. First,
upon heating stoichiometric quantities of 3 in the presence of 2 at 100 0C for 1 h no formation of
4 via ligand exchange was observed. This demonstrates that the ligand interchange does not
occur at the amine bound Pd(II) complex (Figure 3). Next, when 3 was heated to 100 0C for 1
minute in the presence of NaOt-Bu, 2, and an aryl bromide, a mixture of both 5 and 6 was
observed. This suggested that ligand exchange was facile on a Pd(0) complex (Figure 3). It is
worth noting that fast ligand exchange at the Pd(O) complex was also observed at 80 *C;
however, at room temperature it became slow. This is consistent with our findings that the
mixed-ligand catalyst gave optimal results at temperatures 21 00 *C.
NH 2 + 2 NH2 + NH 2
(3) 1 Ci (3) 1' CI (4) 2 C1
100 : 0
Me Me Me Me 5:6
3 + 2 + ArBr Nat-Bu I 100 *C: 36 : 64
dioxane (5) (6) 80 *C: 44: 56
1 min 1 -Pd-Br 2-Pd-Br rt: 97 : 3
ArBr ArBrt
N Pd(0) . 2Pd(0)1
Figure 3. Ligand exchange studies on the Pd(l) amine bound complex and the Pd(O) complex.
Lastly, we wanted to explore whether ligand exchange could occur at the Pd(II) oxidative
addition complex. When a mixture of 5 and 2 were heated in dioxane at 100 0C for 10 minutes,
a mixture of 5 and 6 was observed (Figure 4). We reasoned that two different pathways for
Me Me Me Me Me Me 5:6
( + 2 dO (5) + ( 100 0C,10min: 23:77(5) dioxane (5) (6) 80 *C, 1 h: 93: 7
1-Pd-Br 1-Pd-Br 2-Pd-Br
Me Me
(5)
1-Pd-Br
2
"Pathway 1"
"Pathway 2"
-ArBr
Me Me Me Me
(5)+ (6) q
1-Pd-Br 2-Pd-Br
ArBrt 2 1 ArBr
1Pd(0) A=N Pd(1)2 - 2Pd(0)
(A) (C) (B)
Figure 4. Ligand exchange studies on the Pd(I) oxidative addition complex.
ligand exchange could explain this result. First, exchange could be taking place on the Pd(ll)
oxidative addition complex itself (Figure 4, Pathway 1). Alternatively, complex 5 could undergo
reductive reductive elimination to provide the aryl bromide and 1 Pd(0) (A).14 Intermediate A
could equilibrate with B via the mixed ligand complex, C. Subsequent oxidative addition of B
with the aryl bromide would afford 6 (Figure 4, Pathway 2). In order to test which pathway was
operating a crossover experiment was utilized. Heating the aryl chloride oxidative addition
complex, 7, in the presence of 2 and 100 equivalents of 3,5-dibromobenzene for 10 minutes
resulted in a mixture of 7 and 8 (Figure 5). However, none of the crossover products (5 or 6)
were observed, suggesting that ligand exchange was occurring at the Pd(II) center (Pathway 1)
and not through a Pd(0) pathway.15 Moreover, in order to show that the aryl chloride oxidative
addition complexes were not just more thermodynamically stable than the corresponding aryl
Br
(7) + 2+
1-Pd-Cl Me Me
100 *C
dioxane (7)
10 min 1-Pd-Cl
55
Me Me C 1 Me MeMe Me
(5) 2 dioxane 7 + 8 + (5) + (6)
1-Pd-Br 10 min 1-Pd-Br 2-Pd-Br
0 : 0 : 25 : 75
Figure 5. Competition experiment to distinguish between pathway 1 and pathway 2.
+ (8)
2-Pd-Cl
: 45
+ 5 + 6
: 0 : 0
bromide complexes, 5 was heated in the presence of 2 and 100 equivalents of chlorobenzene
for 10 minutes. This experiment resulted in a 25:75 mixture of 5 and 6 and no detectable
quantities of 7 and 8, which further supports the hypothesis that ligand exchange is occurring via
pathway 1. On the basis of these results we propose that this mixed-ligand system is operating
via the catalytic cycle shown in Figure 6, where the Pd is being shuttled between the two cycles
both at the Pd(0) and the Pd(Il) oxidative addition stage.
ArN(H)R ArNR 2
Ar 2 Ar
1-Pd-N(H)R 1Pd(0) 2Pd(0) 2-Pd-NR2
B-HX 1 Amine ArX 20 Amine B-HX
B A Coupling YCoupling B
Ar 2 Ar Ar1-Pd-NH2R 1-Pd-X 2-Pd-X 2-Pd-N(H)R2
X 1X
H2NR HNR2
Figure 6. Proposed mechanism of the mixed-ligand catalyst system.
7.3 Conclusion
In summary, we have disclosed a new approach to catalyst design where the goal was
to find a catalyst or catalyst mixture that incorporated the reactivity displayed by several of our
previous catalyst systems. This strategy led to the development of a Pd catalyst based on two
biarylphosphine ligands, which displayed the same substrate scope and catalyst activity in C-N
cross-coupling reactions as a catalyst based on either of the ligands separately. For example,
an array of both primary and secondary amines, as well as aryl halides/pseudohalides were
successfully coupled utilizing this system in high yields and with low catalyst loadings. Further,
this mixed catalyst not only encompassed the substrate scope and activity that each catalyst
exhibited alone but also manifested its own reactivity. For example, in the synthesis of
triarylamines the multiligand system was more efficient than a system based on either ligand
independently. Not only do we believe this multiligand catalyst system will see widespread use,
especially in industry, but also expect that this approach toward catalyst design will be
applicable to other cross-coupling methodologies. We hope that the use of multiligand systems
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will facilitate the development of more comprehensive catalysts and, ideally, lead to the
discovery of a truly "universal" system.
7.4 Experimental
General Reagent Information: All reactions were carried out under an argon
atmosphere. The 1,4-dioxane and tert-butanol were purchased from Aldrich Chemical Company
in Sure-Seal bottles and were used as received. Toluene was purchased from J.T. Baker in
CYCLE-TAINER* solvent-delivery kegs and vigorously purged with argon for 2 h. The solvent
was further purified by passing it under argon pressure through two packed columns of neutral
alumina and copper (1l) oxide. Aryl halides, amines, and aryl triflates were purchased from
Aldrich Chemical Co., Alfa Aesar, Acros Organics or TCl America and were used as received
without further purification. Aryl mesylates that were not commercially available were
synthesized using literature procedures.16 A solution of methylamine in THF was purchased
from Alfa Aesar. Anhydrous cesium carbonate was a gift from Chemetall. Sodium tert-butoxide
was purchased from Aldrich Chemical Company and anhydrous tribasic potassium phosphate
was purchased from Fluka Chemical Company. The bases were stored in a nitrogen-filled
glovebox and were taken out in small quantities and stored on the bench for up to two weeks.
Ligands 15 and 2,17 precatalysts 35 and 4 ,6a and Pd complexes 5 and 75 were synthesized using
literature procedures. Flash chromatography was performed using a Biotage SP4 instrument
with prepacked silica cartridges.
General Analytical Information: All compounds were characterized by 1H NMR, 13C
NMR, IR spectroscopy, as well as, in most instances, elemental analysis. Copies of the 1H and
13C spectra can be found at the end of the Supporting Information. Nuclear Magnetic Resonance
spectra were recorded on a Varian 300 MHz instrument and a Varian 500 MHz instrument. All
1H NMR experiments are reported in 6 units, parts per million (ppm), and were measured
relative to the signals for residual chloroform (7.26 ppm) in the deuterated solvent, unless
otherwise stated. All 13C NMR spectra are reported in ppm relative to deuterochloroform (77.23
ppm), unless otherwise stated, and all were obtained with 'H decoupling. All IR spectra were
taken on a Perkin - Elmer 2000 FTIR. All GC analyses were performed on a Agilent 6890 gas
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chromatograph with an FID detector using a J & W DB-1 column (10 m, 0.1 mm I.D.). Elemental
analyses were performed by Atlantic Microlabs Inc., Norcross, GA.
Experimental Procedures for Examples Described in Table 1
O NH O"Br ,, OMe 00 NH OMe
1 mol % Pd,1 mol % L
NaOt-Bu, 100 *C, 10 min
General Procedure for Table la: An oven-dried test tube, which was equipped with a
magnetic stir bar and fitted with a teflon septum, was charged with the ligand (1.0 mol %), the
precatalyst (1 mol %), and NaOt-Bu (134 mg, 1.4 mmol). The vessel was evacuated and
backfilled with argon (this process was repeated a total of 3 times) and then the 3-bromoanisole
(127 [L, 1.0 mmol), morpholine (122 [tL, 1.4 mmol), and 1,4-dioxane (1 mL) were added via
syringe. The solution was heated to 100 0C for 10 min and then was cooled to room
temperature, diluted with ethyl acetate and washed with water. A known amount of dodecane
was added to the solution as an internal standard and then the reaction mixture was analyzed
via GC.
MeO Br H2NOct MeO N(H)Oct
1mol % Pd, 1 mol % L
NaOt-Bu, 100 *C, 10 min
General Procedure for Table 1 b: An oven-dried test tube, which was equipped with a
magnetic stir bar and fitted with a teflon septum, was charged with the ligand (1.0 mol %), the
precatalyst (1 mol %), and NaOt-Bu (164 mg, 1.4 mmol). The vessel was evacuated and
backfilled with argon (this process was repeated a total of 3 times) and then the 3-bromoanisole
(127 [L, 1.0 mmol), octylamine (231 [tL, 1.4 mmol), and 1,4-dioxane (1 mL) were added via
syringe. The solution was heated to 100 0C for 10 min and then was cooled to room
temperature, diluted with ethyl acetate and washed with water. A known amount of dodecane
was added to the solution as an internal standard and then the reaction mixture was analyzed
via GC.
0
N OMe
4-(3-Methoxyphenyl)morpholine. 8 An oven-dried test tube, which was equipped with a
magnetic stir bar and fitted with a teflon septum, was charged with 2 (4.7 mg, 1.0 mol %), 3 (8
mg, 1 mol %), and NaOt-Bu (134 mg, 1.4 mmol). The vessel was evacuated and backfilled with
argon (this process was repeated a total of 3 times) and then the 3-bromoanisole (127 [LL, 1.0
mmol), morpholine (122 [tL, 1.4 mmol), and 1,4-dioxane (1 mL) were added via syringe. The
solution was heated to 100 *C for 10 min and then was cooled to room temre, peratu diluted
with ethyl acetate, washed with water and concentrated in vacuo. The crude product was
purified via the Biotage SP4 (silica-packed 50 g snap column; 0-25% EtOAc/hexanes) to provide
the title compound as a clear oil (173 mg, 90%). 1H NMR (300 MHz, CDCi3) 6: 7.20 (t, J = 8.1
Hz, 1H), 6.54 (d, J= 8.1 Hz, 1H), 6.46 (m, 2H), 3.86 (t, J= 5.1 Hz, 4H), 3.80 (s, 3H), 3.15 (t, J=
5.1 Hz, 4H) ppm. 13C NMR (75 MHz, CDCl3) 6: 160.9, 153.0, 130.1, 108.7, 104.9, 102.4, 67.1,
55.4, 49.5 ppm. IR (neat, cm 1): 2834, 1602, 1497, 1449, 1267, 1205, 1170, 1122, 957, 836.
Anal. Calcd. for C 1 H15N02: C, 68.37; H, 7.82. Found: C, 68.64; H, 7.93.
MeO N(H)Oct
3-Methoxy-N-octylaniline. An oven-dried test tube, which was equipped with a
magnetic stir bar and fitted with a teflon septum, was charged with 2 (4.7 mg, 1.0 mol %), 3 (8
mg, 1 mol %), and NaOt-Bu (134 mg, 1.4 mmol). The vessel was evacuated and backfilled with
argon (this process was repeated a total of 3 times) and then the 3-bromoanisole (127 [tL, 1.0
mmol), octylamine (231 tL, 1.4 mmol), and 1,4-dioxane (1 mL) were added via syringe. The
solution was heated to 100 0C for 10 min and then was cooled to room temperature, diluted with
ethyl acetate, washed with water and concentrated in vacuo. The crude product was purified via
the Biotage SP4 (silica-packed 50 g snap column; 0-25% EtOAc/hexanes) to provide the title
compound as a clear oil (215 mg, 91%). 'H NMR (300 MHz, CDCl3) 6: 7.11 (t, J= 8.1 Hz, 1H),
6.25 (m, 3H), 3.81 (s, 3H), 3.67 (bs, 1H), 3.12 (t, J = 6.9 Hz, 2H), 1.64 (m, 2H), 1.34 (m, 10H),
0.94 (m, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 161.1, 150.2, 130.2, 106.2, 102.4, 98.8, 55.3,
44.2, 32.1, 29.8, 29.7, 29.6, 27.5, 23.0, 14.4 ppm. IR (neat, cm 1): 3406, 2927, 2855, 1615,
1497, 1212, 1162, 1051, 755, 687. Anal. Calcd. for C15H25NO: C, 76.55; H, 10.71. Found: C,
76.98; H, 10.80.
Experimental Procedures for Examples Described in Table 2
General Procedure A: An oven-dried test tube, which was equipped with a magnetic
stir bar, was charged with the base (1.4 equiv). The vessel was evacuated and backfilled with
argon (this process was repeated a total of 3 times) and then the aryl halide (1.0 equiv), amine
(1.4 equiv), and solvent (0.5 mL/mmol) were added via syringe (aryl chlorides and amines that
were solids were added with the base). A solution of 2 and 3 (0.002M, 0.005 - 0.1 mol % 2,
0.005 - 0.1 mol % 3) was added and then the reaction mixture was heated to 110 0C until the
starting material was completely consumed as monitored by GC. The reaction mixture was then
cooled to room temperature, diluted with ethyl acetate, washed with water, concentrated in
vacuo, and purified via the Biotage SP4.
General Procedure B: An oven-dried test tube, which was equipped with a magnetic
stir bar and fitted with a teflon septum, was charged with 2 (0.1 - 1 mol %), 3 (0.1 - 1 mol %)
and the base (1.4 equiv). The vessel was evacuated and backfilled with argon (this process
was repeated a total of 3 times) and then the aryl halide (1.0 equiv), amine (1.4 equiv), and
solvent (2 mL/mmol) were added via syringe (aryl chlorides and amines that were solids were
added with the catalyst and base). The solution was heated to 110 0C until the starting material
was completely consumed as monitored by GC. The reaction mixture was then cooled to room
temperature, diluted with ethyl acetate, washed with water, concentrated in vacuo, and purified
via the Biotage SP4.
MeN
4-Methyl-N-phenylaniline."9 Following general procedure A, a mixture of chlorobenzene
(204 pL, 2.0 mmol), p-toluidine (299 mg, 2.8 mmol), 3 (0.01 mol %), RuPhos (0.01 mol %),
NaOt-Bu (268 mg, 2.8 mmol), and 1,4-dioxane (1 mL) was heated to 110 0C for 24 h. The crude
product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-25%
EtOAc/hexanes) to provide the title compound as a white solid (364 mg, 99%), mp = 88 - 90 0C
(lit. 86 - 87 0C). 1H NMR (300 MHz, CDC13) 6: 7.32 (t, J = 7.5 Hz, 2H), 7.17 (d, J = 8.1 Hz, 2H),
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7.08 (m, 4H), 6.97 (t, J = 7.5 Hz, 1H), 5.64 (bs, 1H), 2.39 (s, 3H) ppm. 13C NMR (75 MHz,
CDC13) 6: 144.3, 140.7, 131.3, 130.3, 129.8, 120.7, 119.3, 117.3, 21.2 ppm. IR (neat, cm 1):
3394, 2917, 1595, 1514, 1309, 1078, 809, 747, 694, 505. Anal. Calcd. for C13H13N: C, 85.21; H,
7.15. Found: C, 85.16; H, 7.28.
H
Me N
4-Methyl-N-phenylaniline.19  Following general procedure A, a mixture of
bromobenzene (211 pL, 2.0 mmol), p-toluidine (299 mg, 2.8 mmol), 3 (0.005 mol %), RuPhos
(0.005 mol %), NaOt-Bu (268 mg, 2.8 mmol), and 1,4-dioxane (1 mL) was heated to 110 0C for
24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-
25% EtOAc/hexanes) to provide the title compound as a white solid (364 mg, 99%), mp = 89 -
90 0C (lit. 86 - 87 *C). 1H NMR (300 MHz, CDC13) 6: 7.34 (t, J = 7.2 Hz, 2H), 7.19 (d, J = 8.4
Hz, 2H), 7.10 (m, 4H), 6.99 (t, J = 7.2 Hz, 1H), 5.65 (bs, 1H), 2.41 (s, 3H) ppm. 13C NMR (75
MHz, CDC13) 6: 144.3, 140.6, 131.2, 130.2, 129.7, 120.6, 119.2, 117.2, 21.1 ppm. IR (neat, cm~
): 3395, 2916, 1595, 1514, 1309, 809, 771, 747, 694, 505. Anal. Calcd. for C13H13N: C, 85.21;
H, 7.15. Found: C, 85.17; H, 7.27.
H
Me
4-Methyl-N-phenylaniline.19 Following general procedure A, a mixture of iodobenzene
(224 pL, 2.0 mmol), p-toluidine (299 mg, 2.8 mmol), 3 (0.005 mol %), RuPhos (0.005 mol %),
NaOt-Bu (268 mg, 2.8 mmol), and 1,4-dioxane (1 mL) was heated to 110 0C for 24 h. The crude
product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-25%
EtOAc/hexanes) to provide the title compound as a white solid (286 mg, 78%), mp = 87 - 89 0C
(lit. 86 - 87 C). 'H NMR (300 MHz, CDC13 ) 6: 7.32 (t, J= 7.5 Hz, 2H), 7.17 (d, J= 8.1 Hz, 2H),
7.08 (m, 4H), 6.97 (t, J = 7.2 Hz, 1H), 5.64 (bs, 1H), 2.39 (s, 3H) ppm. 13C NMR (75 MHz,
CDC13) 6: 144.2, 140.6, 131.2, 130.2, 129.6, 120.6, 119.2, 117.2, 21.0 ppm. IR (neat, cm 1):
3395, 2916, 1596, 1514, 1501, 1309, 810, 747, 694, 506. Anal. Calcd. for C13 H13 N: C, 85.21; H,
7.15. Found: C, 85.24; H, 7.34.
H
F3C N
I I I_
CF 3
N-Phenyl-3,5-bis(trifluoromethyl)aniline. Following general procedure A, a mixture of
chlorobenzene (204 pL, 2.0 mmol), 3,5-bis(trifluoromethyl)aniline (437 pL, 2.8 mmol), 3 (0.01
mol %), RuPhos (0.01 mol %), NaOt-Bu (268 mg, 2.8 mmol), and 1,4-dioxane (1 mL) was
heated to 110 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50
g snap column; 0-40% EtOAc/hexanes) to provide the title compound as a brown solid (606 mg,
99%). 1H NMR (300 MHz, CDC13) 6: 7.40 (m, 5H), 7.17 (m, 3H), 5.99 (bs, 1H) ppm. 13C NMR
(75 MHz, CDC13 ) 6: 145.5, 140.6, 133.6, 133.1, 132.7, 132.3, 130.2, 130.1, 125.4, 124.0, 121.8,
120.6, 115.4, 113.3, 113.2, 113.2, 113.1, 113.1 ppm (observed complexity is due to C-F
splitting). IR (neat, cm 1): 3442, 3055, 1598, 1522, 1385, 1119, 874, 697, 683. Anal. Calcd. for
C14HqF 6N: C, 55.09; H, 2.97. Found: C, 55.21; H, 2.79.
H
N
t-Bu N
4-(tert-Butyl)-N-phenylaniline. 20 Following general procedure B, a mixture of 4-(tert-
butylphenyl)methanesulfonate (228 pL, 1.0 mmol), aniline (110 tL, 1.4 mmol), 3 (1 mol %),
RuPhos (1 mol %), Cs2CO3 (456 mg, 1.4 mmol), and t-BuOH (2 mL) was heated to 110 0C for
16 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-
25% EtOAc/hexanes) to provide the title compound as a white solid (224 mg, 99%), mp = 63 -
66 0C (lit. 66 - 67 *C). 1H NMR (300 MHz, CDC13 ) 6: 7.36 (m, 4H), 7.13 (d, J = 8.7 Hz, 4H), 6.97
(t, J= 7.2 Hz, 1H), 5.68 (bs, 1H), 1.40 (s, 9H) ppm. 13C NMR (75 MHz, CDC13 ) 6:144.5, 144.0,
140.6, 129.6, 126.5, 120.7, 118.4, 117.4, 34.5, 31.8 ppm. IR (neat, cm 1): 3387, 2962, 1597,
1518, 1500, 1315, 1269, 838, 742, 687. Anal. Calcd. for C16H19N: C, 85.28; H, 8.50. Found: C,
85.42; H, 8.57.
Me
N(H)Hex
Me
N-Hexyl-2,5-dimethylaniline.2 Following general procedure A, a mixture of 2-chloro-p-
xylene (269 pL, 2.0 mmol), hexylamine (370 pL, 2.8 mmol), 3 (0.05 mol %), RuPhos (0.05 mol
%), NaOt-Bu (268 mg, 2.8 mmol), and 1,4-dioxane (1 mL) was heated to 110 0C for 24 h. The
crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-40%
EtOAc/hexanes) to provide the title compound as a clear oil (385 mg, 94%). 'H NMR (500 MHz,
CDCl3) 6: 7.17 (d, J = 7.0 Hz, 1H), 6.71 (d, J= 7.5 Hz, 1H), 6.69 (s, 1H), 3.60 (bs, 1H), 3.37 (t,
J = 7.5 Hz, 2H), 2.55 (s, 3H), 2.33 (s, 3H), 1.89 (pentet, J = 7.5 Hz, 2H), 1.67 (pentet, J = 7.0
Hz, 2H), 1.59 (m, 4H), 1.18 (t, J= 7.0 Hz, 3H) ppm. 13C NMR (500 MHz, CDC13 ) 6:146.8,137.1,
130.3, 119.1, 117.7, 111.0, 44.4, 32.2, 30.1, 27.5, 23.2, 22.0, 17.4, 14.6 ppm. IR (neat, cm'):
3430,2956,1616,1584,1523,1467,1376,1298,999,793.
H
MeO N
N-Cyclohexyl-4-methoxyaniline.6b Following general procedure A, a mixture of 4-
chloroanisole (246 pL, 2.0 mmol), cyclohexylamine (319 pL, 2.8 mmol), 3 (0.1 mol %), RuPhos
(0.1 mol %), NaOt-Bu (268 mg, 2.8 mmol), and 1,4-dioxane (1 mL) was heated to 110 0C for 24
h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-40%
EtOAc/hexanes) to provide the title compound as a brown solid (349 mg, 85%), mp = 43 - 46 0C
(lit. 44 - 46 C). 'H NMR (300 MHz, CDCi3) 6: 6.81 (d, J = 8.7 Hz, 2H), 6.61 (d, J = 8.7 Hz, 2H),
3.76 (s, 3H), 3.71 (s, 1H), 3.19 (m, 1H), 2.07 (m, 2H), 1.78 (m, 2H), 1.68 (m, 1H), 1.44 - 1.06
(m, 5H) ppm. 13C NMR (75 MHz, CDC13 ) 6: 152.2, 141.7, 115.3, 115.1, 56.0, 53.1, 33.8, 26.3,
25.4 ppm. IR (neat, cm'): 3389, 2930, 2852, 1512, 1451, 1241, 1039, 819, 756, 516.
H
N A
n-Bul N'A
N-(4-Butylphenyl)adamantan-1-amine. Following general procedure B, a mixture of 4-
n-butylchlorobenzene (169 pL, 1.0 mmol), adamantan-1-amine (181 mg, 1.2 mmol), 3 (8 mg,
1.0 mol %), RuPhos (5 mg, 1 mol %), NaOt-Bu (134 mg, 1.4 mmol), and 1,4-dioxane (1 mL) was
heated to 110 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50
g snap column; 0-40% EtOAc/hexanes) to provide the title compound as a clear oil (226 mg,
80%). 'H NMR (300 MHz, CDC13 ) 6: 7.01 (d, J = 8.4 Hz, 2H), 6.79 (d, J = 8.7 Hz, 2H), 3.38 (bs,
1H), 2.55 (t, J= 7.8 Hz, 2H), 2.12 (s, 3H), 1.86, (s, 5H), 1.66 (m, 7H), 1.38 (sextet, J = 7.8 Hz,
2H), 0.96 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (75 MHz, CDC13 ) 6: 143.5, 134.7, 128.8, 120.9,
52.6, 43.9, 36.8, 35.1, 34.1, 30.2, 22.7, 14.3 ppm. IR (neat, cm-1): 2907, 2850, 1614, 1513,
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1453, 1356, 1309, 1242, 1092, 823. Anal. Calcd. for C20H29N: C, 84.75; H, 10.31. Found: C,
84.61; H, 10.44.
H
n-Bu N'Me
4-Butyl-N-methylaniline.5 Following general procedure B, a mixture of 4-n-
butylchlorobenzene (169 pL, 1.0 mmol), methylamine (2 M in THF, 1 mL, 2.0 mmol), 3 (8 mg,
1.0 mol %), RuPhos (5 mg, 1 mol %), NaOt-Bu (134 mg, 1.4 mmol), and t-BuOH (1 mL) was
heated to 80 0C for 16 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g
snap column; 0-40% EtOAc/hexanes) to provide the title compound as a clear oil (140 mg,
87%). 1H NMR (300 MHz, CDC13) 6: 7.10 (d, J= 8.4 Hz, 2H), 6.63 (d, J= 8.7 Hz, 2H), 3.56 (bs,
1 H), 2.88 (s, 3H), 2.60 (t, J = 7.8 Hz, 2H), 1.65 (pentet, J = 7.8 Hz, 2H), 1.43 (sextet, J = 7.8 Hz,
2H), 1.01 (t, J = 7.2 Hz, 3H) ppm. 13C NMR (75 MHz, CDCi3) 6: 147.6, 132.0, 129.4, 112.8,
35.1, 34.4, 31.3, 22.7, 14.3 ppm. IR (neat, cm-1): 3412, 2927, 2872, 1618, 1522, 1466, 1316,
1263, 1183, 816. Anal. Calcd. for C1 H17N: C, 80.93; H, 10.50. Found: C, 81.02; H, 10.60.
Me
N
N-Methyl-N-phenylaniline.22 Following general procedure A, a mixture of chlorobenzne
(204 pL, 2.0 mmol), N-methylaniline (303 pL, 2.8 mmol), 3 (0.01 mol %), RuPhos (0.01 mol %),
NaOt-Bu (268 mg, 2.8 mmol), and 1,4-dioxane (1 mL) was heated to 110 0C for 24 h. The crude
product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-40%
EtOAc/hexanes) to provide the title compound as a yellow oil (359 mg, 98%). 1H NMR (300
MHz, CDCI3) 6: 7.49 (t, J = 7.2 Hz, 4H), 7.25 (d, J = 7.8 Hz, 4H), 7.18 (t, J = 7.2 Hz, 2H), 3.51
(s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6:149.5, 129.7, 121.8, 120.9, 40.7 ppm. IR (neat, cm-'):
3036, 1591, 1497, 1343, 1253, 1131, 1029, 864, 750, 694. Anal. Calcd. for C13H13N: C, 85.21;
H, 7.15. Found: C, 85.20; H, 7.23.
MeO NPh2
3-Methoxy-N,N-diphenylaniline.2 ' Following general procedure A, a mixture of 3-
chloroanisole (246 pL, 2.0 mmol), diphenylamine (473 mg, 2.8 mmol), 3 (0.05 mol %), RuPhos
(0.05 mol %), NaOt-Bu (268 mg, 2.8 mmol), and 1,4-dioxane (1 mL) was heated to 110 0C for
24 h. The crude product was purified via the Biotage SP4 (NH-packed 55 g snap column; 0-40%
EtOAc/hexanes) to provide the title compound as a clear oil (540 mg, 99%). 1H NMR (300 MHz,
CDCl3) 6: 7.39 (t, J = 8.4 Hz, 4H), 7.28 (m, 5H), 7.16 (t, J = 7.2 Hz, 2H), 6.86 (m, 2H), 6.73 (m,
1H), 3.83 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 160.9, 149.6, 148.2, 130.3, 129.7, 124.9,
123.3, 116.9, 110.2, 108.5, 55.6 ppm. IR (neat, cm-1): 3035, 2834, 1587, 1485, 1312, 1222,
1173, 1049, 754, 696. Anal. Calcd. for C19H17NO: C, 82.88; H, 6.22. Found: C, 83.00; H, 6.22.
MeO I. N
OMe
1-(3,5-Dimethoxyphenyl)piperidine. Following general procedure A, a mixture of 3,5-
dimethoxychlorobenzne (346 mg, 2.0 mmol), piperidine (276 pL, 2.8 mmol), 3 (0.05 mol %),
RuPhos (0.05 mol %), NaOt-Bu (268 mg, 2.8 mmol), and 1,4-dioxane (1 mL) was heated to 110
0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap
column; 0-40% EtOAc/hexanes) to provide the title compound as a yellow oil (354 mg, 79%). 1H
NMR (300 MHz, CDC13) 6: 6.14 (d, J= 2.1 Hz, 2H), 6.02 (t, J = 2.1 Hz, 1H), 3.78 (s, 6H), 3.16
(m, 4H), 1.71 (m, 4H), 1.59 (m, 2H) ppm. 13C NMR (75 MHz, CDC13) 6: 161.7, 154.4, 95.6, 91.4,
55.3, 50.8, 26.1, 24.7 ppm. IR (neat, cm~'): 2934, 2851, 1594, 1461, 1203, 1152, 1127, 1072,
995, 817. Anal. Calcd. for C13H19NO2: C, 70.56; H, 8.65. Found: C, 70.75; H, 8.68.
N.NBu2
n-Bu
N,N,4-Tributylaniline.2 4 Following general procedure A, a mixture of 4-n-
butylchlorobenzene (338 tL, 2.0 mmol), dibutylamine (471 pL, 2.8 mmol), 3 (0.1 mol %),
RuPhos (0.1 mol %), NaOt-Bu (268 mg, 2.8 mmol), and 1,4-dioxane (1 mL) was heated to 110
0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap
column; 0-40% EtOAc/hexanes) to provide the title compound as a clear oil (456 mg, 87%). 1H
NMR (300 MHz, CDC13 ) 6: 7.19 (d, J = 8.7 Hz, 2H), 6.76 (d, J = 8.7 Hz, 2H), 3.40 (t, J = 7.5 Hz,
4H), 2.68 (t, J= 7.5 Hz, 2H), 1.72 (m, 6H), 1.53 (m, 6H), 1.13 (m, 9H) ppm. 13C NMR (75 MHz,
CDC13 ) 6: 146.7, 129.9, 129.4, 112.3, 51.4, 35.0, 34.5, 29.9, 22.8, 20.8, 14.4 ppm. IR (neat, cm~
1): 2930, 1617, 1520, 1465, 1368, 1285, 1218, 1189, 927, 805. Anal. Calcd. for C18H31N: C,
82.69; H, 11.95. Found: C, 82.50; H, 12.00.
MeO N
1-(3-Methoxyphenyl)-1 H-indole.25 Following general procedure B, a mixture of 3-
bromoanisole (126 pL, 1.0 mmol), indole (164 mg, 1.4 mmol), 3 (1 mol %), RuPhos (1 mol %),
Cs2 CO3 (456 mg, 1.4 mmol), and toluene (2 mL) was heated to 110 0C for 24 h. The crude
product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-40%
EtOAc/hexanes) to provide the title compound as a clear oil (221 mg, 99%). 1H NMR (300 MHz,
CDC13) 5: 7.86 (d, J = 8.1 Hz, 1 H), 7.78 (d, J = 7.8 Hz, 1 H), 7.49 (m, 2H), 7.36 (pentet, J = 8.1
Hz, 2H), 7.22 (m, 2H), 7.01 (d, J = 8.4 Hz, 1 H), 6.83 (d, J = 2.7 Hz, 1 H), 3.94 (s, 3H) ppm. 13C
NMR (75 MHz, CDCI3) 6: 160.9, 141.3, 136.2, 130.8, 129.8, 128.3, 122.8, 121.6, 120.8, 116.9,
112.3, 111.1, 110.5, 104.0, 55.8 ppm. IR (neat, cm-1 ): 2937, 2836, 1603, 1460, 1254, 1217,
1179, 1046, 742, 694. Anal. Calcd. for C 5H13NO: C, 80.69; H, 5.87. Found: C, 80.45; H, 6.11.
Me
N
t-Bu N
4-(tert-Butyl)-N-methyl-N-phenylaniline.9 Following general procedure B, a mixture of
4-tert-butylphenylmethanesulfonate (228 mg, 1.0 mmol), N-methylaniline (151 sL, 1.4 mmol), 3
(1 mol %), RuPhos (1 mol %), Cs 2CO3 (456 mg, 1.4 mmol), and t-BuOH (2 mL) was heated to
110 IC for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap
column; 0-40% EtOAc/hexanes) to provide the title compound as a clear oil (219 mg, 92%). 1H
NMR (300 MHz, CDC13) 6: 7.44 (d, J= 9.0 Hz, 2H), 7.36 (t, J= 7.2 Hz, 2H), 7.13 (m, 4H), 7.01
(t, J= 7.2 Hz, 1H), 3.41 (s, 3H), 1.46 (s, 9H) ppm. 13C NMR (75 MHz, CDC13 ) 6: 149.5, 146.7,
145.1, 129.4, 126.4, 121.6, 120.6, 119.3, 40.6, 34.6, 31.9 ppm. IR (neat, cm-1): 2962, 1596,
1513, 1497, 1363, 1343, 1256, 1134, 747, 696. Anal. Calcd. for C17H21N: C, 85.30; H, 8.84.
Found: C, 85.01; H, 8.98.
H
N Ph
MeO ./
N-(4-Methoxyphenyl)benzamide. 26 Following general procedure B, a mixture of 4-
chloroanisole (123 [tL, 1.0 mmol), benzamide (169 mg, 1.4 mmol), 3 (1 mol %), RuPhos (1 mol
%), K3P04 (297 mg, 1.4 mmol), and t-BuOH (2 mL) was heated to 110 0C for 24 h. The crude
product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-50%
EtOAc/hexanes) to provide the title compound as a white solid (187 mg, 82%), mp = 153 - 154
0C (lit. 154 - 155 0C). 'H NMR (500 MHz, CDC13) 6: 7.89 (bs, 1H), 7.86 (d, J= 7.0 Hz, 2H), 7.54
(m, 3H), 7.47 (m, 2H), 6.90 (d, J = 9.0 Hz, 2H), 3.82 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6:
156.8, 135.2, 131.9, 131.2, 129.0, 127.3, 122.4, 114.4, 55.8 ppm. IR (neat, cm~'): 1645, 1515,
1384, 1251, 1107, 1031, 824, 716, 692, 652. Anal. Calcd. for C14H13 NO2 : C, 73.99; H, 5.77.
Found: C, 74.18; H, 5.71.
Experimental Procedures for Examples Described in Table 2
General Procedure C: An oven-dried test tube, which was equipped with a magnetic
stir bar and fitted with a teflon septum, was charged with 2 (0.1 - 1 mol %), 3 (0.1 - 1 mol %)
and the base (1.4 equiv). The vessel was evacuated and backfilled with argon (this process
was repeated a total of 3 times) and then the aryl halide (1.0 equiv), amine (1.4 equiv), and
solvent (2 mL/mmol) were added via syringe (aryl chlorides and amines that were solids were
added with the catalyst and base). The solution was heated to 110 0C until the starting material
was completely consumed as monitored by GC. The reaction mixture was then cooled to room
temperature, concentrated in vacuo, and purified via the Biotage SP4.
H
EtON
0
Ethyl 4-(phenylamino)benzoate. 27 Following general procedure C, a mixture of
chlorobenzene (202 [tL, 0.5 mmol), etheyl 4-aminobenzoate (462 mg, 2.8 mmol), 3 (0.1 mol %),
RuPhos (0.1 mol %), Cs 2 CO3 (913 mg, 2.8 mmol), and t-BuOH (2 mL) was heated to 110 0C for
24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0 -
40% EtOAc/hexanes) to provide the title compound as a white solid (414 mg, 86%), mp = 109 -
111 *C. 'H NMR (300 MHz, CDC13) 6: 7.95 (d, J= 8.7 Hz, 2H), 7.34 (t, J= 8.4 Hz, 2H), 7.18 (d,
J = 7.8 Hz, 2H), 7.06 (t, J = 7.5 Hz, 1 H), 7.01 (d, J = 9.0 Hz, 2H), 6.30 (bs, 1 H), 4.35 (q, J = 7.2
Hz, 2H), 1.39 (t, J = 7.2 Hz, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 166.9, 148.4, 141.2, 131.7,
129.7, 123.2, 121.5, 120.5, 114.8, 60.8, 14.7 ppm. IR (neat, cm'): 3337, 1690, 1678, 1590,
1529,1339,1279,1174,753,695.
H
N N
N -N
N-(Pyrimidin-2-yl)quinolin-6-amine. Following general procedure C, a mixture of 6-
chloroquinoline (82 mg, 0.5 mmol), 2-aminopyrimidine (67 mg, 0.7 mmol), 3 (1 mol %), RuPhos
(1 mol %), Cs 2CO 3 (228 mg, 0.7 mmol), and t-BuOH (1 mL) was heated to 110 0C for 24 h. The
crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 50-100%
EtOAc/hexanes) to provide the title compound as a yellow solid (111 mg, 99%), mp = 150 - 152
C. 'H NMR (300 MHz, CDC13) 6: 8.77 (d, J = 2.4 Hz, 1 H), 8.48 (d, J = 4.8 Hz, 2H), 8.37 (s,
2H), 8.05 (m, 2H), 7.71 (d, J = 9.3 Hz, 1 H), 7.32 (m, 1 H), 6.77 (t, J = 4.5 Hz, 1 H) ppm. 13C NMR
(75 MHz, CDC13) 6: 160.3, 158.3, 148.8, 145.2, 137.8, 135.7, 130.2, 129.3, 124.1, 121.7, 114.5,
113.3 ppm. IR (neat, cm 1): 3270, 3038, 1581, 1539, 1501, 1448, 1412, 1224, 795, 730. Anal.
Calcd. for C13H10N4: C, 70.26; H, 4.54. Found: C, 70.37; H, 4.44.
H
NTN
N-(4-(Thiophen-2-yl)phenyl)pyrazin-2-amine. Following general procedure C, a
mixture of 2-(4-bromophenyl)thiophene (120 mg, 0.5 mmol), aminopyrazine (67 mg, 0.7 mmol),
3 (1 mol %), RuPhos (1 mol %), Cs 2CO3 (228 mg, 0.7 mmol), and t-BuOH (1 mL) was heated to
110 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap
column; 50-100% EtOAc/hexanes) to provide the title compound as a yellow solid (118 mg,
94%), mp = 167 - 170 OC. 1H NMR (300 MHz, CDC13) 6: 8.25 (d, J = 1.2 Hz, 1H), 8.14 (s, 1H),
8.01 (d, J= 2.7 Hz, 1 H), 7.61 (d, J = 8.7 Hz, 2H), 7.47 (d, J = 8.7 Hz, 2H), 7.26 (m, 2H), 7.07 (m,
1H), 6.62 (bs, 1H) ppm. 13C NMR (75 MHz, CDC13) 6: 142.2, 138.8, 135.4, 133.5, 129.9, 128.3,
127.1, 124.6, 122.8, 120.4 ppm. IR (neat, cm 1): 3226, 3022, 1601, 1558, 1458, 1436, 1200,
1008, 821, 711. Anal. Calcd. for C14H11N3S: C, 66.38; H, 4.38. Found: C, 66.65; H, 4.27.
HN N
N-(4-(1H-Pyrrol-1-yl)phenyl)pyridin-2-amine. Following general procedure C, a
mixture of 1-(4-chlorophenyl)-1H-pyrrole (177 mg, 1.0 mmol), 2-aminopyridine (113 mg, 1.2
mmol), 3 (1 mol %), RuPhos (1 mol %), CS2CO3 (228 mg, 0.7 mmol), and t-BuOH (1 mL) was
heated to 110 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50
g snap column; 50-100% EtOAc/hexanes) to provide the title compound as a brown solid (233
mg, 99%), mp = 135 - 137 *C. 'H NMR (300 MHz, DMSO) 6: 9.11 (s, 1H), 8.14 (s, 1 H), 7.75 (d,
J = 8.4 Hz, 2H), 7.54 (t, J =6.9 Hz, 1H), 7.42 (d, J = 8.4 Hz, 2H), 7.23 (s, 2H), 6.80 (d, J = 8.1
Hz, 1H), 6.72 (m, 1H), 6.20 (s, 2H) ppm. 13C NMR (75 MHz, DMSO) 6: 156.4, 147.9, 140.0,
137.9, 133.9, 120.7, 119.6, 119.4, 115.0, 111.4, 110.5 ppm. IR (neat, cm'1): 3046, 1608, 1542,
1524, 1461, 1443, 1322, 1071, 763, 718.
H
NI: 
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.' Me
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1-(4-(Benzo[b]thiophen-3-ylamino)phenyl)ethanone. Following general procedure C,
a mixture of 2-(4-bromophenyl)thiophene (120 mg, 0.5 mmol), aminopyrazine (67 mg, 0.7
mmol), 3 (1 mol %), RuPhos (1 mol %), Cs2CO3 (228 mg, 0.7 mmol), and t-BuOH (1 mL) was
heated to 110 OC for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50
g snap column; 50-100% EtOAc/hexanes) to provide the title compound as a yellow solid (118
mg, 94%), mp = 149 - 150 C. 'H NMR (300 MHz, CDCi3) 6: 7.85 (d, J= 8.7 Hz, 3H), 7.62 (d, J
= 7.2 Hz, 1 H), 7.38 (m, 2H), 7.21 (s, 1 H), 6.87 (d, J = 8.7 Hz, 2H), 6.21 (bs, 1 H), 2.52 (s, 3H)
ppm. 13C NMR (75 MHz, CDC13) 6: 149.9, 139.1, 135.0, 133.0, 130.9, 128.9, 125.4, 124.5,
123.5, 121.2, 115.2, 114.0, 26.4 ppm. IR (neat, cm 1): 3334, 1647, 1597, 1533, 1357, 1280,
1177, 827, 759, 727. Anal. Calcd. for C16H13NOS: C, 71.88; H, 4.90. Found: C, 71.43; H, 4.95.
H Me
0 2N N
'N N
Me
1,3-Dimethyl-N-(3-nitropheny)-1 H-pyrazol-5-amine. Following general procedure C, a
mixture of 3-nitrochlorobenzene (79 mg, 0.5 mmol), 1,3-dimethyl-1 H-pyrazol-5-amine (78 mg,
0.7 mmol), 3 (1 mol %), RuPhos (1 mol %), CS2CO3 (228 mg, 0.7 mmol), and t-BuOH (1 mL)
525
was heated to 110 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-
packed 50 g snap column; 20-100% EtOAc/hexanes) to provide the title compound as a yellow
solid (112 mg, 97%), mp = 123 - 124 OC. 1H NMR (300 MHz, CDC13) 6: 7.65 (d, J = 8.4 Hz,
1H), 7.54 (s, 1H), 7.34 (t, J= 8.4 Hz, 1H), 7.01 (d, J= 8.1 Hz, 1H), 6.20 (bs, 1H), 5.89 (s, 1H),
3.64 (s, 3H), 2.24 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 149.5, 148.1, 146.4, 139.5, 130.4,
120.1, 114.8, 108.9, 99.7, 34.9, 14.3 ppm. IR (neat, cm-1): 2940, 1622, 1595, 1560, 1531, 1484,
1342, 1317, 735, 672. Anal. Calcd. for C 1 H12N40 2 : C, 56.89; H, 5.21. Found: C, 56.73; H, 5.34.
H
N
EtO N
0
Ethyl 4-(pyridin-3-ylamino)benzoate. Following general procedure C, a mixture of ethyl
4-bromobenzoate (82 [tL, 0.5 mmol), 3-aminopyridine (66 mg, 0.7 mmol), 3 (1 mol %), RuPhos
(1 mol %), Cs 2 CO 3 (228 mg, 0.7 mmol), and t-BuOH (1 mL) was heated to 110 0C for 24 h. The
crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 20-100%
EtOAc/hexanes) to provide the title compound as a white solid (116 mg, 96%), mp = 142 - 145
*C. 'H NMR (300 MHz, CDC13) 6: 8.45 (s, 1H), 8.25 (d, J = 4.5 Hz, 1H), 7.92 (d, J = 8.4 Hz,
2H), 7.53 (d, J = 8.1 Hz, 1 H), 7.23 (m, 1 H), 7.01 (d, J = 8.4 Hz, 2H), 6.88 (bs, 1 H), 4.32 (q, J =
7.2 Hz, 2H), 1.35 (t, J = 7.2 Hz, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 166.7, 147.3, 143.6,
142.2, 138.4, 131.7, 126.4, 124.2, 122.5, 115.3, 60.9, 14.6 ppm. IR (neat, cm-1): 2993, 1700,
1609, 1577, 1485, 1332, 1273, 1174, 1106, 719. Anal. Calcd. for C14H14N202: C, 69.41; H, 5.82.
Found: C, 69.19; H, 5.93.
H
N
N-(2-(Furan-2-yl)ethyl)quinolin-2-amine. An oven-dried test tube, which was equipped
with a magnetic stir bar and fitted with a teflon septum, was charged with 2 (1 mol %), 3 (01 mol
%), and 2-chloroquinoline (82 mg, 0.7 mmol). The vessel was evacuated and backfilled with
argon (this process was repeated a total of 3 times) and then 2-(furan-2-yl)ethanamine (82 mg,
0.7 mmol) and a solution of LHMDS in THF (1 M, 0.7 mL, 0.7 mmol) were added via syringe.
The solution was heated to 110 0C for 24 h and then the reaction mixture was then cooled to
room temperature, diluted with ethyl acetate, washed with water, and concentrated in vacuo.
The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 20-100%
EtOAc/hexanes) to provide the title compound as a brown oil (116 mg, 97%). 1H NMR (300
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MHz, CDC13) 6: 7.50 (m, 2H), 7.56 (m, 2H), 7.36 (s, 1 H), 7.23 (t, J = 7.2 Hz, 1 H), 6.58 (d, J =
9.0 Hz, 1H), 6.32 (s, 1H), 6.11 (s, 1H), 4.95 (bs, 1H), 3.82 (q, J = 6.6 Hz, 2H), 3.02 (t, J = 6.6
Hz, 2H) ppm. 13C NMR (75 MHz, CDC13 ) 6: 156.9, 153.8, 148.3, 141.7, 137.5, 129.8, 127.7,
126.5, 123.7, 122.3, 111.9, 110.6, 106.6, 40.4, 28.5 ppm. IR (neat, cm'): 3425, 2926, 1619,
1526, 1401,1246,1145, 818, 756, 732.
Me
NC N
4-(Methyl(pyridin-2-yl)amino)benzonitrile. Following general procedure C, a mixture of
4-iodobenzonitrile (115 mg, 0.5 mmol), N-methylpyridin-2-amine (72 1tL, 0.7 mmol), 3 (1 mol %),
RuPhos (1 mol %), Cs2CO3 (228 mg, 0.7 mmol), and t-BuOH (1 mL) was heated to 110 0C for
24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 20-
100% EtOAc/hexanes) to provide the title compound as a clear oil (102 mg, 97%). 'H NMR (300
MHz, CDCl3) 6: 8.30 (d, J = 4.2 Hz, 1 H), 7.52 (m, 3H), 7.20, (d, J = 8.4 Hz, 2H), 6.94 (d, J = 8.4
Hz, 1H), 6.84 (m, 1H), 3.49 (s, 3H) ppm. 13C NMR (75 MHz, CDC13) 6: 157.8, 150.8, 148.7,
137.9, 133.5, 121.5, 119.6, 117.3, 113.5, 104.9, 38.1 ppm. IR (neat, cm'): 2221, 1607, 1587,
1509, 1473, 1439, 1352, 1178, 1116, 776. Anal. Calcd. for C13HjN 3: C, 74.62; H, 5.30. Found:
C, 74.18; H, 5.41.
N NPh2
F3CU
N, N-Diphenyl-5-(trifluoromethyl)pyridin-2-amine. Following general procedure C, a
mixture of 2-chloro-5-trifluoromethylpyridine (64 [tL, 0.5 mmol), diphenylamine (118 mg, 0.7
mmol), 3 (1 mol %), RuPhos (1 mol %), Cs2CO3 (228 mg, 0.7 mmol), and t-BuOH (1 mL) was
heated to 110 0C for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50
g snap column; 100% toluene) to provide the title compound as a clear oil (141 mg, 90%). 'H
NMR (300 MHz, CDC13) 6: 8.44 (s, 1 H), 7.59 (d, J = 8.7 Hz, 1 H), 7.39 (m, 4H), 7.23 (m, 6H),
6.72 (d, J = 8.7 Hz, 1H) ppm. 13C NMR (75 MHz, CDC13) 6: 161.0, 146.1, 146.0, 145.1, 134.6,
134.5, 130.2, 129.9, 127.3, 126.1, 122.7, 118.2, 117.8, 111.4 ppm (observed complexity due to
C-F splitting). 19C NMR (75 MHz, CDC13) 6: -61.8 ppm. IR (neat, cm-): 3042, 1593, 1493,
1400, 1325, 1165, 1120, 1079, 748, 692. Anal. Calcd. for C18H 3 N2F3: C, 68.78; H, 4.17. Found:
C, 69.08; H, 4.32.
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N-(Quinolin-6-yl)acetamide. " Following general procedure C, a mixture of quinolin-6-yl
trifluoromethanesulfonate (277 mg, 1.0 mmol), acetamide (83 mg, 1.4 mmol), 3 (1 mol %),
RuPhos (1 mol %), Cs 2CO3 (456 mg, 1.4 mmol), and t-BuOH (2 mL) was heated to 110 0C for
24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 20-
100% EtOAc/hexanes) to provide the title compound as a white solid (171 mg, 92%), mp = 121
- 124 *C. 1H NMR (300 MHz, CDC13) 6: 8.92 (s, 1H), 8.79 (s, 1H), 8.40 (s, 1H), 8.06 (d, J= 7.8
Hz, 1 H), 7.96 (d, J = 9.0 Hz, 1 H), 7.58 (d, J = 7.2 Hz, 1 H), 7.34 (m, 1 H), 2.22 (s, 3H) ppm. 13C
NMR (75 MHz, CDC13) 6: 169.5, 149.4, 145.5, 136.6, 136.3, 129.9, 129.1, 123.7, 121.9, 116.4,
24.8 ppm. IR (neat, cm-1): 3284, 1672, 1604, 1580, 1559, 1468, 1382, 1281, 834.
H
Me N
1 0
Me
N-(3,5-Dimethylphenyl)furan-2-carboxamide. Following general procedure C, a
mixture of 3,5-dimethyliodobenzene (72 [tL, 0.5 mmol), 2-furamide (78 mg, 0.7 mmol), 3 (1 mol
%), RuPhos (1 mol %), Cs 2CO3 (228 mg, 1.4 mmol), and t-BuOH (2 mL) was heated to 110 0C
for 24 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column;
20-100% EtOAc/hexanes) to provide the title compound as a white solid (103 mg, 96%), mp =
97 - 99 C. 1H NMR (300 MHz, CDC13) 6: 8.13 (bs, 1 H), 7.46 (m, 1 H), 7.30 (s, 2H), 7.20 (dd, J
= 0.6 Hz, J = 3.3 Hz, 1 H), 6.77 (s, 1 H), 6.51 (dd, J = 1.8 Hz, J = 3.6 Hz, 1 H), 2.30 (s, 6H) ppm.
13C NMR (75 MHz, CDC13 ) 6:156.4, 148.2, 144.4, 139.0, 137.5, 126.5, 118/0, 115.3, 112.8, 21.6
ppm. IR (neat, cm-1): 3304, 1655, 1616, 1585, 1544, 1473, 1294, 1187, 1011, 756.
Experimental Procedures for Examples Described in Figure 2
F3C 
N 
N
N-(4-(1H-Pyrrol-1-yl)phenyl)-N-phenyl-3-(trifluoromethyl)aniline. An oven-dried test
tube, which was equipped with a magnetic stir bar and fitted with a teflon septum, was charged
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with 2 (1 mol %), 3 (1 mol %), NaOt-Bu (240 mg, 2.5 mmol), and 1-(4-chlorophenyl)-1 H-pyrrole
(177 mg, 1.0 mmol). The vessel was evacuated and backfilled with argon (this process was
repeated a total of 3 times) and then 3-aminobenzotrifluoride (125 [tL, 1.0 mmol) and 1,4-
dioxane (2 mL) were added via syringe. The solution was heated to 110 0C for 15 min and then
chlorobenzene (102 [tL, 1.0 mmol) was added via syringe. The solution was heated for an
additional 1 h and then the reaction mixture was cooled to room temperature, diluted with ethyl
acetate, washed with water, and concentrated in vacuo. The crude product was purified via the
Biotage SP4 (silica-packed 50 g snap column; 0 - 40% EtOAc/hexanes) to provide the title
compound as a clear oil (346 mg, 92%). 1H NMR (300 MHz, CDC13) 6: 7.50 - 7.32 (m, 15H),
6.45 (t, J = 2.1 Hz, 2H) ppm. 13C NMR (75 MHz, CDC13) 6: 148.6, 148.4, 147.3, 145.0, 144.8,
137.2, 137.0, 132.7, 132.3, 131.8, 131.4, 130.3, 130.2, 130.1, 129.9, 126.2, 126.1, 126.0, 125.1,
124.3, 122.6, 122.1, 122.0, 119.7, 119.5, 119.4, 119.3, 119.0, 119.0, 118.9, 118.8, 110.9, 110.8
ppm. 19F NMR (300 MHz, CDC13) 6: -63.145. IR (neat, cm-1): 3044, 1590, 1517, 1489, 1328,
1127,1070,1020,726, 698.
t-Bu
F j NH2  Br Cl 1% Catalyst
t-Bu NaOt-Bu, dioxane110*C, 25 min F N
Figure 1b. An oven-dried test tube, which was equipped with a magnetic stir bar and
fitted with a teflon septum, was charged with ligand (1.0 mol %), precatalyst (1.0 mol %), and
NaOt-Bu (230 mg, 2.4 mmol). The vessel was evacuated and backfilled with argon (this process
was repeated a total of 3 times) and then 4-t-butylbromobenzene (173 tL, 1.0 mmol),
chlorobenzene (102 [tL, 1.0 mmol), 3-fluoroaniline (97 1tL, 1.0 mmol) and 1,4-dioxane (1 mL)
were added via syringe. The solution was heated to 110 0C for 25 min and then was cooled to
room temperature, diluted with ethyl acetate and washed with water. A known amount of
dodecane was added to the solution as an internal standard and then the reaction mixture was
analyzed via GC.
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N-(4-(tert-Butyl)phenyl)-3-fluoro-N-phenylaniline. An oven-dried test tube, which was
equipped with a magnetic stir bar and fitted with a teflon septum, was charged with 2 (1.0 mol
%), 3 (1.0 mol %), and NaOt-Bu (230 mg, 2.4 mmol). The vessel was evacuated and backfilled
with argon (this process was repeated a total of 3 times) and then 4-t-butylbromobenzene (173
[tL, 1.0 mmol), chlorobenzene (102 [tL, 1.0 mmol), 3-fluoroaniline (97 [tL, 1.0 mmol) and 1,4-
dioxane (1 mL) were added via syringe. The solution was heated to 110 0C for 25 min and then
the reaction mixture was cooled to room temperature, diluted with ethyl acetate, washed with
water, and concentrated in vacuo. The crude product was purified via the Biotage SP4 (silica-
packed 50 g snap column; 0 - 25% EtOAc/hexanes) to provide the title compound as a yellow
oil (318 mg, 99%). 1H NMR (300 MHz, CDCl3) 6: 7.36 (m, 4H), 7.15 (m, 6H), 6.87 (m, 2H), 6.70
(t, J= 8.4 Hz, 1H), 1.42 (s, 9H) ppm. 13C NMR (75 MHz, CDC13) 6: 165.4, 162.2, 150.2, 150.1,
147.7, 147.0, 144.8, 130.4, 130.2, 129.8, 129.7, 126.6, 125.3, 125.1, 123.6, 118.2, 118.1, 109.7,
109.4, 108.7, 108.4, 34.7, 31.8 ppm (observed complexity due to C-F splitting). 19F NMR (300
MHz, CDC13) 6: -112.5 ppm. IR (neat, cm-1): 2963, 1591, 1513, 1487, 1297, 1261, 1214, 1138,
757, 697.
Me
N 0
Me
N-(4-(1 H-Pyrrol-1-yl)phenyl)-N-phenyl-3-(trifluoromethyl)aniline.7c An oven-dried test
tube, which was equipped with a magnetic stir bar and fitted with a teflon septum, was charged
with 2 (0.2 mol %), 3 (0.2 mol %), NaOt-Bu (230 mg, 2.4 mmol), and benzidine (92 mg, 0.5
mmol). The vessel was evacuated and backfilled with argon (this process was repeated a total
of 3 times) and then 3-bromotoluene (121 tL, 1.0 mmol), chlorobenzene (102 [tL, 1.0 mmol),
and 1,4-dioxane (1 mL) were added via syringe. The solution was heated to 110 0C for 24 h and
then the reaction mixture was cooled to room temperature, diluted with ethyl acetate, washed
with water, and concentrated in vacuo. The crude product was purified via the Biotage SP4
(silica-packed 50 g snap column; 0 - 40% EtOAc/hexanes) to provide the title compound as a
white foam (253 mg, 98%). 'H NMR (300 MHz, CDCl3) 6: 7.54 (d, J = 8.7 Hz, 4H), 7.34 (t, J=
8.1 Hz, 4H), 7.23 (m, 10H), 7.80 (m, 6H), 6.95 (d, J = 7.5 Hz, 2H) ppm. 13C NMR (75 MHz,
CDC13 ) 6: 148.2, 148.0, 147.2, 139.5, 134.9, 129.6, 127.6, 125.5, 124.6, 124.4, 124.2, 123.0,
122.0, 21.8 ppm. IR (neat, cm 1 ): 3032, 1594, 1489, 1315, 1276, 1178, 909, 808, 734, 696.
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